Research

Richardson, S. H., Mackenzie, J., Thekkethil, N., Feng, L., Lee, J., Berry, C., Hill, N., Luo, X., Gao, H. (2024) Cardiac perfusion coupled with a structured coronary network tree. Computer Methods in Applied Mechanics and Engineering, 428, (doi: 10.1016/j.cma.2024.117083)

Conrad, N., Molenberghs, G., Verbeke, G., Zaccardi, F., Lawson, C., Friday, J. M., Su, H., Jhund, P. S., Sattar, N., Rahimi, K., Cleland, J. G., Khunti, K., Budts, W., McMurray, J. J.V. (2024) Temporal trends and patterns in cardiovascular disease incidence: a population-based study in 22 million individuals. British Medical Journal, 385, (doi: 10.1136/bmj-2023-078523)

Kondo, T., Campbell, R., Jhund, P. S., Anand, I. S., Carson, P. E., Lam, C. S.P., Shah, S. J., Vaduganathan, M., Zannad, F., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2024) Low natriuretic peptide levels and outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, (doi: 10.1016/j.jchf.2024.04.027)

Matsumoto, S., Henderson, A. D., Shen, L., Yang, M., Swedberg, K., Vaduganathan, M., van Veldhuisen, D. J., Solomon, S. D., Pitt, B., Zannad, F., Jhund, P. S., McMurray, J. J.V. (2024) Mineralocorticoid receptor antagonists in patients with heart failure and impaired renal function. Journal of the American College of Cardiology, 83, pp. 2426-2436. (doi: 10.1016/j.jacc.2024.03.426)

Friday, J. M., Cleland, J., Pellicori, P., Wolters, M., McMurray, J. J.V., Jhund, P. S., Forsyth, P., McAllister, D. A., Graham, F. J., Jones, Y., Lewsey, J. (2024) Loop diuretic utilisation with or without heart failure: impact on prognosis. European Heart Journal, (doi: 10.1093/eurheartj/ehae345)

Pellicori, P., Cuthbert, J. J., Clark, A. L., Cleland, J. G.F. (2024) Managing water and salt balance in heart failure – is there anything else to consider other than diet and diuretics? European Journal of Heart Failure,

Gök, C., Fuller, W. (2024) Rise of palmitoylation: a new trick to tune NCX1 activity. Biochimica et Biophysica Acta: Molecular Cell Research, 1871, (doi: 10.1016/j.bbamcr.2024.119719)

Loughrey, C. et al. (2024) A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic action: Pre-clinical and phase I study. British Journal of Pharmacology, (doi: 10.1111/bph.16379)

Kondo, T., Mogensen, U. M., Talebi, A., Gasparyan, S. B., Campbell, R. T., Docherty, K. F., de Boer, R. A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2024) Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF. Journal of the American College of Cardiology, 83, pp. 1973-1986. (doi: 10.1016/j.jacc.2024.03.385)

Chung, Y. J., Hoare, Z., Baark, F., Yu, C. S., Guo, J., Fuller, W., Southworth, R., Katschinski, D. M., Murphy, M. P., Eykyn, T. R., Shattock, M. J. (2024) Elevated Na is a dynamic and reversible modulator of mitochondrial metabolism in the heart. Nature Communications, 15, (doi: 10.1038/s41467-024-48474-z)

Curtain, J. P., Talebi, A., McIntosh, A., McConnachie, A., O’Donnell, J., Welsh, P., Osmanska, J., Lee, M. M.Y., Sonecki, P., Akl, T., Seo, J., Gopinathan, V., Hurwitz, J., Thiagarajan, S., Pettit, S., Kalra, P. R., Patel, R. K., Mark, P. B., Lang, N. N., McMurray, J. J.V., Petrie, M. C., Gardner, R. S., Jhund, P. S. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, (doi: 10.1002/ejhf.3290)

Yu, Y.-L. et al. (2024) Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart, (doi: 10.1136/heartjnl-2023-323796)

Carberry, J., Petrie, M. C., Lee, M. M.Y., Brooksbank, K., Campbell, R. T., Good, R., Jhund, P. S., Kellman, P., Lang, N. N., Mangion, K., Mark, P. B., McConnachie, A., McMurray, J. J.V., Meyer, B., Orchard, V., Shaukat, A., Watkins, S., Welsh, P., Sattar, N., Berry, C., Docherty, K. F. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, (doi: 10.1002/ehf2.14830)

Foà, A., Vaduganathan, M., Claggett, B. L., Pabon, M. A., Lu, H., Pfeffer, M. A., Packer, M., Vardeny, O., Rouleau, J. L., Lefkowitz, M., Mentz, R. J., Jhund, P. s., Desai, A. S., McMurray, J. J.V., Solomon, S. D. (2024) Sacubitril/Valsartan-related hypotension in patients with heart failure and preserved or mildly reduced ejection fraction. Journal of the American College of Cardiology, 83, pp. 1731-1739. (doi: 10.1016/j.jacc.2024.02.035)

Yang, M., Kondo, T., Talebi, A., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2024) Dapagliflozin and quality of life measured using the EuroQol 5-Dimension questionnaire in patients with HFrEF and HFmrEF/HFpEF. European Journal of Heart Failure, (doi: 10.1002/ejhf.3263)

McDowell, K., Kondo, T., Talebi, A., Teh, K., Bachus, E., de Boer, R. A., Campbell, R. T., Claggett, B., Desai, A. S., Docherty, K. F., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Simpson, J., Vaduganathan, M., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9, (doi: 10.1001/jamacardio.2024.0284)

Carberry, J., Marquis-Gravel, G., O’Meara, E., Docherty, K. F. (2024) Where are we with treatment and prevention of heart failure in patients post myocardial infarction? JACC: Heart Failure,

Olivera, S., Graham, D. (2024) Modelling pre-eclampsia and its cardiovascular effects. Nature Reviews Cardiology, 21, (doi: 10.1038/s41569-024-01006-0)

Cameron, A., Arnold, M., Katsas, G., Yang, J., Quinn, T. J., Abdul-Rahim, A. H., Campbell, R., Docherty, K., De Marchis, G. M., Arnold, M., Kahles, T., Nedeltchev, K., Cereda, C., Kaegi, G., Bustamante, A., Montaner, J., Ntaios, G., Foerch, C., Spanaus, K., Von Eckardstein, A., Dawson, J., Katan, M. (2024) Natriuretic peptides to classify risk of atrial fibrillation detection after stroke: analysis of the BIOSIGNAL and PRECISE cohort studies. Neurology,

Buendia, R., Karpefors, M., Folkvaljon, F., Hunter, R., Sillen, H., Luu, L., Docherty, K., Cowie, M. R. (2024) Wearable sensors to monitor physical activity in heart failure clinical trials: state-of-the-art review. Journal of Cardiac Failure, 30, pp. 703-716. (doi: 10.1016/j.cardfail.2024.01.016)

Butler, J. et al. (2024) Empagliflozin after acute myocardial infarction. New England Journal of Medicine, 390, pp. 1455-1466. (doi: 10.1056/NEJMoa2314051)

Cleland, J. G.F., Kalra, P. A., Pellicori, P., Graham, F. J., Foley, P. W.X., Squire, I. B., Cowburn, P. J., Seed, A., Clark, A. L., Szwejkowski, B., Banerjee, P., Cooke, J., Francis, M., Clifford, P., Wong, A., Petrie, C., McMurray, J. J.V., Thomson, E. A., Wetherall, K., Robertson, M., Ford, I., Kalra, P. R., the IRONMAN Study Group, (2024) Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. European Heart Journal, 45, pp. 1410-1426. (doi: 10.1093/eurheartj/ehae086)

Kosiborod, M. N. et al. (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes. New England Journal of Medicine, 390, pp. 1394-1407. (doi: 10.1056/NEJMoa2313917)

Rankin, S., Elyan, B., Jones, R., Venugopal, B., Mark, P. B., Lees, J. S., Petrie, M. C., Lang, N. N. (2024) Cardiovascular eligibility criteria and adverse event reporting in combined immune checkpoint and VEGF inhibitors trials. JACC: CardioOncology, 6, pp. 267-279. (doi: 10.1016/j.jaccao.2023.12.010)

Glen, C., Morrow, A., Roditi, G., Hopkins, T., Macpherson, I., Stewart, P., Petrie, M. C., Berry, C., Epstein, F., Lang, N. N., Mangion, K. (2024) Cardiovascular sequalae of trastuzumab and anthracycline in long-term survivors of breast cancer. Heart, 110, pp. 650-656. (doi: 10.1136/heartjnl-2023-323437)

Rastogi, T., Gargani, L., Pellicori, P., Lamiral, Z., Ambrosio, G., Bayés-Genis, A., Domingo, M., Lupon, J., Simonovic, D., Riccardo Pugliese, N., Ruocco, G., Duarte, K., Coiro, S., Palazzuoli, A., Girerd, N. (2024) Prognostic implication of lung ultrasound in heart failure: pooled analysis of international cohorts. European Heart Journal: Cardiovascular Imaging, (doi: 10.1093/ehjci/jeae099)

Hernandez, A. F. et al. (2024) Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial. Circulation, (doi: 10.1161/circulationaha.124.069217)

Collet, C. et al. (2024) A systematic approach to the evaluation of the coronary microcirculation using bolus thermodilution: CATH CMD. Journal of the Society for Cardiovascular Angiography and Interventions, (doi: 10.1016/j.jscai.2024.101934)

Butt, J., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2024) Dapagliflozin and timing of prior heart failure hospitalization a patient-level meta-analysis of DAPA-HF and DELIVER. JACC: Heart Failure, (doi: 10.1016/j.jchf.2024.01.018)

Sattar, N., Butler, J., Lee, M. M.Y., Harrington, J., Sharma, A., Zannad, F., Filippatos, G., Verma, S., Januzzi, J. L., Ferreira, J. P., Pocock, S. J., Pfarr, E., Ofstad, A. P., Brueckmann, M., Packer, M., Anker, S. D. (2024) Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: principal findings and meta-analysis with the DELIVER trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3221)

Udell, J. A. et al. (2024) Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction. Journal of the American College of Cardiology, (doi: 10.1016/j.jacc.2024.03.405)

Jackson, A. M., Goland, S., Farhan, H. A., Yaseen, I. F., Prameswari, H. S., Böhm, M., Jhund, P. S., Maggioni, A. P., van der Meer, P., Sliwa, K., Bauersachs, J., Petrie, M. C. (2024) A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry. European Heart Journal, 45, pp. 1430-1439. (doi: 10.1093/eurheartj/ehad888)

Yang, Y., Husmeier, D., Gao, H., Berry, C., Carrick, D., Radjenovic, A. (2024) Automatic detection of myocardial ischaemia using generalisable spatio-temporal hierarchical Bayesian modelling of DCE-MRI. Computerized Medical Imaging and Graphics, 113, (doi: 10.1016/j.compmedimag.2024.102333)

Peikert, A., Bart, B. A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Kosiborod, M. N., Desai, A. S., Jhund, P. S., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J. V., Solomon, S. D., Vardeny, O. (2024) Contemporary use and implications of beta-blockers in patients with HFmrEF or HFpEF: the DELIVER Trial. JACC: Heart Failure, 12, pp. 631-644. (doi: 10.1016/j.jchf.2023.09.007)

Peikert, A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Foà, A., Desai, A. S., Jhund, P. S., Carberry, J., Lam, C. S.P., Kosiborod, M. N., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Køber, L., Ponikowski, P., Sabatine, M. S., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2024) Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA-HF and DELIVER. European Journal of Heart Failure, 26, pp. 912-924. (doi: 10.1002/ejhf.3184)

Kemi, O. J., Hoydal, M. A., Haram, P. M., Smith, G. L., Ellingsen, O., Koch, L. G., Britton, S. L., Wisloff, U. (2024) Inherited physical capacity: Widening divergence from young to adult to old. Annals of the New York Academy of Sciences, 1534, pp. 145-155. (doi: 10.1111/nyas.15130)

Docherty, K. F., McMurray, J. J.V., Kalra, P., Cleland, J. G.F., Lang, N. N., Petrie, M. C., Robertson, M., Ford, I. (2024) Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction. ESC Heart Failure, (doi: 10.1002/ehf2.14742)

Li, C., Wu, J., Lin, J., Wu, Y., Xu, R., Quian, J., Hau, W. K., Barbato, E., Johnson, N. J., Hennigan, B., Berry, C., Oldroyd, K. G., Song, L., Ge, J. (2024) Validation of a new non-hyperemic physiological index: the constant-resistance ratio (cRR) Journal of Invasive Cardiology, (doi: 10.25270/jic/24.00047)

Kobayashi, M., Ferreira, J. P., Kevin, D., Bresso, E., Huttin, O., Bozec, E., Brunner La Rocca, H.-P., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A.J., Rossignol, P., Cleland, J. G.F., Zannad, F., Girerd, N. (2024) Proteomic profiles of left atrial volume and its influence on response to spironolactone: findings from the HOMAGE trial and STANISLAS cohort. European Journal of Heart Failure, (doi: 10.1002/ejhf.3202)

Abraham, G. R., Berry, C., Fu, Q., Hoole, S. P., Weir-McCall, J. R. (2024) Differences in quantitative myocardial perfusion mapping by CMR at 1.5 T and 3 T. American Heart Journal Plus: Cardiology Research and Practice, 41, (doi: 10.1016/j.ahjo.2024.100388)

Savarese, G., Lindberg, F., Christodorescu, R. M., Ferrini, M., Kumler, T., Toutoutzas, K., Dattilo, G., Bayes-Genis, A., Moura, B., Amir, O., Petrie, M. C., Seferovic, P., Chioncel, O., Metra, M., Coats, A. J.S., Rosano, G. M.C. (2024) Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice. European Journal of Heart Failure, (doi: 10.1002/ejhf.3214)

Bai, M., Gallen, E., Memarzadeh, S., Howie, J., GAO, X., Kuo, C.-W. S., Brown, E., Swingler, S., Wilson, S. J., Shattock, M. J., France, D. J., Fuller, W. (2024) Targeted degradation of zDHHC-PATs decreases substrate S -palmitoylation. PLoS ONE, 19, (doi: 10.1371/journal.pone.0299665)

Knigge, P., Lundberg, S., Strange, J. E., Malik, M. E., Nouhravesh, N., Wagner, A. K., Gislason, G., Fosbøl, E. L., Carlson, N., Zahir, D., Andersson, C., Butt, J. H., Jhund, P., Petrie, M. C., McMurray, J. J.V., Køber, L., Schou, M. (2024) Temporal trends in the initiation of dialysis among patients with heart failure with or without diabetes: a nationwide study from 2002 to 2016. Journal of the American Heart Association, 13, (doi: 10.1161/JAHA.123.032539)

Ashford, F., Kuo, C.-W., Dunning, E., Brown, E., Calagan, S., Jayasinghe, I., Henderson, C., Fuller, W., Wypijewski, K. (2024) Cysteine post-translational modifications regulate protein interactions of caveolin-3. FASEB Journal, 38, (doi: 10.1096/fj.202201497RR)

Campbell, P., Rutten, F. H., Lee, M. M. Y., Hawkins, N. M., Petrie, M. C. (2024) Heart failure with preserved ejection fraction: Everything the clinician needs to know. Lancet, 403, pp. 1083-1092. (doi: 10.1016/S0140-6736(23)02756-3)

Cleland, J. G.F. (2024) Nature and magnitude of the benefits of dapagliflozin and empagliflozin for heart failure. Circulation, 149, pp. 839-842. (doi: 10.1161/circulationaha.123.068089)

Astrauskaite, G., Mohanan, S., Williamson, L., Boland, E., Huethorst, E., Kinegawa, R., Smith, G., Muellenbroich, C. (2024) Remote Focusing for 2-photon Microscopy to Follow Action Potential Propagation Transmurally in Acute Rabbit Cardiac Slices. (doi: 10.1117/12.3002956)

Kite, T. A. et al. (2024) Complex percutaneous coronary intervention in patients unable to undergo coronary artery bypass grafting during the COVID-19 pandemic: insights from the UK-ReVasc Registry. Journal of Invasive Cardiology, (doi: 10.25270/jic/24.00030)

Ang, D. T.Y., Carrick, D., Kamdar, A., Sykes, R., McGeoch, R. J., Collison, D., McConnachie, A., Berry, C. (2024) Intracoronary adenosine derived coronary flow reserve and index of microvascular resistance. Circulation: Cardiovascular Interventions,

Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Anand, I. S., Desai, A. S., Fang, J. C., Hernandez, A. F., Jhund, P. S., Kosiborod, M. N., Sabatine, M. S., Shah, S. J., Vardeny, O., McMurray, J. J. V., Solomon, S. D., Gaziano, T. A. (2024) Cost effectiveness of dapagliflozin for heart failure across the spectrum of ejection fraction: an economic evaluation based on pooled, individual participant data from the DELIVER and DAPA-HF trials. Journal of the American Heart Association, 13, (doi: 10.1161/JAHA.123.032279)

Grobbee, D. E., Filippatos, G., Desai, N. R., Coats, A. J.S., Pinto, F., Rosano, G. M.C., Cleland, J., Kammerer, J., Ramirez de Arellano, A. (2024) Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Failure, (doi: 10.1002/ehf2.14661)

Cleland, J. G.F., Pellicori, P., Lakhal-Littleton, S. (2024) Low serum ferritin might predict incident heart failure but why and is it clinically useful? JACC: Heart Failure, 12, pp. 549-551. (doi: 10.1016/j.jchf.2023.12.012)

Freeman, M., Huethorst, E., Boland, E., Dunne, M., Burton, F., Denning, C., Myles, R., Smith, G. (2024) A novel method for the percutaneous induction of myocardial infarction by occlusion of small coronary arteries in the rabbit. American Journal of Physiology: Heart and Circulatory Physiology, 326, pp. H735--H751. (doi: 10.1152/ajpheart.00657.2023)

Sliwa, K., van der Meer, P., Viljoen, C., Jackson, A. M., Petrie, M. C., Mebazaa, A., Hilfiker-Kleiner, D., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Tavazzi, L., Roos-Hesselink, J. W., Hamdan, R., Frogoudaki, A., Ibrahim, B., Farhan, H. A. F., Mbakwem, A., Seferovic, P., Böhm, M., Pieske, B., Johnson, M. R., Bauersachs, J. (2024) Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry. International Journal of Cardiology, 398, (doi: 10.1016/j.ijcard.2023.131596)

Olowoyo, P. et al. (2024) ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa. Journal of Human Hypertension, 38, pp. 193-199. (doi: 10.1038/s41371-024-00903-8)

Butt, J. H., Jering, K., de Boer, R. A., Claggett, B. L., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Jhund, P. S., Køber, L., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Shah, S. J., Vaduganathan, M., Langkilde, A. M., Bengtsson, O., Petersson, M., Sjöstrand, M., McMurray, J. J.V. (2024) Heart failure, investigator-reported sleep apnea and dapagliflozin: A patient-level pooled meta-analysis of DAPA-HF and DELIVER. Journal of Cardiac Failure, 30, pp. 436-448. (doi: 10.1016/j.cardfail.2023.08.027)

Deo, S. V., Al-Kindi, S., Motairek, I., McAllister, D., Shah, A. S.V., Elgudin, Y. E., Gorodeski, E. Z., Virani, S., Petrie, M. C., Rajagopalan, S., Sattar, N. (2024) Impact of residential social deprivation on prediction of heart failure in patients with type 2 diabetes: External validation and recalibration of the WATCH-DM score using real world data. Circulation: Cardiovascular Quality and Outcomes, 17, pp. 267-276. (doi: 10.1161/circoutcomes.123.010166)

Sykes, R., Hanna, R., Berry, C. (2024) Prognostic importance of fractional flow reserve and left ventricular systolic dysfunction after percutaneous coronary intervention. JACC: Asia, 4, pp. 241-243. (doi: 10.1016/j.jacasi.2023.12.002)

Bosserdt, M. et al. (2024) Age and computed tomography and invasive coronary angiography in stable chest pain: a prespecified secondary analysis of the discharge randomized clinical trial. JAMA Cardiology, 9, pp. 346-356. (doi: 10.1001/jamacardio.2024.0001)

Rudd, A. E., Horgan, G., Khan, H., Gamble, D. T., McGowan, J., Sood, A., McGeoch, R., Irving, J., Watt, J., Leslie, S. J., Petrie, M., Lang, C., Mills, N. L., Newby, D. E., Dawson, D. K. (2024) Cardiovascular and noncardiovascular prescribing and mortality after takotsubo comparison with myocardial infarction and general population. JACC: Advances, 3, (doi: 10.1016/j.jacadv.2023.100797)

Osmanska, J., Petrie, M. C., Campbell, R. T. (2024) Reply: subcutaneous furosemide patch: heart failure decongestion "from the comfort of your home" European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvae015)

Mellbin, L. G., Bhatt, D. L., David, J.-P., Ekström, K., Petrie, M. C., Rasmussen, S., Vilsbøll, T. (2024) Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials. European Heart Journal, 45, pp. 1371-1374. (doi: 10.1093/eurheartj/ehae028)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, (doi: 10.1038/s43856-024-00455-5)

Kelham, M., Vyas, R., Rameseshan, R., Rathod, K., de Winter, R.J., de Winter, R.W., Bendz, B., Thiele, H., Hirlekar, G., Morici, N., Myat, A., Michalis, L., Sanchis, J., Kunadian, V., Berry, C., Mathur, A., Jones, D. (2024) 100.03 Routine Invasive Versus Conservative Management of Non-ST Elevation Acute Coronary Syndromes in Patients With Previous Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. (doi: 10.1016/j.jcin.2024.01.082)

Pellicori, P., Felker, G. M., Cleland, J. G.F. (2024) Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’ European Journal of Heart Failure, 26, pp. 528-528. (doi: 10.1002/ejhf.3159)

Friedman, D. J., Olivas-Martinez, A., Dalgaard, F., Fudim, M., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Ali-Ahmed, F., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Relationship between sex, body size, and cardiac resynchronization therapy benefit: a patient level meta-analysis of randomized controlled trials. Heart Rhythm, (doi: 10.1016/j.hrthm.2024.01.058)

UK HFpEF Collaborative Group, , , (2024) Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry. Heart, 110, pp. 359-365. (doi: 10.1136/heartjnl-2023-323049)

Black, N., Bradley, J., Lewis, G., Lagan, J., Orsborne, C., Soltani, F., Farrant, J. P., McDonagh, T., Schmitt, M., Cavalcante, J. L., Ugander, M., Butler, J., Petrie, M. C., Miller, C. A., Schelbert, E. B. (2024) Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials. medRxiv, (doi: 10.1101/2024.02.07.24302443)

Lakhal-Littleton, S., Cleland, J. G. F. (2024) Iron deficiency and supplementation in heart failure. Nature Reviews Cardiology, (doi: 10.1038/s41569-024-00988-1)

Wang, X., Lam, C. S.P., Vaduganathan, M., Kondo, T., Yang, M., Han, Y., Pham, V. N., Chiang, C.-E., Kitakaze, M., Miao, Z. M., Jhund, P. S., Desai, A. S., Inzucchi, S. E., de Boer, R. A., Martinez, F. A., Kosiborod, M. N., Hernandez, A. F., Claggett, B., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2024) Effects of dapagliflozin in patients in Asia: a post hoc subgroup analysis from the DELIVER trial. JACC: Asia, 4, pp. 108-118. (doi: 10.1016/j.jacasi.2023.10.005)

Goldie, F. C., Lee, M. M. Y., Coats, C. J., Nordin, S. (2024) Advances in multi-modality imaging in hypertrophic cardiomyopathy. Journal of Clinical Medicine, 13, (doi: 10.3390/jcm13030842)

Ammirati, E., Marchetti, D., Colombo, G., Pellicori, P., Gentile, P., D’Angelo, L., Masciocco, G., Verde, A., Macera, F., Brunelli, D., Occhi, L., Musca, F., Perna, E., Bernasconi, D. P., Moreo, A., Camici, P., Metra, M., Oliva, F., Garascia, A. (2024) Estimation of right atrial pressure by ultrasound-assessed jugular vein distensibility in patients with heart failure. Circulation: Heart Failure, 17, (doi: 10.1161/CIRCHEARTFAILURE.123.010973)

Butt, J. H., McDowell, K., Kondo, T., Desai, A. S., Lefkowitz, M. P., Packer, M., Petrie, M. C., Pfeffer, M. A., Rouleau, J. L., Vaduganathan, M., Zile, M. R., Jhund, P. S., Køber, L., Solomon, S., McMurray, J. J.V. (2024) Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan. ESC Heart Failure, 11, pp. 65-77. (doi: 10.1002/ehf2.14558)

Olowoyo, P. et al. (2024) Priorities to reduce the burden of hypertension in Africa through ACHIEVE. Lancet Global Health, 12, pp. e192-e193. (doi: 10.1016/S2214-109X(23)00540-5)

Pellicori, P., Cleland, J. G.F. (2024) Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good? European Journal of Heart Failure, (doi: 10.1002/ejhf.3148)

Omerovic, E., Petrie, M., Redfors, B., Fremes, S., Murphy, G., Marquis-Gravel, G., Lansky, A., Velazquez, E., Perera, D., Reid, C., Smith, J., van der Meer, P., Lipsic, E., Juni, P., McMurray, J., Bauersachs, J., Køber, L., Rouleau, J. L., Doenst, T. (2024) Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-pragmatic research and innovation through multinational experimentation. Trials, 25, (doi: 10.1186/s13063-024-07935-y)

Petrie, M. C., Rouleau, J. L., Claggett, B., Jering, K., van der Meer, P., Køber, L., Miao, Z. M., Lewis, E., Granger, C., De Pasqulae, C. G., Mann, D., Steg, P. G., Maggioni, A., Amir, O., Lefkowitz, M., Braunwald, E., Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A. (2024) Pulmonary congestion and left ventricular dysfunction after myocardial infarction: insights from the PARADISE-MI trial. Circulation, 149, pp. 335-38. (doi: 10.1161/CIRCULATIONAHA.123.066163)

Mary, S., Conti-Ramsden, F., Boder, P., Parveen, H., Setjiadi, D., Fleminger, J., Brockbank, A., Graham, D., Bramham, K., Chappell, L. C., Delles, C. (2024) Pregnancy-associated changes in urinary uromodulin excretion in chronic hypertension. Journal of Nephrology, (doi: 10.1007/s40620-023-01830-6)

Howie, J., Tulloch, L. B., Brown, E., Reilly, L., Ashford, F. B., Kennedy, J., Wypijewski, K. J., Aughton, K. L., Mak, J. K.C., Shattock, M. J., Fraser, N. J., Fuller, W. (2024) Glutathione-dependent depalmitoylation of phospholemman by peroxiredoxin 6. Cell Reports, 43, (doi: 10.1016/j.celrep.2024.113679)

Kosiborod, M. N., Verma, S., Borlaug, B. A., Butler, J., Davies, M. J., Jon Jensen, T., Rasmussen, S., Erlang Marstrand, P., Petrie, M. C., Shah, S. J., Ito, H., Schou, M., Melenovský, V., Abhayaratna, W., Kitzman, D. W., STEP-HFpEF Trial Committees and Investigators, (2024) Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial. Circulation, 149, pp. 204-216. (doi: 10.1161/circulationaha.123.067505)

Cuthbert, J. J., Brown, O. I., Pellicori, P., Dobbs, K., Bulemfu, J., Kazmi, S., Sokoreli, I., Pauws, S. C., Riistama, J. M., Cleland, J. G.F., Clark, A. L. (2024) Medicines optimization prior to discharge in patients admitted to hospital with heart failure. ESC Heart Failure, (doi: 10.1002/ehf2.14638)

Pellicori, P., Hunter, D., Khin, H. H. E., Cleland, J. G.F. (2024) How to diagnose and treat venous congestion in heart failure. European Heart Journal, (doi: 10.1093/eurheartj/ehad883)

Pellicori, P., Cleland, J. G.F. (2024) Atrial myopathy and HFpEF - when a label does more harm than good. European Journal of Heart Failure,

Sidik, N. P., Stanley, B., Sykes, R., Morrow, A. J., Bradley, C. P., Mcdermott, M., Ford, T., Roditi, G., Hargreaves, A., Stobo, D., Adams, J., Byrne, J., Mahrous, A., Young, R., Carrick, D., McGeoch, R., Corcoran, D., Lang, N. N., Heggie, R., Wu, O., McEntegart, M. B., McConnachie, A., Berry, C. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149, pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751)

Osmanska, J., Brooksbank, K., Docherty, K. F., Robertson, S., Wetherall, K., McConnachie, A., Hu, J., Gardner, R. S., Clark, A. L., Squire, I. B., Kalra, P. R., Jhund, P. S., Muntendam, P., McMurray, J. J.V., Petrie, M. C., Campbell, R. T. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073)

Zeitler, E. P., Dalgaard, F., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Friedman, D. J., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis. American Heart Journal, 267, pp. 81-90. (doi: 10.1016/j.ahj.2023.11.002)

Cleland, J. G. F. (2024) Defining iron deficiency in patients with heart failure. Nature Reviews Cardiology, 21, pp. 1-2. (doi: 10.1038/s41569-023-00951-6)

Lee, M. M.Y., Kondo, T., Campbell, R. T., Petrie, M. C., Sattar, N., Solomon, S. D., Vaduganathan, M., Jhund, P. S., McMurray, J. J.V. (2024) Effects of Renin-Angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomised controlled trials. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 68-80. (doi: 10.1093/ehjcvp/pvad067)

Chivardi, C. et al. (2024) Percutaneous revascularization for ischemic left ventricular dysfunction: Cost-effectiveness analysis of the REVIVED-BCIS2 trial. Circulation: Cardiovascular Quality and Outcomes, 17, (doi: 10.1161/circoutcomes.123.010533)

McFall, A., Graham, D., Nicklin, S. A., Work, L. M. (2024) Unscheduled changes in pre-clinical stroke model housing contributes to variance in physiological and behavioural data outcomes: a post hoc analysis. Brain and Neuroscience Advances, 8, (doi: 10.1177/23982128241238934)

Monzo, L., Girerd, N., Ferreira, J. P., Lamiral, Z., Anker, S. D., Cleland, J. G. F., Kondo, T., McMurray, J. J. V., Lam, C. S. P., Mehra, M. R., van Veldhuisen, D. J., Greenberg, B., Zannad, F. (2024) High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm: risk prediction score analysis from the COMMANDER-HF trial. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2023.11.020)

Caiazzo, E., Sharma, M., Rezig, A. O.M., Morsy, M. I., Czesnikiewicz-Guzik, M., Ialenti, A., Sulicka-Grodzicka, J., Pellicori, P., Crouch, S. H., Schutte, A. E., Bruzzese, D., Maffia, P., Guzik, T. J. (2023) Circulating cytokines and risk of developing hypertension: a systematic review and meta-analysis. Pharmacological Research, 200, (doi: 10.1016/j.phrs.2023.107050)

Lee, M. M.Y., Lean, M. E.J., Sattar, N., Petrie, M. C. (2023) Appetite and its regulation: Are there palatable interventions for heart failure? Current Heart Failure Reports, 21, pp. 1-4. (doi: 10.1007/s11897-023-00637-7)

Kosiborod, M. N., Borlaug, B. A., Petrie, M. C. (2023) Semaglutide and heart failure with preserved ejection fraction and obesity. Reply. New England Journal of Medicine, 389, pp. 2398-2399. (doi: 10.1056/NEJMc2312296)

Brum, W. S., Docherty, K. F., Ashton, N. J., Zetterberg, H., Hansson, O., McMurray, J. J. V., Blennow, K. (2023) Effect of neprilysin inhibition on Alzheimer disease plasma biomarkers: a secondary analysis of a randomized clinical trial. JAMA Neurology, (doi: 10.1001/jamaneurol.2023.4719)

Ostrominski, J. W., Vaduganathan, M., Selvaraj, S., Claggett, B. L., Miao, Z. M., Desai, A. S., Jhund, P. S., Kosiborod, M. N., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Maria Langkilde, A., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: The DELIVER trial. Circulation, 148, pp. 1945-1957. (doi: 10.1161/CIRCULATIONAHA.123.065254)

Freeman-Jones, E., Miller, W. H., Work, L. M., Fullerton, J. L. (2023) Polypathologies and animal models of traumatic brain injury. Brain Sciences, 13, (doi: 10.3390/brainsci13121709)

Welsh, P., Kimenai, D. M., Shah, A. S.V., Gadd, D. A., Marioni, R. E., Woodward, M., Sudlow, C. L.M., Campbell, A., Cleland, J. G.F., Pellicori, P., Hayward, C., Mills, N. L., Sattar, N. (2023) Multiple cardiac biomarkers to improve prediction of cardiovascular events: findings from the Generation Scotland Scottish Family Health Study. Clinical Chemistry, 70, pp. 403-413. (doi: 10.1093/clinchem/hvad205)

McMurray, J. J.V., Docherty, K. F., de Boer, R. A., Hammarstedt, A., Kitzman, D. W., Kosiborod, M. N., Langkilde, A. M., Reicher, B., Senni, M., Shah, S. J., Wilderäng, U., Verma, S., Solomon, S. D. (2023) Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials. Circulation, (doi: 10.1161/CIRCULATIONAHA.123.065061)

Lyon, M., Fullerton, J. L., Kennedy, S., Work, L. M. (2023) Hypertension & dementia: pathophysiology & potential utility of antihypertensives in reducing disease burden. Pharmacology and Therapeutics, (doi: 10.1016/j.pharmthera.2023.108575)

Lee, M. M.Y., Masri, A. (2023) Correction to: Differentiating cardiac troponin levels during cardiac myosin inhibition or cardiac myosin activation treatments: drug effect or the canary in the coal mine? Current Heart Failure Reports, (doi: 10.1007/s11897-023-00639-5)

Connelly, P., Osmanska, J., Lee, M. M.Y., Delles, C., McEntegart, M. B., Byrne, J. (2023) A case report of myocardial infarction in a young transgender man with testosterone therapy? raising awareness on healthcare issues in the transgender community and a call for further research. European Heart Journal: Case Reports, 7, (doi: 10.1093/ehjcr/ytad562)

Vardeny, O., Fang, J. C., Desai, A. S., Jhund, P. S., Claggett, B., Vaduganathan, M., de Boer, R. A., Hernandez, A. F., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., Kosiborod, M. N., DeMets, D., O’Meara, E., Zieroth, S., Comin-Colet, J., Drozdz, J., Chiang, C.-E., Kitakaze, M., Petersson, M., Lindholm, D., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature Medicine, 29, pp. 3269-3269. (doi: 10.1038/s41591-023-02302-x)

Matsumoto, S., Kondo, T., Yang, M., Campbell, R. T., Docherty, K. F., de Boer, R. A., Desai, A. S., Lam, C. S.P., Packer, M., Pitt, B., Rouleau, J. L., Vaduganathan, M., Zannad, F., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2023) Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Journal of Heart Failure, 25, pp. 2202-2214. (doi: 10.1002/ejhf.3044)

McErlane, J., McCall, P., Willder, J., Berry, C., Shelley, B. (2023) Cardiac biomarkers and right ventricular dysfunction are independently associated with one year mortality in patients with COVID-19 receiving mechanical ventilation: a prospective cohort study. CHEST Critical Care, 1, (doi: 10.1016/j.chstcc.2023.100015)

Lee, M. M. Y., Masri, A. (2023) Differentiating cardiac troponin levels during cardiac myosin inhibition or cardiac myosin activation treatments: drug effect or the canary in the coal mine? Current Heart Failure Reports, 20, pp. 504-518. (doi: 10.1007/s11897-023-00620-2)

Kondo, T., Butt, J. H., Curtain, J. P., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2023) Efficacy of dapagliflozin according to heart rate: A patient-level pooled analysis of DAPA-HF and DELIVER. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.123.010898)

Da Silva Costa, A., Ghouri, I., Johnston, A., Mcglynn, K., McNair, A., Bowman, P., Malik, N., Hurren, J., Bingelis, T., Dunne, M., Smith, G. L., Kemi, O. J. (2023) Electrically stimulated in vitro heart cell mimic of acute exercise reveals novel immediate cellular responses to exercise: Reduced contractility and metabolism, but maintained calcium cycling and increased myofilament calcium sensitivity. Cell Biochemistry and Function, 41, pp. 1147-1161. (doi: 10.1002/cbf.3847)

Bhatt, A. S., Kosiborod, M. N., Claggett, B. L., Miao, Z. M., Vaduganathan, M., Lam, C. S. P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Jhund, P. S., Desai, A. S., Fang, J. C., Han, Y., Comin‐Colet, J., Drożdż, J., Vardeny, O., Merkely, B., Lindholm, D., Peterson, M., Langkilde, A. M., McMurray, J. J. V., Solomon, S. D. (2023) Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial. European Journal of Heart Failure, 25, pp. 2177-2188. (doi: 10.1002/ejhf.3043)

Zahir Anjum, D., Strange, J. E., Fosbøl, E., Garred, C. H., Malik, M. E., Andersson, C., Jhund, P. S., McMurray, J. J.V., Petrie, M. C., Kober, L., Schou, M. (2023) Initiation of medical therapy for heart failure patients according to kidney function: a Danish nationwide study. Clinical Epidemiology, 15, pp. 855-866. (doi: 10.2147/clep.s412787)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7, pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Chatur, S., Vaduganathan, M., Claggett, B. L., Cunningham, J. W., Docherty, K. F., Desai, A. S., Jhund, P. S., De Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Petersson, M., Langkilde, A.-M., McMurray, J. J. V., Solomon, S. D. (2023) Outpatient worsening among patients with mildly reduced and preserved ejection fraction heart failure in the DELIVER trial. Circulation, 148, pp. 1735-1745. (doi: 10.1161/circulationaha.123.066506)

Pellicori, P., Cleland, J. G.F., Borentain, M., Taubel, J., Graham, F., Khan, J., Bruzzese, D., Kessler, P., McMurray, J. J.V., Voors, A. A., O’Connor, C. M., Teerlink, J. R., Felker, G. M. (2023) Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS‐986231) European Journal of Heart Failure, (doi: 10.1002/ejhf.3077)

Mc Causland, F. R., Claggett, B. L., Vaduganathan, M., Desai, A., Jhund, P., Vardeny, O., Fang, J. C., de Boer, R. A., Docherty, K. F., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Saraiva, J. F. K., McGrath, M. M., Shah, S. J., Verma, S., Langkilde, A. M., Petersson, M., McMurray, J. J. V., Solomon, S. D. (2023) Decline in estimated glomerular filtration rate after dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: A prespecified secondary analysis of the DELIVER randomized clinical trial. JAMA Cardiology, 9, pp. 144-152. (doi: 10.1001/jamacardio.2023.4664)

McDowell, K., Adamson, C., Jackson, C., Campbell, R., Welsh, P., Petrie, M. C., McMurray, J. J.V., Jhund, P., Herring, N. (2023) Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes. European Journal of Heart Failure, (doi: 10.1002/ejhf.3085)

Chatur, S., Vaduganathan, M., Claggett, B. L., Mc Causland, F. R., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Shah, S. J., Sabatine, M. S., Kober, L., Ponikowski, P., Merkely, B., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin in patients with heart failure and deterioration in renal function. Journal of the American College of Cardiology, 82, pp. 1854-1863. (doi: 10.1016/j.jacc.2023.08.026)

Ostrominski, J. W., Thierer, J., Claggett, B. L., Miao, Z. M., Desai, A. S., Jhund, P. S., Kosiborod, M. N., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Cardio-renal-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. JACC: Heart Failure, 11, pp. 1491-1503. (doi: 10.1016/j.jchf.2023.05.015)

Ray, R., Ford, I., Cleland, J. G.F., Graham, F., Ahmed, F. Z., Al-Mohammad, A., Cowburn, P. J., Critoph, C., Kalra, P. A., Lane, R. E., Ludman, A., Pellicori, P., Petrie, M. C., Robertson, M., Seed, A., Squire, I., Kalra, P. R. (2023) The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2023.10.006)

Ostrominski, J. W., Claggett, B. L., Packer, M., Pfeffer, M. A., Lam, C. S.P., Zile, M. R., Desai, A. S., Jhund, P. S., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Duration of heart failure with preserved ejection fraction and outcomes with sacubitril/valsartan: insights from the PARAGON-HF trial. Journal of Cardiac Failure, 29, pp. 1494-1503. (doi: 10.1016/j.cardfail.2023.05.003)

Heerspink, H. J. L., Vart, P., Jongs, N., Neuen, B. L., Bakris, G., Claggett, B., Vaduganathan, M., McCausland, F., Docherty, K. F., Jhund, P. S.,, Solomon, S. D., Perkovic, V., McMurray, J. J. V. (2023) Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: a joint analysis of randomized controlled clinical trials. Diabetes, Obesity and Metabolism, 25, pp. 3327-3336. (doi: 10.1111/dom.15232)

Butt, J. H., Lu, H., Kondo, T., Bachus, E., de Boer, R. A., Inzucchi, S. E., Jhund, P. S., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER. European Journal of Heart Failure, 25, pp. 2078-2090. (doi: 10.1002/ejhf.3000)

Purcell, C., Purvis, A., Cleland, J. G.F., Cowie, A., Dalal, H. M., Ibbotson, T., Murphy, C., Taylor, R. S. (2023) Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study) European Journal of Cardiovascular Nursing, 22, pp. 804-813. (doi: 10.1093/eurjcn/zvad004)

Martin, T. P., MacDonald, E. A., Bradley, A., Watson, H., Saxena, P., Rog-Zielinska, E. A., Raheem, A., Fisher, S., Elbassioni, A. A. M., Almuzaini, O., Booth, C., Campbell, M., Riddell, A., Herzyk, P., Blyth, K., Nixon, C., Zentilin, L., Berry, C., Braun, T., Giacca, M., McBride, M. W., Nicklin, S. R., Cameron, E. R., Loughrey, C. (2023) Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction. Cardiovascular Research, 119, pp. 2663–2671-2663–2671. (doi: 10.1093/cvr/cvad107)

Docherty, K. F. (2023) SGLT2 inhibitors and iron: more than meets the eye. JACC: Heart Failure, 11, pp. 1623-1625. (doi: 10.1016/j.jchf.2023.08.013)

Kondo, T., Gasparyan, S. B., Jhund, P. S., Bengtsson, O., Claggett, B. L., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Køber, L., Lam, C. S.P., Langkilde, A. M., Martinez, F. A., Petersson, M., Ponikowski, P., Sabatine, M. S., Shah, S. J., Sjostrand, M., Wilderang, U., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Use of win statistics to analyze outcomes in the DAPA-HF and DELIVER trials. NEJM Evidence, 2, (doi: 10.1056/EVIDoa2300042)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2023) Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study. European Heart Journal: Quality of Care and Clinical Outcomes, 9, pp. 731-739. (doi: 10.1093/ehjqcco/qcac073)

Fuller, W., Mejías, R. (2023) Editorial: Protein lipidation in health and disease. Frontiers in Physiology, 14, (doi: 10.3389/fphys.2023.1317031)

Selli, A. L., Ghasemi, M., Watters, T., Burton, F., Smith, G., Dietrichs, E. S. (2023) Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 31, (doi: 10.1186/s13049-023-01134-5)

Glen, C., Adam, S., McDowell, K., Waterston, A., Tan, Y. Y., Petrie, M. C., Coats, C. J., Lang, N. N. (2023) Cardiotoxicity of BRAF/MEK inhibitors: a longitudinal study incorporating contemporary definitions and risk scores. JACC: CardioOncology, 5, pp. 628-637. (doi: 10.1016/j.jaccao.2023.04.004)

Jackson, A., Bauersachs, J., Petrie, M. C., van der Meer, P., Laroche, C., Farhan, H. A., Frogoudaki, A., Ibrahim, B., Fouad, D. A., Damasceno, A., Karaye, K., Goland, S., Maggioni, A. P., Briton, O., Sliwa, K. (2023) Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM Registry. European Journal of Heart Failure, (doi: 10.1002/ejhf.3055)

Jackson, A. M., Macartney, M., Brooksbank, K., Brown, C., Dawson, D., Francis, M., Japp, A., Lennie, V., Leslie, S. J., Martin, T., Neary, P., Venakatasubramanian, S., Vickers, D., Weir, R. A., McMurray, J. J.V., Jhund, P. S., Petrie, M. C. (2023) A 20-year population study of peripartum cardiomyopathy. European Heart Journal, (doi: 10.1093/eurheartj/ehad626)

McDonagh, T. A. et al. (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 44, pp. 3627-3639. (doi: 10.1093/eurheartj/ehad195)

Eisner, D., Neher, E., Taschenberger, H., Smith, G. (2023) Physiology of intracellular calcium buffering. Physiological Reviews, 103, pp. 2767-2845. (doi: 10.1152/physrev.00042.2022)

Butt, J., Docherty, K. F., Kosiborod, M. N., Inzucchi, S. E., Køber, L., Langkilde, A. M., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S., Jhund, P. S., McMurray, J. J.V. (2023) Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction. JACC: Heart Failure, 11, pp. 1411-1423. (doi: 10.1016/j.jchf.2023.04.016)

Peikert, A., Goyal, P., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Miao, Z. M., Vardeny, O., Kosiborod, M. N., Desai, A. S., Jhund, P. S., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status. JACC: Heart Failure, 11, pp. 1380-1393. (doi: 10.1016/j.jchf.2023.05.014)

Giommi, A., Gurgel, A. R. B., Smith, G. L., Workman, A. J. (2023) Does the small conductance Ca2+-activated K+ current ISK flow under physiological conditions in rabbit and human atrial isolated cardiomyocytes? Journal of Molecular and Cellular Cardiology, 183, pp. 70-80. (doi: 10.1016/j.yjmcc.2023.09.002)

Malik, M. E., Butt, J. H., Strange, J. E., Falkentoft, A. C., Jensen, J., Andersson, C., Zahir, D., Fosbøl, E., Petrie, M. C., Sattar, N., McMurray, J. J.V., Køber, L., Schou, M. (2023) Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study. Lancet Healthy Longevity, 4, pp. e552-e560. (doi: 10.1016/S2666-7568(23)00164-2)

Lam, C. S.P., Docherty, K. F., Ho, J. E., McMurray, J. J.V., Myhre, P. L., Omland, T. (2023) Recent successes in heart failure treatment. Nature Medicine, 29, pp. 2424-2437. (doi: 10.1038/s41591-023-02567-2)

Cuthbert, J. J., Cleland, J. G.F. (2023) Should we resurrect acetazolamide as a diuretic for congestion due to heart failure? Cardiovascular Research, 119, pp. e149-e151. (doi: 10.1093/cvr/cvad148)

Wei, L., Phillippo, D. M., Shah, A., Cleland, J. G.F., Lewsey, J., McAllister, D. A. (2023) Transportability of two heart failure trials to a disease registry using individual patient data. Journal of Clinical Epidemiology, 162, pp. 160-168. (doi: 10.1016/j.jclinepi.2023.08.019)

Flett, A., Cebula, A., Nicholas, Z., Adam, R., Ewings, S., Prasad, S., Cleland, J. G.F., Eminton, Z., Curzen, N. (2023) Rationale and study protocol for the BRITISH randomised trial (using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with non-ischaemic cardiomyopathy and severe systolic heart failure) American Heart Journal, (doi: 10.1016/j.ahj.2023.09.008)

Perera, D. et al. (2023) Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: Prespecified analyses from the REVIVED-BCIS2 trial. Circulation: Heart Failure, 148, pp. 862-871. (doi: 10.1161/circulationaha.123.065300)

Burger, P. M. et al. (2023) Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: the LIFE-HF model. European Journal of Heart Failure, (doi: 10.1002/ejhf.3028)

Docherty, K. F., McMurray, J. J.V., Diaz, R., Felker, G. M., Metra, M., Solomon, S. D., Adams, K. F., Böhm, M., Brinkley, D. M., Echeverria, L. E., Goudev, A. R., Howlett, J. G., Lund, M., Ponikowski, P., Yilmaz, M. B., Zannad, F., Claggett, B. L., Miao, Z. M., Abbasi, S. A., Divanji, P., Heitner, S. B., Kupfer, S., Malik, F. I., Teerlink, J. R. (2023) The effect of omecamtiv mecarbil in hospitalized patients as compared with outpatients with HFrEF: an analysis of GALACTIC-HF. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2023.08.020)

Fudim, M., Dalgaard, F., Friedman, D. J., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Ali-Ahmed, F., Tang, A., Olivas-Martinez, A., Inoue, L. Y.T., Al-Khatib, S. M., Sanders, G. D. (2023) Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trials. European Journal of Heart Failure, (doi: 10.1002/ejhf.3029)

Lucas-Herald, A. K., Montezano, A. C., Alves-Lopes, R., Haddow, L., O'Toole, S., Flett, M., Lee, B., Amjad, S. B., Steven, M., McNeilly, J., Brooksbank, K., Touyz, R. M., Ahmed, S. F. (2023) Effects of sex hormones on vascular reactivity in boys with hypospadias. Journal of Clinical Endocrinology and Metabolism, (doi: 10.1210/clinem/dgad525)

Kondo, T., Wang, X., Yang, M., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Hernandez, A. F., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Langkilde, A. M., Petersson, M., Zaozerska, N., Bachus, E., Solomon, S. D., McMurray, J. J. V. (2023) Efficacy of dapagliflozin according to geographic location of patients with heart failure. Journal of the American College of Cardiology, 82, pp. 1014-1026. (doi: 10.1016/j.jacc.2023.05.056)

Matsumoto, S., Kondo, T., Jhund, P. S., Campbell, R. T., Swedberg, K., van Veldhuisen, D. J., Pocock, S. J., Pitt, B., Zannad, F., McMurray, J. J.V. (2023) Underutilization of mineralocorticoid antagonists in patients with heart failure with reduced ejection fraction. Journal of the American College of Cardiology, 82, pp. 1080-1091. (doi: 10.1016/j.jacc.2023.06.021)

Graham, F. J., Friday, J., Pellicori, P., Greenlaw, N., Cleland, J. G.F. (2023) Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart, 109, pp. 1294-1301. (doi: 10.1136/heartjnl-2022-322145)

Tromp, J., Ezekowitz, J. A., Ouwerkerk, W., Chandramouli, C., Yiu, K. H., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Collins, S. P., Filippatos, G., Cleland, J. G. F., Lam, C. S. P. (2023) Global variations according to sex in patients hospitalized for heart failure in the REPORT-HF registry. JACC: Heart Failure, 11, pp. 1262-1271. (doi: 10.1016/j.jchf.2023.06.028)

Brennan, A. C., Campbell, R. T., Lee, M. M.Y. (2023) Influenza vaccination: a simple, safe, and effective treatment for patients with ischaemic heart disease and heart failure. European Journal of Heart Failure, 25, pp. 1693-1695. (doi: 10.1002/ejhf.2993)

Sykes, R., Doherty, D., Morrow, A., Mangion, K., Rushd, A., Berry, C. (2023) NT-proBNP in patients presenting with myocardial infarction and non-obstructive coronary arteries without left ventricular systolic dysfunction. American Heart Journal Plus: Cardiology Research and Practice, 33, (doi: 10.1016/j.ahjo.2023.100311)

Bhatt, A. S., Lindholm, D., Nilsson, A., Zaozerska, N., Claggett, B. L., Vaduganathan, M., Kosiborod, M. N., Lam, C. S.P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Desai, A., Jhund, P. S., Langkilde, A. M., Petersson, M., McMurray, J. J.V., Solomon, S. D. (2023) Operational challenges and mitigation measures during the COVID-19 pandemic – lessons from DELIVER. American Heart Journal, 263, pp. 133-140. (doi: 10.1016/j.ahj.2023.05.013)

Keast, T., McErlane, J., Kearns, R., McKinlay, S., Raju, I., Watson, M., Robertson, K. E., Berry, C., Greenlaw, N., Ackland, G., McCall, P., Shelley, B. (2023) Study protocol for IMPRoVE: a multicentre prospective observational cohort study of the incidence, impact and mechanisms of perioperative right ventricular dysfunction in non-cardiac surgery. BMJ Open, 13, (doi: 10.1136/bmjopen-2023-074687)

Ranasinghe, S., Merz, C. N. B., Khan, N., Wei, J., George, M., Berry, C., Chieffo, A., Camici, P. G., Crea, F., Kaski, J. C., Marzilli, M., Gulati, M. (2023) Sex differences in Quality of Life in Patients with Ischemia with No Obstructive Coronary Artery Disease (INOCA): A Patient Self-Report Retrospective Survey from INOCA International. Journal of Clinical Medicine, 12, (doi: 10.3390/jcm12175646)

Bradley, C. P., Orchard, V., McKinley, G., Heggie, R., Wu, O., Good, R., Watkins, S., Lindsay, M., Eteiba, H., McGowan, J., McGeoch, R., Corcoran, D., Kellman, P., McConnachie, A., Berry, C. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, (doi: 10.1016/j.ahj.2023.08.067)

Kondo, T., Dewan, P., Anand, I. S., Desai, A. S., Packer, M., Zile, M. R., Pfeffer, M. A., Solomon, S. D., Abraham, W. T., Shah, S. J., Lam, C. S.P., Jhund, P. S., McMurray, J. J.V. (2023) Clinical characteristics and outcomes in patients with heart failure: are there thresholds and inflection points in left ventricular ejection fraction and thresholds justifying a clinical classification? Circulation, 148, pp. 732-749. (doi: 10.1161/CIRCULATIONAHA.122.063642)

Borlaug, B. A. et al. (2023) Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature Medicine, 29, pp. 2358-2365. (doi: 10.1038/s41591-023-02526-x)

Pabon, M., Claggett, B. L., Wang, X., Miao, Z. M., Chatur, S., Bhatt, A. S., Vaduganathan, M., Fang, J. C., Desai, A. S., Jhund, P., Martinez, F., De Boer, R. A., Kosiborod, M. N., Lam, C. S., Shah, S. J., Hernandez, A. F., McMurray, J. J.V., Solomon, S. D., Vardeny, O. (2023) Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3001)

Harrington, J., Udell, J. A., Jones, W. S., Anker, S. D., Bhatt, D. L., Petrie, M. C., Andersen, K. R., Sumin, M., Zwiener, I., Hernandez, A. F., Butler, J. (2023) Baseline characteristics of patients enrolled in the EMPACT‐MI trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2990)

Berry, C., McClure, J. D., Oldroyd, K. (2023) Death at 5-years in the DEFINE-FLAIR and iFR-SWEDEHEART trials: a pooled analysis. European Heart Journal,

Ioannou, A. et al. (2023) Conventional heart failure therapy in cardiac ATTR amyloidosis. European Heart Journal, 44, pp. 2893-2907. (doi: 10.1093/eurheartj/ehad347)

Chatur, S., Vaduganathan, M., Claggett, B., Vardeny, O., Desai, A. S., Jhund, P. S., de Boer, R. A., Lam, C. S.P., Kosiborod, M. N., Shah, S. J., Martinez, F., Inzucchi, S. E., Hernandez, A. F., Haddad, T., Mitter, S. S., Miao, Z. M., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. European Heart Journal, 44, pp. 2930-2943. (doi: 10.1093/eurheartj/ehad283)

Yeoh, S. E., Osmanska, J., Petrie, M. C., Brooksbank, K. J.M., Clark, A. L., Docherty, K. F., Foley, P. W.X., Guha, K., Halliday, C. A., Jhund, P. S., Kalra, P. R., McKinley, G., Lang, N. N., Lee, M. M.Y., McConnachie, A., McDermott, J. J., Platz, E., Sartipy, P., Seed, A., Stanley, B., Weir, R. A.P., Welsh, P., McMurray, J. J.V., Campbell, R. T. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44, pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341)

Yang, M., Kondo, T., Butt, J. H., Abraham, W. T., Anand, I. S., Desai, A. S., Køber, L., Packer, M., Pfeffer, M. A., Rouleau, J. L., Sabatine, M. S., Solomon, S. D., Swedberg, K., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2023) Stroke in patients with heart failure and reduced or preserved ejection fraction. European Heart Journal, 44, pp. 2998-3013. (doi: 10.1093/eurheartj/ehad338)

AI Abel, A., Samuel, N. A., Cuthbert, J. J., Brown, O. I., Pellicori, P., Kazmi, S., Cleland, J. G.F., Johnson, M. J., Clark, A. L. (2023) Hospital admissions in the last year of life of patients with heart failure. European Heart Journal: Quality of Care and Clinical Outcomes, (doi: 10.1093/ehjqcco/qcad047)

Mangion, K., Morrow, A. J., Sykes, R., Kamdar, A., Bagot, C., Bruce, G., Connelly, P., Delles, C., Gibson, V. B., Gillespie, L., Hall Barrientos, P., Lennie, V., Roditi, G., Sattar, N., Stobo, D., Allwood-Spiers, S., McConnachie, A., Berry, C., CISCO-19 investigators, (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, (doi: 10.1186/s12872-023-03412-7)

Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13, (doi: 10.3390/diagnostics13152612)

Rigattieri, S., Barbato, E., Berry, C. (2023) Microvascular resistance reserve: a reference test of the coronary microcirculation? European Heart Journal, 44, pp. 2870-2872. (doi: 10.1093/eurheartj/ehad291)

Jones, R. E. et al. (2023) Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery disease. Nature Cardiovascular Research, 2, pp. 733-745. (doi: 10.1038/s44161-023-00312-z)

Docherty, K. F., Jackson, A. M., Macartney, M., Campbell, R. T., Petrie, M. C., Pfeffer, M. A., McMurray, J. J.V., Jhund, P. S. (2023) Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016. European Journal of Heart Failure, 25, pp. 1213-1224. (doi: 10.1002/ejhf.2965)

Docherty, K. F., Lam, C. S.P., Rakisheva, A., Coats, A. J.S., Greenhalgh, T., Metra, M., Petrie, M. C., Rosano, G. M.C. (2023) Heart failure diagnosis in the general community - who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 25, pp. 1185-1198. (doi: 10.1002/ejhf.2946)

Iaconelli, A., Pellicori, P., Caiazzo, E., Rezig, A. O. M., Bruzzese, D., Maffia, P., Cleland, J. G. F. (2023) Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials. Clinical Research in Cardiology, 112, pp. 1007-1019. (doi: 10.1007/s00392-022-02104-0)

McDowell, K., Campbell, R., Simpson, J., Cunningham, J. W., Desai, A. S., Jhund, P. S., Lefkowitz, M. P., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Incremental prognostic value of biomarkers in PARADIGM-HF. European Journal of Heart Failure, 28, pp. 1406-1414-1406-1414. (doi: 10.1002/ejhf.2887)

Iaconelli, A., Cuthbert, J., Kazmi, S., Maffia, P., Clark, A. L., Cleland, J. G.F., Pellicori, P. (2023) Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity. Clinical Research in Cardiology, 112, pp. 1077-1086. (doi: 10.1007/s00392-023-02178-4)

Sykes, R., Ang, D. T. Y., Berry, C. (2023) Invasive coronary microvascular function assessment: pharmacological versus exercise testing. Heart, 109, pp. 1130-1131. (doi: 10.1136/heartjnl-2023-322512)

Olivera, S., Graham, D. (2023) Sex differences in preclinical models of hypertension. Journal of Human Hypertension, 37, pp. 619-625. (doi: 10.1038/s41371-022-00770-1)

de Koning, M.-S. L.Y., Emmens, J. E., Romero-Hernández, E., Bourgonje, A. R., Assa, S., Figarska, S. M., Cleland, J. G.F., Samani, N. J., Ng, L. L., Lang, C. C., Metra, M., Filippatos, G. S., van Veldhuisen, D. J., Anker, S. D., Dickstein, K., Voors, A. A., Lipsic, E., van Goor, H., van der Harst, P. (2023) Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. Clinical Research in Cardiology, 112, pp. 1056-1066. (doi: 10.1007/s00392-023-02171-x)

Gargani, L., Girerd, N., Platz, E., Pellicori, P., Stankovic, I., Palazzuoli, A., Pivetta, E., Miglioranza, M. H., Soliman-Aboumarie, H., Agricola, E., Volpicelli, G., Price, S., Donal, E., Cosyns, B., Neskovic, A. N. (2023) Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) European Heart Journal, (doi: 10.1093/ehjci/jead169)

Docherty, K. F., McDowell, K., Welsh, P., Osmanska, J., Anand, I., de Boer, R. A., Køber, L., Kosiborod, M. N., Martinez, F. A., O’Meara, E., Ponikowski, P., Schou, M., Berg, D. D., Sabatine, M. S., Morrow, D. A., Jarolim, P., Hammarstedt, A., Sjöstrand, M., Langkilde, A. M., Solomon, S. D., Sattar, N., Jhund, P. S., McMurray, J. J.V. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82, pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011)

Nadarajah, R., Younsi, T., Romer, E., Raveendra, K., Nakao, Y., Nakao, K., Shuweidhi, F., Hogg, D., Arbel, R., Zahger, D., Iakobishvili, Z., Fonarow, G. C., Petrie, M. C., Wu, J., Gale, C. P. (2023) Prediction models for heart failure in the community: a systematic review and meta‐analysis. European Journal of Heart Failure, (doi: 10.1002/ejhf.2970)

Yang, M., Kondo, T., Adamson, C., Butt, J. H., Abraham, W. T., Desai, A. S., Jering, K. S., Køber, L., Kosiborod, M. N., Packer, M., Rouleau, J. L., Solomon, S. D., Vaduganathan, M., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2023) Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction. European Journal of Heart Failure, (doi: 10.1002/ejhf.2962)

Graham, F. J., Pellicori, P., Masini, G., Cuthbert, J. J., Clark, A. L., Cleland, J. G.F. (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Failure, (doi: 10.1002/ehf2.14438)

Peikert, A., Chandra, A., Kosiborod, M. N., Claggett, B. L., Desai, A. S., Jhund, P. S., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Janssens, S. P., Bělohlávek, J., Borleffs, C. J. W., Dobreanu, D., Langkilde, A. M., Bengtsson, O., Petersson, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Association of dapagliflozin vs placebo with individual Kansas City Cardiomyopathy Questionnaire components in patients with heart failure with mildly reduced or preserved ejection fraction. JAMA Cardiology, 8, pp. 684-690. (doi: 10.1001/jamacardio.2023.1342)

Lee, M. M.Y., Sattar, N. (2023) A review of current key guidelines for managing high risk patients with diabetes and heart failure and future prospects. Diabetes, Obesity and Metabolism, 25, pp. 33-47. (doi: 10.1111/dom.15085)

Dowsett, L., Duluc, L., Higgins, E., Alghamdi, F., Fast, W., Salt, I. P., Leiper, J. (2023) Asymmetric dimethylarginine positively modulates calcium-sensing receptor signalling to promote lipid accumulation. Cellular Signalling, 107, (doi: 10.1016/j.cellsig.2023.110676)

Iaconelli, A., Pellicori, P., Dolce, P., Busti, M., Ruggio, A., Aspromonte, N., D'Amario, D., Galli, M., Princi, G., Caiazzo, E., Rezig, A. O.M., Maffia, P., Pecorini, G., Crea, F., Cleland, J. G.F. (2023) Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials. European Journal of Heart Failure, 25, pp. 1170-1175. (doi: 10.1002/ejhf.2911)

Bhatt, A. S., Kosiborod, M. N., Vaduganathan, M., Claggett, B. L., Miao, Z. M., Kulac, I. J., Lam, C. S.P., Hernandez, A. F., Martinez, F., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Jhund, P. S., Desai, A. S., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Effect of dapagliflozin on health status and quality-of-life across the spectrum of ejection fraction: participant-level pooled analysis from the DAPA-HF & DELIVER trials. European Journal of Heart Failure, 25, pp. 981-988. (doi: 10.1002/ejhf.2909)

Patel, T. R., Villines, T., Kramer, C. M., Kwong, R. Y., Raharjo, D. E., Kunadian, V., Berry, C. (2023) Great Debate: computed tomography coronary angiography should be the initial diagnostic test in suspected angina. European Heart Journal, 44, pp. 2366-2375. (doi: 10.1093/eurheartj/ehac597)

Jhund, P. S. (2023) Improving heart failure outcomes with SGLT-2 inhibitors in different patient groups. Diabetes, Obesity and Metabolism, 25, pp. 26-32. (doi: 10.1111/dom.15171)

Caiazzo, E., Sharma, M., Rezig, A. O., Morsy, M., Ialenti, A., Pellicori, P., Bruzzese, D., Maffia, P., Guzik, T. J. (2023) Inflammatory Cytokines and Risk of Developing Hypertension: A Systematic Review and Meta-Analysis. (doi: 10.1111/bph.16105)

Talha, K. M., Butler, J., Greene, S. J., Aggarwal, R., Anker, S. D., Claggett, B. L., Docherty, K. F., Solomon, S. D., McMurray, J. J.V., Januzzi, J. L., Vaduganathan, M., Fonarow, G. C. (2023) Potential global impact of sodium‐glucose cotransporter‐2 inhibitors in heart failure. European Journal of Heart Failure, 25, pp. 999-1009. (doi: 10.1002/ejhf.2864)

Kondo, T., Jering, K. S., Jhund, P. S., Anand, I. S., Desai, A. S., Lam, C. S.P., Maggioni, A. P., Martinez, F. A., Packer, M., Petrie, M. C., Pfeffer, M. A., Redfield, M. M., Rouleau, J. L., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2023) Predicting stroke in heart failure and preserved ejection fraction without atrial fibrillation. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.010377)

Curtain, J. P., Adamson, C., Docherty, K. F., Jhund, P. S., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Prevalent and incident anemia in PARADIGM-HF and the effect of sacubitril/valsartan. JACC: Heart Failure, 11, pp. 749-759. (doi: 10.1016/j.jchf.2022.12.012)

Araki, T., Kondo, T., Imaizumi, T., Sumita, Y., Nakai, M., Tanaka, A., Okumura, T., Yang, M., Butt, J. H., Petrie, M. C., Murohara, T. (2023) Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support. American Heart Journal, 261, pp. 109-123. (doi: 10.1016/j.ahj.2023.03.017)

Pugliese, N. R., Pellicori, P., Filidei, F., Del Punta, L., De Biase, N., Balletti, A., Di Fiore, V., Mengozzi, A., Taddei, S., Gargani, L., Mullens, W., Cleland, J. G.F., Masi, S. (2023) The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure. European Heart Journal: Cardiovascular Imaging, 24, pp. 961-971. (doi: 10.1093/ehjci/jeac254)

Morrow, A. J., McFarlane, R., Berry, C. (2023) Novel therapy for ischaemia with no obstructive coronary arteries. European Heart Journal, (doi: 10.1093/eurheartj/ehad391)

Yang, M., Kondo, T., Adamson, C., Butt, J. H., Abraham, W. T., Desai, A. S., Jering, K. S., Køber, L., Kosiborod, M. N., Packer, M., Rouleau, J. L., Solomon, S. D., Vaduganathan, M., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2023) Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, (doi: 10.1002/ejhf.2944)

Butt, J. H., Kondo, T., Yang, M., Jhund, P. S., Docherty, K. F., Vaduganathan, M., Claggett, B. L., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Shah, S. J., Zaozerska, N., Wilderäng, U., Bengtsson, O., Solomon, S. D., McMurray, J. J.V. (2023) Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER. European Heart Journal, 44, pp. 2170-2183. (doi: 10.1093/eurheartj/ehad276)

Tolomeo, P., Butt, J. H., Kondo, T., Campo, G., Desai, A. S., Jhund, P. S., Køber, L., Lefkowitz, M. P., Rouleau, J. L., Solomon, S. D., Swedberg, K., Vaduganathan, M., Zile, M. R., Packer, M., McMurray, J. J.V. (2023) Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. European Heart Journal, 44, pp. 2202-2212. (doi: 10.1093/eurheartj/ehad210)

Bozkurt, B., Savarese, G., Adamsson Eryd, S., Bodegård, J., Cleland, J. G.F., Khordoc, C., Kishi, T., Thuresson, M., Vardeny, O., Zhang, R., Lund, L. H. (2023) Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization: EVOLUTION HF. JACC: Heart Failure, (doi: 10.1016/j.jchf.2023.04.017)

Cleland, J. G.F., Pellicori, P., Graham, F. J. (2023) Redefining both iron deficiency and anaemia in cardiovascular disease. European Heart Journal, 44, pp. 1992-1994. (doi: 10.1093/eurheartj/ehad154)

Campbell, R. T., Docherty, K. F. (2023) Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance? European Heart Journal, 44, pp. 2006-2008. (doi: 10.1093/eurheartj/ehad209)

Markousis-Mavrogenis, G., Minich, W. B., Al-Mubarak, A. A., Anker, S. D., Cleland, J. G.F., Dickstein, K., Lang, C. C., Ng, L. L., Samani, N. J., Zannad, F., Metra, M., Seemann, P., Hoeg, A., Lopez, P., van Veldhuisen, D. J., de Boer, R. A., Voors, A. A., van der Meer, P., Schomburg, L., Bomer, N., The BIOSTAT-CHF Consortium, (2023) Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. Cardiovascular Research, 119, pp. 1690-1705. (doi: 10.1093/cvr/cvad042)

Smilowitz, N. R., Toleva, O., Chieffo, A., Perera, D., Berry, C. (2023) Coronary microvascular disease in contemporary clinical practice. Circulation: Cardiovascular Interventions, 16, pp. 386-395. (doi: 10.1161/CIRCINTERVENTIONS.122.012568)

Graham, F., Iaconelli, A., Sonecki, P., Campbell, R. T., Hunter, D., Cleland, J. G.F., Pellicori, P. (2023) Defining heart failure based on imaging the heart and beyond. Cardiac Failure Review, 9, (doi: 10.15420/cfr.2022.29)

Jhund, P. S., Claggett, B. L., Talebi, A., Butt, J. H., Gasparyan, S. B., Wei, L.-J., McCaw, Z. R., Wilderäng, U., Bengtsson, O., Desai, A. S., Petersson, M., Langkilde, A. M., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Shah, S. J., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction. A prespecified analysis of the DELIVER trial. JAMA Cardiology, 8, pp. 554-563. (doi: 10.1001/jamacardio.2023.0711)

Curtain, J. P., Lee, M. M.Y., McMurray, J. J.V., Gardner, R. S., Petrie, M. C., Jhund, P. S. (2023) Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis. Heart, 109, pp. 823-831. (doi: 10.1136/heartjnl-2022-321885)

Rabbani, A., Gao, H., Lazarus, A., Dalton, D., Ge, Y., Mangion, K., Berry, C., Husmeier, D. (2023) Image-based estimation of the left ventricular cavity volume using deep learning and Gaussian process with cardio-mechanical applications. Computerized Medical Imaging and Graphics, 106, (doi: 10.1016/j.compmedimag.2023.102203)

Farmakis, D., Tromp, J., Marinaki, S., Ouwerkerk, W., Angermann, C. E., Bistola, V., Dahlstrom, U., Dickstein, K., Ertl, G., Ghadanfar, M., Hassanein, M., Obergfell, A., Perrone, S. V., Polyzogopoulou, E., Schweizer, A., Boletis, I., Cleland, J. G.F., Collins, S. P., Lam, C. S.P., FIlippatos, G. (2023) Impact of left ventricular ejection fraction phenotypes on healthcare-resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. European Journal of Heart Failure, 25, pp. 818-828. (doi: 10.1002/ejhf.2833)

Gard, E. K., Beale, A. L., Telles, F., Silvestry, F. E., Hanff, T., Hummel, S. L., Litwin, S. E., Petrie, M. C., Shah, S. J., Borlaug, B. A., Burkhoff, D., Komtebedde, J., Kaye, D. M., Nanayakkara, S. (2023) Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction. European Journal of Heart Failure, 25, pp. 806-814. (doi: 10.1002/ejhf.2805)

Simitev, R. D., Al dawoud, A., Aziz, M. H.N., Myles, R., Smith, G. L. (2023) Phenomenological analysis of simple ion channel block in large populations of uncoupled cardiomyocytes. Mathematical Medicine and Biology, 40, pp. 175-198. (doi: 10.1093/imammb/dqad001)

Butcher, C.J.T., Cantor, E., Sohaib, S.M.A., Shun-Shin, M., Haynes, R., Khan, H., Kyriacou, A., Shi, R., Chen, Z., Haldar, S., Cleland, J., Hussain, W., Markides, V., Jones, D., Lane, R.E., Mason, M.J., Whinnett, Z., Francis, D., Wong, T. (2023) Variation in optimal hemodynamic atrio-ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics. Journal of Cardiovascular Electrophysiology, 34, pp. 1431-1440. (doi: 10.1111/jce.15862)

Sykes, R. A., Neves, K. B., Alves-Lopes, R., Caputo, I., Jamieson, N. B., Kamdar, A., Legrini, A., Leslie, H., McIntosh, A., McConnachie, A., Morrow, A., McFarlane, R. W., Mangion, K., McAbney, J., Montezano, A. C., Touyz, R. M., Wood, C., Berry, C. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9, pp. 371-386. (doi: 10.1093/ehjcvp/pvad025)

Metra, M. et al. (2023) Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 25, pp. 776-791. (doi: 10.1002/ejhf.2874)

Yeoh, S. E., Docherty, K. F., Campbell, R. T., Jhund, P. S., Hammarstedt, A., Heerspink, H. J.L., Jarolim, P., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Solomon, S. D., Sjöstrand, M., Bengtsson, O., Greasley, P. J., Sattar, N., Welsh, P., Sabatine, M. S., Morrow, D. A., McMurray, J. J.V. (2023) Endothelin-1, outcomes in patients with heart failure and reduced ejection fraction, and effects of dapagliflozin: findings from DAPA-HF. Circulation, 147, pp. 1670-1683. (doi: 10.1161/CIRCULATIONAHA.122.063327)

Lam, C. S. P., Harding, E., Bains, M., Chin, A., Kanumilli, N., Petrie, M. C., Pohja-Hutchison, P., Yang, J., Butler, J. (2023) Identification of urgent gaps in public and policymaker knowledge of heart failure: results of a global survey. BMC Public Health, 23, (doi: 10.1186/s12889-023-15405-4)

Chatur, S., Cunningham, J. W., Vaduganathan, M., Mc Causland, F. R., Claggett, B. L., Desai, A. S., Miao, Z. M., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: insights from the DELIVER trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2915)

Chatur, S., Kondo, T., Claggett, B. L., Docherty, K., Miao, Z. M., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: insights from DELIVER and DAPA-HF. European Journal of Heart Failure, (doi: 10.1002/ejhf.2912)

Clephas, P.R.D., Radhoe, S.P., Boersma, E., Gregson, J., Jhund, P.S., Abraham, W.T., McMurray, J.J.V., de Boer, R.A., Brugts, J.J. (2023) Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials. European Heart Journal, (doi: 10.1093/eurheartj/ehad346)

Rasmussen, M. et al. (2023) Global variations in heart failure etiology, management, and outcomes. JAMA: Journal of the American Medical Association, 329, pp. 1650-1661. (doi: 10.1001/jama.2023.5942)

Khan, J., Graham, F. J., Masini, G., Iaconelli, A., Friday, J. M., Lang, C. C., Pellicori, P. (2023) Congestion and use of diuretics in heart failure and cardiomyopathies: a practical guide. Current Cardiology Reports, 25, pp. 411-420. (doi: 10.1007/s11886-023-01865-y)

Dewan, P., Ferreira, J. P., Butt, J. H., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Stewart, S., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2023) Impact of multimorbidity on mortality in HFrEF : which comorbidities matter most? – an analysis of PARADIGM‐HF and ATMOSPHERE. European Journal of Heart Failure, 25, pp. 687-697. (doi: 10.1002/ejhf.2856)

Girerd, N. et al. (2023) Protein biomarkers of new-onset heart failure: insights from the Heart Omics and Ageing cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation: Heart Failure, 16, pp. 426-441. (doi: 10.1161/CIRCHEARTFAILURE.122.009694)

Fuller, W. (2023) zDHHC9 and the control of natriuretic peptide secretion by the heart. JACC: Basic to Translational Science, 8, pp. 543-545. (doi: 10.1016/j.jacbts.2023.02.013)

Tromp, J., Jackson, A. M., Abdelhamid, M., Fouad, D., Youssef, G., Petrie, M. C., Bauersachs, J., Sliwa, K., van der Meer, P. (2023) Thrombo‐embolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. European Journal of Heart Failure, (doi: 10.1002/ejhf.2871)

Field, R. J., Adamson, C., Jhund, P., Lewsey, J. (2023) Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality. BMC Medical Research Methodology, 23, (doi: 10.1186/s12874-023-01918-4)

Kobayashi, M., Huttin, O., Ferreira, J. P., Duarte, K., González, A., Heymans, S., Verdonschot, J. A.J., Brunner-La Rocca, H.-P., Pellicori, P., Clark, A. L., Petutschnigg, J., Edelmann, F., Cleland, J. G., Rossignol, P., Zannad, F., Girerd, N. (2023) A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2859)

Ferreira, J. P., Cleland, J. G., Girerd, N., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., González, A., Diez, J., Solomon, S. D., Claggett, B., Pfeffer, M. A., Pitt, B., Petutschnigg, J., Pieske, B., Edelmann, F., Zannad, F. (2023) Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: pooled analysis of three randomized trials. International Journal of Cardiology, 377, pp. 86-88. (doi: 10.1016/j.ijcard.2023.01.088)

Lu, H. R., Van de Sande, D., Mohammadreza, G., Watters, T., Burton, F., Pham, L., Altrocchi, C., Gallacher, D. J., Smith, G. (2023) Are more mature hiPSC-cardiomyocytes better for the detection of drug-induced cardiotoxicity? Biomolecules, 13, (doi: 10.3390/biom13040676)

Butler, J., Petrie, M. C., Bains, M., Bawtinheimer, T., Code, J., Levitch, T., Malvolti, E., Monteleone, P., Stevens, P., Vafeiadou, J., Lam, C. S. P. (2023) Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post–hospital discharge period. Research Involvement and Engagement, 9, (doi: 10.1186/s40900-023-00412-x)

Congreve, S. D., Main, A., Butler, A. S., Gao, X., Brown, E., Du, C., Choisy, S. C., Cheng, H., Hancox, J. C., Fuller, W. (2023) Palmitoylation regulates the magnitude of HCN4-mediated currents in mammalian cells. Frontiers in Physiology, 14, (doi: 10.3389/fphys.2023.1163339)

Lee, M. M. Y., McMurray, J. J. V. (2023) Lack of benefit of renin-angiotensin system inhibitors in COVID-19. JAMA: Journal of the American Medical Association, 329, pp. 1155-1156. (doi: 10.1001/jama.2023.4405)

Kondo, T., Jering, K. S., Borleffs, C. J. W., de Boer, R. A., Claggett, B. L., Desai, A. S., Dobreanu, D., Inzucchi, S. E., Hernandez, A. F., Janssens, S. P., Jhund, P., Kosiborod, M. N., Lam, C. S.P., Langkilde, A. M., Martinez, F. A., Petersson, M., Vinh, P. N., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial. Circulation, 147, pp. 1067-1078. (doi: 10.1161/CIRCULATIONAHA.122.062918)

Butt, J. H., Petrie, M. C., Jhund, P. S., Sattar, N., Desai, A. S., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. European Heart Journal, 44, pp. 1136-1153. (doi: 10.1093/eurheartj/ehad083)

Bruhn, J., Malmborg, M., Garred, C. H., Ravn, P., Zahir, D., Andersson, C., Gislason, G., Torp-Pedersen, C., Kragholm, K., Fosbol, E., Butt, J. H., Lang, N. N., Petrie, M. C., McMurray, J., Kober, L., Schou, M. (2023) Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study. European Heart Journal, 44, pp. 1124-1132. (doi: 10.1093/eurheartj/ehac797)

Mooney, L., Jackson, C. E., Adamson, C., McConnachie, A., Welsh, P., Myles, R. C., McMurray, J. J.V., Jhund, P. S., Petrie, M. C., Lang, N. N. (2023) Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.010051)

Collison, D., Copt, S., Mizukami, T., Collet, C., McLaren, R., Didagelos, M., Aetesam-ur-Rahman, M., McCartney, P., Ford, T. J., Lindsay, M., Shaukat, A., Rocchiccioli, P., Brogan, R., Watkins, S., McEntegart, M., Good, R., Robertson, K., O’Boyle, P., Davie, A., Khan, A., Hood, S., Eteiba, H., Berry, C., Oldroyd, K. G. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16, (doi: 10.1161/CIRCINTERVENTIONS.122.012511)

Cuthbert, J.J., Pellicori, P., Rigby, A.S., Abel, A.A.I., Kalvickbacka-Bennet, A., Shah, P., Kearsley, J.W., Kazmi, S., Cleland, J.G.F., Clark, A.L. (2023) Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 9, pp. 281-292. (doi: 10.1093/ehjqcco/qcac035)

Butt, J. H., Docherty, K. F., Claggett, B. L., Desai, A. S., Petersson, M., Langkilde, A. M., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Køber, L., Lam, C. S. P., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Shah, S. J., Vaduganathan, M., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2023) Association of dapagliflozin use with clinical outcomes and the introduction of uric acid–lowering therapy and colchicine in patients with heart failure with and without gout. JAMA Cardiology, 8, pp. 386-393. (doi: 10.1001/jamacardio.2022.5608)

Desai, A. S., Petrie, M. C. (2023) Centrally adjudicated heart failure outcomes are needed in clinical trials. JACC: Heart Failure, 11, pp. 418-421. (doi: 10.1016/j.jchf.2023.01.028)

Dobbin, S. J.H., Shen, L., Petrie, M. C., Packer, M., Solomon, S. D., McMurray, J. J.V., Lang, N. N., Jhund, P. S. (2023) Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials. European Journal of Heart Failure, 25, pp. 488-496. (doi: 10.1002/ejhf.2818)

Butt, J. H. et al. (2023) Dapagliflozin in Black and White patients with heart failure across the ejection fraction spectrum. JACC: Heart Failure, 11, pp. 375-388. (doi: 10.1016/j.jchf.2022.11.014)

Leo, V. C., Kazmi, S., Brownrigg, J., Araghi, M., Sarna, H. S., Pellicori, P., Cuthbert, J., Cleland, J. G.F., Clark, A. L. (2023) Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis. ESC Heart Failure, 10, pp. 1492-1496. (doi: 10.1002/ehf2.14315)

Graham, F. J., Pellicori, P., Kalra, P. R., Ford, I., Bruzzese, D., Cleland, J. G.F. (2023) Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. European Journal of Heart Failure, 25, pp. 528-537. (doi: 10.1002/ejhf.2810)

Fullerton, J., Bettencourt, C., Daniels, M., Mclean, F., Simpson, S., Smith, A., Woodling, N., Kerr, F. (2023) Creating connections: developing an online space for cross-regional mentorship and network building in the dementia research field. Health Open Research, 4, (doi: 10.12688/amrcopenres.13091.2)

Ferreira, J. P., Cleland, J. G.F., Girerd, N., Pellicori, P., Hazebroek, M. R., Verdonschot, J., Collier, T. J., Retutschnigg, J., Clark, A. L., Staessen, J. A., Heymans, S., Rossignol, P., Zannad, F. (2023) Effect of spironolactone on QRS duration in patients at risk for heart failure (from the HOMAGE trial) American Journal of Cardiology, 191, pp. 39-42. (doi: 10.1016/j.amjcard.2022.12.016)

Friedman, D. J., Al-Khatib, S. M., Dalgaard, F., Fudim, M., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Ali-Ahmed, F., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D. (2023) Cardiac resynchronization therapy improves outcomes in patients with intraventricular conduction delay but not right bundle branch block: a patient-level meta-analysis of randomized controlled trials. Circulation, 147, pp. 812-823. (doi: 10.1161/CIRCULATIONAHA.122.062124)

Vaduganathan, M., Claggett, B. L., Jhund, P., Miao, Z. M., de Boer, R. A., Lam, C. S.P., Desai, A. S., Bengsston, O., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology, 81, pp. 1004-1006. (doi: 10.1016/j.jacc.2022.12.026)

Packer, M., Cleland, J. G.F. (2023) Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events? Journal of Cardiac Failure, 29, pp. 403-406. (doi: 10.1016/j.cardfail.2022.12.007)

Nuzzi, V., Cannatà, A., Pellicori, P., Manca, P., Stolfo, D., Gregorio, C., Barbati, G., Bromage, D. I., McDonagh, T., Cleland, J. G.F., Merlo, M., Sinagra, G. (2023) Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. Clinical Research in Cardiology, 112, pp. 419-430. (doi: 10.1007/s00392-022-02126-8)

Adamson, C., Welsh, P., Docherty, K. F., de Boer, R. A., Diez, M., Drożdż, J., Dukát, A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ljungman, C. E.A., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Morrow, D. A., Lindholm, D., Hammarstedt, A., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Solomon, S. D., Sattar, N., McMurray, J. J.V., Jhund, P. S. (2023) IGFBP-7 and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF. JACC: Heart Failure, 11, pp. 291-304. (doi: 10.1016/j.jchf.2022.09.004)

Butt, J. H., Ibrahim, W., Dewan, P., Desai, A. S., Køber, L., Prescott, M. F., Lefkowitz, M. P., Rouleau, J. L., Solomon, S. D., Zile, M. R., Packer, M., Jhund, P. S., McMurray, J. J.V. (2023) Urinary cGMP (cyclic guanosine monophosphate)/BNP (B-type natriuretic peptide) ratio, sacubitril/valsartan, and outcomes in heart failure with reduced ejection fraction: an analysis of the PARADIGM-HF trial. Circulation: Heart Failure, 16, pp. 247-258. (doi: 10.1161/CIRCHEARTFAILURE.122.010111)

Curtain, J. P., Adamson, C., Kondo, T., Butt, J., Desai, A. S., Zannad, F., Rouleau, J. L., Rohde, L. E., Kober, L., Anand, I. S., van Veldhuisen, D. J., Zile, M. R., Lefkowitz, M. P., Solomon, S. D., Packer, M., Petrie, M. C., Jhund, P. S., McMurray, J. J.V. (2023) Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction. European Heart Journal, 44, pp. 668-677. (doi: 10.1093/eurheartj/ehac801)

Wang, X. et al. (2023) Sex differences in characteristics, outcomes and treatment response with dapagliflozin across the range of ejection fraction in patients with heart failure: insights from DAPA-HF and DELIVER. Circulation, 147, pp. 624-634. (doi: 10.1161/CIRCULATIONAHA.122.062832)

Kuo, C.-W. S., Dobi, S., Gök, C., Da Silva Costa, A., Main, A., Robertson-Gray, O., Baptista-Hon, D., Wypijewski, K. J., Costello, H., Hales, T. G., MacQuaide, N., Smith, G. L., Fuller, W. (2023) Palmitoylation of the pore-forming subunit of Ca(v)1.2 controls channel voltage sensitivity and calcium transients in cardiac myocytes. Proceedings of the National Academy of Sciences of the United States of America, 120, (doi: 10.1073/pnas.2207887120)

Gladysheva, I. P., Sullivan, R. D., Pellicori, P. (2023) Editorial: Edema in heart failure with reduced ejection fraction. Frontiers in Cardiovascular Medicine, 10, (doi: 10.3389/fcvm.2023.1141937)

Kosiborod, M. N., Bhatt, A. S., Claggett, B. L., Vaduganathan, M., Kulac, I. J., Lam, C. S.P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Jhund, P. S., Desai, A. S., Fang, J. C., Han, Y., Comin-Colet, J., Vardeny, O., Lindholm, D., Wilderäng, U., Bengtsson, O., McMurray, J. J.V., Solomon, S. D. (2023) Effect of dapagliflozin on health status in patients with preserved or mildly reduced ejection fraction. Journal of the American College of Cardiology, 81, pp. 460-473. (doi: 10.1016/j.jacc.2022.11.006)

Docherty, K. F., Jhund, P. S. (2023) A welcome ‘failure’ of gliflozins: blood pressure reduction in heart failure. European Heart Journal, 44, pp. 408-410. (doi: 10.1093/eurheartj/ehac712)

Boorsma, E. M., ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., Lang, C. C., Ng, L., Anker, S. D., Cleland, J. G., Pellicori, P., Gansevoort, R.T., Heerspink, H. J.L., Voors, A. A., Emmens, J. E. (2023) Albuminuria as a marker of systemic congestion in patients with heart failure. European Heart Journal, 44, pp. 368-380. (doi: 10.1093/eurheartj/ehac528)

Pathak, S., Lai, F. Y., Miksza, J., Petrie, M. C., Roman, M., Murray, S., Dearling, J., Perera, D., Murphy, G. J. (2023) Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial. European Heart Journal, 44, pp. 351-364. (doi: 10.1093/eurheartj/ehac670)

Whinnett, Z. I. et al. (2023) Effects of haemodynamically atrio‐ventricular optimized His‐pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) randomised, double‐blind, cross‐over trial. European Journal of Heart Failure, 25, pp. 274-283. (doi: 10.1002/ejhf.2736)

Docherty, K. F., McMurray, J. J.V., Claggett, B. L., Miao, Z. M., Adams, K. F., Arias‐Mendoza, A., Cleland, J. G.F., Diaz, R., Echeverría Correa, L. E., Felker, G. M., Fonseca, C., Li, J., Metra, M., Sliwa‐Hahnle, K., Solomon, S. D., Vandekerckhove, H. J., Vinereanu, D., Voors, A. A., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Teerlink, J. R. (2023) Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B ‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. European Journal of Heart Failure, 25, pp. 248-259. (doi: 10.1002/ejhf.2763)

Boden, W. E., Marzilli, M., Crea, F., Mancini, G.B. J., Weintraub, W. S., Taqueti, V. R., Pepine, C. J., Escaned, J., Al-Lamee, R., Gowdak, L. H. W., Berry, C., Kaski, J. C. (2023) Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week. Journal of the American College of Cardiology, 81, pp. 505-514. (doi: 10.1016/j.jacc.2022.08.814)

Alexander, C., Bishop, M. J., Gilchrist, R. J., Burton, F. L., Smith, G. L., Myles, R. C. (2023) Initiation of ventricular arrhythmia in the acquired long QT syndrome. Cardiovascular Research, 119, pp. 465-476. (doi: 10.1093/cvr/cvac103)

Kondo, T., Araki, T., Imaizumi, T., Sumita, Y., Nakai, M., Tanaka, A., Okumura, T., Butt, J. H., Petrie, M. C., McMurray, J. J.V., Murohara, T. (2023) Prognosis in patients with cardiogenic shock who received temporary mechanical circulatory support. JACC: Asia, 3, pp. 122-134. (doi: 10.1016/j.jacasi.2022.10.004)

Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147, pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632)

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. (doi: 10.1136/heartjnl-2022-BSCMR.26)

Gulati, M., Khan, N., George, M., Berry, C., Chieffo, A., Camici, P. G., Crea, F., Kaski, J.-C., Marzilli, M., Merz, C. N. B. (2023) Ischemia with no obstructive coronary artery disease (INOCA): a patient self-report quality of life survey from INOCA international. International Journal of Cardiology, 371, pp. 28-39. (doi: 10.1016/j.ijcard.2022.09.047)

Savarese, G., von Haehling, S., Butler, J., Cleland, J. G.F., Ponikowski, P., Anker, S. D. (2023) Iron deficiency and cardiovascular disease. European Heart Journal, 44, pp. 14-27. (doi: 10.1093/eurheartj/ehac569)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10, (doi: 10.1136/openhrt-2022-002192)

Ouwerkerk, W., Tromp, J., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Filippatos, G., Collins, S. P., Lam, C. S. (2023) Association of time‐to‐IV ‐furosemide with mortality in acute heart failure: data from REPORT‐HF. European Journal of Heart Failure, 25, pp. 43-51. (doi: 10.1002/ejhf.2708)

Mc Causland, F. R., Claggett, B. L., Vaduganathan, M., Desai, A. S., Jhund, P., de Boer, R. A., Docherty, K., Fang, J., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Saraiva, J. F. K., McGrath, M. M., Shah, S. J., Verma, S., Langkilde, A. M., Petersson, M., McMurray, J. J. V., Solomon, S. D. (2023) Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction. JAMA Cardiology, 8, pp. 56-65. (doi: 10.1001/jamacardio.2022.4210)

Lee, M. M.Y., Campbell, R. T., Claggett, B. L., Lewis, E. F., Docherty, K. F., Lindner, M., Liu, J., Solomon, S. D., McMurray, J. J.V., Platz, E. (2023) Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion. European Journal of Heart Failure, 25, pp. 54-60. (doi: 10.1002/ejhf.2699)

Petrie, M. C., Jhund, P. S., Connolly, E., Mark, P. B., MacDonald, M. R., Robertson, M., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Wheeler, D. C., Tomson, C. R.V., Ford, I., McMurray, J. J.V., Macdougall, I. C. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119, pp. 213-220. (doi: 10.1093/cvr/cvab317)

Inciardi, R., Pellicori, P., Chandra, A. (2023) Identification and quantification of congestion in heart failure: a work in progress. European Journal of Heart Failure, 25, pp. 61-62. (doi: 10.1002/ejhf.2751)

Perera, D., Berry, C., Hoole, S. P., Sinha, A., Rahman, H., Morris, P. D., Kharbanda, R. K., Petraco, R., Channon, K. (2023) Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart, 109, pp. 88-95. (doi: 10.1136/heartjnl-2021-320718)

Manla, Y., Kuan, W., Clark, A. L., Cleland, J. G. F., Pellicori, P. (2023) Ketone bodies in acute heart failure: fuel for thought. Journal of Cardiac Failure, 29, pp. 42-44. (doi: 10.1016/j.cardfail.2022.11.002)

Everett, C. C., Berry, C., McCann, G. P., Fernandez, C., Reynolds, C., Bucciarelli-Ducci, C., Dall’Armellina, E., Prasad, A., Foley, J. R., Mangion, K., Bijsterveld, P., Brown, J., Stocken, D., Walker, S., Sculpher, M., Plein, S., Greenwood, J. P. (2023) Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2. Open Heart, 10, (doi: 10.1136/openhrt-2022-002221)

Hlatky, M. A., Wilding, S., Stuart, B., Nicholas, Z., Shambrook, J., Eminton, Z., Fox, K., Connolly, D., O’Kane, P., Hobson, A., Chauhan, A., Uren, N., Mccann, G. P., Berry, C., Carter, J., Roobottom, C., Mamas, M., Rajani, R., Ford, I., Douglas, P. S., Curzen, N. (2023) Randomized comparison of chest pain evaluation with FFRCT or standard care: factors determining US costs. Journal of Cardiovascular Computed Tomography, 17, pp. 52-59. (doi: 10.1016/j.jcct.2022.09.005)

Ferreira, J. P., Cleland, J. G., Girerd, N., Bozec, E., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., Solomon, S. D., Pitt, B., Pfeffer, M. A., Shah, A. M., Petutschnigg, J., Pieske, B., Edelmann, F., Zannad, F. (2023) Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials. European Journal of Heart Failure, 25, pp. 108-113. (doi: 10.1002/ejhf.2726)

Mizani, M. A., Dashtban, A., Pasea, L., Lai, A. G., Thygesen, J., Tomlinson, C., Handy, A., Mamza, J. B., Morris, T., Khalid, S., Zaccardi, F., Macleod, M. J., Torabi, F., Canoy, D., Akbari, A., Berry, C., Bolton, T., Nolan, J., Khunti, K., Denaxas, S., Hemingway, H., Sudlow, C., Banerjee, A. (2023) Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19–a data-driven retrospective cohort study. Journal of the Royal Society of Medicine, 116, pp. 10-20. (doi: 10.1177/01410768221131897)

Perera, D., Ryan, M., Morgan, H. P., Greenwood, J. P., Petrie, M. C., Dodd, M., Weerackody, R., O'Kane, P. D., Masci, P. G., Nazir, M. S., Papachristidis, A., Chahal, N., Khattar, R., Ezad, S. M., Kapetanakis, S., Dixon, L. J., De Silva, K., McDiarmid, A. K., Marber, M. S., McDonagh, T., McCann, G. P., Clayton, T. C., Senior, R., Chiribiri, A. (2023) Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 Trial. JAMA Cardiology, 8, pp. 1154-1161. (doi: 10.1001/jamacardio.2023.3803)

Collet, C., Collison, D., Mizukami, T., McCartney, P., Sonck, J., Ford, T., Munhoz, D., Berry, C., De Bruyne, B., Oldroyd, K. (2022) Differential improvement in angina and health-related quality of life after PCI in focal and diffuse coronary artery disease. JACC: Cardiovascular Interventions, 15, pp. 2506-2518. (doi: 10.1016/j.jcin.2022.09.048)

Kalra, P. R., Cleland, J. G.F., Petrie, M. C., Thomson, E. A., Kalra, P. A., Squire, I. B., Ahmed, F. Z., Al-Mohammad, A., Cowburn, P. J., Foley, P. W.X., Graham, F. J., Japp, A. G., Lane, R. E., Lang, N. N., Ludman, A. J., Macdougall, I. C., Pellicori, P., Ray, R., Robertson, M., Seed, A., Ford, I. (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400, pp. 2199-2209. (doi: 10.1016/S0140-6736(22)02083-9)

Mehran, R., Steg, P. G., Pfeffer, M. A., Jering, K., Claggett, B., Lewis, E. F., Granger, C., Køber, L., Maggioni, A., Mann, D. L., McMurray, J. J.V., Rouleau, J.-L., Solomon, S. D., Ducrocq, G., Berwanger, O., De Pasquale, C. G., Landmesser, U., Petrie, M., Leng, D. S. K., van der Meer, P., Lefkowitz, M., Zhou, Y., Braunwald, E. (2022) The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial. Circulation, 146, pp. 1749-1757. (doi: 10.1161/CIRCULATIONAHA.122.060841)

Bhandari, S., Mehta, S., Khwaja, A., Cleland, J. G.F., Ives, N., Brettell, E., Chadburn, M., Cockwell, P. (2022) Renin-angiotensin system inhibition in advanced chronic kidney disease. New England Journal of Medicine, 387, pp. 2021-2032. (doi: 10.1056/NEJMoa2210639)

Saxena, P., Myles, R. C., Smith, G. L., Workman, A. J. (2022) Adrenoceptor sub-type involvement in Ca2+ current stimulation by noradrenaline in human and rabbit atrial myocytes. Pflügers Archiv European Journal of Physiology, 474, pp. 1311-1321. (doi: 10.1007/s00424-022-02746-z)

Vardeny, O., Fang, J. C., Desai, A. S., Jhund, P. S., Claggett, B., Vaduganathan, M., de Boer, R. A., Hernandez, A. F., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., Kosiborod, M. N., DeMets, D., O’Meara, E., Zieroth, S., Comin-Colet, J., Drozdz, J., Chiang, C.-E., Kitakaze, M., Petersson, M., Lindholm, D., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature Medicine, 28, pp. 2504-2511. (doi: 10.1038/s41591-022-02102-9)

Yang, M., Butt, J. H., Kondo, T., Jering, K. S., Docherty, K. F., Jhund, P. S., de Boer, R. A., Claggett, B. L., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Langkilde, A. M., Martinez, F. A., Petersson, M., Shah, S. J., Vaduganathan, M., Wilderäng, U., Solomon, S. D., McMurray, J. J.V. (2022) Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan. European Journal of Heart Failure, 24, pp. 2307-2319. (doi: 10.1002/ejhf.2722)

Gregers, M. C. T., Schou, M., Jensen, M. T., Jensen, J., Petrie, M. C., Vilsbøll, T., Goetze, J. P., Rossing, P., Jørgensen, P. G. (2022) Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes. Scandinavian Cardiovascular Journal, 56, pp. 256-263. (doi: 10.1080/14017431.2022.2095435)

Monzo, L., Ferreira, J. P., Cleland, J. G.F., Pellicori, P., Mariottoni, B., Hazebroek, M. R., Collier, T. J., Cuthbert, J. J., Pieske, B., Petutschnigg, J., Ahmed, F. Z., Girerd, N., Clark, A. L., Cosmi, F., Staessen, J. A., Heymans, S., Rossignol, P., Zannad, F. (2022) Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial. ESC Heart Failure, 9, pp. 4352-4357. (doi: 10.1002/ehf2.14086)

Inzucchi, S. E., Claggett, B. L., Vaduganathan, M., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Shah, S. J., Verma, S., Han, Y., Kerr Saraiva, J. F., Bengtsson, O., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes and Endocrinology, 10, pp. 869-881. (doi: 10.1016/S2213-8587(22)00308-4)

Pugliese, N. R., Pellicori, P., Filidei, F., De Biase, N., Maffia, P., Guzik, T. J., Masi, S., Taddei, S., Cleland, J. G.F. (2022) Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. Cardiovascular Research, 118, pp. 3536-3555. (doi: 10.1093/cvr/cvac133)

Myhre, P. L., Vaduganathan, M., Claggett, B. L., Miao, Z. M., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., Lindholm, D., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Influence of NT-proBNP on efficacy of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. JACC: Heart Failure, 10, pp. 902-913. (doi: 10.1016/j.jchf.2022.08.007)

Bracun, V., van Essen, B., Voors, A. A., van Veldhuisen, D. J., Dickstein, K., Zannad, F., Metra, M., Anker, S., Samani, N. J., Ponikowski, P., Filippatos, G., Cleland, J. G.F., Lang, C. C., Ng, L. L., Shi, C., de Wit, S., About Msallem, J. P., Meijers, W. C., Klip, I. T., van der Meer, P., de Boer, R. A. (2022) Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. ESC Heart Failure, 9, pp. 4167-4176. (doi: 10.1002/ehf2.14120)

Mark, P. B., Mangion, K., Rankin, A. J., Rutherford, E., Lang, N. N., Petrie, M. C., Stoumpos, S., Patel, R. K. (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clinical Kidney Journal, 15, pp. 2186-2199. (doi: 10.1093/ckj/sfac146)

Suda, A., Takahashi, J., Schwidder, M., Ong, P., Ang, D., Berry, C., Camici, P. G., Crea, F., Carlos Kaski, J., Pepine, C., Rimoldi, O., Sechtem, U., Yasuda, S., Beltrame, J. F., Noel Bairey Merz, C., Shimokawa, H., Coronary Vasomotor Disorders International Study COVADIS Group, . (2022) Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS- International Journal of Cardiology: Heart and Vasculature, 43, (doi: 10.1016/j.ijcha.2022.101139)

Kalra, P. R., Cleland, J. G. F., Petrie, M. C., Ahmed, F. Z., Foley, P. W. X., Kalra, P. A., Lang, N. N., Lane, R. E., Macdougall, I. C., Pellicori, P., Pope, M. T. B., Robertson, M., Squire, I. B., Thomson, E. A., Ford, I. (2022) Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart, 108, pp. 1979-1985. (doi: 10.1136/heartjnl-2022-321304)

Bradley, C., Berry, C. (2022) Retinal microvascular function: a tractable biomarker of cardiovascular risk? Cardiovascular Research, 118, pp. 3169-3170. (doi: 10.1093/cvr/cvac170)

Kumar, A. A., Yeo, N., Whittaker, M., Attra, P., Barrick, T. R., Bridges, L. R., Dickson, D. W., Esiri, M. M., Farris, C. W., Graham, D., Lin, W. L., Meijles, D. N., Pereira, A. C., Perry, G., Rosene, D. L., Shtaya, A. B., Van Agtmael, T., Zamboni, G., Hainsworth, A. H. (2022) Vascular collagen type-IV in hypertension and cerebral small vessel disease. Stroke, 53, pp. 3696-3705. (doi: 10.1161/STROKEAHA.122.037761)

Cervilla-Martínez, J. F., Rodríguez-Gotor, J. J., Wypijewski, K. J., Fontán-Lozano, Á., Wang, T., Santamaría, E., Fuller, W., Mejías, R. (2022) Altered cortical palmitoylation induces widespread molecular disturbances in Parkinson's disease. International Journal of Molecular Sciences, 23, (doi: 10.3390/ijms232214018)

McErlane, J., McCall, P., Willder, J., Berry, C., Shelley, B. (2022) Right ventricular free wall longitudinal strain is independently associated with mortality in mechanically ventilated patients with COVID-19. Annals of Intensive Care, 12, (doi: 10.1186/s13613-022-01077-7)

Tromp, J., Bauer, D., Claggett, B. L., Frost, M., Iversen, M. B., Prasad, N., Petrie, M. C., Larson, M. G., Ezekowitz, J. A., Solomon, S. D. (2022) A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram. Nature Communications, 13, (doi: 10.1038/s41467-022-34245-1)

Vaduganathan, M., Claggett, B. L., Jhund, P., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., Lindholm, D., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Estimated event-free survival benefits with dapagliflozin in HF with mildly reduced or preserved ejection fraction. Journal of the American College of Cardiology, 80, pp. 1775-1784. (doi: 10.1016/j.jacc.2022.08.745)

Paterson, C., Hinterberg, M. A., Morrow, A. J., Sykes, R., Mangion, K., Welsh, P., McConnachie, A., Sattar, N., Berry, C., Williams, S. A. (2022) Utility of a Proteomic Surrogate for Cardiovascular Outcomes to Predict and Monitor COVID-19 Induced Myocarditis. (doi: 10.1161/circ.146.suppl_1.12132)

Kondo, T., Abdul-Rahim, A. H., Talebi, A., Abraham, W. T., Desai, A. S., Dickstein, K., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Packer, M., Petrie, M., Ponikowski, P., Rouleau, J. L., Sabatine, M. S., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. European Heart Journal, 43, pp. 4469-4479. (doi: 10.1093/eurheartj/ehac487)

Zhang, L. et al. (2022) Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction. Circulation, 146, pp. 1411-1414. (doi: 10.1161/CIRCULATIONAHA.122.061481)

Adamson, C. et al. (2022) Dapagliflozin for heart failure according to body mass index: the DELIVER trial. European Heart Journal, 43, pp. 4406-4417. (doi: 10.1093/eurheartj/ehac481)

Butt, J. H., Kondo, T., Jhund, P. S., Comin-Colet, J., de Boer, R. A., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Janssens, S. P., Kosiborod, M. N., Lam, C. S.P., Langkilde, A. M., Lindholm, D., Martinez, F., Petersson, M., Shah, S. J., Thierer, J., Vaduganathan, M., Verma, S., Wilderäng, U., Claggett, B. C., Solomon, S. D., McMurray, J. J.V. (2022) Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER. Journal of the American College of Cardiology, 80, pp. 1705-1717. (doi: 10.1016/j.jacc.2022.08.718)

Butler, J. et al. (2022) Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European Heart Journal, 43, pp. 4362-4373. (doi: 10.1093/eurheartj/ehac401)

Pellicori, P., Kalra, P. R., Clark, A. L., Friday, J., Cleland, J. G. F. (2022) Chronic kidney disease (CKD) and CKD-ism in heart failure – what a mess! European Journal of Heart Failure, 24, pp. 2196-2198. (doi: 10.1002/ejhf.2696)

Yang, Y., Gao, H., Berry, C., Carrick, D., Radjenovic, A., Husmeier, D. (2022) Classification of myocardial blood flow based on dynamic contrast-enhanced magnetic resonance imaging using hierarchical Bayesian models. Journal of the Royal Statistical Society: Series C (Applied Statistics), 71, pp. 1085-1115. (doi: 10.1111/rssc.12568)

Inciardi, R. M., Pagnesi, M., Lombardi, C. M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Pellicori, P., Ponikowski, P., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Solomon, S. D., Voors, A. A., Metra, M. (2022) Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure. European Journal of Heart Failure, 24, pp. 2131-2139. (doi: 10.1002/ejhf.2593)

Morris, P. D., Al-Lamee, R. K., Berry, C., on behalf of the BCIS Research and Development Committee, (2022) Coronary physiological assessment in the catheter laboratory: haemodynamics, clinical assessment and future perspectives. Heart, 108, pp. 1737-1746. (doi: 10.1136/heartjnl-2020-318743)

Lachaud, Q., Aziz, M. H. N., Burton, F. L., Macquaide, N., Myles, R. C., Simitev, R. D., Smith, G. L. (2022) Electrophysiological heterogeneity in large populations of rabbit ventricular cardiomyocytes. Cardiovascular Research, 118, pp. 3112-3125. (doi: 10.1093/cvr/cvab375)

Harrington, J., Udell, J. A., Jones, W. S., Anker, S. D., Bhatt, D. L., Petrie, M. C., Vedin, O., Sumin, M., Zwiener, I., Hernandez, A. F., Butler, J. (2022) Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. American Heart Journal, 253, pp. 86-98. (doi: 10.1016/j.ahj.2022.05.010)

Sun, G., Yafasova, A., Andersson, C., McMurray, J. J.V., Jhund, P. S., Docherty, K. F., Faurschou, M., Nielsen, C. T., Schou, M., Gislason, G. H., Torp-Pedersen, C., Fosbøl, E. L., Køber, L., Butt, J. H. (2022) Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis. Rheumatology, 61, pp. 4374-4383. (doi: 10.1093/rheumatology/keac072)

Jhund, P. S. (2022) Implementing the evidence – the true summit of evidence based care and the false peak of guidelines. European Journal of Heart Failure, 24, pp. 2090-2092. (doi: 10.1002/ejhf.2712)

Arulmurugananthavadivel, A., Holt, A., Parveen, S., Lamberts, M., Gislason, G. H., Torp-Pedersen, C., Madelaire, C., Andersson, C., Zahir, D., Butt, J. H., Petrie, M. C., McMurray, J., Fosbol, E. L., Kober, L., Schou, M. (2022) Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark 1997–2017. European Heart Journal: Quality of Care and Clinical Outcomes, 8, pp. 750-760. (doi: 10.1093/ehjqcco/qcab073)

Adamson, C., Jhund, P. S., McMurray, J. J.V. (2022) Reply to 'the 50 shades of bilirubin'. Letter regarding the article 'liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF' European Journal of Heart Failure, 24, pp. 2206-2207. (doi: 10.1002/ejhf.2683)

Mary, S., Boder, P., Padmanabhan, S., McBride, M. W., Graham, D., Delles, C., Dominiczak, A. F. (2022) The role of uromodulin in salt-sensitive hypertension. Hypertension, 79, pp. 2419-2429. (doi: 10.1161/HYPERTENSIONAHA.122.19888)

Seckin, M., Johnston, B., Petrie, M. C., Stewart, S., Chan, Y.-K. (2022) Characteristics of symptoms and symptom change across different heart failure subtypes: a sex-stratified analysis. European Journal of Cardiovascular Nursing, (doi: 10.1093/eurjcn/zvac099)

Salah, H. M., Goldberg, L. R., Molinger, J., Felker, G. M., Applefeld, W., Rassaf, T., Tedford, R. J., Mirro, M., Cleland, J. G.F., Fudim, M. (2022) Diaphragmatic function in cardiovascular disease: JACC review topic of the week. Journal of the American College of Cardiology, 80, pp. 1647-1659. (doi: 10.1016/j.jacc.2022.08.760)

Butt, J. H. et al. (2022) Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial. Circulation, 146, pp. 1210-1224. (doi: 10.1161/CIRCULATIONAHA.122.061754)

Bruegmann, T., Smith, G. L., Lehnart, S. E. (2022) Editorial: Cardiac optogenetics: Using light to observe and excite the heart. Frontiers in Physiology, 13, (doi: 10.3389/fphys.2022.1031062)

Lota, A. S. et al. (2022) Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation, 146, pp. 1123-1134. (doi: 10.1161/CIRCULATIONAHA.121.058457)

Main, A., Bogusalvskyii, A., Howie, J., Kuo, C.-W., Rankin, A., Burton, F. L., Smith, G. L., Hajjar, R., Baillie, G. S., Campbell, K. S., Shattock, M. J., Fuller, W. (2022) Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies. Frontiers in Physiology, 13, (doi: 10.3389/fphys.2022.1023237)

Garred, C. H., Zahir, D., Butt, J. H., Ravn, P. B., Bruhn, J., Gislason, G. H., Fosbøl, E. L., Torp‐Pedersen, C., Petrie, M. C., McMurray, J. J.V., Køber, L., Schou, M. (2022) Adherence and discontinuation of optimal heart failure therapies according to age: a Danish nationwide study. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.122.026187)

Ford, T. J., Adamson, C., Morrow, A. J., Rocchiccioli, P., Collison, D., McCartney, P. J., Shaukat, A., Lindsay, M., Good, R., Watkins, S., Eteiba, H., Robertson, K., Berry, C., Oldroyd, K. G., McEntegart, M. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.121.024492)

Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Desai, A. S., Jhund, P. S., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., McGrath, M. M., O’Meara, E., Wilderäng, U., Lindholm, D., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Dapagliflozin in patients recently hospitalized with heart failure and mildly reduced or preserved ejection fraction. Journal of the American College of Cardiology, 80, pp. 1302-1310. (doi: 10.1016/j.jacc.2022.07.021)

Shah, A. M., Claggett, B., Prasad, N., Li, G., Volquez, M., Jering, K., Cikes, M., Kovacs, A., Mullens, W., Nicolau, J. C., Køber, L., van der Meer, P., Jhund, P. S., Ibram, G., Lefkowitz, M., Zhou, Y., Solomon, S. D., Pfeffer, M. A. (2022) Impact of sacubitril/valsartan compared to ramipril on cardiac structure and function following acute myocardial infarction: The PARADISE-MI echocardiographic sub-study. Circulation, 146, pp. 1067-1081. (doi: 10.1161/CIRCULATIONAHA.122.059210)

Desai, A. S., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Miao, Z. M., Kondo, T., Barkoudah, E., Brahimi, A., Connolly, E., Finn, P., Lang, N. N., Mc Causland, F. R., McGrath, M., Petrie, M. C., McMurray, J. J.V., Solomon, S. D. (2022) Effect of dapagliflozin on cause-specific mortality in patients with heart failure across the spectrum of ejection fraction. JAMA Cardiology, 7, pp. 1227-1234. (doi: 10.1001/jamacardio.2022.3736)

Baumhove, L., Tromp, J., Figarska, S., van Essen, B. J., Anker, S. D., Dickstein, K., Cleland, J. G., Lang, C. C., Filippatos, G., Ng, L. L., Samani, N. J., Metra, M., van Veldhuisen, D. J., Lam, C. S.P., Voors, A. A., van der Meer, P. (2022) Heart failure with normal LVEF in BIOSTAT-CHF. International Journal of Cardiology, 364, pp. 85-90. (doi: 10.1016/j.ijcard.2022.05.054)

Bayes‐Genis, A. et al. (2022) Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 24, pp. 1767-1777. (doi: 10.1002/ejhf.2675)

Jhund, P. S. (2022) Cardiopulmonary functional capacity: another piece of the puzzle of SGLT2 inhibition in heart failure? European Journal of Heart Failure, 24, pp. 1827-1828. (doi: 10.1002/ejhf.2672)

Núñez, J. et al. (2022) Congestion in heart failure: a circulating biomarker‐based perspective. European Journal of Heart Failure, 24, pp. 1751-1766. (doi: 10.1002/ejhf.2664)

Ostrominski, J. W., Vaduganathan, M., Claggett, B. L., de Boer, R. A., Desai, A. S., Dobreanu, D., Hernandez, A. F., Inzucchi, S. E., Jhund, P. S., Kosiborod, M., Lam, C. S.P., Langkilde, A. M., Lindholm, D., Martinez, F. A., O'Meara, E., Petersson, M., Shah, S. J., Thierer, J., McMurray, J. J.V., Solomon, S. D. (2022) Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. European Journal of Heart Failure, 24, pp. 1892-1901. (doi: 10.1002/ejhf.2652)

Kazmi, S., Kambhampati, C., Cleland, J. G.F., Cuthbert, J., Kazmi, K. S., Pellicori, P., Rigby, A. S., Clark, A. L. (2022) Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure. ESC Heart Failure, 9, pp. 3009-3018. (doi: 10.1002/ehf2.14028)

Peikert, A., Martinez, F. A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Desai, A. S., Jhund, P. S., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Shah, S. J., Katova, T., Merkely, B., Vardeny, O., Wilderäng, U., Lindholm, D., Petersson, M., Langkilde, A.-M., McMurray, J. J.V., Solomon, S. D. (2022) Efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial. Circulation: Heart Failure, 15, pp. 934-943. (doi: 10.1161/CIRCHEARTFAILURE.122.010080)

Harrington, J., Petrie, M. C., Anker, S. D., Bhatt, D. L., Jones, S. W., Udell, J. A., Hernandez, A. F., Butler, J. (2022) Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction. JAMA Cardiology, 7, pp. 1067-1075. (doi: 10.1001/jamacardio.2022.2847)

Adamson, C., Cowan, L. M., de Boer, R. A., Diez, M., Drożdż, J., Dukát, A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ljungman, C. E.A., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Lindholm, D., Bengtsson, O., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V., Jhund, P. S. (2022) Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF. European Journal of Heart Failure, 24, pp. 1856-1868. (doi: 10.1002/ejhf.2649)

Claggett, B. L., McCaw, Z. R., Tian, L., McMurray, J. J.V., Jhund, P. S., Uno, H., Pfeffer, M. A., Solomon, S. D., Wei, L.-J. (2022) Quantifying treatment effects in trials with multiple event-time outcomes. NEJM Evidence, 1, (doi: 10.1056/EVIDoa2200047)

Welsh, P., Campbell, R. T., Mooney, L., Kimenai, D. M., Hayward, C., Campbell, A., Porteous, D., Mills, N., Lang, N. N., Petrie, M. C., Januzzi, J. L., McMurray, J. J.V., Sattar, N. (2022) Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circulation: Heart Failure, 15, pp. 957-967. (doi: 10.1161/CIRCHEARTFAILURE.121.009427)

Cooper, T. J., Pellicori, P., Ushakov, A., Dickstein, K. (2022) Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease' European Journal of Heart Failure, 24, pp. 1990-1992. (doi: 10.1002/ejhf.2690)

McDowell, K., Jhund, P. S., McMurray, J. J.V. (2022) Reply to 'sodium-glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction - lessons from clinical trials' European Journal of Heart Failure, 24, pp. 1994. (doi: 10.1002/ejhf.2686)

Jhund, P. S. (2022) SGLT2 inhibitors and heart failure with preserved ejection fraction. Heart Failure Clinics, 18, pp. 579-586. (doi: 10.1016/j.hfc.2022.03.010)

Fertig, B., Ling, J., Nollet, E. E., Dobi, S., Busiau, T., Ishikawa, K., Yamada, K., Lee, A., Kho, C., Wills, L., Tibbo, A. J., Scott, M., Grant, K., Campbell, K. S., Birks, E. J., MacQuaide, N., Hajjar, R., Smith, G. L., van der Velden, J., Baillie, G. (2022) SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca2+ FEBS Journal, 289, pp. 6267-6285. (doi: 10.1111/febs.16537)

Berry, C., Morrow, A. J., Marzilli, M., Pepine, C. J. (2022) What is the role of assessing ischemia to optimize therapy and outcomes for patients with stable angina and non-obstructed coronary arteries? Cardiovascular Drugs and Therapy, 36, pp. 1027-1038. (doi: 10.1007/s10557-021-07179-x)

Ferreira, J. P., Claggett, B. L., Docherty, K. F., Jhund, P. S., Zannad, F., Solomon, S. D., McMurray, J. J.V. (2022) Within trial comparison of survival time projections from short-term follow-up with long-term follow-up findings. ESC Heart Failure, 9, pp. 3655-3658. (doi: 10.1002/ehf2.13731)

Docherty, K. F., Welsh, P., Verma, S., De Boer, R. A., O'Meara, E., Bengtsson, O., Køber, L., Kosiborod, M. N., Hammarstedt, A., Langkilde, A. M., Lindholm, D., Little, D. J., Sjöstrand, M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Morrow, D. A., Schou, M., Solomon, S. D., Sattar, N., Jhund, P. S., McMurray, J. J.V. (2022) Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF. Circulation, 146, pp. 980-994. (doi: 10.1161/CIRCULATIONAHA.122.060511)

Solomon, S. D. et al. (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. New England Journal of Medicine, 387, pp. 1089-1098. (doi: 10.1056/NEJMoa2206286)

Butt, J. H., Dewan, P., Jhund, P. S., Anand, I. S., Atar, D., Ge, J., Desai, A. S., Echeverria, L. E., Køber, L., Lam, C. S.P., Maggioni, A. P., Martinez, F., Packer, M., Rouleau, J. L., Sim, D., Van Veldhuisen, D. J., Vrtovec, B., Zannad, F., Zile, M. R., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Solomon, S. D., McMurray, J. J.V. (2022) Sacubitril/valsartan and frailty in patients with heart failure and preserved ejection fraction. Journal of the American College of Cardiology, 80, pp. 1130-1143. (doi: 10.1016/j.jacc.2022.06.037)

Vaduganathan, M., Docherty, K. F., Claggett, B. L., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., McMurray, J. J.V., Solomon, S. D. (2022) SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet, 400, pp. 757-767. (doi: 10.1016/S0140-6736(22)01429-5)

Mc Causland, F. R., Lefkowitz, M. P., Claggett, B., Packer, M., Senni, M., Gori, M., Jhund, P. S., McGrath, M. M., Rouleau, J. L., Shi, V., Swedberg, K., Vaduganathan, M., Zannad, F., Pfeffer, M. A., Zile, M., McMurray, J. J.V., Solomon, S. D. (2022) Angiotensin‐neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure. European Journal of Heart Failure, 24, pp. 1591-1598. (doi: 10.1002/ejhf.2421)

Jhund, P. S., Kondo, T., Butt, J. H., Docherty, K. F., Claggett, B. L., Desai, A. S., Vaduganathan, M., Gasparyan, S. B., Bengtsson, O., Lindholm, D., Petersson, M., Langkilde, A. M., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Køber, L., Lam, C. S. P., Martinez, F. A., Sabatine, M. S., Shah, S. J., Solomon, S. D., McMurray, J. J. V. (2022) Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nature Medicine, 28, pp. 1956-1964. (doi: 10.1038/s41591-022-01971-4)

Ravera, A., Santema, B. T., de Boer, R. A., Anker, S. D., Samani, N. J., Lang, C. C., Ng, L., Cleland, J. G.F., Dickstein, K., Lam, C. S.P., Van Spall, H., Filippatos, G., van Veldhuisen, D. J., Metra, M., Voors, A. A., Sama, I. E. (2022) Distinct pathophysiological pathways in women and men with heart failure. European Journal of Heart Failure, 24, pp. 1532-1544. (doi: 10.1002/ejhf.2534)

Gao, X., Kuo, C.-W., Main, A., Brown, E., Rios, F. J., De Lucca Camargo, L., Mary, S., Wypijewski, K., Gök, C., Touyz, R. M., Fuller, W. (2022) Palmitoylation regulates cellular distribution of and transmembrane Ca flux through TrpM7. Cell Calcium, 106, (doi: 10.1016/j.ceca.2022.102639)

Kobayashi, M., Girerd, N., Ferreira, J. P., Kevin, D., Huttin, O., González, A., Bozec, E., Clark, A. L., Cosmi, F., Cuthbert, J., Diez, J., Edelmann, F., Hazebroek, M., Heymans, S., Mariottoni, B., Pellicori, P., Petutschnigg, J., Pieske, B., Staessen, J. A., Verdonschot, J. A.J., Rossignol, P., Cleland, J. G.F., Zannad, F. (2022) The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24, pp. 1559-1568. (doi: 10.1002/ejhf.2579)

Stables, R. H. et al. (2022) Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease: the RIPCORD 2 trial. Circulation, 146, pp. 687-698. (doi: 10.1161/CIRCULATIONAHA.121.057793)

Adamson, C., Docherty, K. F., Heerspink, H. J.L., de Boer, R. A., Damman, K., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Solomon, S. D., Verma, S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Jhund, P. S., McMurray, J. J.V. (2022) Initial decline ("dip") in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF. Circulation, 146, pp. 438-449. (doi: 10.1161/CIRCULATIONAHA.121.058910)

Mangion, K., Berry, C. (2022) Multisystem involvement in COVID-19: what have we learnt? British Journal of Hospital Medicine, 83, pp. 1-5. (doi: 10.12968/hmed.2022.0290)

Savarese, G., Uijl, A., Ouwerkerk, W., Tromp, J., Anker, S. D., Dickstein, K., Hage, C., Lam, C. S.P., Lang, C. C., Metra, M., Ng, L. L., Orsini, N., Samani, N. J., van Veldhuisen, D. J., Cleland, J. G.F., Voors, A. A., Lund, L. H. (2022) Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction. ESC Heart Failure, 9, pp. 2107-2118. (doi: 10.1002/ehf2.13917)

Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G. S., Inciardi, R. M., Lang, C. C., Lombardi, C. M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Voors, A. A., Metra, M. (2022) Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. Clinical Research in Cardiology, 111, pp. 912-923. (doi: 10.1007/s00392-022-01991-7)

Bradley, C., Berry, C. (2022) Definition and epidemiology of coronary microvascular disease. Journal of Nuclear Cardiology, 29, pp. 1763-1775. (doi: 10.1007/s12350-022-02974-x)

Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, T., Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, L., Fiuzat, M., McMurray, J. J.V. (2022) Effects of dapagliflozin according to the heart failure collaboratory medical therapy score insights from DAPA-HF. JACC: Heart Failure, 10, pp. 543-555. (doi: 10.1016/j.jchf.2022.03.009)

Segar, M. W., Hall, J. L., Jhund, P. S., Powell-Wiley, T. M., Morris, A. A., Kao, D., Fonarow, G. C., Hernandez, R., Ibrahim, N. E., Rutan, C., Navar, A. M., Stevens, L. S., Pandey, A. (2022) Machine learning–based models incorporating social determinants of health vs traditional models for predicting in-hospital mortality in patients with heart failure. JAMA Cardiology, 7, pp. 844-854. (doi: 10.1001/jamacardio.2022.1900)

Hoes, M. F., Arany, Z., Bauersachs, J., Hilfiker-Kleiner, D., Petrie, M. C., Sliwa, K., van der Meer, P. (2022) Pathophysiology and risk factors of peripartum cardiomyopathy. Nature Reviews Cardiology, 19, pp. 555-565. (doi: 10.1038/s41569-021-00664-8)

Rossignol, P., Silva-Cardoso, J., Kosiborod, M.N., Brandenburg, V., Cleland, J.G., Hadimeri, H., Hullin, R., Makela, S., Mörtl, D., Paoletti, E., Pollock, C., Vogt, L., Jadoul, M., Butler, J. (2022) Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease. Pharmacological Research, 182, (doi: 10.1016/j.phrs.2022.106277)

Ryan, M., Perera, D., Petrie, M. C. (2022) Revascularisation and HFpEF – time for randomised trials. European Journal of Heart Failure, 24, pp. 1439-1440. (doi: 10.1002/ejhf.2583)

Deo, S. V., Reddy, Y. N.V., Zakeri, R., Karnib, M., Selvaganesan, P., Elgudin, Y., Kilic, A., Rubelowsky, J., Altarabsheh, S. E., Osman, M. N., Josephson, R. A., Mohan, S. K. M., Cmolik, B., Simon, D. I., Rajagopalan, S., Cleland, J. G.F., Sahadevan, J., Sundaram, V. (2022) Revascularization in ischemic heart failure with preserved ejection fraction: a nationwide cohort study. European Journal of Heart Failure, 24, pp. 1427-1438. (doi: 10.1002/ejhf.2446)

Jorbendaze, A., Young, R., Shaburishvili, T., Demyanchuk, V., Buriak, R., Todurov, B., Rudenko, K., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P., Mirro, M., Fudim, M., Goldberg, L. R., Cleland, J. G.F. (2022) Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first‐in‐patient study. ESC Heart Failure, 9, pp. 2207-2214. (doi: 10.1002/ehf2.13984)

Girerd, N., Von Hunolstein, J.-J., Pellicori, P., Bayés-Genís, A., Jaarsma, T., Lund, L. H., Bilbault, P., Boivin, J.-M., Chouihed, T., Costa, J., Eicher, J.-C., Fall, E., Kenizou, D., Maillier, B., Nazeyrollas, P., Roul, G., Zannad, N., Rossignol, P., Seronde, M.-F. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, 9, pp. 2063-2069. (doi: 10.1002/ehf2.13929)

Lip, S., Dempster, G., Jain, S., Brooksbank, K., Ghouri, N., McCallum, L., Padmanabhan, S. (2022) Underrepresentation of ethnic minorities in hypertension research—a survey of enablers and barriers among South Asian and African communities in Glasgow. Trials, 23, (doi: 10.1186/s13063-022-06542-z)

Yang, Y., Gao, H., Berry, C., Radjenovic, A., Husmeier, D. (2022) Myocardial Perfusion Classification Using A Markov Random Field Constrained Gaussian Mixture Model. (doi: 10.11159/icsta22.146)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) Circulation, 146, pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851)

Lewis, G. D., Voors, A. A., Cohen-Solal, A., Metra, M., Whellan, D. J., Ezekowitz, J. A., Böhm, M., Teerlink, J. R., Docherty, K. F., Lopes, R. D., Divanji, P. H., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Wohltman, A., Felker, G. M. (2022) Effect of omecamtiv mecarbil on exercise capacity in chronic heart failure with reduced ejection fraction. JAMA: Journal of the American Medical Association, 328, pp. 259-269. (doi: 10.1001/jama.2022.11016)

Lewinter, C., Nielsen, T. H., Edfors, L. R., Linde, C., Bland, J. M., LeWinter, M., Cleland, J. G.F., Køber, L., Braunschweig, F., Mansson-Broberg, A. (2022) A systematic review and meta-analysis of beta-blockers and inhibitors of the renin-angiotensin system for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. European Heart Journal, 43, pp. 2562-2569. (doi: 10.1093/eurheartj/ehab843)

Shen, L., Jhund, P. S., Docherty, K. F., Vaduganathan, M., Petrie, M. C., Desai, A. S., Køber, L., Schou, M., Packer, M., Solomon, S. D., Zhang, X., McMurray, J. J. V. (2022) Accelerated and personalized therapy for heart failure with reduced ejection fraction. European Heart Journal, 43, pp. 2573-2587. (doi: 10.1093/eurheartj/ehac210)

Cowie, M., Cleland, J. G.F. (2022) The COVID-19 pandemic and heart failure: lessons from GUIDE-HF. European Heart Journal, 43, pp. 2619-2621. (doi: 10.1093/eurheartj/ehac226)

Ferreira, V. M., Berry, C. (2022) The health economics of ischemia with nonobstructive coronary arteries. JACC: Cardiovascular Imaging, 14, pp. 1380-1383. (doi: 10.1016/j.jcmg.2021.03.017)

Cester, L., Starshynov, I., Jones, Y., Pellicori, P., Cleland, J. G.F., Faccio, D. (2022) Remote laser-speckle sensing of heart sounds for health assessment and biometric identification. Biomedical Optics Express, 13, pp. 3743-3750. (doi: 10.1364/BOE.451416)

Rao, S., Li, Y., Ramakrishnan, R., Hassaine, A., Canoy, D., Cleland, J. G., Lukasiewicz, T., Salimi-Khorshidi, G., Rahimi, K. (2022) An explainable transformer-based deep learning model for the prediction of incident heart failure. IEEE Journal of Biomedical and Health Informatics, 26, pp. 3362-3372. (doi: 10.1109/JBHI.2022.3148820)

Bularga, A. et al. (2022) Assessment of oxygen supply-demand imbalance and outcomes among patients with type 2 myocardial infarction: a secondary analysis of the High-STEACS cluster randomized clinical trial. JAMA Network Open, 5, (doi: 10.1001/jamanetworkopen.2022.20162)

Cooper, T. J., Cleland, J. G.F., Guazzi, M., Pellicori, P., Ben Gal, T., Amir, O., Al‐Mohammad, A., Clark, A. L., McConnachie, A., Steine, K., Dickstein, K. (2022) Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomised placebo‐controlled multicentre trial. European Journal of Heart Failure, 24, pp. 1239-1248. (doi: 10.1002/ejhf.2527)

Ang, D., Berry, C. (2022) FAVOR III China: quantitative flow ratio-guided coronary intervention in practice. Cardiovascular Research, 118, pp. e78-e80. (doi: 10.1093/cvr/cvac109)

Gallacher, P. J. et al. (2022) High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with renal impairment. Kidney International, 102, pp. 149-159. (doi: 10.1016/j.kint.2022.02.019)

Houchen-Wolloff, L. et al. (2022) Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19. Thorax, 77, pp. 717-720. (doi: 10.1136/thoraxjnl-2021-218582)

Santema, B. T., Artola Arita, V., Sama, I. E., Kloosterman, M., van den Berg, M. P., Nienhuis, H. L.A., Van Gelder, I. C., van der Meer, P., Zannad, F., Metra, M., Ter Maaten, J. M., Cleland, J. G., Ng, L. L., Anker, S. D., Lang, C. C., Samani, N. J., Dickstein, K., Filippatos, G., van Veldhuisen, D. J., Lam, C. S.P., Rienstra, M., Voors, A. A. (2022) Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovascular Research, 118, pp. 2478-2487. (doi: 10.1093/cvr/cvab331)

Cohen, D. J., Magnuson, E., Stone, G. W., Cleland, J. G.F. (2022) Response to: correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock. Heart, 108, (doi: 10.1136/heartjnl-2022-321180)

McCall, P.J., Willder, J.M., Stanley, B.L., Messow, C.-M., Allan, J., Gemmell, L., Puxty, A., Strachan, D., Berry, C., Shelley, B.G. (2022) Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study. Anaesthesia, 77, pp. 772-784. (doi: 10.1111/anae.15745)

McDowell, K., Docherty, K. F. (2022) Sodium-glucose cotransporter 2 inhibitors: the first universal treatment for heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 8, pp. 371-373. (doi: 10.1093/ehjqcco/qcab088)

Lip, S., McCallum, L., Delles, C., McClure, J. D., Guzik, T., Berry, C., Touyz, R., Padmanabhan, S. (2022) Rationale and design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR) Open Heart, 9, (doi: 10.1136/openhrt-2022-002057)

Aktaa, S., Batra, G., Cleland, J. G.F., Coats, A., Lund, L. H., McDonagh, T., Rosano, G., Seferovic, P., Vasko, P., Wallentin, L., Maggioni, A. P., Casadei, B., Gale, C. P. (2022) Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) European Heart Journal, 43, pp. 2185-2195. (doi: 10.1093/eurheartj/ehac151)

Tromp, J., Ouwerkerk, W., Teng, T.-H. K., Cleland, J. G.F., Bamadhaj, S., Angermann, C. E., Dahlstrom, U., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Collins, S. P., Filippatos, G., Lam, C. S.P. (2022) Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. European Heart Journal, 43, pp. 2224-2234. (doi: 10.1093/eurheartj/ehac103)

Fernando, J., Lee, M., Quinn, D., Corcoran, D., Connolly, E. (2022) Assessing the Impact of the Covid-19 Pandemic on Rapid Access Chest Pain Clinics: A Retrospective Audit in Glasgow. (doi: 10.1136/heartjnl-2022-BCS.70)

Tayal, U. et al. (2022) Precision phenotyping of dilated cardiomyopathy using multidimensional data. Journal of the American College of Cardiology, 79, pp. 2219-2232. (doi: 10.1016/j.jacc.2022.03.375)

Mangion, K. et al. (2022) Multi-system investigation of COVID-19 illness. (doi: 10.1136/heartjnl-2022-BCS.157)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28, pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9)

Schwartze, J. T., Havenga, M., Bakker, W. A. M., Bradshaw, A. C., Nicklin, S. A. (2022) Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. Journal of Molecular Medicine, 100, pp. 875-901. (doi: 10.1007/s00109-022-02208-0)

Jackson, A. M., Benson, L., Savarese, G., Hage, C., Jhund, P. S., Petrie, M. C., Dahlström, U., McMurray, J. J.V., Lund, L. H. (2022) Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry. JACC: Heart Failure, 10, pp. 380-392. (doi: 10.1016/j.jchf.2022.04.006)

Ho, F. K., Ferguson, L. D., Celis-Morales, C. A., Gray, S. R., Forrest, E., Alazawi, W., Gill, J. M.R., Katikireddi, S. V., Cleland, J. G.F., Welsh, P., Pell, J. P., Sattar, N. (2022) Association of gamma-glutamyltransferase levels with total mortality, liver-related, and cardiovascular outcomes: a prospective cohort study in the UK Biobank. EClinicalMedicine, 48, (doi: 10.1016/j.eclinm.2022.101435)

Boyalla, V., Harling, L., Snell, A., Kralj-Hans, I., Barradas-Pires, A., Haldar, S., Khan, H. R., Cleland, J. G.F., Athanasiou, T., Harding, S. E., Wong, T. (2022) Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis. Clinical Research in Cardiology, 111, pp. 680-691. (doi: 10.1007/s00392-021-01978-w)

Aimo, A. et al. (2022) Cardiac remodelling part 2: clinical, imaging and laboratory findings: a review from the Biomarkers Working Group of the Heart Failure Association of the ESC. European Journal of Heart Failure, 24, pp. 944-958. (doi: 10.1002/ejhf.2522)

González, A. et al. (2022) Cardiac remodelling – part 1: from cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 24, pp. 927-943. (doi: 10.1002/ejhf.2493)

Halliday, B. P., Owen, R., Gregson, J., Vazir, A., Wassall, R., Khalique, Z., Lota, A. S., Tayal, U., Hammersley, D. J., Jones, R. E., Pennell, D. J., Cowie, M. R., Cleland, J. G.F., Prasad, S. K. (2022) Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy. ESC Heart Failure, 9, pp. 1616-1624. (doi: 10.1002/ehf2.13872)

Streng, K. W., Hillege, H. L., Maaten, J. M., Veldhuisen, D. J., Dickstein, K., Ng, L. L., Samani, N. J., Metra, M., Ponikowski, P., Cleland, J. G., Anker, S. D., Romaine, S. P.R., Damman, K., Meer, P., Lang, C. C., Voors, A. A. (2022) Clinical implications of low estimated protein intake in patients with heart failure. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 1762-1770. (doi: 10.1002/jcsm.12973)

Curtain, J. P., Campbell, R. T., Petrie, M. C., Jackson, A. M., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2022) Clinical outcomes related to background diuretic use and new diuretic initiation in patients with HFrEF. JACC: Heart Failure, 10, pp. 415-427. (doi: 10.1016/j.jchf.2022.01.020)

Rastogi, T., Ho, F. K., Rossignol, P., Merkling, T., Butler, J., Clark, A., Collier, T., Delles, C., Jukema, J. W., Heymans, S., Latini, R., Mebazaa, A., Pellicori, P., Sever, P., Staessen, J. A., Thijs, L., Cleland, J. G., Sattar, N., Zannad, F., Girerd, N. (2022) Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. European Journal of Heart Failure, 24, pp. 976-984. (doi: 10.1002/ejhf.2495)

McDowell, K., Welsh, P., Docherty, K. F., Morrow, D. A., Jhund, P. S., De Boer, R. A., O’Meara, E., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Hammarstedt, A., Langkilde, A. M., Sjöstrand, M., Lindholm, D., Solomon, S. D., Sattar, N., Sabatine, M. S., McMurray, J. J.V. (2022) Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF. European Journal of Heart Failure, 24, pp. 1066-1076. (doi: 10.1002/ejhf.2433)

Butt, J. H., Dewan, P., Merkely, B., Belohlávek, J., Drożdż, J., Kitakaze, M., Inzucchi, S. E., Kosiborod, M. N., Martinez, F. A., Tereshchenko, S., Ponikowski, P., Bengtsson, O., Lindholm, D., Langkilde, A. M., Schou, M., Sjöstrand, M., Solomon, S. D., Sabatine, M. S., Chiang, C.-E., Docherty, K. F., Jhund, P. S., Køber, L., McMurray, J. J.V. (2022) Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction. Annals of Internal Medicine, 175, pp. 820-830. (doi: 10.7326/m21-4776)

Pellicori, P., Cleland, J. G. F. (2022) Heart failure: age is no excuse for complacency. European Journal of Heart Failure, 24, pp. 1063-1065. (doi: 10.1002/ejhf.2517)

McMurray, J. J.V., Docherty, K. F. (2022) Insights into foundational therapies for heart failure with reduced ejection fraction. Clinical Cardiology, 45, pp. S26-S30. (doi: 10.1002/clc.23847)

Gok, C., Robertson, A. D., Fuller, W. (2022) Insulin-induced palmitoylation regulates the Cardiac Na+/Ca2+ Exchanger NCX1. Cell Calcium, 104, (doi: 10.1016/j.ceca.2022.102567)

Bomer, N., Pavez-Giani, M. G., Grote Beverborg, N., Cleland, J. G.F., van Veldhuisen, D. J., van der Meer, P. (2022) Micronutrient deficiencies in heart failure: mitochondrial dysfunction as a common pathophysiological mechanism? Journal of Internal Medicine, 291, pp. 713-731. (doi: 10.1111/joim.13456)

Berry, C., Sykes, R. (2022) Microvascular dysfunction in heart failure with preserved ejection fraction: a modifiable therapeutic target? JACC: Cardiovascular Imaging, 15, pp. 1012-1014. (doi: 10.1016/j.jcmg.2022.04.008)

McNaughton, C. D., McConnachie, A., Cleland, J. G., Spertus, J. A., Angermann, C. E., Duklas, P., Tromp, J., Lam, C. S.P., Filippatos, G., Dahlstrom, U., Dickstein, K., Schweizer, A., Perrone, S. V., Hassanein, M., Ertl, G., Obergfell, A., Ghadanfar, M., Collins, S. P. (2022) Quality of life assessed six months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) European Journal of Heart Failure, 24, pp. 1020-1029. (doi: 10.1002/ejhf.2508)

Israr, M. Z., Zhan, H., Salzano, A., Voors, A. A., Cleland, J. G.F., Anker, S. D., Metra, M., van Veldhuisen, D. J., Lang, C. C., Zannad, F., Samani, N. J., Ng, L. L., Suzuki, T. (2022) Surrogate markers of gut dysfunction are related to heart failure severity and outcome - from the BIOSTAT-CHF consortium. American Heart Journal, 248, pp. 108-119. (doi: 10.1016/j.ahj.2022.03.002)

Goldberg, L. R., Jorbenadze, A., Shaburishvilli, T., Mirro, M. J., Fudim, M., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P., Cleland, J. G. (2022) Synchronized diaphragmatic stimulation: a case report of a novel extra-cardiac intervention for chronic heart failure. ESC Heart Failure, 9, pp. 1677-1681. (doi: 10.1002/ehf2.13882)

Fullerton, J. L., Thomas, J. M., Gonzalez-Trueba, L., Trivett, C., Van Kralingen, J. C., Allan, S. M., Quinn, T. J., Work, L. M. (2022) Systematic review: association between circulating microRNA expression & stroke. Journal of Cerebral Blood Flow and Metabolism, 42, pp. 935-951. (doi: 10.1177/0271678X221085090)

Crea, F., Badimon, L., Berry, C., De Caterina, R., Elliott, P. M., Hatala, R., Libby, P., Linde, C., Tybjaerg-Hansen on behalf of the EHJ Editorial Board, A. (2022) The European Heart Journal: fulfilling the mission. European Heart Journal, 43, pp. 2181-2184. (doi: 10.1093/eurheartj/ehac171)

Cleland, J. G.F., Bristow, M. R., Freemantle, N., Olshansk, B., Gras, D., Saxon, L., Tavazzi, L., Boehmer, J., Ghio, S., Feldman, A. M., Daubert, J.-C., deMets, D. (2022) The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual-patient-data meta-analysis of COMPANION and CARE-HF. European Journal of Heart Failure, 24, pp. 1080-1090. (doi: 10.1002/ejhf.2524)

Nath, M., Romaine, S. P.R., Koekemoer, A., Hamby, S., Webb, T. R., Nelson, C. P., Castellanos-Uribe, M., Papakonstantinou, M., Anker, S. D., Lang, C. C., Metra, M., Zannad, F., Filippatos, G., van Veldhuisen, D. J., Cleland, J. G., Ng, L. L., May, S. T., Marelli-Berg, F., Voors, A. A., Timmons, J. A., Samani, N. J. (2022) Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure. European Journal of Heart Failure, 24, pp. 1009-1019. (doi: 10.1002/ejhf.2540)

Malagueta-Vieira, L., Fernández-Ruocco, J., Hortigon, M., Zamora, V., Zayas-Arrabal, J., Echeazarra, L., Smith, G. L., Vila Petroff, M., Medei, E., Casis, Ó., Gallego, M. (2022) Metformin reduces potassium currents and prolongs repolarization in non-diabetic heart. International Journal of Molecular Sciences, 23, (doi: 10.3390/ijms23116021)

Borlaug, B. A. et al. (2022) Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation, 145, pp. 1592-1604. (doi: 10.1161/CIRCULATIONAHA.122.059486)

Udell, J. A., Jones, W. S., Petrie, M. C., Harrington, J., Anker, S. D., Bhatt, D. L., Hernandez, A. F., Butler, J. (2022) Sodium glucose cotransporter-2 inhibition for acute myocardial infarction: JACC Review Topic of the Week. Journal of the American College of Cardiology, 79, pp. 2058-2068. (doi: 10.1016/j.jacc.2022.03.353)

Girerd, N., Cleland, J., Anker, S. D., Byra, W., Lam, C. S.P., Lapolice, D., Mehra, M. R., van Veldhuisen, D. J., Bresso, E., Lamiral, Z., Greenberg, B., Zannad, F. (2022) Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Scientific Reports, 12, (doi: 10.1038/s41598-022-12385-0)

Fairbairn, T. et al. (2022) Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. JAMA: Journal of the American Medical Association, 327, pp. 1875-1887. (doi: 10.1001/jama.2022.5776)

Lucas-Herald, A. K., Montezano, A. C., Alves-Lopes, R., Haddow, L., Alimussina, M., O’Toole, S., Flett, M., Lee, B., Amjad, S. B., Steven, M., Brooksbank, K., McCallum, L., Delles, C., Padmanabhan, S., Ahmed, S. F., Touyz, R. M. (2022) Vascular dysfunction and increased cardiovascular risk in hypospadias. European Heart Journal, 43, pp. 1832-1845. (doi: 10.1093/eurheartj/ehac112)

Jhund, P. S., Docherty, K. F., McMurray, J. J.V. (2022) Age-adjusted survival extrapolations—results may differ from those generated by the Weibull model—reply. JAMA Cardiology, 7, pp. 570. (doi: 10.1001/jamacardio.2021.6032)

Cohen, D. J., Wang, K., Magnuson, E. A., Smith, R. D., Petrie, M. C., Buch, M. H., Abraham, W. T., Lindenfeld, J., Mack, M. J., Stone, G. W., Cleland, J. G. F. (2022) Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation. Heart, 108, pp. 717-724. (doi: 10.1136/heartjnl-2021-320005)

Lewis, G. D., Docherty, K. F., Voors, A. A., Cohen-Solal, A., Metra, M., Whellan, D. J., Ezekowitz, J. A., Ponikowski, P., Böhm, M., Teerlink, J. R., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Felker, G. M. (2022) Developments in exercise capacity assessment in heart failure clinical trials and the rationale for the design of METEORIC-HF. Circulation: Heart Failure, 15, (doi: 10.1161/CIRCHEARTFAILURE.121.008970)

Butt, J. H., Adamson, C., Docherty, K. F., Vaduganathan, M., Solomon, S. D., Anand, I. S., Zannad, F., Køber, L., Jhund, P. S., McMurray, J. J.V. (2022) Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new CKD-EPI creatinine equation for estimating glomerular filtration rate. European Journal of Heart Failure, 24, pp. 861-866. (doi: 10.1002/ejhf.2460)

Ferreira, J. P., Verdonschot, J. A.J., Girerd, N., Bozec, E., Pellicori, P., Collier, T., Mariottoni, B., Cosmi, F., Hazebroek, M., Cuthbert, J., Petutschnigg, J., Heymans, S., Staessen, J. A., Pieske, B., Edelman, F., Clark, A. L., Díez, J., González, A., Rossignol, P., Cleland, J. G., Zannad, F. (2022) Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24, pp. 771-778. (doi: 10.1002/ejhf.2455)

He, W. et al. (2022) Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size. Cardiovascular Research, 118, pp. 1535-1547. (doi: 10.1093/cvr/cvab204)

Cleland, J. G.F. (2022) Maintaining public trust in medical advice—could less be more? JAMA Network Open, 5, (doi: 10.1001/jamanetworkopen.2022.11113)

Halliday, B. P., Cleland, J. G. F. (2022) Maintaining success for patients with dilated cardiomyopathy and remission of heart failure. JACC: Basic to Translational Science, 7, pp. 500-503. (doi: 10.1016/j.jacbts.2022.03.008)

Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Fereirra, J. P., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., Lang, C.C., Metra, M., Samani, N.J., de Boer, R.A., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2022) Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovascular Research, 118, pp. 1964-1977. (doi: 10.1093/cvr/cvab235)

Graham, F. J., Masini, G., Pellicori, P., Cleland, J. G.F., Greenlaw, N., Friday, J., Kazmi, S., Clark, A. L. (2022) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure, 24, pp. 807-817. (doi: 10.1002/ejhf.2251)

Girerd, N., Newton, N., Tartière, J.-M., Guijarro, D., Jourdain, P., Damy, T., Lamblin, N., Bayes-Génis, A., Pellicori, P., Januzzi, J., Rossignol, P., Roubille, F. (2022) Practical outpatient management of worsening chronic heart failure. European Journal of Heart Failure, 24, pp. 750-761. (doi: 10.1002/ejhf.2503)

Pellicori, P., McConnachie, A., Carlin, C., Wales, A., Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, (doi: 10.1016/j.phrs.2022.106199)

Rastogi, T., Bozec, E., Pellicori, P., Bayes Genis, A., Coiro, S., Domingo, M., Gargani, L., Palazzuoli, A., Girerd, N. (2022) Prognostic value and therapeutic utility of lung ultrasound in acute and chronic heart failure: a meta-analysis. JACC: Cardiovascular Imaging, 15, pp. 950-952. (doi: 10.1016/j.jcmg.2021.11.024)

Yeoh, S. E., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2022) Relationship of dapagliflozin with serum sodium: findings from the DAPA-HF trial. JACC: Heart Failure, 10, pp. 306-318. (doi: 10.1016/j.jchf.2022.01.019)

Lee, M. M.Y., Docherty, K. F., Jhund, P. S. (2022) Sodium–glucose co-transporter-2 inhibitors. Oxford University Press

Al-Lamee, R., Aubiniere-Robb, L., Berry, C. (2022) The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond. Heart, 108, pp. 800-806. (doi: 10.1136/heartjnl-2021-320150)

Verdonschot, J. A.J., Ferreira, J. P., Pizard, A., Pellicori, P., Brunner La Rocca, H.-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Waring, O. J., Henkens, M. H.T.M., Mariottoni, B., Petutschnigg, J., Rossignol, P., Hazebroek, M. R., Cleland, J. G.F., Zannad, F., Heymans, S. R.B. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28, pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005)

Kite, T. A., Banning, A. S., Ladwiniec, A., Gale, C. P., Greenwood, J. P., Dalby, M., Hobson, R., Barber, S., Parker, E., Berry, C., Flather, M. D., Curzen, N., Banning, A. P., McCann, G. P., Gershlick, A. H. (2022) Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial. BMJ Open, 12, (doi: 10.1136/bmjopen-2021-055878)

Maurovich-Horvat, P. et al. (2022) CT or invasive coronary angiography in stable chest pain. New England Journal of Medicine, 386, pp. 1591-1602. (doi: 10.1056/NEJMoa2200963)

Malfait, F., Forlino, A., Sengle, G., Van Agtmael, T. (2022) Editorial: molecular mechanisms of heritable connective tissue disorders. Frontiers in Genetics, 13, (doi: 10.3389/fgene.2022.866665)

Berry, C., Ang, D. T.Y. (2022) Picture perfect? Performance of quantitative coronary angiography-based vessel FFR versus pressure wire-based FFR. EuroIntervention, 17, pp. 1463-1465. (doi: 10.4244/EIJ-E-22-00005)

Fullerton, J. L., Cosgrove, C. C., Rooney, R. A., Work, L. (2022) Extracellular vesicles and their microRNA cargo in ischaemic stroke. Journal of Physiology, (doi: 10.1113/JP282050)

Cotton, S. et al. (2022) Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS) Trials, 23, (doi: 10.1186/s13063-022-06226-8)

Mileva, N., Nagumo, S., Mizukami, T., Sonck, J., Berry, C., Gallinoro, E., Monizzi, G., Candreva, A., Munhoz, D., Vassilev, D., Penicka, M., Barbato, E., De Bruyne, B., Collet, C. (2022) Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta‐analysis. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.121.023207)

Docherty, K. F., Anand, I. S., Chiang, C.-E., Chopra, V. K., Desai, A. S., Kitakaze, M., Verma, S., Vinh, P. N., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Langkilde, A. M., Jhund, P. S., McMurray, J. J.V. (2022) Effects of dapagliflozin in Asian patients with heart failure and reduced ejection fraction in DAPA-HF. JACC: Asia, 2, pp. 139-153. (doi: 10.1016/j.jacasi.2022.02.004)

Täger, T., Frankenstein, L., Atar, D., Agewall, S., Frey, N., Grundtvig, M., Clark, A. L., Cleland, J. G.F., Fröhlich, H. (2022) Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical Research in Cardiology, 111, pp. 428-439. (doi: 10.1007/s00392-021-01913-z)

Abraham, G. R., Morrow, A. J., Oliveira, J., Weir-McCall, J. R., Davenport, E. E., Berry, C., Davenport, A. P., Hoole, S. P. (2022) Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study. International Journal of Cardiology: Heart and Vasculature, 39, (doi: 10.1016/j.ijcha.2022.100980)

Tayal, U., Gregson, J., Buchan, R., Whiffin, N., Halliday, B. P., Lota, A., Roberts, A. M., Baksi, A. J., Voges, I., Jarman, J. W.E., Baruah, R., Frenneaux, M., Cleland, J. G., Barton, P. J., Pennell, D. J., Ware, J. S., Cook, S. A., Prasad, S. K. (2022) Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy. Heart, 108, pp. 619-625. (doi: 10.1136/heartjnl-2021-319418)

Cleland, J. G.F., Butler, J., Januzzi, J. L., Pellicori, P., McDonagh, T. (2022) Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. European Journal of Heart Failure, 24, pp. 678-680. (doi: 10.1002/ejhf.2488)

Tibbo, A. J., Mika, D., Dobi, S., Ling, J., McFall, A., Tejeda, G. S., Blair, C., MacLeod, R., MacQuaide, N., Gök, C., Fuller, W., Smith, B. O., Smith, G. L., Vandecasteele, G., Brand, T., Baillie, G. S. (2022) Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins. Journal of Molecular and Cellular Cardiology, 165, pp. 86-102. (doi: 10.1016/j.yjmcc.2022.01.001)

Tromp, J., Beusekamp, J. C., Ouwerkerk, W., Meer, P., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Dickstein, K., Collins, S. P., Lam, C. S.P. (2022) Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry. European Journal of Heart Failure, 24, pp. 645-652. (doi: 10.1002/ejhf.2431)

Dietrichs, E. S., Smith, G. L. (2022) Prediction of ventricular arrhythmias by QRS/QTc - ratio in Citalopram or Escitalopram intoxication. Frontiers in Medicine, 9, (doi: 10.3389/fmed.2022.866454)

Ang, D. T.Y., Sidik, N. P., Morrow, A. J., Sykes, R., McEntegart, M. B., Berry, C. (2022) Interventional diagnostic procedure: A practical guide for the assessment of coronary vascular function. Journal of Visualized Experiments, 181, (doi: 10.3791/62265)

Coats, A. J. S. et al. (2022) Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. European Heart Journal, 43, pp. 863-867. (doi: 10.1093/eurheartj/ehab834)

Divorty, N., Jenkins, L., Ganguly, A., Butcher, A. J., Hudson, B. D., Schulz, S., Tobin, A. B., Nicklin, S. A., Milligan, G. (2022) Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. Journal of Biological Chemistry, 298, (doi: 10.1016/j.jbc.2022.101655)

Cleland, J. G.F. (2022) Aspirin for primary and secondary prevention of cardiovascular disease: time to stop? Thrombosis and Haemostasis, 122, pp. 311-314. (doi: 10.1055/s-0041-1740639)

Pellicori, P., Vaduganathan, M., Ferreira, J. P., Zannad, F., Sanyal, A. J. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes and Metabolism, 48, (doi: 10.1016/j.diabet.2021.101281)

Butt, J. H., Docherty, K. F., Jhund, P. S., De Boer, R. A., Böhm, M., Desai, A. S., Howlett, J. G., Inzucchi, S. E., Kosiborod, M. N., Martinez, F. A., Nicolau, J. C., Petrie, M. C., Ponikowski, P., Bengtsson, O., Langkilde, A. M., Schou, M., Sjöstrand, M., Solomon, S. D., Sabatine, M. S., McMurray, J. J.V., Køber, L. (2022) Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF. European Journal of Heart Failure, 24, pp. 513-525. (doi: 10.1002/ejhf.2381)

Jackson, A. M. et al. (2022) Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 24, pp. 497-509. (doi: 10.1002/ejhf.2403)

Kondo, T., Jhund, P. S., McMurray, J. J.V. (2022) Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose? European Journal of Heart Failure, 24, pp. 421-430. (doi: 10.1002/ejhf.2447)

Curtain, J. P., Jackson, A., Shen, L., Jhund, P. S., Docherty, K. F., Petrie, M. C., Castagno, D., Desai, A. S., Rohde, L. E., Lefkowitz, M. P., Rouleau, J.-L., Zile, M. R., Solomon, S. D., Swedberg, K., Packer, M., McMurray, J. J.V. (2022) Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. European Journal of Heart Failure, 24, pp. 551-561. (doi: 10.1002/ejhf.2419)

Ferguson, L. D., Cathcart, S., Rimmer, D., Semple, G., Brooksbank, K., Paterson, C., Brown, R., Harvie, J., Gao, X., Radjenovic, A., Welsh, P., McInnes, I. B., Sattar, N., Siebert, S. (2022) Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease – results of the Immune Metabolic Associations in Psoriatic Arthritis study. Rheumatology, 61, pp. 1026-1034. (doi: 10.1093/rheumatology/keab474)

Yeoh, S. E., Dewan, P., Serenelli, M., Ferreira, J. P., Pitt, B., Swedberg, K., Veldhuisen, D. J., Zannad, F., Jhund, P. S., McMurray, J. J.V. (2022) Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES. European Journal of Heart Failure, 24, pp. 529-538. (doi: 10.1002/ejhf.2350)

Sundaram, V., Nagai, T., Chiang, C.-E., Reddy, Y. N.V., Chao, T.-F., Zakeri, R., Bloom, C., Nakai, M., Nishimura, K., Hung, C.-L., Miyamoto, Y., Yasuda, S., Banerjee, A., Anzai, T., Simon, D. I., Rajagopalan, S., Cleland, J. G.F., Sahadevan, J., Quint, J. K. (2022) Hospitalization for heart failure in the USA, UK, Taiwan and Japan: an international comparison of administrative health records on 417,385 individual patients. Journal of Cardiac Failure, 28, pp. 353-366. (doi: 10.1016/j.cardfail.2021.08.024)

Glen, C., Tan, Y. Y., Waterston, A., Evans, T. R. J., Jones, R. J., Petrie, M. C., Lang, N. N. (2022) Mechanistic and clinical overview cardiovascular toxicity of BRAF and MEK inhibitors: JACC: CardioOncology state-of-the-art review. JACC: CardioOncology, 4, pp. 1-18. (doi: 10.1016/j.jaccao.2022.01.096)

Martin, T. P., MacDonald, E. A., Elbassioni, A. A., Zaeri, A. A. I., O'Toole, D., Nicklin, S. A., Gray, G. A., Loughrey, C. M. (2022) Pre-clinical models of myocardial infarction: from mechanism to translation. British Journal of Pharmacology, 179, pp. 770-791. (doi: 10.1111/bph.15595)

Lee, M. M.Y., Docherty, K. F., Sattar, N., Mehta, N., Kalra, A., Nowacki, A. S., Solomon, S. D., Vaduganathan, M., Petrie, M. C., Jhund, P. S., McMurray, J. J.V. (2022) Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 165-178. (doi: 10.1093/ehjcvp/pvaa138)

Ferreira, J. P., Collier, T., Clark, A. L., Mamas, M. A., Rocca, H.-P. B.-L., Heymans, S., González, A., Ahmed, F. Z., Petutschnigg, J., Mujaj, B., Cuthbert, J., Rouet, P., Pellicori, P., Mariottoni, B., Cosmi, F., Edelmann, F., Thijs, L., Staessen, J. A., Hazebroek, M., Verdonschot, J., Rossignol, P., Girerd, N., Cleland, J. G., Zannad, F. (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 149-156. (doi: 10.1093/ehjcvp/pvab031)

Stoyek, M. R., MacDonald, E., Mantifel, M., Baillie, J. S., Selig, B. M., Croll, R. P., Smith, F. M., Quinn, T. A. (2022) Drivers of sinoatrial node automaticity in zebrafish: comparison with mechanisms of mammalian pacemaker function. Frontiers in Physiology, 13, (doi: 10.3389/fphys.2022.818122)

Reynolds, H. R., Bairey Merz, C. N., Berry, C., Samuel, R., Saw, J., Smilowitz, N. R., de Souza, A. C. d. A.H., Sykes, R., Taqueti, V. R., Wei, J. (2022) Coronary arterial function and disease in women with no obstructive coronary arteries. Circulation Research, 130, pp. 529-551. (doi: 10.1161/CIRCRESAHA.121.319892)

Adamson, C., Jhund, P. S. (2022) Bringing FIDELITY to the estimate of treatment effects of finerenone in chronic kidney disease due to type 2 diabetes. European Heart Journal, 43, pp. 485-487. (doi: 10.1093/eurheartj/ehab827)

Huethorst, E., Mortensen, P., Simitev, R. D., Gao, H., Pohjolainen, L., Talman, V., Ruskoaho, H., Burton, F. L., Gadegaard, N., Smith, G. L. (2022) Conventional rigid 2D substrates cause complex contractile signals in monolayers of human induced pluripotent stem cell derived cardiomyocytes. Journal of Physiology, 600, pp. 483-507. (doi: 10.1113/JP282228)

Masini, G., Graham, F. J., Pellicori, P., Cleland, J. G.F., Cuthbert, J. J., Kazmi, S., Inciardi, R. M., Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology, 79, pp. 341-351. (doi: 10.1016/j.jacc.2021.11.039)

Mujaj, B., ZHang, Z.-Y., Yang, W.-Y., Thijs, L., Wei, F.-F., Verhamme, P., Delles, C., Butler, J., Sever, P., Latini, R., Cleland, J. G. F., Zannad, F., Staessen, J. A. (2022) Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis. ESC Heart Failure, 9, pp. 685-694. (doi: 10.1002/ehf2.13688)

Ravassa, S., López, B., Ferreira, J. P., Girerd, N., Bozec, E., Pellicori, P., Mariottoni, B., Cosmi, F., Hazebroek, M., Verdonschot, J. A.J., Cuthbert, J., Petutschnigg, J., Moreno, M. U., Heymans, S., Staessen, J. A., Pieske, B., Edelmann, F., Clark, A. L., Cleland, J. G.F., Zannad, F., Díez, J., González, A. (2022) Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial. European Journal of Heart Failure, 24, pp. 321-331. (doi: 10.1002/ejhf.2394)

Main, A., Fuller, W. (2022) Protein S‐palmitoylation: advances and challenges in studying a therapeutically important lipid modification. FEBS Journal, 289, pp. 861-882. (doi: 10.1111/febs.15781)

Deis, T., Wolsk, E., Mujkanovic, J., Komtebedde, J., Burkhoff, D., Kaye, D., Hasenfuß, G., Hayward, C., Van der Heyden, J., Petrie, M.C., Shah, S.J., Borlaug, B.A., Kahwash, R., Litwin, S., Hoendermis, E., Hummel, S., Gustafsson, F. (2022) Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction. ESC Heart Failure, 9, pp. 186-195. (doi: 10.1002/ehf2.13697)

Docherty, K. F., Petrie, M. C. (2022) Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure. Heart, 108, pp. 312-320. (doi: 10.1136/heartjnl-2020-318658)

Caiazzo, E., Rezig, A. O.M., Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F., Guzik, T. J., Maffia, P., Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, (doi: 10.1016/j.phrs.2021.106053)

Emmens, J. E., ter Maaten, J. M., Matsue, Y., Figarska, S. M., Sama, I. E., Cotter, G., Cleland, J. G.F., Davison, B. A., Felker, G. M., Givertz, M. M., Greenberg, B., Pang, P. S., Severin, T., Gimpelewicz, C., Metra, M., Voors, A. A., Teerlink, J. R. (2022) Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure, 24, pp. 365-374. (doi: 10.1002/ejhf.2384)

Mesin, L., Albani, S., Policastro, P., Pasquero, P., Porta, M., Melchiorri, C., Leonardi, G., Albera, C., Scacciatella, P., Pellicori, P., Stolfo, D., Grillo, A., Fabris, B., Bini, R., Giannoni, A., Pepe, A., Ermini, L., Seddone, S., Sinagra, G., Antonini-Canterin, F., Roatta, S. (2022) Assessment of phasic changes of vascular size by automated edge tracking-state of the art and clinical perspectives. Frontiers in Cardiovascular Medicine, 8, (doi: 10.3389/fcvm.2021.775635)

Berg, D. D., Docherty, K. F., Sattar, N., Jarolim, P., Welsh, P., Jhund, P. S., Anand, I. S., Chopra, V., de Boer, R. A., Kosiborod, M. N., Nicolau, J. C., O'Meara, E., Schou, M., Hammarstedt, A., Langkilde, A.-M., Lindholm, D., Sjöstrand, M., McMurray, J. J.V., Sabatine, M. S., Morrow, D. A. (2022) Serial assessment of high-sensitivity cardiac troponin and the effect of dapagliflozin in patients with heart failure with reduced ejection fraction: an analysis of the DAPA-HF trial. Circulation, 145, pp. 158-169. (doi: 10.1161/CIRCULATIONAHA.121.057852)

Gabriel, J. L., Tinti, M., Fuller, W., Ashford, M. L.J. (2022) Identifying the beta-site amyloid precursor protein cleaving enzyme 1 interactome through the proximity-dependent biotin identification assay. Neuroscience Letters, 767, (doi: 10.1016/j.neulet.2021.136302)

Ryan, M., Morgan, H., Chiribiri, A., Nagel, E., Cleland, J., Perera, D. (2022) Myocardial viability testing: all STICHed up, or about to be REVIVED? European Heart Journal, 43, pp. 118-126. (doi: 10.1093/eurheartj/ehab729)

Januzzi, J. L., Garasic, J. M., Kasner, S. E., McDonald, V., Petrie, M. C., Seltzer, J., Mauro, M., Croce, K., Berman, E., Deininger, M., Hochhaus, A., Pinilla-Ibarz, J., Nicolini, F., Kim, D.-W., DeAngelo, D. J., Kantarjian, H., Xu, J., Hall, T., Srivastava, S., Naranjo, D., Cortes, J. (2022) Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. Journal of Hematology and Oncology, 15, (doi: 10.1186/s13045-021-01221-z)

Pfeffer, M. A. et al. (2022) Impact of sacubitril/valsartan versus ramipril on total heart failure events in the PARADISE-MI trial. Circulation, 145, pp. 87-89. (doi: 10.1161/CIRCULATIONAHA.121.057429)

Faulkner-Jones, A., Zamora, V., Hortigon-Vinagre, M. P., Wang, W., Ardron, M., Smith, G. L., Shu, W. (2022) A bioprinted heart-on-a-chip with human pluripotent stem cell-derived cardiomyocytes for drug evaluation. Bioengineering, 9, (doi: 10.3390/bioengineering9010032)

Tromp, J., Ouwerkerk, W., Cleland, J. G.F., Chandramouli, C., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Collins, S. P., Filippatos, G., Lam, C. S. (2022) A global perspective of racial differences and outcomes in patients presenting with acute heart failure. American Heart Journal, 243, pp. 11-14. (doi: 10.1016/j.ahj.2021.09.001)

Alnuwaysir, R. I.S., Grote Beverborg, N., Hoes, M. F., Markousis‐Mavrogenis, G., Gomez, K. A., van der Wal, H. H., Cleland, J. G.F., Dickstein, K., Lang, C. C., Ng, L. L., Ponikowski, P., Anker, S. D., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2022) Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 24, pp. 192-204. (doi: 10.1002/ejhf.2393)

Lee, M. M.Y., Kristensen, S. L., Gerstein, H. C., McMurray, J. J.V., Sattar, N. (2022) Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 16, (doi: 10.1016/j.dsx.2021.102382)

Rossing, P. et al. (2022) Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes and Endocrinology, 10, pp. 24-34. (doi: 10.1016/S2213-8587(21)00295-3)

Cuthbert, J.J., Brown, O.I., Urbinati, A., Pan, D., Pellicori, P., Dobbs, K., Bulemfu, J., Kazmi, S., Sokoreli, I., Pauws, S.C., Riistama, J.M., Cleland, J.G.F., Clark, A.L. (2022) Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal: Acute Cardiovascular Care, 11, pp. 43-52. (doi: 10.1093/ehjacc/zuab097)

Ferreira, J. P., Cleland, J. G., Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., LaPolice, D. A., Greenberg, B., Zannad, F. (2022) New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clinical Research in Cardiology, 111, pp. 50-59. (doi: 10.1007/s00392-021-01891-2)

Rodríguez-Gómez, I., Gray, S. R., Ho, F. K., Petermann-Rocha, F., Welsh, P., Cleland, J., Iliodromiti, S., Ara, I., Pell, J., Sattar, N., Ferguson, L. D., Celis-Morales, C. (2022) Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank prospective cohort study. Mayo Clinic Proceedings, 97, pp. 110-121. (doi: 10.1016/j.mayocp.2021.07.019)

Lam, P. H., Keramida, K., Filippatos, G. S., Gupta, N., Faselis, C., Deedwania, P., George, B., Iskandrian, A., Cleland, J. G.F., Choudhary, G., Wu, W.-C., Morgan, C. J., Fonarow, G. C., Ahmed, A. (2022) Right ventricular ejection fraction and beta-blocker effect in heart failure with reduced ejection fraction: Beta-blocker and outcomes in HFrEF by RVEF. Journal of Cardiac Failure, 28, pp. 65-70. (doi: 10.1016/j.cardfail.2021.07.026)

Romaine, S. P. R., Denniff, M., Codd, V., Nath, M., Koekemoer, A., Anker, S. D., Cleland, J. G., Filippatos, G., Levin, D., Metra, M., Mordi, I. R., Ouwerkerk, W., ter Maaten, J. M., van Veldhuisen, D. J., Zannad, F., Ng, L. L., van der Harst, P., Lang, C. C., Voors, A. A., Nelson, C. P., Samani, N. J. (2022) Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart, 108, pp. 124-129. (doi: 10.1136/heartjnl-2020-318654)

Chan, Y., Seckin, M., Johnston, B., Petrie, M., Stewart, S. (2022) Characteristics of symptom change in men and women with different heart failure subtypes. Heart, Lung and Circulation, 31, (doi: 10.1016/j.hlc.2022.06.074)

Cuthbert, J. J., Pellicori, P., Clark, A. L. (2022) Optimal management of heart failure and chronic obstructive pulmonary disease: clinical challenges. International Journal of General Medicine, 15, pp. 7961-7975. (doi: 10.2147/IJGM.S295467)

Morrow, A., Gray, S. R., Bayes, H. K., Sykes, R., McGarry, E., Anderson, D., Boiskin, D., Burke, C., Cleland, J. G. F., Goodyear, C., Ibbotson, T., Lang, C. C., McConnachie, A., Mair, F., Mangion, K., Patel, M., Sattar, N., Taggart, D., Taylor, R., Dawkes, S., Berry, C. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, (doi: 10.1186/s13063-022-06632-y)

Mooney, L., Hawkins, N. M., Jhund, P. S., Redfield, M. M., Muthiah Vaduganathan, M., Desai, A. S., Rouleau, J. L., Minamisawa, M., Shah, A. M., Lefkowitz, M. P., Zile, M. R., Van Veldhuisen, D. J., Pfeffer, M. A., Anand, I. S., Maggioni, A. P., Senni, M., Claggett, B. L., Solomon, S. D., McMurray, J. J. V. (2021) Impact of chronic obstructive pulmonary disease in patients with heart failure with preserved ejection fraction: insights from PARAGON‐HF. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.121.021494)

Chung, Y. J., Park, K. C., Tokar, S., Eykyn, T. R., Fuller, W., Pavlovic, D., Swietach, P., Shattock, M. J. (2021) Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart. Cardiovascular Research, 117, pp. 2794-2806. (doi: 10.1093/cvr/cvaa323)

Collison, D., Didagelos, M., Aetesam-Ur-Rahman, M., Copt, S., McDade, R., McCartney, P., Ford, T. J., McClure, J., Lindsay, M., Shaukat, A., Rocchiccioli, P., Brogan, R., Watkins, S., McEntegart, M., Good, R., Robertson, K., O’Boyle, P., Davie, A., Khan, A., Hood, S., Eteiba, H., Berry, C., Oldroyd, K. G. (2021) Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR) European Heart Journal, 42, pp. 4656-4668. (doi: 10.1093/eurheartj/ehab449)

Chung, Y. J., Park, K. C., Tokar, S., Eykyn, T. R., Fuller, W., Pavlovic, D., Swietach, P., Shattock, M. J. (2021) SGLT2 inhibitors and the cardiac Na+/H+ exchanger-1: the plot thickens. Cardiovascular Research, 117, pp. 2702-2704. (doi: 10.1093/cvr/cvab184)

Butt, J. H., Adamson, C., Docherty, K. F., de Boer, R. A., Petrie, M. C., Inzucchi, S. E., Kosiborod, M. N., Maria Langkilde, A., Lindholm, D., Martinez, F. A., Bengtsson, O., Schou, M., O’Meara, E., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V., Køber, L. (2021) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide: insights from the DAPA-HF trial. Circulation: Heart Failure, 14, (doi: 10.1161/CIRCHEARTFAILURE.121.008837)

Omar, R., Malfait, F., Van Agtmael, T. (2021) Four decades in the making: collagen III and mechanisms of vascular Ehlers Danlos Syndrome. Matrix Biology Plus, 12, (doi: 10.1016/j.mbplus.2021.100090)

Diamant, M. J., Andrade, J. G., Virani, S. A., Jhund, P. S., Petrie, M. C., Hawkins, N. M. (2021) Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Failure, 8, pp. 4484-4496. (doi: 10.1002/ehf2.13526)

Jackson, A. M. et al. (2021) Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. European Journal of Heart Failure, 23, pp. 2058-2069. (doi: 10.1002/ejhf.2264)

Desai, A. S., Vaduganathan, M., Cleland, J. G., Claggett, B. L., Barkoudah, E., Finn, P., McCausland, F. R., Yilmaz, M. B., Lefkowitz, M., Shi, V., Pfeffer, M. A., McMurray, J. J.V., Soloman, S. D. (2021) Mode of death in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation: Heart Failure, 14, (doi: 10.1161/CIRCHEARTFAILURE.121.008597)

Ferreira, J. P., Girerd, N., Rocca, H.-P. B.-L., Pellicori, P., Cleland, J. G., Rossignol, P., Zannad, F. (2021) No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial = Pas d’influence de la spironolactone sur les concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE. Archives of Cardiovascular Diseases, 114, pp. 814-817. (doi: 10.1016/j.acvd.2021.10.003)

Lota, A. S., Tsao, A., Owen, R., Halliday, B. P., Auger, D., Vassiliou, V. S., Tayal, U., Almogheer, B., Vilches, S., Al-Balah, A., Patel, A., Mouy, F., Buchan, R., Newsome, S., Gregson, J., Ware, J. S., Cook, S. A., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2021) Prognostic significance of nonischaemic myocardial fibrosis in patients with normal left ventricular volumes and ejection-fraction. JACC: Cardiovascular Imaging, 14, pp. 2353-2365. (doi: 10.1016/j.jcmg.2021.05.016)

Keenan, N. G., Captur, G., McCann, G. P., Berry, C., Myerson, S. G., Fairbairn, T., Hudsmith, L., O'Regan, D. P., Westwood, M., Greenwood, J. P. (2021) Regional variation in cardiovascular magnetic resonance service delivery across the UK. Heart, 107, pp. 1974-1979. (doi: 10.1136/heartjnl-2020-318667)

Mary, S., Boder, P., Rossitto, G., Graham, L., Scott, K., Flynn, A., Kipgen, D., Graham, D., Delles, C. (2021) Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats. Clinical Science, 135, pp. 2749-2761. (doi: 10.1042/CS20211017)

Lumbers, R. T. et al. (2021) The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Failure, 8, pp. 5531-5541. (doi: 10.1002/ehf2.13517)

Mark, P. B., Jhund, P. S., Walters, M. R., Petrie, M. C., Power, A., White, C., Robertson, M., Connolly, E., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., McMurray, J. J.V., Macdougall, I. C., Ford, I. (2021) Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial. Kidney360, 2, pp. 1761-1769. (doi: 10.34067/KID.0004272021)

Müllenbroich, M. C., Kelly, A., Acker, C., Bub, G., Bruegmann, T., Di Bona, A., Entcheva, E., Ferrantini, C., Kohl, P., Lehnart, S. E., Mongillo, M., Parmeggiani, C., Richter, C., Sasse, P., Zaglia, T., Sacconi, L., Smith, G. L. (2021) Novel optics-based approaches for cardiac electrophysiology: a review. Frontiers in Physiology, 12, (doi: 10.3389/fphys.2021.769586)

Rankin, A. J., Mangion, K., Lees, J. S., Rutherford, E., Gillis, K. A., Edy, E., Dymock, L., Treibel, T. A., Radjenovic, A., Patel, R. K., Berry, C., Roditi, G., Mark, P. B. (2021) Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal. Journal of Cardiovascular Magnetic Resonance, 23, (doi: 10.1186/s12968-021-00822-4)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print] Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Sveberg Dietrichs, E., Myles, R., Smith, G. (2021) Is hypothermia more neuroprotective than avoiding fever after cardiac arrest? Cardiovascular Research, 117, pp. e159-e161. (doi: 10.1093/cvr/cvab297)

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. (doi: 10.1136/heartjnl-2021-BSCMR.3)

Täger, T., Atar, D., Agewall, S., Katus, H. A., Grundtvig, M., Cleland, J. G.F., Clark, A. L., Fröhlich, H., Frankenstein, L. (2021) Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Failure Reviews, 26, pp. 1421-1435. (doi: 10.1007/s10741-020-09954-8)

Docherty, K. F., Jhund, P. S., Claggett, B., Ferreira, J. P., Bengtsson, O., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2021) Extrapolating long-term event-free and overall survival with dapagliflozin in patients with heart failure and reduced ejection fraction: an exploratory analysis of a phase 3 randomized clinical trial. JAMA Cardiology, 6, pp. 1298-1305. (doi: 10.1001/jamacardio.2021.2632)

Pan, D., Pellicori, P., Dobbs, K., Bulemfu, J., Sokoreli, I., Urbinati, A., Brown, O., Sze, S., Rigby Cstat, A. R., Kazmi, S., Riistama, J. M., Cleland, J. G.F., Clark, A. L. (2021) Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology, 110, pp. 1743-1756. (doi: 10.1007/s00392-021-01836-9)

Cuthbert, J. J., Pellicori, P., Flockton, R., Kallvikbacka-Bennett, A., Khan, J., Rigby, A. S., Girerd, N., Zannad, F., Cleland, J. G.F., Clark, A. L. (2021) The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure. European Journal of Heart Failure, 23, pp. 1831-1840. (doi: 10.1002/ejhf.2353)

He, T. et al. (2021) Urinary peptides in heart failure: a link to molecular pathophysiology. European Journal of Heart Failure, 23, pp. 1875-1887. (doi: 10.1002/ejhf.2195)

Shoaib, A., Rashid, M., Berry, C., Curzen, N., Kontopantelis, E., Timmis, A., Ahmad, A., Kinnaird, T., Mamas, M. A. (2021) Clinical characteristics, management strategies, and outcomes of non–ST‐segment–elevation myocardial infarction patients with and without prior coronary artery bypass grafting. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.018823)

Lee, M., Campbell, R. T., Claggett, B.L., Lewis, E.F., Groarke, J.D., Docherty, K. F., Lindner, M., Liu, J., Soloman, S.D., McMurray, J. J.V., Platz, E. (2021) Lung Ultrasound in Acute Heart Failure: Association Between Quality of Life, Symptoms and B-Lines. (doi: 10.1093/eurheartj/ehab724.1043)

Curzen, N. et al. (2021) Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. European Heart Journal, 42, pp. 3844-3852. (doi: 10.1093/eurheartj/ehab444)

Shah, P., Abel, A. A.I., Boyalla, V., Pellicori, P., Kallvikbacka-Bennett, A., Sze, S., Cleland, J. G.F., Clark, A. L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8, pp. 3929-3934. (doi: 10.1002/ehf2.13402)

Papageorgiou, V., Jones, K., Halliday, B. P., Mindham, R., Bruton, J., Wassall, R., Cleland, J. G.F., Prasad, S. K., Ward, H. (2021) A qualitative exploration of participant and investigator perspectives from the TRED-HF trial. ESC Heart Failure, 8, pp. 3760-3768. (doi: 10.1002/ehf2.13524)

Touyz, R. M., Boyd, M. O.E., Guzik, T., Padmanabhan, S., McCallum, L., Delles, C., Mark, P. B., Petrie, J. R., Rios, F., Montezano, A. C., Sykes, R., Berry, C. (2021) Cardiovascular and renal risk factors and complications associated with COVID-19. CJC Open, 3, pp. 1257-1272. (doi: 10.1016/j.cjco.2021.05.020)

Sattar, N., Lee, M. M.Y., Kristensen, S. L., Branch, K. R.H., Del Prato, S., Khurmi, N. S., Lam, C. S.P., Lopes, R. D., McMurray, J. J.V., Pratley, R. E., Rosenstock, J., Gerstein, H. C. (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes and Endocrinology, 9, pp. 653-662. (doi: 10.1016/S2213-8587(21)00203-5)

Meijers, W. C., Bayes‐Genis, A., Mebazaa, A., Bauersachs, J., Cleland, J. J.G., Coats, A. J.S., Januzzi, J. L., Maisel, A. S., McDonald, K., Mueller, T., Richards, A. M., Seferovic, P., Mueller, C., de Boer, R. A. (2021) Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) European Journal of Heart Failure, 23, pp. 1610-1632. (doi: 10.1002/ejhf.2346)

Dalal, H., Taylor, R. S., Cleland, J. G. (2021) Correspondence to European Heart Journal—Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures. European Heart Journal: Quality of Care and Clinical Outcomes, 7, pp. e7. (doi: 10.1093/ehjqcco/qcab033)

Adamson, C., Jhund, P. S., Docherty, K. F., Bělohlávek, J., Chiang, C.‐E., Diez, M., Drożdż, J., Dukát, A., Howlett, J., Ljungman, C. E.A., Petrie, M. C., Schou, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Langkilde, A. M., Lindholm, D., Sjöstrand, M., McMurray, J. J.V. (2021) Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. European Journal of Heart Failure, 23, pp. 1662-1672. (doi: 10.1002/ejhf.2308)

Rankin, A. J., Zhu, L., Mangion, K., Rutherford, E., Gillis, K. A., Lees, J. S., Woodward, R., Patel, R. K., Berry, C., Roditi, G., Mark, P. B. (2021) Global longitudinal strain by feature tracking cardiovascular MRI predicts mortality in patients with end stage kidney disease. Clinical Kidney Journal, 14, pp. 2187-2196. (doi: 10.1093/ckj/sfab020)

Ferreira, J. P., Cleland, J. G., Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Pitt, B., Greenberg, B., Zannad, F. (2021) Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clinical Research in Cardiology, 110, pp. 1554-1563. (doi: 10.1007/s00392-021-01830-1)

Raafs, A. et al. (2021) Identification of sex‐specific biomarkers predicting new‐onset heart failure. ESC Heart Failure, 8, pp. 3512-3520. (doi: 10.1002/ehf2.13476)

Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Ponikowski, P., Ravera, A., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Voors, A. A., Metra, M. (2021) Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. European Journal of Heart Failure, 23, pp. 1750-1758. (doi: 10.1002/ejhf.2276)

Rush, C. J., Berry, C., Oldroyd, K. G., Rocchiccioli, J. P., Lindsay, M. M., Touyz, R. M., Murphy, C. L., Ford, T. J., Sidik, N., McEntegart, M. B., Lang, N. N., Jhund, P. S., Campbell, R. T., McMurray, J. J.V., Petrie, M. C. (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiology, 6, pp. 1130-1143. (doi: 10.1001/jamacardio.2021.1825)

Anderson, J. J., Ho, F. K., Niedzwiedz, C. L., Katikireddi, V., Celis-Morales, C., Iliodromiti, S., Welsh, P., Pellicori, P., Demou, E., Hastie, C. E., Lyall, D. M., Gray, S. R., Forbes, J. F., Gill, J. M.R., Mackay, D. F., Berry, C., Cleland, J. G.F., Sattar, N., Pell, J. P. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19, pp. 2533-2538. (doi: 10.1111/jth.15452)

Graham, F. J., Pellicori, P., Cleland, J. G.F., Clark, A. L. (2021) Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure' European Journal of Heart Failure, 23, pp. 1800-1801. (doi: 10.1002/ejhf.2304)

Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C., Wong, I. C.K., Berry, C., Sattar, N., Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96, pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002)

Camafort, M., Jhund, P. S., Formiga, F., Castro- Salomó, A., Arévalo-Lorido, J. C., Sobrino-Martínez, J., Manzano, L., Diez-Manglano, J., Aramburu, O., Pérez-Barquero, M. M. (2021) Utilidad pronóstica de las cifras ambulatorias de presión arterial en pacientes de edad avanzada con insuficiencia cardíaca. Resultados del estudio DICUMAP = Prognostic value of ambulatory blood pressure values in elderly patients with heart failure. Results of the DICUMAP study. Revista Clínica Española, 221, pp. 433-440. (doi: 10.1016/j.rce.2020.11.010)

MacDonald, E. A., Quinn, T. A. (2021) What keeps us ticking? Sinoatrial node mechano-sensitivity: the grandfather clock of cardiac rhythm. Biophysical Reviews, 13, pp. 707-716. (doi: 10.1007/s12551-021-00831-8)

Curtain, J. P., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2021) Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. European Heart Journal, 42, pp. 3727-3738. (doi: 10.1093/eurheartj/ehab560)

Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H.-D., Lam, C. S.P., Lefkowitz, M. P., Linssen, G., Lund, L. H., Maggioni, A. P., Pfeffer, M. A., Rouleau, J. L., Saraiva, J. F.K., Senni, M., Vardeny, O., Wijkman, M. O., Yilmarz, M. B., Saito, Y., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2021) Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European Heart Journal, 42, pp. 3741-3752. (doi: 10.1093/eurheartj/ehab499)

Cleland, J. G.F., Pellicori, P. (2021) To master heart failure, first master congestion. Lancet, 398, pp. 935-936. (doi: 10.1016/S0140-6736(21)01914-0)

Ferreira, J. P., Ouwerkerk, W., Santema, B. T., van Veldhuisen, D. J., Lang, C. C., Ng, L. L., Anker, S. D., Dickstein, K., Metra, M., Cleland, J. G.F., Nilesh, S. J., Filippatos, G., Aboumsallem, J.-P., de Boer, R. A., Figarska, S., Sama, I. E., Voors, A. A., Zannad, F. (2021) Differences in biomarkers and molecular pathways according to age for patients with HFrEF. Cardiovascular Research, 117, pp. 2228-2236. (doi: 10.1093/cvr/cvaa279)

Pokhilko, A., Brezzo, G., Handunnetthi, L., Heilig, R., Lennon, R., Smith, C., Allan, S. M., Granata, A., Sinha, S., Wang, T., Markus, H. S., Naba, A., Fischer, R., Van Agtmael, T., Horsburgh, K., Cader, M. Z. (2021) Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease. Journal of Cerebral Blood Flow and Metabolism, 41, pp. 2423-2438. (doi: 10.1177/0271678X211004307)

Sigfrid, L. et al. (2021) Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Regional Health - Europe, 8, (doi: 10.1016/j.lanepe.2021.100186)

Romaszko, L., Borowska, A., Lazarus, A., Dalton, D., Berry, C., Luo, X., Husmeier, D., Gao, H. (2021) Neural network-based left ventricle geometry prediction from CMR images with application in biomechanics. Artificial Intelligence In Medicine, 119, (doi: 10.1016/j.artmed.2021.102140)

Alves-Lopes, R., Montezano, A. C., Neves, K. B., Harvey, A., Rios, F. J., Skiba, D. S., Arendse, L. B., Guzik, T. J., Graham, D., Poglitsch, M., Sturrock, E., Touyz, R. M. (2021) Selective inhibition of the C-domain of ACE (angiotensin-converting enzyme) combined with inhibition of NEP (neprilysin): a potential new therapy for hypertension. Hypertension, 78, pp. 604-616. (doi: 10.1161/HYPERTENSIONAHA.121.17041)

Pellicori, P., Cleland, J. G.F. (2021) Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition. European Journal of Preventive Cardiology, 28, pp. 921-923. (doi: 10.1177/2047487320937135)

Bayes‐Genis, A., Januzzi, J. L., Richards, A. M., Arfsten, H., de Boer, R. A., Emdin, M., González, A., Jaarsma, T., Jhund, P. S., Mueller, C., Núñez, J., Rossignol, P., Milinkovic, I., Rosano, G. M.C., Coats, A., Seferovic, P. (2021) The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe. European Journal of Heart Failure, 23, pp. 1432-1436. (doi: 10.1002/ejhf.2293)

McDonagh, T. A. et al. (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42, pp. 3599-3726. (doi: 10.1093/eurheartj/ehab368)

Welsh, P., Welsh, C. E., Jhund, P. S., Woodward, M., Brown, R., Lewsey, J., Celis-Morales, C. A., Ho, F. K., MacKay, D. F., Gill, J. M.R., Gray, S. R., Katikireddi, S. V., Pell, J. P., Forbes, J., Sattar, N. (2021) Derivation and validation of a 10-year risk score for symptomatic abdominal aortic aneurysm: cohort study of nearly 500 000 individuals. Circulation, 144, pp. 604-614. (doi: 10.1161/CIRCULATIONAHA.120.053022)

Heggie, R., Briggs, A., Stanley, B., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., YII, E., Collison, D., Oldroyd, K., Ford, T. J., Berry, C. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016)

Zakeri, R., Morgan, A. D., Sundaram, V., Bloom, C., Cleland, J. G.F., Quint, J. K. (2021) Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Medicine, 19, (doi: 10.1186/s12916-021-02048-8)

Jabbour, R. J. et al. (2021) In vivo grafting of large engineered heart tissue patches for cardiac repair. JCI Insight, 6, (doi: 10.1172/jci.insight.144068)

Verdonschot, J. A.J., Ferreira, J. P., Pellicori, P., Brunner La Rocca, H.-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Mariottoni, B., Petutschnigg, J., Rossignol, P., Cleland, J. G.F., Zannad, F., Heymans, S. R.B. (2021) Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial. Cardiovascular Diabetology, 20, (doi: 10.1186/s12933-021-01357-9)

Rørth, R., Clausen, M. F., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Jhund, P. S., Petrie, M. C., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2021) Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer. PLoS ONE, 16, (doi: 10.1371/journal.pone.0255364)

Ambrosy, A. P., von Haehling, S., Kalra, P. R., Court, E., Bhandari, S., McDonagh, T., Cleland, J. G.F. (2021) Safety and efficacy of intravenous ferric derisomaltose compared to iron sucrose for iron deficiency anemia in patients with chronic kidney disease with and without heart failure. American Journal of Cardiology, 152, pp. 138-145. (doi: 10.1016/j.amjcard.2021.04.042)

Cleland, J. G.F., Pellicori, P., González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27, pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9)

Kobayashi, M., Gargani, L., Palazzuoli, A., Ambrosio, G., Bayés-Genis, A., Lupon, J., Pellicori, P., Pugliese, N. R., Reddy, Y. N.V., Ruocco, G., Duarte, K., Huttin, O., Rossignol, P., Coiro, S., Girerd, N. (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure findings from a pooled analysis of four cohort studies. Clinical Research in Cardiology, 110, pp. 1181-1192. (doi: 10.1007/s00392-020-01724-8)

Shen, L., Jhund, P. S., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Køber, L., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. (2021) Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction. Clinical Research in Cardiology, 110, pp. 1234-1248. (doi: 10.1007/s00392-020-01786-8)

Shen, L., Claggett, B. L., Jhund, P. S., Abraham, W. T., Desai, A. S., Dickstein, K., Gong, J., Køber, L. V., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2021) Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. Clinical Research in Cardiology, 110, pp. 1334-1349. (doi: 10.1007/s00392-021-01888-x)

Kerr, M., Dennis, K.M.J.H., Carr, C.A., Fuller, W., Berridge, G., Rohling, S., Aitken, C.L., Lopez, C., Fischer, R., Miller, J.J., Clarke, K., Tyler, D.J., Heather, L.C. (2021) Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischaemia. FASEB Journal, 35, (doi: 10.1096/fj.202100394R)

Jorbenadze, A., Fudim, M., Mahfoud, F., Adamson, P. B., Bekfani, T., Wachter, R., Sievert, H., Ponikowski, P. P., Cleland, J. G.F., Anker, S. D. (2021) Extra-cardiac targets in the management of cardiometabolic disease: device-based therapies. ESC Heart Failure, 8, pp. 3327-3338. (doi: 10.1002/ehf2.13361)

Bates, E. A., Counsell, J. R., Alizert, S., Baker, A. T., Suff, N., Boyle, A., Bradshaw, A. C., Waddington, S. N., Nicklin, S. A., Baker, A. H., Parker, A. L. (2021) In vitro and in vivo evaluation of human adenovirus type 49 as a vector for therapeutic applications. Viruses, 13, (doi: 10.3390/v13081483)

Graham, F. J., Pellicori, P., Ford, I., Petrie, M. C., Kalra, P. R., Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110, pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8)

Petrie, M. C., Lee, M. M.Y., Docherty, K. F. (2021) Sodium–glucose co-transporter 2 inhibitors—the first successful treatment for heart failure with preserved ejection fraction? European Journal of Heart Failure, 23, pp. 1256-1259. (doi: 10.1002/ejhf.2108)

Patanapirunhakit, P., Karlsson, H., Mulder, M., Ljunggren, S., Graham, D., Freeman, D. (2021) Sphingolipids in HDL – potential markers for adaptation to pregnancy? Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids, 1866, (doi: 10.1016/j.bbalip.2021.158955)

Boland, E., Quondamatteo, F., Van Agtmael, T. (2021) The role of basement membranes in cardiac biology and disease. Bioscience Reports, 41, pp. BSR20204185. (doi: 10.1042/bsr20204185)

Castrichini, M., Nuzzi, V., Sinagra, G., Cleland, J., Pellicori, P. (2021) Use of social media by cardiovascular health care professionals: is patient privacy respected? JACC: Cardiovascular Imaging, 14, pp. 1680-1682. (doi: 10.1016/j.jcmg.2021.02.012)

Chung, J. et al. (2021) Rare missense functional variants at COL4A1 and COL4A2 in sporadic intracerebral hemorrhage. Neurology, 97, pp. e236-e247. (doi: 10.1212/WNL.0000000000012227)

Lee, M. M.Y., McMurray, J. J.V., Jhund, P. S., Petrie, M. C., Sattar, N. (2021) Response by Lee et al to letter regarding article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)" Circulation, 144, pp. e40. (doi: 10.1161/CIRCULATIONAHA.121.055067)

Docherty, K. F., Campbell, R. T., Brooksbank, K. J.M., Dreisbach, J. G., Forsyth, P., Godeseth, R., Hopkins, T., Jackson, A. M., Lee, M. M.Y., McConnachie, A., Roditi, G., Squire, I. B., Stanley, B., Welsh, P., Jhund, P. S., Petrie, M., McMurray, J. J.V. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144, pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892)

Simpson, J., Jackson, C. E., Haig, C., Jhund, P. S., Tomaszewski, M., Gardner, R. S., Tsorlalis, Y., Petrie, M. C., McMurray, J. J.V., Squire, I. B., Gupta, P. (2021) Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 7, pp. 296-301. (doi: 10.1093/ehjcvp/pvaa071)

Bistola, V., Simitsis, P., Parissis, J., Ouwerkerk, W., van Veldhuisen, D. J., Cleland, J. G., Anker, S. D., Samani, N. J., Metra, M., Zannad, F., Polyzogopoulou, E., Keramida, K., Farmakis, D., Voors, A. A., Filippatos, G. (2021) Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum. European Journal of Heart Failure, 23, pp. 1170-1181. (doi: 10.1002/ejhf.2219)

Lang, N. N., Ahmad, F. A., Cleland, J. G., O'Connor, C. M., Teerlink, J. R., Voors, A. A., Taubel, J., Hodes, A. R., Anwar, M., Karra, R., Sakata, Y., Ishihara, S., Senior, R., Khemka, A., Prasad, N. G., DeSouza, M. M., Seiffert, D., Ye, J. Y., Kessler, P. D., Borentain, M., Solomon, S. D., Felker, G. M., McMurray, J. J.V. (2021) Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. European Journal of Heart Failure, 23, pp. 1147-1155. (doi: 10.1002/ejhf.2138)

Jhund, P. S., Petrie, M. C., Robertson, M., Mark, P. B., MacDonald, M. R., Connolly, E., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Wheeler, D. C., Tomson, C. R.V., Ford, I., McMurray, J. J.V., Macdougall, I. C. (2021) Heart failure hospitalization in adults receiving maintenance hemodialysis and effect of intravenous iron therapy: A report from PIVOTAL. JACC: Heart Failure, 9, pp. 518-527. (doi: 10.1016/j.jchf.2021.04.005)

Halliday, B. P., Vazir, A., Owen, R., Gregson, J., Wassall, R., Lota, A. S., Khalique, Z., Tayal, U., Jones, R. E., Hammersley, D., Pantazis, A., Baksi, A. J., Rosen, S., Pennell, D. J., Cowie, M. R., Cleland, J. G.F., Prasad, S. K. (2021) Heart rate as a marker of relapse during withdrawal of therapy in recovered dilated cardiomyopathy. JACC: Heart Failure, 9, pp. 509-517. (doi: 10.1016/j.jchf.2021.03.010)

Randles, M., Lausecker, F., Kong, Q., Suleiman, H., Reid, G., Kolatsi-Joannou, M., Tian, P., Falcone, S., Davenport, B., Potter, P., Van Agtmael, T., Norman, J., Long, D., Humphries, M., Miner, J., Lennon, R. (2021) Identification of an altered matrix signature in kidney aging and disease. Journal of the American Society of Nephrology, 32, pp. 1713-1732. (doi: 10.1681/ASN.2020101442)

Gök, C., Main, A., Gao, X., Kerekes, Z., Plain, F., Kuo, C.-W., Robertson, A. D., Fraser, N. J., Fuller, W. (2021) Insights into the molecular basis of the palmitoylation and depalmitoylation of NCX1. Cell Calcium, 97, (doi: 10.1016/j.ceca.2021.102408)

Gupta, P., Voors, A. A., Patel, P., Lane, D., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G., Lang, C.C., Veldhuisen, D. J., Metra, M., Zannad, F., Samani, N. J., Jones, D. J.L., Squire, I. B., Ng, L. L. (2021) Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study) European Journal of Heart Failure, 23, pp. 1182-1190. (doi: 10.1002/ejhf.2160)

Diaz-Navarro, R., Urrútia, G., Cleland, J. G.F., Poloni, D., Villagran, F., Acosta-Dighero, R., Bangdiwala, S. I., Rada, G., Madrid, E. (2021) Stem cell therapy for dilated cardiomyopathy. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.cd013433.pub2)

Markousis-Mavrogenis, G., Tromp, J., Mentz, R. J., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2021) The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. Journal of Cardiac Failure, 27, pp. 808-811. (doi: 10.1016/j.cardfail.2021.01.008)

Holmes, A. P., Saxena, P., Kabir, S. N., O'Shea, C., Kuhlmann, S. M., Gupta, S., Fobian, D., Apicella, C., O'Reilly, M., Syeda, F., Reyat, J. S., Smith, G. L., Workman, A. J., Pavlovic, D., Fabritz, L., Kirchhof, P. (2021) The atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone. Heart Rhythm, 18, pp. 1212-1220. (doi: 10.1016/j.hrthm.2021.03.016)

Rush, C. J., Cleland, J. G.F., Veldtman, G. (2021) The emerging burden of heart failure in adults with congenital heart disease. International Journal of Cardiology Congenital Heart Disease, 4, (doi: 10.1016/j.ijcchd.2021.100171)

Pellicori, P., Fitchett, D., Kosiborod, M. N., Ofstad, A. P., Seman, L., Zinman, B., Zwiener, I., Wanner, C., George, J., Inzucchi, S. E., Testani, J. M., Cleland, J. G.F. (2021) Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. European Journal of Heart Failure, 23, pp. 1085-1093. (doi: 10.1002/ejhf.2220)

Cleland, J. G.F., Pfeffer, M. A., Clark, A. L., Januzzi, J. L., McMurray, J. J.V., Mueller, C., Pellicori, P., Richards, M., Teerlink, J. R., Zannad, F., Bauersachs, J. (2021) The struggle towards a universal definition of heart failure—how to proceed? European Heart Journal, 42, pp. 2331-2343. (doi: 10.1093/eurheartj/ehab082)

Anand, A., Lee, K. K., Chapman, A. R., Ferry, A. V., Adamson, P. D., Strachan, F. E., Berry, C., Findlay, I., Cruikshank, A., Reid, A., Collinson, P. O., Apple, F. S., McAllister, D., Maguire, D., Fox, K. A.A., Newby, D. E., Tuck, C., Harkess, R., Keerie, C., Weir, C. J., Parker, R. A., Gray, A., Shah, A. S.V., Mills, N. (2021) High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial. Circulation, 143, pp. 2214-2224. (doi: 10.1161/CIRCULATIONAHA.120.052380)

Reuten, R. et al. (2021) Basement membrane stiffness determines metastases formation. Nature Materials, 20, pp. 892-903. (doi: 10.1038/s41563-020-00894-0)

Butt, J. H., Docherty, K. F., Petrie, M. C., Schou, M., Kosiborod, M. N., O’Meara, E., Katova, T., Ljungman, C. E.A., Diez, M., Ogunniyi, M. O., Langkilde, A. M., Sjöstrand, M., Lindholm, D., Bengtsson, O., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Jhund, P. S., McMurray, J. J.V., Køber, L. (2021) Efficacy and safety of dapagliflozin in men and women with heart failure with reduced ejection fraction: results from the DAPA-HF trial. JAMA Cardiology, 6, pp. 678-689. (doi: 10.1001/jamacardio.2021.0379)

Sierpinski, R., Josiak, K., Suchocki, T., Wojtas‐Polc, K., Mazur, G., Butrym, A., Rozentryt, P., Meer, P., Comin‐Colet, J., Haehling, S., Kosmala, W., Przewlocka‐Kosmala, M., Banasiak, W., Nowak, J., Voors, A. A., Anker, S. D., Cleland, J. G.F., Ponikowski, P., Jankowska, E. A. (2021) High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. European Journal of Heart Failure, 23, pp. 919-932. (doi: 10.1002/ejhf.2036)

Espersen, C., Campbell, R. T., Claggett, B., Lewis, E. F., Groarke, J. D., Docherty, K. F., Lee, M. M.Y., Lindner, M., Biering‐Sørensen, T., Solomon, S. D., McMurray, J. J.V., Platz, E. (2021) Sex differences in congestive markers in patients hospitalized for acute heart failure. ESC Heart Failure, 8, pp. 1784-1795. (doi: 10.1002/ehf2.13300)

Pandhi, P., Streng, K. W., Anker, S. D., Cleland, J. G., Damman, K., Dickstein, K., Pellicori, P., Lang, C. C., Ng, L., Samani, N. J., Metra, M., Rossignol, P., Filippatos, G., van Veldhuisen, D. J., Voors, A. A., ter Maaten, J. M. (2021) The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. Journal of Cachexia, Sarcopenia and Muscle, 12, pp. 555-567. (doi: 10.1002/jcsm.12690)

Maznyczka, A. M., Carrick, D., Oldroyd, K. G., James-Rae, G., McCartney, P., Greenwood, J. P., Good, R., McEntegart, M., Eteiba, H., Lindsay, M., Cotton, J. M., Petrie, M. C., Berry, C. (2021) Thermodilution-derived temperature recovery time, a novel predictor of microvascular reperfusion and prognosis after myocardial infarction. EuroIntervention, 17, pp. 220-228. (doi: 10.4244/EIJ-D-19-00904)

Bowman, P. R.T., Smith, G. L., Gould, G. W. (2021) Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease? PeerJ, 9, (doi: 10.7717/peerj.11485)

Beggs, S. A.S., Jhund, P. S., McMurray, J. J.V. (2021) Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA. European Heart Journal, 42, pp. e5-e7. (doi: 10.1093/eurheartj/ehy609)

Jhund, P. S., Ponikowski, P., Docherty, K. F., Gasparyan, S. B., Böhm, M., Chang, C.-E., Desai, A. S., Howlett, J., Kitakaze, M., Petrie, M. C., Verma, S., Bengtsson, O., Langkilde, A.-M., Sjöstrand, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2021) Dapagliflozin and recurrent heart failure hospitalizations in heart failure with reduced ejection fraction: an analysis of DAPA-HF. Circulation, 143, pp. 1962-1972. (doi: 10.1161/CIRCULATIONAHA.121.053659)

Emmens, J. E., Jia, C., Ng, L. L., van Veldhuisen, D. J., Dickstein, K., Anker, S. D., Lang, C. C., Filippatos, G., Cleland, J. G.F., Metra, M., Voors, A. A., de Boer, R. A., Tietge, U. J.F. (2021) Impaired high-density lipoprotein function in patients with heart failure. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019123)

Rossitto, G., Maiolino, G., Lerco, S., Ceolotto, G., Blackburn, G., Mary, S., Antonelli, G., Berton, C., Bisogni, V., Cesari, M., Seccia, T. M., Lenzini, L., Pinato, A., Montezano, A., Touyz, R. M., Petrie, M. C., Daly, R., Welsh, P., Plebani, M., Rossi, G. P., Delles, C. (2021) High sodium intake, glomerular hyperfiltration and protein catabolism in patients with essential hypertension. Cardiovascular Research, 117, pp. 1372-1381. (doi: 10.1093/cvr/cvaa205)

Lee, M. M.Y., Ghouri, N., McGuire, D. K., Rutter, M. K., Sattar, N. (2021) Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2i and GLP-1RA in Asian vs. White patients with and without type 2 diabetes. Diabetes Care, 44, pp. 1236-1241. (doi: 10.2337/dc20-3007)

Heath Richardson, S. I., Gao, H., Cox, J., Janiczek, R., Griffith, B. E., Berry, C., Luo, X. (2021) A poroelastic immersed finite element framework for modeling cardiac perfusion and fluid-structure interaction. International Journal for Numerical Methods in Biomedical Engineering, 37, (doi: 10.1002/cnm.3446)

Schofield, C. L., Rodrigo-Navarro, A., Dalby, M. J., Van Agtmael, T., Salmeron-Sanchez, M. (2021) Biochemical­­– and biophysical–induced barriergenesis in the blood brain barrier: a review of barriergenic factors for use in in vitro models. Advanced NanoBiomed Research, 1, (doi: 10.1002/anbr.202000068)

Dean, A., Van Agtmael, T. (2021) Collagen IV-related diseases and therapies. Springer

Wolsk, E., Kaye, D. M., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Cleland, J. G., Hasenfuß, G., Hassager, C., Møller, J. E., Gustafsson, F. (2021) Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 23, pp. 754-764. (doi: 10.1002/ejhf.2146)

Tromp, J., Ouwerkerk, W., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Teng, K. T.-H., Bamadhaj, S., Ertl, G., Hassanein, M., Perrone, S. V., Ghandanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Collins, S. P., Lam, C. S.P., Dickstein, K. (2021) Global differences in burden and treatment of ischemic heart disease in acute heart failure: REPORT-HF. JACC: Heart Failure, 9, pp. 349-359. (doi: 10.1016/j.jchf.2020.12.015)

Mutambudzi, M., Niedzwiedz, C. L., Macdonald, E. B., Leyland, A. H., Mair, F. S., Anderson, J. J., Celis-Morales, C. A., Cleland, J. G., Forbes, J., Gill, J. M.R., Hastie, C. E., Ho, F. K., Jani, B. D., Mackay, D. F., Nicholl, B. I., O'Donnell, C. A., Sattar, N., Welsh, P., Pell, J. P., Katikireddi, S. V., Demou, E. (2021) Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78, pp. 307-314. (doi: 10.1136/oemed-2020-106731)

Ferreira, J. P., Claggett, B. L., Liu, J., Desai, A. S., Pfeffer, M. A., Anand, I. S., Van Veldhuisen, D. J., Kober, L., Cleland, J. G.F., Rouleau, J. L., Packer, M., Zile, M. R., Shi, V. C., Lefkowitz, M. P., Shah, S. J., Vardeny, O., Zanannd, F., Solomon, S. D., McMurray, J. J.V. (2021) Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial. European Journal of Heart Failure, 23, pp. 776-784. (doi: 10.1002/ejhf.2134)

Zhang, J., Pellicori, P., Schutte, R., Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289, pp. 747-748. (doi: 10.1111/joim.13226)

Berg, D. D., Jhund, P. S., Docherty, K. F., Murphy, S. A., Verma, S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V., Sabatine, M. S. (2021) Time to clinical benefit of dapagliflozin and significance of prior heart failure hospitalization in patients with heart failure with reduced ejection fraction. JAMA Cardiology, 6, pp. 499-507. (doi: 10.1001/jamacardio.2020.7585)

Pellicori, P., Platz, E., Dauw, J., ter Maaten, J. M., Martens, P., Pivetta, E., Cleland, J. G.F., McMurray, J. J.V., Mullens, W., Solomon, S. D., Zannad, F., Gargani, L., Girerd, N. (2021) Ultrasound imaging of congestion in heart failure – examinations beyond the heart. European Journal of Heart Failure, 23, pp. 703-712. (doi: 10.1002/ejhf.2032)

Shen, L., Jhund, P. S., Anand, I. S., Bhatt, A. S., Desai, A. S., Maggioni, A. P., Martinez, F. A., Pfeffer, M. A., Rizkala, A. R., Rouleau, J. L., Swedberg, K., Vaduganathan, M., Vardeny, O., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Packer, M., Solomon, S. D., McMurray, J. J.V. (2021) Incidence and outcomes of pneumonia in patients with heart failure. Journal of the American College of Cardiology, 77, pp. 1961-1973. (doi: 10.1016/j.jacc.2021.03.001)

McMurray, J. J.V., Solomon, S. D., Docherty, K. F., Jhund, P. S. (2021) The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context. European Heart Journal, 42, pp. 1199-1202. (doi: 10.1093/eurheartj/ehz916)

Coats, A. J. et al. (2021) The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European Heart Journal, 42, pp. 1254-1269. (doi: 10.1093/eurheartj/ehab086)

Mooney, L., Goodyear, C. S., Chandra, T., Kirschner, K., Copland, M., Petrie, M. C., Lang, N. N. (2021) Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure. Clinical Science, 135, pp. 991-1007. (doi: 10.1042/CS20200306)

Scott, K., Morgan, H. L., Delles, C., Fisher, S., Graham, D., McBride, M. W. (2021) Distinct uterine artery gene expression profiles during early gestation in the stroke-prone spontaneously hypertensive rat. Physiological Genomics, 53, pp. 160-171. (doi: 10.1152/physiolgenomics.00159.2020)

Docherty, K. F., Curtain, J. P., Anand, I. S., Bengtsson, O., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2021) Effect of dapagliflozin on anaemia in DAPA-HF. European Journal of Heart Failure, 23, pp. 617-628. (doi: 10.1002/ejhf.2132)

Dewan, P., Docherty, K. F., Bengtsson, O., de Boer, R. A., Desai, A. S., Drozdz, J., Hawkins, N. M., Inzucchi, S. E., Kitakaze, M., Køber, L., Kosiborod, M. N., Langkilde, A. M., Lindholm, D., Martinez, F. A., Merkely, B., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Sjöstrand, M., Solomon, S. D., Verma, S., Jhund, P. S., McMurray, J. J.V. (2021) Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA-HF. European Journal of Heart Failure, 23, pp. 632-643. (doi: 10.1002/ejhf.2083)

Butt, J. H., Nicolau, J. C., Verma, S., Docherty, K. F., Petrie, M. C., Inzucchi, S. E., Schou, M., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Bengtsson, O., Jhund, P. S., McMurray, J., Køber, L. (2021) Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial. European Journal of Heart Failure, 23, pp. 601-613. (doi: 10.1002/ejhf.2124)

Mbakwem, A. C., Bauersachs, J., Viljoen, C., Hoevelmann, J., Meer, P., Petrie, M. C., Mebazaa, A., Goland, S., Karaye, K., Laroche, C., Sliwa, K. (2021) Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. ESC Heart Failure, 8, pp. 879-889. (doi: 10.1002/ehf2.13172)

Ferreira, J. P., Lam, C. S. P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Cleland, J. G.F., Greenberg, B., Zannad, F. (2021) Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial. European Journal of Heart Failure, 23, pp. 648-656. (doi: 10.1002/ejhf.2003)

Ferreira, J. P. et al. (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC: Heart Failure, 9, pp. 268-277. (doi: 10.1016/j.jchf.2020.11.010)

Sliwa, K. et al. (2021) Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 23, pp. 527-540. (doi: 10.1002/ejhf.2133)

Sigfrid, L. et al. (2021) What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-043887)

Uijl, A., Vaartjes, I., Denaxas, S., Hemingway, H., Shah, A. D., Cleland, J., Grobbee, D. E., Hoes, A. W., Asselbergs, F. W., Koudstaal, S. (2021) Temporal trends in heart failure medication prescription in a population-based cohort study. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-043290)

Mortensen, P., Gao, H., Smith, G., Simitev, R. D. (2021) Action potential propagation and block in a model of atrial tissue with myocyte-fibroblast coupling. Mathematical Medicine and Biology, 38, pp. 106-131. (doi: 10.1093/imammb/dqaa014)

Pellicori, P., Doolub, G., Wong, C. M., Lee, K. S., Mangion, K., Ahmad, M., Berry, C., Squire, I., Lambiase, P., Lyon, A. R., McConnachie, A., Taylor, R. S., Cleland, J. G.F. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.CD013879)

Briscoe, M., Sykes, R., Krystofiak, T., Peck, O., Mangion, K., Berry, C. (2021) Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury. Clinical Cardiology, 44, pp. 332-339. (doi: 10.1002/clc.23530)

Smart, N. A., Pearson, M. J., Taylor, R. S., Cleland, J. (2021) Exercise training for heart failure with preserved ejection fraction (ExTraMATCH III): protocol for an individual patient data meta-analysis. Journal of Clinical Exercise Physiology, 10, pp. 3-11. (doi: 10.31189/2165-7629-10.1.3)

Mordi, I. R., Ouwerkerk, W., Anker, S. D., Cleland, J. G., Dickstein, K., Metra, M., Ng, L. L., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Voors, A. A., Lang, C. C. (2021) Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. European Journal of Heart Failure, 23, pp. 436-444. (doi: 10.1002/ejhf.1799)

Ferreira, J. P., Cleland, J. G.F., Lam, C. S.P., van Veldhuisen, D., Byra, W. M., La Police, D. A., Anker, S. D., Mehra, M. R., Leroy, C., Eschwege, V., Toussaint-Hacquard, M., Rossignol, P., Greenberg, B., Zannad, F. (2021) Impact of geographic region on the COMMANDER-HF Trial. JACC: Heart Failure, 9, pp. 201-211. (doi: 10.1016/j.jchf.2020.11.007)

Sykes, R. A., Mohamed, M. O., Kwok, C. S., Mamas, M. A., Berry, C. (2021) Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (nationwide readmissions database) Clinical Cardiology, 44, pp. 291-306. (doi: 10.1002/clc.23543)

Doherty, D. J., Sykes, R., Mangion, K., Berry, C. (2021) Predictors of microvascular reperfusion after myocardial infarction. Current Cardiology Reports, 23, (doi: 10.1007/s11886-021-01442-1)

Tomasoni, D., Petrie, M. C., Adamo, M., Metra, M. (2021) Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. European Journal of Heart Failure, 23, pp. 486-488. (doi: 10.1002/ejhf.2098)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2021) The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. American Journal of Clinical Nutrition, 113, pp. 695-705. (doi: 10.1093/ajcn/nqaa311)

Hortigon-Vinagre, M.P., Zamora, V., Burton, F. L., Smith, G. L. (2021) The use of voltage sensitive dye di-4-ANEPPS and video-based contractility measurements to assess drug effects on excitation-contraction coupling in human induced pluripotent stem cell-derived cardiomyocytes. Journal of Cardiovascular Pharmacology, 77, pp. 280-290. (doi: 10.1097/FJC.0000000000000937)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8, (doi: 10.1136/openhrt-2020-001453)

Ehteshami-Afshar, S., Mooney, L., Dewan, P., Desai, A. S., Lang, N. N., Lefkowitz, M. P., Petrie, M. C., Rizkala, A. R., Rouleau, J. L., Solomon, S. D., Swedberg, K., Shi, V. C., Zile, M. R., Packer, M., McMurray, J. J.V., Jhund, P. S., Hawkins, N. M. (2021) Clinical characteristics and outcomes of patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: insights from PARADIGM-HF. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019238)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) Circulation, 143, pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186)

Petrie, M. C., Lee, M. M., Lang, N. N. (2021) EMPEROR-REDUCED reigns while EMPERIAL whimpers. European Heart Journal, 42, pp. 711-714. (doi: 10.1093/eurheartj/ehaa965)

Cleland, J. G.F. et al. (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European Heart Journal, 42, pp. 684-696. (doi: 10.1093/eurheartj/ehaa758)

Li, W., Gao, H., Mangion, K., Berry, C., Luo, X. (2021) Apparent growth tensor of left ventricular post myocardial infarction – in human first natural history study. Computers in Biology and Medicine, 129, (doi: 10.1016/j.compbiomed.2020.104168)

Inzucchi, S. E., Docherty, K. F., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Verma, S., Bělohlávek, J., Böhm, M., Chiang, C.-E., de Boer, R. A., Diez, M., Dukát, A., Ljungman, C. E.A., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Jhund, P. S., McMurray, J. J.V. (2021) Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA-HF. Diabetes Care, 44, pp. 586-594. (doi: 10.2337/dc20-1675)

Maznyczka, A. M., McCartney, P., Duklas, P., McEntegart, M., Oldroyd, K., Greenwood, J., Muir, D., Chowdhary, S., Gershlick, A. H., Eteiba, H., Cotton, J., Wragg, A., Curzen, N., Tait, R., Macfarlane, P., Welsh, P., Sattar, N., Petrie, M., Ford, I., Fox, K., McConnachie, A., Berry, C. (2021) Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial. Heart, 107, pp. 299-312. (doi: 10.1136/heartjnl-2020-317828)

Felker, G. M. et al. (2021) Effects of a novel nitroxyl donor in acute heart failure: the STAND-UP AHF Study. JACC: Heart Failure, 9, pp. 146-157. (doi: 10.1016/j.jchf.2020.10.012)

Halliday, B. P., Owen, R., Gregson, J., Vassiliou, V., Chen, X., Wage, R., Lota, A. S., Khalique, Z., Tayal, U., Hammersley, D. J., Jones, R. E., Baksi, A. J., Cowie, M. R., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2021) Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy – insights from TRED‐HF. European Journal of Heart Failure, 23, pp. 293-301. (doi: 10.1002/ejhf.2063)

Docherty, K. F., Campbell, R. T., Brooksbank, K. J.M., Godeseth, R. L., Forsyth, P., McConnachie, A., Roditi, G., Stanley, B., Welsh, P., Jhund, P. S., Petrie, M. C., McMurray, J. J.V. (2021) Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling. ESC Heart Failure, 8, pp. 129-138. (doi: 10.1002/ehf2.13137)

Maznyczka, A. M., McCartney, P. J., Oldroyd, K. G., Lindsay, M., McEntegart, M., Eteiba, H., Rocchiccioli, J. P., Good, R., Shaukat, A., Robertson, K., Malkin, C. J., Greenwood, J. P., Cotton, J. M., Hood, S., Watkins, S., Collison, D., Gillespie, L., Ford, T. J., Weir, R. A.P., McConnachie, A., Berry, C. (2021) Risk stratification guided by the index of microcirculatory resistance and left ventricular end-diastolic pressure in acute myocardial infarction. Circulation: Cardiovascular Interventions, 14, (doi: 10.1161/CIRCINTERVENTIONS.120.009529)

Platz, E., Jhund, P. S. (2021) Risk stratification in patients presenting with acute heart failure. European Heart Journal: Acute Cardiovascular Care, 10, pp. 113-115. (doi: 10.1093/ehjacc/zuab005)

Robertson-Gray, O., Fuller, W. (2021) The role of protein S-acylation in cardiac function. Clinical Laboratory International, Feb, pp. 10-13.

Jhund, P. S. et al. (2021) Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF. Circulation, 143, pp. 289-309. (doi: 10.1161/CIRCULATIONAHA.120.050391)

Samuel, N. A., Cuthbert, J. J., Brown, O. I., Kazmi, S., Cleland, J. G.F., Rigby, A. S., Clark, A. L. (2021) Relation between thyroid function and mortality in patients with chronic heart failure. American Journal of Cardiology, 139, pp. 57-63. (doi: 10.1016/j.amjcard.2020.10.034)

Teerlink, J. R. et al. (2021) Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. New England Journal of Medicine, 384, pp. 105-116. (doi: 10.1056/NEJMoa2025797)

Main, A., Robertson-Gray, O., Fuller, W. (2021) Cyclophilin D palmitoylation and permeability transition: a new twist in the tale of myocardial ischaemia-reperfusion injury. Cardiovascular Research, 117, pp. 15-17. (doi: 10.1093/cvr/cvaa149)

Corcoran, D., Radjenovic, A., Mordi, I., Nazir, S. A., Wilson, S. J., Hinder, M., Yates, D. P., Machineni, S., Alcantara, J., Prescott, M. F., Gugliotta, B., Pang, Y., Tzemos, N., Semple, S. I., Newby, D. E., McCann, G. P., Squire, I., Berry, C. (2021) Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial. Cardiovascular Research, 117, pp. 320-329. (doi: 10.1093/cvr/cvz345)

Bekfani, T., Fudim, M., Cleland, J. G.F., Jorbenadze, A., Haehling, S., Lorber, A., Rothman, A. M.‐K., Stein, K., Abraham, W. T., Sievert, H., Anker, S. D. (2021) A current and future outlook on upcoming technologies in the remote monitoring of patients with heart failure. European Journal of Heart Failure, 23, pp. 175-185. (doi: 10.1002/ejhf.2033)

Dobbin, S. J.H., Petrie, M. C., Myles, R. C., Touyz, R. M., Lang, N. N. (2021) Cardiotoxic effects of angiogenesis inhibitors. Clinical Science, 135, pp. 71-100. (doi: 10.1042/CS20200305)

Davison, B. A., Senger, S., Sama, I. E., Koch, G. G., Mebazaa, A., Dickstein, K., Samani, N. J., Metra, M., Anker, S. D., Cleland, J. G., Ng, L. L., Mordi, I. R., Zannad, F., Filippatos, G. S., Hillege, H. L., Ponikowski, P., Veldhuisen, D. J., Lang, C. C., Meer, P., Núñez, J., Bayés‐Genís, A., Edwards, C., Voors, A. A., Cotter, G. (2021) Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF. European Journal of Heart Failure, 23, pp. 43-57. (doi: 10.1002/ejhf.2077)

Docherty, K. F., Vaduganathan, M. (2021) OUTSTEP‐HF: re‐evaluating the role of physical activity measures in drug and device development in heart failure. European Journal of Heart Failure, 23, pp. 136-139. (doi: 10.1002/ejhf.2106)

McCallum, L., Brooksbank, K., McConnachie, A., Aman, A., Lip, S., Dawson, J., MacIntyre, I. M., MacDonald, T. M., Webb, D. J., Padmanabhan, S. (2021) Rationale and design of the genotype-blinded trial of torasemide for the treatment of hypertension (BHF UMOD) American Journal of Hypertension, 34, pp. 92-99. (doi: 10.1093/ajh/hpaa166)

McMurray, J. J.V., Docherty, K. F. (2021) SOLOIST-WHF: Sodium-glucose cotransporter 2 (SGLT2) inhibitors should be initiated in patients hospitalised with worsening heart failure. European Journal of Heart Failure, 23, pp. 27-30. (doi: 10.1002/ejhf.2075)

He, T., Melgarejo, J. D., Clark, A. L., Yu, Y.‐L., Thijs, L., Díez, J., López, B., González, A., Cleland, J. G., Schanstra, J. P., Vlahou, A., Latosinska, A., Mischak, H., Staessen, J. A., Zhang, Z.‐Y., Jankowski, V. (2021) Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure. Clinical and Translational Medicine, 11, (doi: 10.1002/ctm2.267)

Willder, J. M., McCall, P., Messow, C.-M., Gillies, M., Berry, C., Shelley, B. (2021) Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-042098)

Burton, R. F., Burton, F. L. (2021) When is sitting height a better measure of adult body size than total height, and why? The contrasting examples of body mass, waist circumference and lung volume. American Journal of Human Biology, 33, (doi: 10.1002/ajhb.23433)

Mortensen, P., Gao, H., Smith, G., Simitev, R. D. (2021) Addendum: Action potential propagation and block in a model of atrial tissue with myocyte-fibroblast coupling. Mathematical Medicine and Biology, 38, pp. 292-298. (doi: 10.1093/imammb/dqab005)

Jacobs, M., Benovoy, M., Chang, L.-C., Corcoran, D., Berry, C., Arai, A. E., Hsu, L.-Y. (2021) Automated segmental analysis of fully quantitative myocardial blood flow maps by first-pass perfusion cardiovascular magnetic resonance. IEEE Access, 9, pp. 52796-52811. (doi: 10.1109/ACCESS.2021.3070320)

Kamdar, A., Sykes, R., Morrow, A., Mangion, K., Berry, C. (2021) Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis. Reviews in Cardiovascular Medicine, 22, pp. 1479-1490. (doi: 10.31083/j.rcm2204152)

Da Silva Costa, A., Mortensen, P., Hortigon-Vinagre, M. P., van der Heyden, M. A. G., Burton, F. L., Gao, H., Simitev, R. D., Smith, G. L. (2021) Electrophysiology of hiPSC-cardiomyocytes co-cultured with HEK cells expressing the inward rectifier channel. International Journal of Molecular Sciences, 22, (doi: 10.3390/ijms22126621)

Anderson, J. J., Welsh, P., Ho, F. K., Ferguson, L. D., Welsh, C. E., Pellicori, P., Cleland, J. G.F., Forbes, J., Iliodromiti, S., Boyle, J., Lindsay, R., Celis-Morales, C., Gray, S. R., Katikireddi, S. V., Gill, J. M. R., Pell, J. P., Sattar, N. (2021) Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening. BMJ Open Diabetes Research and Care, 9, (doi: 10.1136/bmjdrc-2021-002176)

Boguslavskyi, A., Tokar, S., Prysyazhna, O., Rudyk, O., Sanchez-Tatay, D., Lemmey, H. A.L., Dora, K. A., Garland, C. J., Warren, H. R., Doney, A., Palmer, C. N.A., Caulfield, M. J., Vlachaki Walker, J., Howie, J., Fuller, W., Shattock, M. J. (2021) Phospholemman phosphorylation regulates vascular tone, blood pressure and hypertension in mice and man. Circulation, 143, pp. 1123-1138. (doi: 10.1161/CIRCULATIONAHA.119.040557)

Wijkman, M. O., Malachias, M. V.B., Claggett, B. L., Cheng, S., Matsushita, K., Shah, A. M., Jhund, P. S., Coresh, J., Solomon, S. D., Vardeny, O. (2021) Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study. Journal of Clinical Hypertension, 23, pp. 1887-1896. (doi: 10.1111/jch.14269)

Shoaib, A., Van Spall, H. G.C., Wu, J., Cleland, J. G.F., McDonagh, T. A., Rashid, M., Mohamed, M. O., Ahmed, F. Z., Deanfield, J., de Belder, M., Gale, C. P., Mamas, M. A. (2021) Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal: Quality of Care and Clinical Outcomes, 7, pp. 378-387. (doi: 10.1093/ehjqcco/qcab040)

Shah, P., Pellicori, P., Hanning, I., Zhang, J., Clark, A. L., Bhandari, S. (2021) The effect of digoxin on renal function in patients with heart failure. BMC Nephrology, 22, (doi: 10.1186/s12882-021-02562-0)

Sykes, R., Briscoe, M., Krystofiak, T., Peck, O., Mangion, K., Berry, C. (2021) Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to de-risk clinical trials. Open Heart, 8, (doi: 10.1136/openhrt-2021-001633)

Ang, D. T. Y., Berry, C. (2021) What an interventionalist needs to know about INOCA. Interventional Cardiology Review, 16, (doi: 10.15420/icr.2021.16)

Sykes, R., Doherty, D., Mangion, K., Morrow, A., Berry, C. (2021) What an interventionalist needs to know about MI with non-obstructive coronary arteries. Interventional Cardiology Review, 16, (doi: 10.15420/icr.2021.10)

Rossitto, G., Mary, S., McAllister, C., Neves, K. B., Haddow, L., Rocchiccioli, J. P., Lang, N. N., Murphy, C. L., Touyz, R. M., Petrie, M. C., Delles, C. (2020) Reduced lymphatic reserve in heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 76, pp. 2817-2829. (doi: 10.1016/j.jacc.2020.10.022)

Lee, M. (2020) Studies of Empagliflozin and its Cardiovascular, Renal and Metabolic Effects in Patients With Diabetes Mellitus (or Prediabetes) and Heart Failure: a Randomized Controlled Trial (SUGAR-DM-HF) (doi: 10.1161/CIR.0000000000000940)

Purcell, C., Daw, P., Kerr, C., Cleland, J., Cowie, A., Dalal, H., Ibbotson, T., Murphy, C., Taylor, R. (2020) Protocol for an implementation study of an evidence-based home cardiac rehabilitation programme for people with heart failure and their caregivers in Scotland (SCOT:REACH-HF) BMJ Open, 10, (doi: 10.1136/bmjopen-2020-040771)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116, pp. 2185-2196. (doi: 10.1093/cvr/cvaa209)

Mangion, K., Loughrey, C., Auger, D. A., McComb, C., Lee, M. M., Corcoran, D., McEntegart, M., Davie, A., Good, R., Lindsay, M., Eteiba, H., Rocchiccioli, J. P., Watkins, S., Hood, S., Shaukat, A., Haig, C., Epstein, F. H., Berry, C. (2020) Displacement encoding with stimulated echoes enables the identification of infarct transmurality early postmyocardial infarction. Journal of Magnetic Resonance Imaging, 52, pp. 1722-1731. (doi: 10.1002/jmri.27295)

Pellicori, P., Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., Zinman, B., Brueckmann, M., Lindenfeld, J. (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7, pp. 3401-3407. (doi: 10.1002/ehf2.12891)

Felker, G. M., Solomon, S. D., McMurray, J. J.V., Cleland, J. G.F., Abbasi, S. A., Malik, F. I., Zhang, H., Globe, G., Teerlink, J. R. (2020) Effects of omecamtiv mecarbil on symptoms and health-related quality of life in patients with chronic heart failure: results from the COSMIC-HF study. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.120.007814)

Ferreira, J. P., Docherty, K. F., Stienen, S., Jhund, P. S., Claggett, B. L., Solomon, S. D., Petrie, M. C., Gregsone, J., Pocock, S. L., Zannad, F., McMurray, J. (2020) Estimating the lifetime benefits of treatments for heart failure. JACC: Heart Failure, 8, pp. 984-995. (doi: 10.1016/j.jchf.2020.08.004)

Main, A., Fuller, W., Baillie, G. S. (2020) Post-translational regulation of cardiac myosin binding protein-C: a graphical review. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109788)

Kristensen, S. L., Castagno, D., Shen, L., Jhund, P., Docherty, K., Rørth, R., Abraham, W. T., Desai, A., Dickstein, K., Rouleau, J. L., Zile, M. R., Swedberg, K., Packer, M., Solomon, S. D., Køber, L., McMurray, J. J.V. (2020) Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM‐HF and ATMOSPHERE. European Journal of Heart Failure, 22, pp. 2370-2379. (doi: 10.1002/ejhf.1972)

Brown, O., Costanzo, P., Clark, A. L., Condorelli, G., Cleland, J. G.F., Sathyapalan, T., Hepburn, D., Kilpatrick, E. S., Atkin, S. L. (2020) Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus. Cardiovascular Endocrinology and Metabolism, 9, pp. 177-182. (doi: 10.1097/XCE.0000000000000202)

Yeoh, S. E., Dewan, P., Desai, A. S., Solomon, S. D., Rouleau, J. L., Lefkowitz, M., Rizkala, A., Swedberg, K., Zile, M. R., Jhund, P. S., Packer, M., McMurray, J. J.V. (2020) Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF. ESC Heart Failure, 7, pp. 3355-3364. (doi: 10.1002/ehf2.12972)

O'Toole, D., Zaeri, A. A. I., Nicklin, S. A., French, A. T., Loughrey, C. M., Martin, T. P. (2020) Signalling pathways linking cysteine cathepsins to adverse cardiac remodelling. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109770)

McFall, A., Nicklin, S. A., Work, L. M. (2020) The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: insight from preclinical stroke studies and therapeutic potential. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109809)

Pashova, A., Work, L.M., Nicklin, S.A. (2020) The role of extracellular vesicles in neointima formation post vascular injury. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109783)

Gök, C., Fuller, W. (2020) Topical review: shedding light on molecular and cellular consequences of NCX1 palmitoylation. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109791)

Mackenzie, I. S. et al. (2020) Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet, 396, pp. 1745-1757. (doi: 10.1016/S0140-6736(20)32234-0)

Beazer, J. D., Patanapirunhakit, P., Gill, J. M.R., Graham, D., Karlsson, H., Ljunggren, S., Mulder, M., Freeman, D. J. (2020) High-density lipoprotein’s vascular protective functions in metabolic and cardiovascular disease - could extracellular vesicles be at play? Clinical Science, 134, pp. 2977-2986. (doi: 10.1042/CS20200892)

Ho, F. K., Celis-Morales, C. A., Gray, S. R., Katikireddi, S. V., Niedzwiedz, C. L., Hastie, C., Ferguson, L. D., Berry, C., Mackay, D. F., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P. (2020) Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open, 10, (doi: 10.1136/bmjopen-2020-040402)

Briscoe, M., Sykes, R. A., Krysztofiak, T., Peck, O. H., Mangion, K., Berry, C. (2020) Clinical Significance of Coronavirus Disease 2019 in Hospitalized Patients With Myocardial Injury. (doi: 10.1161/circ.142.suppl_3.15932)

Briscoe, M., Sykes, R. A., Krysztofiak, T., Mangion, K., Peck, O. H., Berry, C. (2020) Clinical Significance of Troponin Elevation in a Contemporary Hospitalized Population: Endotypes, Morbidity and In-hospital Mortality. (doi: 10.1161/circ.142.suppl_3.14870)

Psotka, M. A. et al. (2020) Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel. Journal of the American College of Cardiology, 76, pp. 2368-2378. (doi: 10.1016/j.jacc.2020.09.544)

Dietrichs, E. S., McGlynn, K., Allan, A., Connolly, A., Bishop, M., Burton, F., Kettlewell, S., Myles, R., Tveita, T., Smith, G. L. (2020) Moderate but not severe hypothermia causes pro-arrhythmic changes in cardiac electrophysiology. Cardiovascular Research, 116, pp. 2081-2090. (doi: 10.1093/cvr/cvz309)

McEwan, P., Darlington, O., McMurray, J. J.V., Jhund, P. S., Docherty, K. F., Böhm, M., Petrie, M. C., Bergenheim, K., Qin, L. (2020) Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF. European Journal of Heart Failure, 22, pp. 2147-2156. (doi: 10.1002/ejhf.1978)

Ferreira, J. P., Dewan, P., Jhund, P., Lorenzo-Almorós, A., Duarte, K., Petrie, M., Carson, P. E., McKelvie, R., Komajda, M., Zile, M., Zannad, F., McMurray, J. J.V. (2020) Covariate adjusted reanalysis of the I-Preserve trial. Clinical Research in Cardiology, 109, pp. 1358-1365. (doi: 10.1007/s00392-020-01632-x)

Docherty, K., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Kober, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2020) Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy. Diabetes Care, 43, pp. 2878-2881. (doi: 10.2337/dc20-1402)

Charla, E., Mercer, J., Maffia, P., Nicklin, S. (2020) Extracellular vesicle signalling in atherosclerosis. Cellular Signalling, 75, (doi: 10.1016/j.cellsig.2020.109751)

Seferović, P. M. et al. (2020) Heart Failure Association of the European Society of Cardiology update on sodium glucose co‐transporter‐2 inhibitors in heart failure (an update on the Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. The position paper of the Heart Failure Association of the European Society of Cardiology) European Journal of Heart Failure, 22, pp. 1984-1986. (doi: 10.1002/ejhf.2026)

McCartney, P. J. et al. (2020) Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT. Efficacy and Mechanism Evaluation, 7, (doi: 10.3310/eme07050)

Teerlink, J. R. et al. (2020) Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials. European Journal of Heart Failure, 22, pp. 2160-2171. (doi: 10.1002/ejhf.2015)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007)

Ferreira, J. P., Mogensen, U. M., Jhund, P. S., Desai, A. S., Zile, M. R., Rossignol, P., Zannad, F., Packer, M., Solomon, S. D., McMurray, J. J.V. (2020) Serum potassium in the PARADIGM-HF trial. European Journal of Heart Failure, 22, pp. 2056-2064. (doi: 10.1002/ejhf.1987)

Selvaraj, S., Claggett, B. L., Pfeffer, M. A., Desai, A. S., McCausland, F. R., McGrath, M. M., Anand, I. S., van van Veldhuisen, D. J., Kober, L., Janssens, S., Cleland, J. G.F., Pieske, B., Rouleau, J. L., Zile, M. R., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2020) Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. European Journal of Heart Failure, 22, pp. 2093-2101. (doi: 10.1002/ejhf.1984)

Dewan, P., Jackson, A., Jhund, P. S., Shen, L., Ferreira, J. P., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2020) The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. European Journal of Heart Failure, 22, pp. 2123-2133. (doi: 10.1002/ejhf.1832)

Palazzuoli, A., Ruocco, G., Franci, B., Evangelista, I., Lucani, B., Nuti, R., Pellicori, P. (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clinical Research in Cardiology, 109, pp. 1423-1433. (doi: 10.1007/s00392-020-01642-9)

Docherty, K. F. et al. (2020) Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction: a prespecified analysis of DAPA-HF. Circulation, 142, pp. 1623-1632. (doi: 10.1161/CIRCULATIONAHA.120.047480)

Kunadian, V., Chieffo, A., Camici, P. G., Berry, C., Escaned, J., Maas, A. H. E. M., Prescott, E., Karam, N., Appelman, Y., Fraccaro, C., Louise Buchanan, G., Manzo-Silberman, S., Al-Lamee, R., Regar, E., Lansky, A., Abbott, J. D., Badimon, L., Duncker, D. J., Mehran, R., Capodanno, D., Baumbach, A. (2020) An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. European Heart Journal, 41, pp. 3504-3520. (doi: 10.1093/eurheartj/ehaa503)

Lang, N. N., Dobbin, S. J.H., Petrie, M. C. (2020) Vericiguat in worsening heart failure – agonising over, or celebrating, agonism. Cardiovascular Research, 116, pp. e152-e155. (doi: 10.1093/cvr/cvaa247)

Solomon, S. D., Jhund, P. S., Claggett, B. L., Dewan, P., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Inzucchi, S. E., Desai, A. S., Bengtsson, O., Lindholm, D., Sjostrand, M., Langkilde, A. M., McMurray, J. J.V. (2020) Effect of dapagliflozin in patients with HFrEF treated with sacubitril/valsartan: the DAPA-HF trial. JACC: Heart Failure, 8, pp. 811-818. (doi: 10.1016/j.jchf.2020.04.008)

Rahimi, K., Nazarzadeh, M., Pinho-Gomes, A.-C., Woodward, M., Salimi-Khorshidi, G., Ohkuma, T., Fitzpatrick, R., Tarassenko, L., Denis, M., Cleland, J. (2020) Home monitoring with technology-supported management in chronic heart failure: a randomised trial. Heart, 106, pp. 1573-1578. (doi: 10.1136/heartjnl-2020-316773)

von Haehling, S., Garfias Macedo, T., Valentova, M., Anker, M. S., Ebner, N., Bekfani, T., Haarmann, H., Schefold, J. C., Lainscak, M., Cleland, J. G.F., Doehner, W., Hasenfuss, G., Anker, S. D. (2020) Muscle wasting as an independent predictor of survival in patients with chronic heart failure. Journal of Cachexia, Sarcopenia and Muscle, 11, pp. 1242-1249. (doi: 10.1002/jcsm.12603)

Malachias, M. V.B., Jhund, P., Claggett, B. L., Wijkman, M. O., Bentley-Lewis, R., Chaturvedi, N., Desai, A. S., Haffner, S. M., Parving, H.-H., Prescott, M. F., Solomon, S. D., De Zeeuw, D., McMurray, J. J.V., Pfeffer, M. A. (2020) N-terminal pro-B-type natriuretic peptide by itself predicts death and cardiovascular events in high-risk patients with type 2 diabetes. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.120.017462)

Butt, J. H., Fosbøl, E. L., Gerds, T. A., Andersson, C., McMurray, J. J.V., Petrie, M. C., Gustafsson, F., Madelaire, C., Kristensen, S. L., Gislason, G. H., Torp-Pedersen, C., Køber, L., Schou, M. (2020) Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort. European Journal of Heart Failure, 22, pp. 1777-1785. (doi: 10.1002/ejhf.1800)

Docherty, K. F., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2020) Sacubitril/valsartan: neprilysin inhibition 5 Years after PARADIGM-HF. JACC: Heart Failure, 8, pp. 800-810. (doi: 10.1016/j.jchf.2020.06.020)

Dewan, P., Jhund, P. S., McMurray, J. J.V. (2020) VICTORIA in context. European Journal of Heart Failure, 22, pp. 1747-1751. (doi: 10.1002/ejhf.1833)

Mc Causland, F. R., Lekowitz, M. P., Claggett, B., Anavekar, N. S., Senni, M., Gori, M., Jhund, P. S., McGrath, M. M., Packer, M., Shi, V., Van Veldhuisen, D. J., Zannad, F., Comin-Colet, J., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2020) Angiotensin-neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction. Circulation, 142, pp. 1236-1245. (doi: 10.1161/CIRCULATIONAHA.120.047643)

Serenelli, M. et al. (2020) Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF) European Heart Journal, 41, pp. 3402-3418. (doi: 10.1093/eurheartj/ehaa496)

Dowsett, L., Higgins, E., Alanazi, S., Alshuwayer, N. A., Leiper, F. C., Leiper, J. (2020) ADMA: A key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. Journal of Clinical Medicine, 9, (doi: 10.3390/jcm9093026)

Jackson, A. M. et al. (2020) Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF. Circulation, 142, pp. 1040-1054. (doi: 10.1161/CIRCULATIONAHA.120.047077)

Ford, T. J., Corcoran, D., Padmanabhan, S., Aman, A., Rocchiccioli, P., Good, R., McEntegart, M., Maguire, J. J., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., Sattar, N., Hsu, L.-Y., Arai, A. E., Oldroyd, K. G., Touyz, R. M., Davenport, A. P., Berry, C. (2020) Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction. European Heart Journal, 41, pp. 3239-3252. (doi: 10.1093/eurheartj/ehz915)

Sattar, N., Ho, F. K., Gill, J. M.R., Ghouri, N., Gray, S. R., Celis-Morales, C. A., Katikireddi, S. V., Berry, C., Pell, J. P., McMurray, J. J.V., Welsh, P. (2020) BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, pp. 1149-1151. (doi: 10.1016/j.dsx.2020.06.060)

Voors, A. A. et al. (2020) Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. European Journal of Heart Failure, 22, pp. 1649-1658. (doi: 10.1002/ejhf.1933)

Pellicori, P., Ferreira, J. P., Mariottoni, B., Brunner-La Rocca, H.-P., Ahmed, F. Z., Job, V., Collier, T., Cuthbert, J. J., Petutschnigg, J., Mujaj, B., Girerd, N., González, A., Clark, A. L., Cosmi, F., Staessen, J. A., Heymans, S., Latini, R., Rossignol, P., Zannand, F., Cleland, J. G.F. (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European Journal of Heart Failure, 22, pp. 1711-1723. (doi: 10.1002/ejhf.1716)

Ngandu Mpoyi, E., Cantini, M., Sin, Y. Y., Fleming, L., Zhou, D. W., Costell, M., Lu, Y., Kadler, K., García, A. J., Van Agtmael, T., Salmeron-Sanchez, M. (2020) Material-driven fibronectin assembly rescues matrix defects due to mutations in collagen IV in fibroblasts. Biomaterials, 252, (doi: 10.1016/j.biomaterials.2020.120090)

Seferović, P. M. et al. (2020) Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 22, pp. 1495-1503. (doi: 10.1002/ejhf.1954)

Aksentijević, D., Karlstaedt, A., Basalay, M. V., O’Brien, B. A., Sanchez-Tatay, D., Eminaga, S., Thakker, A., Tennant, D. A., Fuller, W., Eykyn, T. R., Taegtmeyer, H., Shattock, M. J. (2020) Intracellular sodium elevation reprograms cardiac metabolism. Nature Communications, 11, (doi: 10.1038/s41467-020-18160-x)

Ford, T. J., Ong, P., Sechtem, U., Beltrame, J., Camici, P. G., Crea, F., Kaski, J.-C., Bairey Merz, C. N., Pepine, C. J., Shimokawa, H., Berry, C. (2020) Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how and when. JACC: Cardiovascular Interventions, 13, pp. 1847-1864. (doi: 10.1016/j.jcin.2020.05.052)

Rossitto, G., Mary, S., Chen, J. Y., Bodder, P., Chew, K. S., Neves, K. B., Alves, R. L., Montezano, A. C., Welsh, P., Petrie, M. C., Graham, D., Touyz, R. M., Delles, C. (2020) Tissue sodium excess is not hypertonic and reflects extracellular volume expansion. Nature Communications, 11, (doi: 10.1038/s41467-020-17820-2)

McClure, J. D., Ramsay, J. C., Berry, C. (2020) Pooled analysis of bleeding and major adverse cardiovascular events in clinical trials of time-constrained dual-antiplatelet therapy after percutaneous coronary intervention. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.120.017109)

Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewksi, M., Maffia, P., D'Acquisto, F., Nicklin, S. A., Marian, A. J., Nosalski, R., Murray, E. C., Guzik, B., Berry, C., Touyz, R. M., Kreutz, R., Wang, D. W., Bhella, D., Sagliocco, O., Crea, F., Thomson, E. C., McInnes, I. B. (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116, pp. 1666-1687. (doi: 10.1093/cvr/cvaa106)

Ouwerkerk, W., Teng, T.-H. K., Tromp, J., Ting Tay, W., Cleland, J. G., van Veldhuisen, D. J., Dickstein, K., Ng, L. L., Lang, C. C., Anker, S. D., Zannad, F., Hung, C.-L., Sawhney, J.P.S., Naik, A., Shimizu, W., Hagiwara, N., Singh Wander, G., Anand, I., Richards, A. M., Voors, A. A., Lam, C. S.P. (2020) Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. European Journal of Heart Failure, 22, pp. 1472-1482. (doi: 10.1002/ejhf.1869)

Zou, Z.-G., Rios, F. J., Neves, K. B., Alves-Lopes, R., Ling, J., Baillie, G. S., Gao, X., Fuller, W., Camargo, L. L., Gudermann, T., Chubanov, V., Montezano, A. C., Touyz, R. M. (2020) Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function. Clinical Science, 134, pp. 2019-2035. (doi: 10.1042/CS20200827)

Lombardi, C. M., Ferreira, J. P., Carubelli, V., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Voors, A., Metra, M. (2020) Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clinical Research in Cardiology, 109, pp. 967-977. (doi: 10.1007/s00392-019-01588-7)

ter Maaten, J. M., Martens, P., Damman, K., Dickstein, K., Ponikowski, P., Lang, C. C., Ng, L. L., Anker, S. D., Samani, N. J., Filippatos, G., Cleland, J. G., Zannad, F., Hillege, H. L., van Veldhuisen, D. J., Metra, M., Voors, A. A., Mullens, W. (2020) Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clinical Research in Cardiology, 109, pp. 1048-1059. (doi: 10.1007/s00392-020-01598-w)

Bomer, N., Grote Beverborg, N., Hoes, M. F., Streng, K. W., Vermeer, M., Dokter, M. M., IJmker, J., Anker, S. D., Cleland, J. G.F., Hillege, H. L., Lang, C. C., Ng, L. L., Samani, N. J., Tromp, J., Veldhuisen, D. J., Touw, D. J., Voors, A. A., Meer, P. (2020) Selenium and outcome in heart failure. European Journal of Heart Failure, 22, pp. 1415-1423. (doi: 10.1002/ejhf.1644)

Campbell, R. T., Jasilek, A., Mischak, H., Nkuipou-Kenfack, E., Latosinska, A., Welsh, P. I., Jackson, C. E., Cannon, J., McConnachie, A., Delles, C., McMurray, J. J.V. (2020) The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure. ESC Heart Failure, 7, pp. 1595-1604. (doi: 10.1002/ehf2.12708)

Shi, C., van der Wal, H. H., Silljé, H. H.W., Dokter, M. M., van den Berg, F., Huizinga, L., Vriesema, M., Post, J., Anker, S. D., Cleland, J. G., Ng, L. L., Samani, N. J., Dickstein, K., Zannad, F., Lang, C. C., van Haelst, P. L., Gietema, J. A., Metra, M., Ameri, P., Canepa, M., van Veldhuisen, D. J., Voors, A. A., de Boer, R. A. (2020) Tumor biomarkers: association with heart failure outcomes. Journal of Internal Medicine, 288, pp. 207-218. (doi: 10.1111/joim.13053)

Salerno, S., Solvang-Garten, K., Smith, G. L., Stølen, T., Kelly, A. (2020) Two-photon excitation of FluoVolt allows improved interrogation of transmural electrophysiological function in the intact mouse heart. Progress in Biophysics and Molecular Biology, 154, pp. 11-20. (doi: 10.1016/j.pbiomolbio.2019.08.007)

Dobbie, L. J., Mackin, S. T., Hogarth, K., Lonergan, F., Kannenkeril, D., Brooksbank, K., Delles, C. (2020) Validation of semi-automated flow mediated dilation measurement in healthy volunteers. Blood Pressure Monitoring, 25, pp. 216-223. (doi: 10.1097/MBP.0000000000000448)

Plain, F., Howie, J., Kennedy, J., Brown, E., Shattock, M. J., Fraser, N. J., Fuller, W. (2020) Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase. Communications Biology, 3, (doi: 10.1038/s42003-020-01145-3)

MacDonald, E. A., Madl, J., Greiner, J., Ramadan, A. F., Wells, S. M., Torrente, A. G., Kohl, P., Rog-Zielinska, E. A., Quinn, T. A. (2020) Sinoatrial node structure, mechanics, electrophysiology and the chronotropic response to stretch in rabbit and mouse. Frontiers in Physiology, 11, (doi: 10.3389/fphys.2020.00809)

Fong, L. C. W., Ford, T. J., da Costa, B. R., Jüni, P., Berry, C. (2020) Bias and loss to follow-up in cardiovascular randomized trials: a systematic review. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.119.015361)

Bulluck, H., Carberry, J., Carrick, D., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Mahrous, A., Ford, I., Oldroyd, K. G., Berry, C. (2020) Redefining adverse and reverse left ventricular remodeling by cardiovascular magnetic resonance following ST-segment elevation myocardial infarction and their implications on long-term prognosis. Circulation: Cardiovascular Imaging, 13, (doi: 10.1161/CIRCIMAGING.119.009937)

Lees, J. S., Mangion, K., Rutherford, E., Witham, M. D., Woodward, R., Roditi, G., Hopkins, T., Brooksbank, K., Jardine, A., Mark, P. B. (2020) Vitamin K for kidney transplant organ recipients: investigating vEssel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart, 7, (doi: 10.1136/openhrt-2019-001070)

Vaduganathan, M., Claggett, B. L., Jhund, P., Cunningham, J. W., Ferreira, J. P., Zannad, F., Packer, M., Fonarow, G. C., McMurray, J., Solomon, S. D. (2020) Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet, 396, pp. 121-128. (doi: 10.1016/S0140-6736(20)30748-0)

Vaduganathan, M., Jhund, P. S., Claggett, B. L., Packer, M., Widimský, J., Seferovic, P., Rizkala, A., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2020) A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction. European Heart Journal, 41, pp. 2356-2362. (doi: 10.1093/eurheartj/ehaa184)

Cleland, J. G.F., Li, C., Jones, Y. (2020) Artificial intelligence needs clinical intelligence to succeed. JACC: Heart Failure, 8, pp. 588-591. (doi: 10.1016/j.jchf.2020.06.002)

Dobbin, S. J.H., Mangion, K., Berry, C., Roditi, G., Basak, S., Sourbron, S., White, J., Venugopal, B., Touyz, R. M., Jones, R. J., Petrie, M. C., Lang, N. N. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22, pp. 1276-1277. (doi: 10.1002/ejhf.1847)

Pan, D., Pellicori, P., Walklett, C., Green, A., Masse, A. R., Wood, J., Purdy, J., Clark, A. L. (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26, pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002)

Docherty, K. F., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., DeMets, D. L., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Desai, A. S., Diez, M., Howlett, J. G., Katova, T., Ljungman, C. E. A., O’Meara, E., Petrie, M. C., Schou, M., Verma, S., Vinh, P. N., Solomon, S. D., McMurray, J. J.V. (2020) Effects of dapagliflozin in DAPA-HF according to background heart failure therapy. European Heart Journal, 41, pp. 2379-2392. (doi: 10.1093/eurheartj/ehaa183)

Dewan, P., Solomon, S. D., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., DeMets, D. L., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Anand, I. S., Bělohlávek, J., Chopra, V. K., Dukát, A., Kitakaze, M., Merkely, B., O'Meara, E., Schou, M., Vinh, P. N., McMurray, J. J.V. (2020) Efficacy and safety of sodium–glucose co‐transporter 2 inhibition according to left ventricular ejection fraction in DAPA‐HF. European Journal of Heart Failure, 22, pp. 1247-1258. (doi: 10.1002/ejhf.1867)

Taya, U., Wage, R., Newsome, S., Manivarmane, R., Izgi, C., Muthumala, A., Dungu, J. N., Assomull, R., Hatipoglu, S., Halliday, B. P., Lota, A. S., Ware, J. S., Gregson, J., Frenneaux, M., Cook, S. A., Pennell, D. J., Scott, A. D., Cleland, J. G.F., Prasad, S. K. (2020) Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study. European Journal of Heart Failure, 22, pp. 1160-1170. (doi: 10.1002/ejhf.1734)

Riddell, A., McBride, M., Braun, T., Nicklin, S. A., Cameron, E., Loughrey, C. M., Martin, T. P. (2020) RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovascular Research, 116, pp. 1410-1423. (doi: 10.1093/cvr/cvaa034)

Cleland, J. G.F., Lyon, A. R., McDonagh, T., McMurray, J. J.V. (2020) The year in cardiology 2019: heart failure. Romanian Journal of Cardiology, 30, pp. 185-204. (doi: 10.47803/rjc.2020.30.2.185)

Al-Hussaini, A., Abdelaty, A. M.S.E.K., Gulsin, G. S., Arnold, J. R., Garcia-Guimaraes, M., Premawardhana, D., Budgeon, C., Wood, A., Natarajan, N., Mangion, K., Rakhit, R., Hoole, S. P., Johnson, T. W., Berry, C., Hudson, I., Gershlick, A. H., Ladwiniec, A., Kovac, J., Squire, I., Samani, N. J., Plein, S., McCann, G. P., Adlam, D. (2020) Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management. European Heart Journal, 41, pp. 2197-2205. (doi: 10.1093/eurheartj/ehz895)

Gök, C., Plain, F., Robertson, A., Howie, J., Baillie, G. S., Fraser, N. J., Fuller, W. (2020) Dynamic palmitoylation of the sodium-calcium exchanger modulates its structure, affinity for lipid ordered domains, and inhibition by XIP. Cell Reports, 31, (doi: 10.1016/j.celrep.2020.107697)

Anker, S. D. et al. (2020) Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) European Heart Journal, 41, pp. 2109-2117. (doi: 10.1093/eurheartj/ehaa461)

Katus, H. A., Cleland, J. G.F., Jaffe, A. S. (2020) Myocardial injury in severe COVID-19 infection. European Heart Journal, 41, pp. 2080-2082. (doi: 10.1093/eurheartj/ehaa447)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. (2020) Agreement and classification performance of malnutrition tools in patients with chronic heart failure. Current Developments in Nutrition, 4, (doi: 10.1093/cdn/nzaa071)

Cleland, J. G.F., Clark, R. A., Pellicori, P., Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22, pp. 995-998. (doi: 10.1002/ejhf.1864)

Sidik, N., McDermott, M., McEntegart, M. B., Berry, C. (2020) Chest pain without obstructive coronary artery disease: a case series report. European Heart Journal: Case Reports, 4, pp. 1-6. (doi: 10.1093/ehjcr/ytaa060)

Sama, I. E., Woolley, R. J., Nauta, J. F., Romaine, S. P.R., Tromp, J., ter Maaten, J. M., van der Meer, P., Lam, C. S.P., Samani, N. J., Ng, L. L., Metra, M., Dickstein, K., Anker, S. D., Zannad, F., Lang, C. C., Cleland, J. G.F., van Veldhuisen, D. J., Hillege, H. L., oors, A. A.V. (2020) A network analysis to identify pathophysiological pathways distinguishing ischemic from non-ischemic heart failure. European Journal of Heart Failure, 22, pp. 821-833. (doi: 10.1002/ejhf.1811)

Błyszczuk, P., Zuppinger, C., Costa, A., Nurzynska, D., Di Meglio, F., Stellato, M., Agarkova, I., Smith, G., Distler, O., Kania, G. (2020) Activated cardiac fibroblasts control contraction of human fibrotic cardiac microtissues by a β-adrenoreceptor-dependent mechanism. Cells, 9, (doi: 10.3390/cells9051270)

Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41, pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415)

Voors, A. A., van Veldhuisen, D. J., Metra, M., Ponikowski, P., Anker, S. D., Filippatos, G., Lang, C. C., Dickstein, K., Ng, L. L., Samani, N. J., Friedrich, A. W., Rienstra, M., Cleland, J. G.F., ter Maaten, J. M., van Goor, H., Santema, B. T., Ravera, A., Sama, I. E. (2020) Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. European Heart Journal, 41, pp. 1810-1817. (doi: 10.1093/eurheartj/ehaa373)

Collison, D., McClure, J. D., Berry, C., Oldroyd, K. G. (2020) A randomized controlled trial of a physiology‐guided percutaneous coronary intervention optimization strategy: rationale and design of the TARGET FFR study. Clinical Cardiology, 43, pp. 414-422. (doi: 10.1002/clc.23342)

Hayes, S., Forbes, J. F., Celis-Morales, C., Anderson, J., Ferguson, L., Gill, J. M.R., Gray, S., Hastie, C., Iliodromoti, S., Lyall, D., Pellicori, P., Sattar, N., Welsh, C. E., Pell, J. (2020) Association between walking pace and stroke incidence: findings from the UK Biobank prospective cohort study. Stroke, 51, pp. 1388-1395. (doi: 10.1161/STROKEAHA.119.028064)

Maznyczka, A. M., Oldroyd, K. G., Greenwood, J. P., McCartney, P. J., Cotton, J., Lindsay, M., McEntegart, M., Rocchiccioli, J. P., Good, R., Robertson, K., Eteiba, H., Watkins, S., Shaukat, A., Petrie, C. J., Murphy, A., Petrie, M. C., Berry, C. (2020) Comparative significance of invasive measures of microvascular injury in acute myocardial infarction. Circulation: Cardiovascular Interventions, 13, (doi: 10.1161/CIRCINTERVENTIONS.119.008505)

Stienen, S., Ferreira, J. P., Pitt, B., Cleland, J. G., Pellicori, P., Girerd, N., Rossignol, P., Zannad, F. (2020) Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure. European Journal of Heart Failure, 22, pp. 901-903. (doi: 10.1002/ejhf.1812)

Fudim, M., Dalgaard, F., Al-Khatib, S. M., J. Friedman, D., Lallinger, K., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Schaber, D. E., Tang, A., Ali-Ahmed, F., Goldstein, S. A., Kaufman, B., Fortman, R., Davis, J. K., Inoue, L. Y.T., Sanders, G. D. (2020) Future research prioritization in cardiac resynchronization therapy. American Heart Journal, 223, pp. 48-58. (doi: 10.1016/j.ahj.2020.02.011)

Hawkins, N. M., Osmanska, J., Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22, pp. 868-870. (doi: 10.1002/ejhf.1803)

Cunningham, J. W., Ferreira, J. P., Deng, H., Anker, S. D., Byra, W. M., Cleland, J. G.F., Gheorghiade, M., Lam, C. S.P., La Police, D., Mehra, M. R., Neaton, J. D., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B., Zannad, F. (2020) Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: insights from COMMANDER HF. JACC: Heart Failure, 8, pp. 359-368. (doi: 10.1016/j.jchf.2019.12.009)

Hennigan, B., Berry, C., Collison, D., Corcoran, D., Eteiba, H., Good, R., McEntegart, M., Watkins, S., McClure, J., Mangion, K., Ford, T., Petrie, M. C., Hood, S., Rocchiccioli, P., Shaukat, A., Lindsay, M., Oldroyd, K. G. (2020) Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial. Heart, 106, pp. 714-715. (doi: 10.1136/heartjnl-2019-316075)

Docherty, K. F., Ferreira, J. P., Sharma, A., Girerd, N., Gregson, J., Duarte, K., Petrie, M. C., Jhund, P. S., Dickstein, K., Pfeffer, M. A., Pitt, B., Rossignol, P., Zannad, F., McMurray, J. J.V. (2020) Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. European Journal of Heart Failure, 22, pp. 848-855. (doi: 10.1002/ejhf.1694)

Quint, J. K., Rajagopalan, S., Cleland, J. G.F., Simon, D. I., Banerjee, A., Briere, J.-B., Bowrin, K., Cohen, A., Halcox, J., Zakeri, R., Bloom, C., Sundaram, V. (2020) Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015. European Heart Journal, 41, pp. 1636-1649. (doi: 10.1093/eurheartj/ehz880)

Li, W., Lazarus, A., Gao, H., Martinez De Azcona Naharro, A., Fontana, M., Hawkins, P., Biswas, S., Janiczek, R., Cox, J., Berry, C., Husmeier, D., Luo, X. (2020) Analysis of cardiac amyloidosis progression using model-based markers. Frontiers in Physiology, 11, (doi: 10.3389/fphys.2020.00324)

Petrie, M. C., et al. (2020) Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes. JAMA: Journal of the American Medical Association, 323, pp. 1353-1368. (doi: 10.1001/jama.2020.1906)

Dietrichs, E. S., Tveita, T., Myles, R., Smith, G. (2020) A novel ECG-biomarker for cardiac arrest during hypothermia. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 28, (doi: 10.1186/s13049-020-00721-0)

Nosalski, R., Siedlinski, M., Denby, L., Mcginnigle, E., Nowak, M., Nguyen Dinh Cat, A., Medina-Ruiz, L., Cantini, M., Skiba, D., Wilk, G., Osmenda, G., Rodor, J., Salmeron-Sanchez, M., Graham, G., Maffia, P., Graham, D., Baker, A. H., Guzik, T. J. (2020) T cell-derived miRNA-214 mediates perivascular fibrosis in hypertension. Circulation Research, 126, pp. 988-1003. (doi: 10.1161/CIRCRESAHA.119.315428)

Pandhi, P., Maaten, J. M., Emmens, J. E., Struck, J., Bergmann, A., Cleland, J. G., Givertz, M. M., Metra, M., O'Connor, C. M., Teerlink, J. R., Ponikowski, P., Cotter, G., Davison, B., Veldhuisen, D. J., Voors, A. A. (2020) Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. European Journal of Heart Failure, 22, pp. 683-691. (doi: 10.1002/ejhf.1693)

Frazier, S., McBride, M. W., Mulvana, H., Graham, D. (2020) From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia. Clinical Science, 134, pp. 1001-1025. (doi: 10.1042/CS20200023)

Jackson, A. M., Zhang, R., Findlay, I., Robertson, K., Lindsay, M., Morris, T., Forbes, B., Papworth, R., McConnachie, A., Mangion, K., Jhund, P. S., McCowan, C., Berry, C. (2020) Healthcare disparities for women hospitalised with myocardial infarction and angina. European Heart Journal: Quality of Care and Clinical Outcomes, 6, pp. 156-165. (doi: 10.1093/ehjqcco/qcz040)

Simpson, J., Jhund, P. S., Lund, L. H., Padmanabhan, S., Clagget, B. L., Shen, L., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Kober, L., Paker, M., Rouleau, J. L., Mueller-Velten, G., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2020) Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiology, 5, pp. 432-441. (doi: 10.1001/jamacardio.2019.5850)

Mangion, K., Adamson, P. D., Williams, M. C., Hunter, A., Pawade, T., Shah, A. S.V., Lewis, S., Boon, N. A., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D., McAllister, D., Berry, C. (2020) Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain. European Heart Journal, 41, pp. 1337-1345. (doi: 10.1093/eurheartj/ehz903)

Wehner, G. J., Jing, L., Haggerty, C. M., Suever, J. D., Leader, J. B., Hartzel, D. N., Kirchner, H. L., Manus, J. N.A., James, N., Ayar, Z., Gladding, P., Good, C. W., Cleland, J. G.F., Fornwalt, B. K. (2020) Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? European Heart Journal, 41, pp. 1249-1257. (doi: 10.1093/eurheartj/ehz550)

Cleland, J. G.F., Lyon, A. R., McDonagh, T., McMurray, J. J.V. (2020) The year in cardiology: heart failure. European Heart Journal, 41, pp. 1232-1248. (doi: 10.1093/eurheartj/ehz949)

Berry, C., Duncker, D. J. (2020) Coronary microvascular disease: the next frontier for Cardiovascular Research. Cardiovascular Research, 116, pp. 737-740. (doi: 10.1093/cvr/cvaa035)

MacDonald, E. A., Rose, R. A., Quinn, T. A. (2020) Neurohumoral control of sinoatrial node activity and heart rate: insight from experimental models and findings from humans. Frontiers in Physiology, 11, (doi: 10.3389/fphys.2020.00170)

Ford, T. J., Berry, C. (2020) Angina: contemporary diagnosis and management. Heart, 106, pp. 387-398. (doi: 10.1136/heartjnl-2018-314661)

Shen, L., Jhund, P., McMurray, J. (2020) Dyslipidaemia, a factor worthy of adjustment: reply. European Journal of Heart Failure, 22, pp. 564-565. (doi: 10.1002/ejhf.1718)

Lee, M. M.Y., Petrie, M. C., McMurray, J. J.V., Sattar, N. (2020) How do SGLT2 (sodium-glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists reduce cardiovascular outcomes? Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 506-522. (doi: 10.1161/atvbaha.119.311904)

Tromp, J., Bamadhaj, S., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ouwerkerk, W., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Hu, D., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Lam, C. S.P., Filippatos, G., Collins, S. P. (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Global Health, 8, pp. e411-e422. (doi: 10.1016/S2214-109X(20)30004-8)

Sidik, N. P., McEntegart, M., Roditi, G., Ford, T. J., McDermott, M., Morrow, A., Byrne, J., Adams, J., Hargreaves, A., Oldroyd, K. G., Stobo, D., Wu, O., Messow, C.-M., McConnachie, A., Berry, C. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015)

Fuller, W., Gök, C. (2020) Regulation of NCX1 by palmitoylation. Cell Calcium, 86, (doi: 10.1016/j.ceca.2019.102158)

Docherty, K. F., Shen, L., Castagno, D., Petrie, M. C., Abraham, W. T., Böhm, M., Desai, A. S., Dickstein, K., Køber, L. V., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Vazir, A., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2020) Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. European Journal of Heart Failure, 22, pp. 528-538. (doi: 10.1002/ejhf.1682)

Santema, B. T., Chan, M. M.Y., Tromp, J., Dokter, M., van der Wal, H. H., Emmens, J. E., Takens, J., Samani, N. J., Ng, L. L., Lang, C. C., van der Meer, P., ter Maaten, J. M., Damman, K., Dickstein, K., Cleland, J. G., Zannad, F., Anker, S. D., Metra, M., van der Harst, P., de Boer, R. A., van Veldhuisen, D. J., Rienstra, M., Lam, C. S.P., Voors, A. A. (2020) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clinical Research in Cardiology, 109, pp. 331-338. (doi: 10.1007/s00392-019-01513-y)

Serenelli, M., Jackson, A., Dewan, P., Jhund, P. S., Petrie, M. C., Rossignol, P., Campo, G., Pitt, B., Zannad, F., Ferreira, J. P., McMurray, J. J.V. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8, pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011)

Rorth, R., Jhund, P. S., Yilmaz, M. B., Kristensen, S. L., Welsh, P., Desai, A. S., Køber, L., Prescott, M. F., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2020) Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.119.006541)

Huethorst, E., Cutiongco, M. F.A., Campbell, F. A., Saeed, A., Love, R., Reynolds, P. M., Dalby, M. J., Gadegaard, N. (2020) Customizable, engineered substrates for rapid screening of cellular cues. Biofabrication, 12, (doi: 10.1088/1758-5090/ab5d3f)

McMurray, J. J.V. et al. (2020) Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF. Circulation, 141, pp. 338-351. (doi: 10.1161/CIRCULATIONAHA.119.044491)

Maznyczka, A. M., McCartney, P. J., Oldroyd, K. G., Lindsay, M., McEntegart, M., Eteiba, H., Rocchiccioli, P., Good, R., Shaukat, A., Robertson, K., Kodoth, V., Greenwood, J. P., Cotton, J. M., Hood, S., Watkins, S., Macfarlane, P. W., Kennedy, J., Tait, C., Welsh, P., Sattar, N., Collison, D., Gillespie, L., McConnachie, A., Berry, C. (2020) Effects of intracoronary alteplase on microvascular function in acute myocardial infarction. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.119.014066)

Morrow, A., Sidik, N., Berry, C. (2020) ISCHEMIA: new questions from a landmark trial. Cardiovascular Research, 116, pp. e23-e25. (doi: 10.1093/cvr/cvz343)

Rankin, A. J., Allwood-Spiers, S., Lee, M. M.Y., Zhu, L., Woodward, R., Kuehn, B., Radjenovic, A., Sattar, N., Roditi, G., Mark, P. B., Gillis, K. A. (2020) Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients. Magnetic Resonance Materials in Physics, Biology and Medicine, 33, pp. 103-112. (doi: 10.1007/s10334-019-00809-4)

Seferović, P. M. et al. (2020) European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure. European Journal of Heart Failure, 22, pp. 196-213. (doi: 10.1002/ejhf.1673)

Bégué, C., Mörner, S., Brito, D., Hengstenberg, C., Cleland, J. G.F., Arbustini, E., Galve, E., Wichter, T., Richter, A., Golmard, J.-L., Bernard, M., Dubourg, O., Komajda, M., Charron, P., Isnard, R. (2020) Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy. Heart, 106, pp. 196-202. (doi: 10.1136/heartjnl-2019-314826)

Maznyczka, A. M. et al. (2020) One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention. The T-TIME randomized trial. Circulation: Cardiovascular Interventions, 13, (doi: 10.1161/CIRCINTERVENTIONS.119.008855)

Ford, T. J., Khan, A., Docherty, K. F., Jackson, A., Morrow, A., Sidik, N., Rocchiccioli, P., Good, R., Eteiba, H., Watkins, S., Shaukat, A., Lindsay, M., Robertson, K., Petrie, M., Berry, C., Oldroyd, K., McEntegart, M. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95, pp. 232-241. (doi: 10.1002/ccd.28373)

Jhund, P. S. (2020) The recurring problem of heart failure hospitalisations. European Journal of Heart Failure, 22, pp. 249-250. (doi: 10.1002/ejhf.1721)

Fraser, N. J., Howie, J., Wypijewski, K. J., Fuller, W. (2020) Therapeutic targeting of protein S-acylation for the treatment of disease. Biochemical Society Transactions, 48, pp. 281-290. (doi: 10.1042/BST20190707)

Welsh, C., Welsh, P., Celis Morales, C. A., Mark, P., Mackay, D., Ghouri, N., Ho, F., Ferguson, L. D., Brown, R., Lewsey, J., Cleland, J. G., Gray, S. R., Lyall, D. M., Anderson, J., Jhund, P. S., Pell, J., McGuire, D. K., Gill, J. M.R., Sattar, N. (2020) Glycated hemoglobin, prediabetes and the links to cardiovascular disease: data from UK Biobank. Diabetes Care, 43, pp. 440-445. (doi: 10.2337/dc19-1683)

Kosiborod, M. N., Jhund, P., Docherty, K. F., Diez, M., Petrie, M. C., Verma, S., Nicolau, J. C., Merkely, B., Kitakaze, M., DeMets, D. L., Inzucchi, S. E., Køeber, L., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Lindholm, D., Niklasson, A., Sjöstrand, M., Langkilde, A. M., McMurray, J. J.V. (2020) Effects of dapagliflozin on symptoms, function and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial. Circulation, 141, pp. 90-99. (doi: 10.1161/CIRCULATIONAHA.119.044138)

Martinez, F. A., Serenelli, M., Nicolau, J. C., Petrie, M. C., Chiang, C.-E., Tereshchenko, S., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ponikowski, P., Sabatine, M. S., DeMets, D. L., Dutkiewicz-Piasecka, M., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Jhund, P., McMurray, J. J.V. (2020) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age: insights from DAPA-HF. Circulation, 141, pp. 100-111. (doi: 10.1161/CIRCULATIONAHA.119.044133)

Ford, T. J., Stanley, B., Sidik, N., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., McCartney, P., Corcoran, D., Collison, D., Rush, C., Sattar, N., McConnachie, A., Touyz, R. M., Oldroyd, K. G., Berry, C. (2020) 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA) JACC: Cardiovascular Interventions, 13, pp. 33-45. (doi: 10.1016/j.jcin.2019.11.001)

Filippatos, G., Angermann, C. E., Cleland, J. G.F., Lam, C. S.P., Dahlström, U., Dickstein, K., Ertl, G., Hassanein, M., Hart, K. W., Lindsell, C. J., Perrone, S. V., Guerin, T., Ghadanfar, M., Schweizer, A., Obergfell, A., Collins, S. P. (2020) Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiology, 5, pp. 401-410. (doi: 10.1001/jamacardio.2019.5108)

Ferreira, J. P., Ouwerkerk, W., Tromp, J., Ng, L., Dickstein, K., Anker, S., Filippatos, G., Cleland, J. G., Metra, M., van Veldhuisen, D. J., Voors, A. A., Zannad, F. (2020) Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 22, pp. 81-89. (doi: 10.1002/ejhf.1654)

Pellicori, P., Cleland, J. G.F., Clark, A. L. (2020) Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Failure Clinics, 16, pp. 33-44. (doi: 10.1016/j.hfc.2019.08.003)

Nikolaidou, T., Samuel, N. A., Marincowitz, C., Fox, D. J., Cleland, J. G.F., Clark, A. L. (2020) Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: a systematic review and meta‐analysis. Annals of Noninvasive Electrocardiology, 25, (doi: 10.1111/anec.12710)

Li, Z. et al. (2020) General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico Strategy. Clinical Pharmacology and Therapeutics, 107, pp. 102-111. (doi: 10.1002/cpt.1647)

Kobayashi, M., Voors, A. A., Girerd, N., Billotte, M., Anker, S. D., Cleland, J. G., Lang, C. C., Ng, L. L., van Veldhuisen, D. J., Dickstein, K., Metra, M., Duarte, K., Rossignol, P., Zannad, F., Ferreira, J. P. (2020) Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. European Journal of Internal Medicine, 71, pp. 62-69. (doi: 10.1016/j.ejim.2019.10.017)

Pellicori, P., Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L., Cleland, J. G.F. (2020) High sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116, pp. 91-100. (doi: 10.1093/cvr/cvz198)

Chapman, A. R., Adamson, P. D., Shah, A. S.V., Anand, A., Strachan, F. E., Ferry, A. V., Lee, K. K., Berry, C., Findlay, I., Cruikshank, A., Reid, A., Gray, A., Collinson, P. O., Apple, F., McAllister, D., McAllister, D. A., Maguire, D., Fox, K. A.A., Vallejos, C. A., Keerie, C., Weir, C. J., Newby, D. E., Mills, N. L. (2020) High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation, 141, pp. 161-171. (doi: 10.1161/CIRCULATIONAHA.119.042960)

Sidik, N., Morrow, A., Berry, C. (2020) Human microcirculation in ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 11-13. (doi: 10.1161/ATVBAHA.119.313579)

Pellicori, P., Khan, M. J. I., Graham, F. J., Cleland, J. G.F. (2020) New perspectives and future directions in the treatment of heart failure. Heart Failure Reviews, 25, pp. 147-159. (doi: 10.1007/s10741-019-09829-7)

Cao, T. H., Jones, D. J.L., Voors, A. A., Quinn, P. A., Sandhu, J. K., Chan, D. C.S., Parry, H. M., Mohan, M., Mordi, I. R., Sama, I. E., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Lang, C. C., Ng, L. L. (2020) Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. European Journal of Heart Failure, 22, pp. 70-80. (doi: 10.1002/ejhf.1608)

McArthur, L., Riddell, A., Chilton, L., Smith, G. L., Nicklin, S. A. (2020) Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model. Heliyon, 6, (doi: 10.1016/j.heliyon.2019.e03031)

Kao, D., Purohit, S., Jhund, P. (2020) Therapeutic futility and phenotypic heterogeneity in heart failure with preserved ejection fraction: what is the role of bionic learning? European Journal of Heart Failure, 22, pp. 159-161. (doi: 10.1002/ejhf.1658)

de Korte, T., Katili, P. A., Mohd Yusof, N. A.N., van Meer, B. J., Saleem, U., Burton, F. L., Smith, G. L., Clements, P., Mummery, C. L., Eschenhagen, T., Hansen, A., Denning, C. (2020) Unlocking personalized biomedicine and drug discovery with human induced pluripotent stem cell–derived cardiomyocytes: fit for purpose or forever elusive? Annual Review of Pharmacology and Toxicology, 60, pp. 529-551. (doi: 10.1146/annurev-pharmtox-010919-023309)

Anker, M. S., Hülsmann, M., Cleland, J. G. (2020) What do patients with heart failure die from? A single assassin or a conspiracy? European Journal of Heart Failure, 22, pp. 26-28. (doi: 10.1002/ejhf.1689)

Heggie, R., Wu, O., Boyd, K., Lee, M. M.Y., Petrie, M. C., McEntegart, M., Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes.

Israr, M. Z. et al. (2020) Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF. European Journal of Heart Failure, 22, pp. 1486-1490. (doi: 10.1002/ejhf.1951)

McCartney, P. J., Maznyczka, A. M., Eteiba, H., McEntegart, M., Oldroyd, K. G., Greenwood, J. P., Mareida, N., Schmitt, M., McCann, G. P., Fairbairn, T., McAlindon, E., Tait, C., Welsh, P., Sattar, N., Orchard, V., Corcoran, D., Ford, T. J., Radjenovic, A., Ford, I., McConnachie, A., Berry, C. (2020) Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time. Journal of the American College of Cardiology, 75, pp. 1406-1421. (doi: 10.1016/j.jacc.2020.01.041)

Tardif, J.-C. et al. (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. New England Journal of Medicine, 381, pp. 2497-2505. (doi: 10.1056/NEJMoa1912388)

Gould, G., Bowman, P., Smith, G. (2019) Cardiac SNARE expression in health and disease. Frontiers in Endocrinology, 10, (doi: 10.3389/fendo.2019.00881)

Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J.V., Wikstrand, J., Anker, S. D., van Veldhuisen, D. J., Manzano, L., von Lueder, T. G., Rigby, A. S., Andersson, B., Kjekshus, J., Wedel, H., Ruschitzka, F., Cleland, J. G.F., Damman, K., Redon, J., Coats, A. J.S. (2019) Impact of renal impairment on beta-blocker efficacy in patients with heart failure. Journal of the American College of Cardiology, 74, pp. 2893-2904. (doi: 10.1016/j.jacc.2019.09.059)

Dewan, P., Rorth, R., Raparelli, V., Campbell, R. T., Shen, L., Jhund, P. S., Petrie, M. C., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Køber, L., Komajda, M., McKelvie, R. S., O'Meara, E., Pfeffer, M. A., Pitt, B., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Sex-related differences in heart failure with preserved ejection fraction. Circulation: Heart Failure, 12, (doi: 10.1161/CIRCHEARTFAILURE.119.006539)

Nagel, E., Berry, C. (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. Reply. New England Journal of Medicine, 381, pp. 2277-2278. (doi: 10.1056/NEJMc1913968)

Ford, T. J., Yii, E., Sidik, N., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., McCartney, P., Corcoran, D., Collison, D., Rush, C., Stanley, B., McConnachie, A., Sattar, N., Touyz, R. M., Oldroyd, K. G., Berry, C. (2019) Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.008126)

Johnson, M. J., Cockayne, S., Currow, D. C., Bell, K., Hicks, K., Fairhurst, C., Gabe, R., Torgerson, D., Jefferson, L., Oxberry, S., Ghosh, J., Hogg, K. J., Murphy, J., Allgar, V., Cleland, J. G.F., Clark, A. L. (2019) Oral modified release morphine for breathlessness in chronic heart failure: a randomised placebo-controlled trial. ESC Heart Failure, 6, pp. 1149-1160. (doi: 10.1002/ehf2.12498)

Avtaar Singh, S. S., Das De, S., Rushton, S., Berry, C., Al-Attar, N. (2019) PREDICTA: a model to predict primary graft dysfunction after adult heart transplantation in the United Kingdom. Journal of Cardiac Failure, 25, pp. 971-977. (doi: 10.1016/j.cardfail.2019.07.009)

Adamson, C., Rocchiccioli, P., Brogan, R., Berry, C., Ford, T. J. (2019) Post-operative myocardial infarction following aortic root surgery with coronary reimplantation: a case series treated with percutaneous coronary intervention. European Heart Journal: Case Reports, 3, pp. 1-6. (doi: 10.1093/ehjcr/ytz181)

Sharma, V. et al. (2019) Report from the Annual Conference of the British Society of Echocardiography, November 2017, Edinburgh International Conference Centre, Edinburgh. Echo Research and Practice, 6, pp. M1-M2. (doi: 10.1530/ERP-19-0056)

Jackson, A. M., Jhund, P. S. (2019) The price of a failing heart. European Journal of Heart Failure, 21, pp. 1532-1533. (doi: 10.1002/ejhf.1605)

Mehra, M. R., Vaduganathan, M., Fu, M., Ferreira, J. P., Anker, S. A., Cleland, J. G.F., Lam, C. S.P., van Veldhuisen, D. J., Byra, W. M., Spiro, T., Deng, H., Zannad, F., Greenberg, B. (2019) A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. European Heart Journal, 40, pp. 3593-3602. (doi: 10.1093/eurheartj/ehz427)

McMurray, J. J.V. et al. (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine, 381, pp. 1995-2008. (doi: 10.1056/NEJMoa1911303)

Bularga, A., Lee, K. K., Stewart, S., Ferry, A. V., Chapman, A. R., Marshall, L., Strachan, F. E., Cruickshank, A., Maguire, D., Berry, C., Findlay, I., Shah, A. S.V., Newby, D. E., Mills, N. L., Anand, A. (2019) High-sensitivity troponin and the application of risk stratification thresholds in patients with suspected acute coronary syndrome. Circulation, 140, pp. 1557-1568. (doi: 10.1161/CIRCULATIONAHA.119.042866)

Docherty, K. F., McMurray, J. J.V. (2019) PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction. Cardiovascular Research, 115, pp. e136-e139. (doi: 10.1093/cvr/cvz223)

Sillars, A., Celis-Morales, C. A., Ho, F., Petermann, F., Welsh, P., Iliodromiti, S., Ferguson, L. D., Lyall, D. M., Anderson, J., Mackay, D., Pellicori, P., Cleland, J., Pell, J. P., Gill, J. M.R., Gray, S. R., Sattar, N. (2019) Association of fitness and grip-strength with heart failure: findings from the UK Biobank population-based study. Mayo Clinic Proceedings, 94, pp. 2230-2240. (doi: 10.1016/j.mayocp.2019.04.041)

Davies, V., Noè, U., Lazarus, A., Gao, H., Macdonald, B., Berry, C., Luo, X., Husmeier, D. (2019) Fast parameter inference in a biomechanical model of the left ventricle by using statistical emulation. Journal of the Royal Statistical Society: Series C (Applied Statistics), 68, pp. 1555-1576. (doi: 10.1111/rssc.12374)

Lees, J. S., Welsh, C. E., Celis-Morales, C. A., Mackay, D., Lewsey, J., Gray, S. R., Lyall, D. M., Cleland, J. G., Gill, J. M.R., Jhund, P. S., Pell, J., Sattar, N., Welsh, P., Mark, P. B. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8)

Beusekamp, J. C., Tromp, J., Cleland, J. G.F., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Ouwerkerk, W., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2019) Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality. JACC: Heart Failure, 7, pp. 970-979. (doi: 10.1016/j.jchf.2019.07.010)

Pellicori, P., Urbinati, A., Kaur, K., Zhang, J., Shah, P., Kazmi, S., Capucci, A., Cleland, J. G.F., Clark, A. L. (2019) Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. American Journal of Cardiology, 124, pp. 1554-1560. (doi: 10.1016/j.amjcard.2019.08.018)

Conrad, N., Judge, A., Canoy, D., Tran, J., Pinho-Gomes, A. C., Millett, E. R.C., Salimi-Khorshidi, G., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2019) Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86 000 individuals. JAMA Cardiology, 4, pp. 1102-1111. (doi: 10.1001/jamacardio.2019.3593)

Beldhuis, I. E., Streng, K. W., van der Meer, P., Ter Maaten, J. M., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Cotter, G., Cleland, J. G.F., Davison, B. A., Givertz, M. M., Teerlink, J. R., Bloomfield, D. M., Voors, A. A., Damman, K. (2019) Trajectories of changes in renal function in patients with acute heart failure. Journal of Cardiac Failure, 25, pp. 866-874. (doi: 10.1016/j.cardfail.2019.07.004)

Solomon, S. D. et al. (2019) Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction. New England Journal of Medicine, 381, pp. 1609-1620. (doi: 10.1056/NEJMoa1908655)

Selvaraj, S., Claggett, B., Pozzi, A., McMurray, J. J.V., Jhund, P. S., Packer, M., Desai, A. S., Lewis, E. F., Vaduganathan, M., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Zile, M. R., Swedberg, K., Solomon, S. D. (2019) Prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction: PARADIGM-HF. Circulation, 140, pp. 1369-1379. (doi: 10.1161/CIRCULATIONAHA.119.039920)

Santema, B. T. et al. (2019) Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet, 394, (doi: 10.1016/S0140-6736(19)31792-1)

Stirrat, C. G., Alam, S., MacGillivray, T. J., Gray, C., Dweck, M. R., Jones, V., Wallace, W., Payne, J. R., Prasad, S. K., Gardner, R. S., Petrie, M. C., Mirsadraee, S., Henriksen, P., Newby, D. E., Semple, S. (2019) Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation. Open Heart, 6, (doi: 10.1136/openhrt-2019-001115)

Howlett, J. G., Stebbins, A., Petrie, M. C., Jhund, P. S., Castelvecchio, S., Cherniavsky, A., Sueta, C. A., Roy, A., Piña, I. L., Wurm, R., Drazner, M. H., Andersson, B., Batlle, C., Senni, M., Chrzanowski, L., Merkely, B., Carson, P., Desvigne-Nickens, P. M., Lee, K. L., Velazquez, E. J., Al-Khalidi, H. R. (2019) CABG improves outcomes in patients with ischemic cardiomyopathy 10-year follow-up of the STICH trial. JACC: Heart Failure, 7, pp. 878-887. (doi: 10.1016/j.jchf.2019.04.018)

Seferovic, P. M. et al. (2019) Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 21, pp. 1169-1186. (doi: 10.1002/ejhf.1531)

Rahman, H., Corcoran, D., Aetesam-Ur-Rahman, M., Hoole, S. P., Berry, C., Perera, D. (2019) Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart, 105, pp. 1536-1542. (doi: 10.1136/heartjnl-2019-315042)

Hausenloy, D. J. et al. (2019) Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet, 394, pp. 1415-1424. (doi: 10.1016/S0140-6736(19)32039-2)

Packer, M. et al. (2019) Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial. European Journal of Heart Failure, 21, pp. 1270-1278. (doi: 10.1002/ejhf.1536)

Anker, S. D. et al. (2019) Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial. European Journal of Heart Failure, 21, pp. 1279-1287. (doi: 10.1002/ejhf.1596)

Yazaki, Y., Salzano, A., Nelson, C. P., Voors, A. A., Anker, S. D., Cleland, J. G., Lang, C. C., Metra, M., Samani, N. J., Ng, L. L., Suzuki, T. (2019) Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis. European Journal of Heart Failure, 21, pp. 1291-1294. (doi: 10.1002/ejhf.1550)

Adamson, P. D., Williams, M. C., Dweck, M. R., Mills, N. L., Boon, N. A., Daghem, M., Bing, R., Moss, A. J., Mangion, K., Flather, M., Forbes, J., Hunter, A., Norrie, J., Shah, A. S.V., Timmis, A. D., van Beek, E. J.R., Ahmadi, A. A., Leipsic, J., Narula, J., Newby, D. E., Roditi, G., McAllister, D. A., Berry, C. (2019) Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain. Journal of the American College of Cardiology, 74, pp. 2058-2070. (doi: 10.1016/j.jacc.2019.07.085)

Platz, E., Campbell, R. T., Claggett, B., Lewis, E. F., Groarke, J. D., Docherty, K. F., Lee, M. M.Y., Merz, A. A., Silverman, M., Swamy, V., Lindner, M., Rivero, J., Solomon, S. D., McMurray, J. J.V. (2019) Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short- and long-term outcomes. JACC: Heart Failure, 7, pp. 849-858. (doi: 10.1016/j.jchf.2019.07.008)

Lee, K. K., Ferry, A. V., Anand, A., Strachan, F. E., Chapman, A. R., Kimenai, D. M., Meex, S. J.R., Berry, C., Findlay, I., Reid, A., Cruickshank, A., Gray, A., Collinson, P. O., Apple, F. S., McAllister, D. A., Maguire, D., Fox, K. A.A., Newby, D. E., Tuck, C., Keerie, C., Weir, C. J., Shah, A. S.V., Mills, N. L. (2019) Sex-specific thresholds of high-sensitivity troponin in patients with suspected acute coronary syndrome. Journal of the American College of Cardiology, 74, pp. 2032-2043. (doi: 10.1016/j.jacc.2019.07.082)

Lee, M. M.Y., Sattar, N., McMurray, J. J.V., Packard, C. J. (2019) Statins in the prevention and treatment of heart failure: a review of the evidence. Current Atherosclerosis Reports, 21, (doi: 10.1007/s11883-019-0800-z)

Nicolau, J. C., Stevens, S. R., Al-Khalidi, H. R., Jatene, F. B., Furtado, R. H.M., Dallan, L. A.O., Lisboa, L. A.F., Desvigne-Nickens, P., Haddad, H., Jolicoeur, E. M., Petrie, M. C., Doenst, T., Michler, R. E., Ohman, E. M., Maddury, J., Ali, I., Deja, M. A., Rouleau, J. L., Velazquez, E. J., Hill, J. A. (2019) Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. International Journal of Cardiology, 291, pp. 36-41. (doi: 10.1016/j.ijcard.2019.03.029)

Gatseva, A., Sin, Y. Y., Brezzo, G., Van Agtmael, T. (2019) Basement membrane collagens and disease mechanisms. Essays in Biochemistry, 63, pp. 297-312. (doi: 10.1042/EBC20180071)

Kristensen, S. L., Rorth, R., Jhund, P. S., Docherty, K., Sattar, N., Preiss, D., Kober, L., Petrie, M. C., McMurray, J. J.V. (2019) Cardiovascular, mortality and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes and Endocrinology, 7, pp. 776-785. (doi: 10.1016/S2213-8587(19)30249-9)

Dérimay, F., Johnson, N. P., Zimmermann, F. M., Adjedj, J., Witt, N., Hennigan, B., Koo, B.‐K., Barbato, E., Esposito, G., Trimarco, B., Rioufol, G., Park, S.‐J., Baptista, S. B., Chrysant, G. S., Leone, A. M., Jeremias, A., Berry, C., De Bruyne, B., Oldroyd, K. G., Pijls, N. H.J., Fearon, W. F. (2019) Predictive factors of discordance between the instantaneous wave‐free ratio and fractional flow reserve. Catheterization and Cardiovascular Interventions, 94, pp. 356-363. (doi: 10.1002/ccd.28116)

Avtaar Singh, S. S., Dalzell, J. R., Berry, C., Al-Attar, N. (2019) Primary graft dysfunction after heart transplantation: a thorn amongst the roses. Heart Failure Reviews, 24, pp. 805-820. (doi: 10.1007/s10741-019-09794-1)

Metra, M. et al. (2019) Effects of serelaxin in patients with acute heart failure. New England Journal of Medicine, 381, pp. 716-726. (doi: 10.1056/NEJMoa1801291)

McMurray, J. J.V., Docherty, K. F. (2019) Phosphodiesterase-9 inhibition in heart failure: a further opportunity to augment the effects of natriuretic peptides? Journal of the American College of Cardiology, 74, pp. 902-904. (doi: 10.1016/j.jacc.2019.07.008)

Täger, T., Fröhlich, H., Grundtvig, M., Seiz, M., Schellberg, D., Goode, K., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Clark, A. L., Frankenstein, L. (2019) Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure – a multicenter propensity score matched analysis. International Journal of Cardiology, 289, pp. 83-90. (doi: 10.1016/j.ijcard.2019.01.109)

Yang, Y., Gao, H., Berry, C., Radjenovic, A., Husmeier, D. (2019) Quantification of Myocardial Perfusion Lesions Using Spatially Variant Finite Mixture Modelling of DCE-MRI. (doi: 10.11159/icsta19.26)

Husmeier, D., Lazarus, A., Noè, U., Davies, V., Borowska, A., Macdonald, B., Gao, H., Berry, C., Luo, X. (2019) Statistical Emulation of Cardiac Mechanics: an Important Step Towards a Clinical Decision Support System. (doi: 10.11159/icsta19.29)

Welsh, C., Celis-Morales, C. A., Brown, R., Mackay, D. F., Lewsey, J., Mark, P. B., Gray, S. R., Ferguson, L. D., Anderson, J. J., Lyall, D. M., Cleland, J. G., Jhund, P. S., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P. (2019) Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease: data from UK Biobank. Circulation, 140, pp. 542-552. (doi: 10.1161/CIRCULATIONAHA.119.041149)

Cleland, J. G.F., Pellicori, P. (2019) Myocardial dysfunction and coronary artery disease as therapeutic targets in heart failure. Circulation, 140, pp. 538-541. (doi: 10.1161/CIRCULATIONAHA.119.041523)

Tromp, J., Shen, L., Jhund, P. S., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Køber, L., Swedberg, K., Zile, M. R., Pitt, B., Lam, C. S.P., McMurray, J. J.V. (2019) Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 74, pp. 601-612. (doi: 10.1016/j.jacc.2019.05.052)

Johnson, N. P., Li, W., Chen, X., Hennigan, B., Watkins, S., Berry, C., Fearon, W. F., Oldroyd, K. G. (2019) Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio. European Heart Journal, 40, pp. 2585-2594. (doi: 10.1093/eurheartj/ehz230)

Rørth, R., Dewan, P., Kristensen, S. L., Jhund, P. S., Petrie, M. C., Køber, L., McMurray, J. J.V. (2019) Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction. Clinical Research in Cardiology, 108, pp. 868-877. (doi: 10.1007/s00392-019-01415-z)

Fröhlich, H., Rosenfeld, N., Täger, T., Goode, K., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Clark, A. L., Frankenstein, L., Grundtvig, M. (2019) Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart, 105, pp. 1252-1259. (doi: 10.1136/heartjnl-2018-314256)

Shen, L., Rørth, R., Cosmi, D., Kristensen, S. L., Petrie, M. C., Cosmi, F., Latini, R., Køber, L., Anand, I. S., Carson, P. E., Granger, C. B., Komajda, M., McKelvie, R. S., Solomon, S. D., Staszewsky, L., Swedberg, K., Huynh, T., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2019) Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. European Journal of Heart Failure, 21, pp. 974-984. (doi: 10.1002/ejhf.1535)

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.007830)

Crea, F., Bairey Merz, C. N., Beltrame, J. F., Berry, C., Camici, P. G., Kaski, J. C., Ong, P., Pepine, C. J., Sechtem, U., Shimokawa, H. (2019) Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. European Heart Journal, 40, pp. 2455-2462. (doi: 10.1093/eurheartj/ehy857)

Halliday, B. P., Baksi, A. J., Gulati, A., Ali, A., Newsome, S., Izgi, C., Arzanauskaite, M., Lota, A., Tayal, U., Vassiliou, V. S., Gregson, J., Alpendurada, F., Frenneaux, M. P., Cook, S. A., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2019) Outcome in dilated cardiomyopathy related to the extent, location and pattern of late gadolinium enhancement. JACC: Cardiovascular Imaging, 12, pp. 1645-1655. (doi: 10.1016/j.jcmg.2018.07.015)

Felker, G. M., Borentain, M., Cleland, J. G.F., DeSouza, M. M., Kessler, P. D., O'Connor, C. M., Seiffert, D., Teerlink, J. R., Voors, A. A., McMurray, J. J.V. (2019) Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. European Journal of Heart Failure, 21, pp. 1022-1031. (doi: 10.1002/ejhf.1504)

Welsh, C. E., Welsh, P., Jhund, P., Sattar, N., Mark, P. B. (2019) Response by Welsh et al to letter regarding article “Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease” Hypertension, 74, pp. e27-e28. (doi: 10.1161/HYPERTENSIONAHA.119.13349)

Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Devalaraja, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., Zwinderman, A. H., Hillege, H. L., van Veldhuisen, D. J., Kakkar, R., Voors, A. A., van der Meer, P. (2019) The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF Study. European Journal of Heart Failure, 21, pp. 965-973. (doi: 10.1002/ejhf.1482)

Noè, U., Lazarus, A., Gao, H., Davies, V., Macdonald, B., Mangion, K., Berry, C., Luo, X., Husmeier, D. (2019) Gaussian process emulation to accelerate parameter estimation in a mechanical model of the left ventricle: a critical step towards clinical end-user relevance. Journal of the Royal Society: Interface, 16, (doi: 10.1098/rsif.2019.0114)

Bowman, P. R.T., Smith, G. L., Gould, G. W. (2019) GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes. PLoS ONE, 14, (doi: 10.1371/journal.pone.0217885)

Halliday, B. P., Cleland, J. G.F., Prasad, S. K. (2019) When can heart failure treatment be stopped safely? – Authors' reply. Lancet, 394, pp. 217-218. (doi: 10.1016/S0140-6736(19)30499-4)

Ibanez, B., Aletras, A. H., Arai, A. E., Arheden, H., Bax, J., Berry, C., Bucciarelli-Ducci, C., Croisille, P., Dall'Armellina, E., Dharmakumar, R., Eitel, I., Fernández-Jiménez, R., Friedrich, M. G., García-Dorado, D., Hausenloy, D. J., Kim, R. J., Kozerke, S., Kramer, C. M., Salerno, M., Sánchez-González, J., Sanz, J., Fuster, V. (2019) Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel. Journal of the American College of Cardiology, 74, pp. 238-256. (doi: 10.1016/j.jacc.2019.05.024)

Rankin, J., Rowen, D., Howe, A., Cleland, J. G.F., Whitty, J. A. (2019) Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses. Heart Failure Reviews, 24, pp. 549-563. (doi: 10.1007/s10741-019-09780-7)

Suzuki, T., Yazaki, Y., Voors, A. A., Jones, D. J.L., Chan, D. C.S., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., Ng, L. L. (2019) Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure (from BIOSTAT‐CHF) European Journal of Heart Failure, 21, pp. 877-886. (doi: 10.1002/ejhf.1338)

Ubaid, S., Ford, T. J., Berry, C., Murray, H. M., Wrigley, B., Khan, N., Thomas, M. R., Armesilla, A. L., Townend, J. N., Khogali, S. S., Munir, S., Martins, J., Hothi, S. S., McAlindon, E. J., Cotton, J. M. (2019) Cangrelor versus ticagrelor in patients treated with primary percutaneous coronary intervention: impact on platelet activity, myocardial microvascular function and infarct size: a randomized controlled trial. Thrombosis and Haemostasis, 119, pp. 1171-1181. (doi: 10.1055/s-0039-1688789)

Nuzzi, V., Pellicori, P., Nikolaidou, T., Kallvikbacka-Bennett, A., Torromeo, C., Barilla, F., Damien, S., Kaur, K., Monzo, L., Cleland, J. G.F., Clark, A. L. (2019) Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine, 20, pp. 442-449. (doi: 10.2459/JCM.0000000000000802)

Beverborg, N. G., van der Wal, H., Klip, I. T., Anker, S. D., Cleland, J. G.F., Dickstein, K., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2019) Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies. JAMA Cardiology, 4, pp. 696-701. (doi: 10.1001/jamacardio.2019.1739)

Kettlewell, S., Saxena, P., Dempster, J., Colman, M. A., Myles, R. C., Smith, G. L., Workman, A. J. (2019) Dynamic‐clamping human and rabbit atrial calcium current: narrowing ICaL window abolishes early afterdepolarisations. Journal of Physiology, 597, pp. 3619-3638. (doi: 10.1113/JP277827)

Platz, E., Jhund, P. S., Girerd, N., Pivetta, E., McMurray, J. J.V., Peacock, W. F., Masip, J., Martin-Sanchez, F. J., Miro, Ò., Price, S., Cullen, L., Maisel, A. S., Vrints, C., Cowie, M. R., DiSomma, S., Bueno, H., Mebazaa, A., Gualandro, D. M., Tavares, M., Metra, M., Coats, A. J.S., Ruschitzka, F., Seferovic, P. M., Mueller, C. (2019) Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure. European Journal of Heart Failure, 21, pp. 844-851. (doi: 10.1002/ejhf.1499)

Doszpoly, A., de la Cuesta, F., Lopez-Gordo, E., Bénézech, C., Nicklin, S. A., Baker, A. H. (2019) Human adenovirus serotype 5 is sensitive to IgM-independent neutralization in vitro and in vivo. Viruses, 11, (doi: 10.3390/v11070616)

Niccoli, G., Montone, R. A., Ibanez, B., Thiele, H., Crea, F., Heusch, G., Bulluck, H., Hausenloy, D. J., Berry, C., Stiermaier, T., Camici, P. G., Eitel, I. (2019) Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis. Circulation Research, 125, pp. 245-258. (doi: 10.1161/circresaha.119.315344)

Bauersachs, J., König, T., Meer, P., Petrie, M. C., Hilfiker‐Kleiner, D., Mbakwem, A., Hamdan, R., Jackson, A. M., Forsyth, P., Boer, R. A., Mueller, C., Lyon, A. R., Lund, L. H., Piepoli, M. F., Heymans, S., Chioncel, O., Anker, S. D., Ponikowski, P., Seferovic, P. M., Johnson, M. R., Mebazaa, A., Sliwa, K. (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21, pp. 827-843. (doi: 10.1002/ejhf.1493)

Pellicori, P., Shah, P., Cuthbert, J., Urbinati, A., Zhang, J., Kallvikbacka-Bennett, A., Clark, A. L., Cleland, J. G.F. (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. European Journal of Heart Failure, 21, pp. 904-916. (doi: 10.1002/ejhf.1383)

Mordi, I. R., Santema, B. T., Kloosterman, M., Choy, A.-M., Rienstra, M., van Gelder, I., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Metra, M., Ng, L. L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Voors, A. A., Lang, C. C. (2019) Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. Clinical Research in Cardiology, 108, pp. 797-805. (doi: 10.1007/s00392-018-1409-x)

Cleland, J. G.F., Hindricks, G., Petrie, M. (2019) The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization. European Heart Journal, 40, pp. 2128-2130. (doi: 10.1093/eurheartj/ehz409)

Nagel, E., Greenwood, J. P., McCann, G. P., Bettencourt, N., Shah, A. M., Hussain, S. T., Perera, D., Plein, S., Bucciarelli-Ducci, C., Paul, M., Westwood, M. A., Marber, M., Richter, W.-S., Puntmann, V. O., Schwenke, C., Schulz-Menger, J., Das, R., Wong, J., Hausenloy, D. J., Steen, H., Berry, C. (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. New England Journal of Medicine, 380, pp. 2418-2428. (doi: 10.1056/NEJMoa1716734)

Shoaib, A., Mamas, M. A., Ahmad, Q. S., McDonagh, T. M., Hardman, S. M.C., Rashid, M., Butler, R., Duckett, S., Satchithananda, D., Nolan, J., Dargie, H. J., Clark, A. L., Cleland, J. G.F. (2019) Characteristics and outcome of acute heart failure patients according to the severity of peripheral oedema. International Journal of Cardiology, 285, pp. 40-46. (doi: 10.1016/j.ijcard.2019.03.020)

Dewan, P., Docherty, K. F., McMurray, J. J.V. (2019) Sacubitril/valsartan in Asian patients with heart failure with reduced ejection fraction. Korean Circulation Journal, 49, pp. 469-484. (doi: 10.4070/kcj.2019.0136)

Simpson, J., Benson, L., Jhund, P.S., Dahlström, U., McMurray, J.J.V., Lund, L.H. (2019) "Real world" eligibility for sacubitril/valsartan in unselected heart failure patients: data from the Swedish Heart Failure Registry. Cardiovascular Drugs and Therapy, 33, pp. 315-322. (doi: 10.1007/s10557-019-06873-1)

Mikolajczyk, T. P., Nosalski, R., Skiba, D. S., Koziol, J., Mazur, M., Justo Junior, A. S., Kowalczyk, P., Kusmierczyk, Z., Schramm Luc, A., Luc, K., Maffia, P., Graham, D., Kiss, A. K., Naruszewicz, M., Guzik, T. J. (2019) 1,2,3,4,6 penta-O -galloyl-β-D-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension. British Journal of Pharmacology, 176, pp. 1951-1965. (doi: 10.1111/bph.14583)

Greenberg, B., Neaton, J. D., Anker, S. D., Byra, W. M., Cleland, J. G.F., Deng, H., Fu, M., La Police, D. A., Lam, C. S. P., Mehra, M. R., Nessel, C. C., Spiro, T. E., van Veldhuisen, D. J., Vanden Boom, C. M., Zannad, F. (2019) Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial. JAMA Cardiology, 4, pp. 515-523. (doi: 10.1001/jamacardio.2019.1049)

ter Maaten, J. M., Kremer, D., Demissei, B. G., Struck, J., Bergmann, A., Anker, S. D., Ng, L. L., Dickstein, K., Metra, M., Samani, N. J., Romaine, S. P.R., Cleland, J., Girerd, N., Lang, C. C., van Veldhuisen, D. J., Voors, A. A. (2019) Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure. European Journal of Heart Failure, 21, pp. 732-743. (doi: 10.1002/ejhf.1437)

Clark, A. L., Kalra, P. R., Petrie, M. C., Mark, P. B., Tomlinson, L. A., Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105, pp. 904-910. (doi: 10.1136/heartjnl-2018-314158)

Haig, C., Carrick, D., Carberry, J., Mangion, K., Maznyczka, A., Wetherall, K., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ahmed, N., May, V. T. Y., Ford, I., Radjenovic, A., Welsh, P., Sattar, N., Oldroyd, K. G., Berry, C. (2019) Current smoking and prognosis after acute ST-segment elevation myocardial infarction: new pathophysiological insights. JACC: Cardiovascular Imaging, 12, pp. 993-1003. (doi: 10.1016/j.jcmg.2018.05.022)

Mueller, C., McDonald, K., deBoer, R. A., Maisel, A., Cleland, J. G.F., Kozhuharov, N., Coats, A. J.S., Metra, M., Mebazaa, A., Ruschitzka, F., Lainscak, M., Filippatos, G., Seferovic, P. M., Meijers, W. C., Bayes-Genis, A., Mueller, T., Richards, M., Januzzi, J. L. (2019) Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure, 21, pp. 715-731. (doi: 10.1002/ejhf.1494)

House, A. A. et al. (2019) Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies conference. Kidney International, 95, pp. 1304-1317. (doi: 10.1016/j.kint.2019.02.022)

Kinch, K., Fullerton, J. L., Stewart, W. (2019) One-hundred years (and counting) of blast-associated traumatic brain injury. Journal of the Royal Army Medical Corps, 165, pp. 180-182. (doi: 10.1136/jramc-2017-000867)

Balmforth, C., Simpson, J., Shen, L., Jhund, P. S., Lefkowitz, M., Rizkala, A. R., Rouleau, J. L., Shi, V., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2019) Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF. JACC: Heart Failure, 7, pp. 457-465. (doi: 10.1016/j.jchf.2019.02.015)

Ahmad, F. A., Petrie, M. C., McMurray, J. J.V., Lang, N. N. (2019) Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it. European Journal of Heart Failure, 21, pp. 699-702. (doi: 10.1002/ejhf.1463)

Czesnikiewicz-Guzik, M., Nosalski, R., Mikolajczyk, T. P., Vidler, F., Dohnal, T., Dembowska, E., Graham, D., Harrison, D. G., Guzik, T. J. (2019) Th1 type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II dependent hypertension and vascular dysfunction. British Journal of Pharmacology, 176, pp. 1922-1931. (doi: 10.1111/bph.14536)

Welsh, C., Welsh, P., Jhund, P., Delles, C., Celis-Morales, C., Lewsey, J., Gray, S., Lyall, D., Iliodromiti, S., Gill, J., Sattar, N., Mark, P. (2019) Urinary sodium excretion, blood pressure and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease. Hypertension, 73, pp. 1202-1209. (doi: 10.1161/HYPERTENSIONAHA.119.12726)

Maznyczka, A. M., Oldroyd, K. G., McCartney, P., McEntegart, M., Berry, C. (2019) The potential use of the index of microcirculatory resistance to guide stratification of patients for adjunctive therapy in acute myocardial infarction. JACC: Cardiovascular Interventions, 12, pp. 951-966. (doi: 10.1016/j.jcin.2019.01.246)

Raber, I., McCarthy, C. P., Vaduganathan, M., Bhatt, D. L., Wood, D. A., Cleland, J. G.F., Blumenthal, R. S., McEvoy, J. W. (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet, 393, pp. 2155-2167. (doi: 10.1016/S0140-6736(19)30541-0)

Ford, T., Berry, C. (2019) How to diagnose and manage angina without obstructive coronary artery disease: Lessons from the British Heart Foundation CorMicA trial. Interventional Cardiology Review, 14, pp. 76-82. (doi: 10.15420/icr.2019.04.R1)

Cleland, J. G.F., Pellicori, P., Clark, A. L. (2019) Prevention or procrastination for heart failure?: Why we need a universal definition of heart failure. Journal of the American College of Cardiology, 73, pp. 2398-2400. (doi: 10.1016/j.jacc.2019.03.471)

Jhund, P. S. (2019) Improving recruitment for clinical trials: the human touch. Medical Journal of Australia, 210, pp. 401-402. (doi: 10.5694/mja2.50161)

Schanstra, J. P., Luong, T. T.D., Makridakis, M., Van Linthout, S., Lygirou, V., Latosinska, A., Alesutan, I., Boehme, B., Schelski, N., Von Lewinski, D., Mullen, W., Nicklin, S., Delles, C., Feuillet, G., Denis, C., Lang, F., Pieske, B., Bascands, J.-L., Mischak, H., Saulnier-Blache, J.-S., Voelkl, J., Vlahou, A., Klein, J. (2019) Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment. JCI Insight, 4, (doi: 10.1172/jci.insight.125638)

Smith, G. L., Eisner, D. A. (2019) Calcium buffering in the heart in health and disease. Circulation, 139, pp. 2358-2371. (doi: 10.1161/circulationaha.118.039329)

McMurray, J. J.V. et al. (2019) A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF) European Journal of Heart Failure, 21, pp. 665-675. (doi: 10.1002/ejhf.1432)

Singh, A., Horsfield, M. A., Bekele, S., Greenwood, J. P., Dawson, D. K., Berry, C., Hogrefe, K., Kelly, D. J., Houston, J. G., Guntur Ramkumar, P., Uddin, A., Suzuki, T., McCann, G. P. (2019) Aortic stiffness in aortic stenosis assessed by cardiovascular MRI: a comparison between bicuspid and tricuspid valves. European Radiology, 29, pp. 2340-2349. (doi: 10.1007/s00330-018-5775-6)

Conrad, N., Judge, A., Canoy, D., Tran, J., O’Donnell, J., Nazarzadeh, M., Salimi-Khorshidi, G., Hobbs, F.D. R., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2019) Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: a cohort study of 93,000 UK patients. PLoS Medicine, 16, (doi: 10.1371/journal.pmed.1002805)

Dewan, P. et al. (2019) Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. European Journal of Heart Failure, 21, pp. 577-587. (doi: 10.1002/ejhf.1347)

Shoaib, A., Farag, M., Nolan, J., Rigby, A., Patwala, A., Rashid, M., Kwok, C.S., Perveen, R., Clark, A.L., Komajda, M., Cleland, J.G.F. (2019) Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from The First Euro Heart Failure Survey. Clinical Research in Cardiology, 108, pp. 510-519. (doi: 10.1007/s00392-018-1380-6)

Shen, L., Jhund, P. S., Docherty, K. F., Petrie, M. C., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Prior pacemaker implantation and clinical outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 7, pp. 418-427. (doi: 10.1016/j.jchf.2018.12.006)

Ferreira, J. P. et al. (2019) Proteomic bioprofiles and mechanistic pathways of progression to heart failure: the HOMAGE study. Circulation, 12, (doi: 10.1161/CIRCHEARTFAILURE.118.005897)

Olson, E., Pravenec, M., Landa, V., Koh-Tan, H. H. C., Dominiczak, A. F., McBride, M. W., Graham, D. (2019) Transgenic overexpression of glutathione S-transferase μ-type 1 reduces hypertension and oxidative stress in the stroke-prone spontaneously hypertensive rat. Journal of Hypertension, 37, pp. 985-996. (doi: 10.1097/HJH.0000000000001960)

Shah, P., Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Pan, D., Clark, A. L. (2019) Warm water immersion in patients with chronic heart failure: a pilot study. Clinical Research in Cardiology, 108, pp. 468-476. (doi: 10.1007/s00392-018-1376-2)

Docherty, K. F., McMurray, J. J.V. (2019) Angiotensin receptor-neprilysin inhibitors: a new paradigm in heart failure with reduced ejection fraction. International Journal of Cardiology, 281, pp. 179-185. (doi: 10.1016/j.ijcard.2018.05.124)

Anderson, S. G., Shoaib, A., Myint, P. K., Cleland, J. G., Hardman, S. M., McDonagh, T. A., Dargie, H., Keavney, B., Garratt, C. J., Mamas, M. A. (2019) Does rhythm matter in Acute Heart Failure? An insight from the British Society for Heart Failure National Audit. Clinical Research in Cardiology, (doi: 10.1007/s00392-019-01463-5)

Ghouri, I. A., Kelly, A., Salerno, S., Garten, K., Stølen, T., Kemi, O.-J., Smith, G. L. (2019) Corrigendum: Characterization of electrical activity in post-myocardial infarction scar tissue in rat hearts using multiphoton microscopy. Frontiers in Physiology, 10, (doi: 10.3389/fphys.2019.00364)

Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S.P., van Veldhuisen, D. J., Ponikowski, P., Petrie, M. C., Hassager, C., Møller, J. E., Gustafsson, F. (2019) Central and peripheral determinants of exercise capacity in heart failure patients with preserved ejection fraction. JACC: Heart Failure, 7, pp. 321-332. (doi: 10.1016/j.jchf.2019.01.006)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2019) Identification of frailty in chronic heart failure. JACC: Heart Failure, 7, pp. 291-302. (doi: 10.1016/j.jchf.2018.11.017)

Dewan, P., Rørth, R., Jhund, P. S., Ferreira, J. P., Zannad, F., Shen, L., Køber, L., Abraham, W. T., Desai, A. S., Dickstein, K., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Income inequality and outcomes in heart failure: a global between-country analysis. JACC: Heart Failure, 7, pp. 336-346. (doi: 10.1016/j.jchf.2018.11.005)

Maznyczka, A. M., Carrick, D., Carberry, J., Mangion, K., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Ford, I., Welsh, P., Sattar, N., Oldroyd, K. G., Berry, C. (2019) Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction. Open Heart, 6, (doi: 10.1136/openhrt-2018-000979)

Pettit, S. J., Petrie, M. C. (2019) Transplantation of hearts donated after circulatory-determined death: a song of fire and ice. Circulation: Heart Failure, 12, (doi: 10.1161/CIRCHEARTFAILURE.119.005991)

Sokoreli, I., Cleland, J.G., Pauws, S.C., Steyerberg, E.W., de Vries, J.J.G., Riistama, J.M., Dobbs, K., Bulemfu, J., Clark, A.L. (2019) Added value of frailty and social support in predicting risk of 30-day unplanned re-admission or death for patients with heart failure: an analysis from OPERA-HF. International Journal of Cardiology, 278, pp. 167-172. (doi: 10.1016/j.ijcard.2018.12.030)

Mangion, K., Burke, N. M.M., Mccomb, C., Carrick, D., Woodward, R., Berry, C. (2019) Feature-tracking myocardial strain in healthy adults- a magnetic resonance study at 3.0 tesla. Scientific Reports, 9, (doi: 10.1038/s41598-019-39807-w)

Bastug-Özel, Z., Wright, P. T., Kraft, A. E., Pavlovic, D., Howie, J., Froese, A., Fuller, W., Gorelik, J., Shattock, M. J., Nikolaev, V. O. (2019) Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain. Cardiovascular Research, 115, pp. 546-555. (doi: 10.1093/cvr/cvy221)

Dietrichs, E. S., Tveita, T., Smith, G. (2019) Hypothermia and cardiac electrophysiology: a systematic review of clinical and experimental data. Cardiovascular Research, 115, pp. 501-509. (doi: 10.1093/cvr/cvy305)

Januzzi, J., Ferreira, J. P., Böhm, M., Kaul, S., Wanner, C., Brueckmann, M., Petrie, M., Ofstad, A.-P., Zeller, C., George, J., Fitchett, D., Zannad, F. (2019) Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline. European Journal of Heart Failure, 21, pp. 386-388. (doi: 10.1002/ejhf.1419)

Kristensen, S. L., Mogensen, U. M., Jhund, P. S., Rørth, R., Anand, I. S., Carson, P. E., Desai, A. S., Pitt, B., Pfeffer, M. A., Solomon, S. D., Zile, M. R., Køber, L., McMurray, J. J.V. (2019) N-terminal pro-B-type natriuretic peptide levels for risk prediction in patients with heart failure and preserved ejection fraction according to atrial fibrillation status. Circulation: Heart Failure, 12, (doi: 10.1161/circheartfailure.118.005766)

Mangion, K., Carrick, D., Clerfond, G., Rush, C., McComb, C., Oldroyd, K. G., Petrie, M. C., Eteiba, H., Lindsay, M., McEntegart, M., Hood, S., Watkins, S., Davie, A., Auger, D. A., Zhong, X., Epstein, F. H., Haig, C. E., Berry, C. (2019) Predictors of segmental myocardial functional recovery in patients after an acute ST-elevation myocardial infarction. European Journal of Radiology, 112, pp. 121-129. (doi: 10.1016/j.ejrad.2019.01.010)

Loader, J., Chan, Y.-K., A Hawley, J., Moholdt, T., McDonald, C. F., Jhund, P., Petrie, M. C., McMurray, J. J., Scuffham, P. A., Ramchand, J., Burrell, L. M., Stewart, S. (2019) Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: analysis of 1598 patients and 4588 patient-years follow-up. International Journal of Cardiology, 279, pp. 126-132. (doi: 10.1016/j.ijcard.2018.12.060)

de Boer, R. A. et al. (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. European Journal of Heart Failure, 21, pp. 272-285. (doi: 10.1002/ejhf.1406)

Mamet, H., Petrie, M. C., Rocchiccioli, P. (2019) Type 1 diabetes mellitus and coronary revascularization. Cardiovascular Endocrinology and Metabolism, 8, pp. 35-38. (doi: 10.1097/XCE.0000000000000166)

Celis-Morales, C. A., Gray, S., Petermann, F., Iliodromiti, S., Welsh, P., Lyall, D. M., Anderson, J., Pellicori, P., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R. (2019) Walking pace is associated with lower risk of all-cause and cause-specific mortality. Medicine and Science in Sports and Exercise, 51, pp. 472-480. (doi: 10.1249/MSS.0000000000001795)

Cleland, J. G.F., van Veldhuisen, D. J., Ponikowski, P. (2019) The year in cardiology 2018: heart failure. European Heart Journal, 40, pp. 651-661. (doi: 10.1093/eurheartj/ehz010)

Arroja, M.M.C., Reid, E., Roy, L.A., Vallatos, A.V., Holmes, W.M., Nicklin, S.A., Work, L.M., McCabe, C. (2019) Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion. Scientific Reports, 9, (doi: 10.1038/s41598-019-39102-8)

Jones, F. E., Murray, L. S., McNeilly, S., Dean, A., Aman, A., Lu, Y., Nikolova, N., Malomgre, R., Horsburgh, K., Holmes, W. M., Kadler, K. E., Van Agtmael, T. (2019) 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease. Human Molecular Genetics, 28, pp. 628-638. (doi: 10.1093/hmg/ddy369)

Brooksbank, K., O'Donnell, J., Corbett, V., Shield, S., Ainsworth, R., Shearer, R., Montgomery, S., Gallagher, A., Duncan, H., Hamilton, L., Laszlo, V., Noone, R., Baxendale, A., Blane, D., Logue, J. (2019) Discussing weight management with type 2 diabetes patients in primary care using the Small Talk Big Difference intervention: Protocol for a randomised controlled trial. JMIR Research Protocols, 8, (doi: 10.2196/12162)

Avtaar Singh, S. S., Das De, S., Nappi, F., Al-Adhami, A., Hegazy, Y., Dalzell, J., Doshi, H., Sinclair, A., Curry, P., Petrie, M., Berry, C., Al-Attar, N. (2019) Mechanical circulatory support for refractory cardiogenic shock post-acute myocardial infarction-a decade of lessons. Journal of Thoracic Disease, 11, pp. 542-548. (doi: 10.21037/jtd.2019.01.21)

Palazzuoli, A., Ruocco, G., Pellicori, P., Incampo, E., Di Tommaso, C., Favilli, R., Evangelista, I., Nuti, R., Testani, J. M. (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. International Journal of Cardiology, 276, pp. 198-203. (doi: 10.1016/j.ijcard.2018.11.108)

Zhang, J., Begley, A., Jackson, R., Harrison, M., Pellicori, P., Clark, A. L., Cleland, J. G.F. (2019) Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis. Clinical Research in Cardiology, 108, pp. 119-132. (doi: 10.1007/s00392-018-1302-7)

Mangion, K., Carrick, D., Carberry, J., Mahrous, A., McComb, C., Oldroyd, K. G., Eteiba, H., Lindsay, M., McEntegart, M., Hood, S., Petrie, M. C., Watkins, S., Davie, A., Zhong, X., Epstein, F. H., Haig, C. E., Berry, C. (2019) Circumferential strain predicts major adverse cardiovascular events following an acute ST-segment-elevation myocardial infarction. Radiology, 290, pp. 329-337. (doi: 10.1148/radiol.2018181253)

Ferreira, J. P., Metra, M., Anker, S. D., Dickstein, K., Lang, C. C., Ng, L., Samani, N. J., Cleland, J. G., van Veldhuisen, D. J., Voors, A. A., Zannad, F. (2019) Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. European Journal of Heart Failure, 21, pp. 218-226. (doi: 10.1002/ejhf.1380)

Osmanska, J., Jhund, P. S. (2019) Contemporary management of heart failure in the elderly. Drugs and Aging, 36, pp. 137-146. (doi: 10.1007/s40266-018-0625-4)

Avtaar Singh, S. S., Banner, N. R., Rushton, S., Simon, A. R., Berry, C., Al-Attar, N. (2019) ISHLT primary graft dysfunction incidence, risk factors and outcome: a UK national study. Transplantation, 103, pp. 336-343. (doi: 10.1097/TP.0000000000002220)

Kaye, D. M., Petrie, M. C., McKenzie, S., Hasenfuβ, G., Malek, F., Post, M., Doughty, R. N., Trochu, J.-N., Gustafsson, F., Lang, I., Kolodziej, A., Westenfeld, R., Penicka, M., Rosenberg, M., Hausleiter, J., Raake, P., Jondeau, G., Bergmann, M. W., Spelman, T., Aytug, H., Ponikowski, P., Hayward, C. (2019) Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Failure, 6, pp. 62-69. (doi: 10.1002/ehf2.12350)

Bekfani, T., Pellicori, P., Morris, D., Ebner, N., Valentova, M., Sandek, A., Doehner, W., Cleland, J. G., Lainscak, M., Schulze, P. C., Anker, S. D., von Haehling, S. (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clinical Research in Cardiology, 108, pp. 203-211. (doi: 10.1007/s00392-018-1344-x)

Ford, T., Corcoran, D., Sidik, N., Oldroyd, K. G., Rocchiccioli, P., McEntegart, M., Berry, C. (2019) MINOCA: Requirement for definitive diagnostic work-up. Heart, Lung and Circulation, 28, pp. e4-e6. (doi: 10.1016/j.hlc.2018.04.001)

Sze, S., Pellicori, P., Zhang, J., Clark, A. L. (2019) Malnutrition, congestion and mortality in ambulatory patients with heart failure. Heart, 105, pp. 297-306. (doi: 10.1136/heartjnl-2018-313312)

Ferreira, J. P., Rossignol, P., Pizard, A., Machu, J.-L., Collier, T., Girerd, N., Huby, A.-C., Gonzalez, A., Diez, J., López, B., Sattar, N., Cleland, J. G., Sever, P. S., Zannad, F. (2019) Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Heart, 105, pp. 307-314. (doi: 10.1136/heartjnl-2018-313182)

McCartney, P. J., Berry, C. (2019) Redefining successful primary PCI. European Heart Journal, 20, pp. 133-135. (doi: 10.1093/ehjci/jey159)

Berry, C., Sidik, N., Pereira, A. C., Ford, T. J., Touyz, R. M., Kaski, J.-C., Hainsworth, A. H. (2019) Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. Journal of the American Heart Association, 8, (doi: 10.1161/JAHA.118.011104)

Ambrosy, A. P., Stevens, S. R., Al-Khalidi, H. R., Rouleau, J. L., Bouabdallaoui, N., Carson, P. E., Adlbrecht, C., Cleland, J. G.F., Dabrowski, R., Golba, K. S., Pina, I. L., Sueta, C. A., Roy, A., Sopko, G., Bonow, R. O., Velazquez, E. J. (2019) Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. European Journal of Heart Failure, 21, pp. 373-381. (doi: 10.1002/ejhf.1404)

Lee, M. M.Y., Campbell, R. T., Kelly, R., Petrie, M. C., Sonecki, P. (2019) Does “Scar” at Rest Echocardiography Predict Lack of Contractility Reserve at Dobutamine Stress Echocardiography. (doi: 10.1093/ehjci/jey266)

Keeble, T. R., Karamasis, G. V., Rothman, M. T., Ricksten, S.-E., Ferrari, M., Hullin, R., Scherstén, F., Reitan, O., Kirking, S. T., Cleland, J. G.F., Smith, E. J. (2019) Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP) International Journal of Cardiology, 275, pp. 53-58. (doi: 10.1016/j.ijcard.2018.09.085)

Dewan, P., Rørth, R., Jhund, P. S., Shen, L., Raparelli, V., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Mogensen, U. M., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Differential impact of heart failure with reduced ejection fraction on men and women. Journal of the American College of Cardiology, 73, pp. 29-40. (doi: 10.1016/j.jacc.2018.09.081)

Halliday, B. P. et al. (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet, 393, pp. 61-73. (doi: 10.1016/S0140-6736(18)32484-X)

McCartney, P. J. et al. (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321, pp. 56-68. (doi: 10.1001/jama.2018.19802)

Kerr, D. M.I., Brooksbank, K. J.M., Taylor, R. G., Pinel, K., Rios, F. J., Touyz, R. M., Delles, C. (2019) Acute effects of electronic and tobacco cigarettes on vascular and respiratory function in healthy volunteers: a cross-over study. Journal of Hypertension, 37, pp. 154-166. (doi: 10.1097/HJH.0000000000001890)

Berry, C., Corcoran, D., Mangion, K. (2019) Cardiovascular health technology assessment: recommendations to improve the quality of evidence. Open Heart, 6, (doi: 10.1136/openhrt-2018-000930)

Mazlan-Kepli, W., Dawson, J., Berry, C., Walters, M. (2019) Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome. Heart, 105, pp. 67-74. (doi: 10.1136/heartjnl-2018-313148)

Lee, M. M. Y., McMurray, J. J.V., Lorenzo-Almorós, A., Kristensen, S. L., Sattar, N., Jhund, P. S., Petrie, M. C. (2019) Diabetic cardiomyopathy. Heart, 105, pp. 337-345. (doi: 10.1136/heartjnl-2016-310342)

Rørth, R., Jhund, P. S., Kristensen, S. L., Desai, A. S., Køber, L., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2019) The prognostic value of troponin T and N‐terminal pro B‐type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. European Journal of Heart Failure, 21, pp. 40-49. (doi: 10.1002/ejhf.1359)

Morrow, A., Nordin, S., O'Boyle, P., Berry, C. (2019) 'Acute micro-coronary syndrome': detailed coronary physiology in a patient with Takotsubo cardiomyopathy. BMJ Case Reports, 12, (doi: 10.1136/bcr-2019-229618)

Purnama Sidik, N., McCartney, P., Berry, C. (2019) Coronary microvascular disease. Springer

Pfeiffer-Kaushik, E. R., Smith, G. L., Cai, B., Dempsey, G. T., Hortigon-Vinagre, M. P., Zamora, V., Feng, S., Ingermanson, R., Zhu, R., Hariharan, V., Nguyen, C., Pierson, J., Gintant, G. A., Tung, L. (2019) Electrophysiological characterization of drug response in hSC-derived cardiomyocytes using voltage-sensitive optical platforms. Journal of Pharmacological and Toxicological Methods, 99, (doi: 10.1016/j.vascn.2019.106612)

Rush, C. J., Petrie, M. C. (2019) Heart failure with preserved ejection fraction. Springer

Jackson, A. M., Jhund, P. S. (2019) Heart failure with reduced ejection fraction. Springer

Corcoran, D., Ford, T. J., Berry, C. (2019) Stable coronary syndromes. Springer

Graham, D. (2019) Vascular physiology. Springer

Nather, K., Loughrey, C. M., Nicklin, S. A. (2019) Vasoactive peptides: renin-angiotensin-aldosterone system. Springer

Lemme, M., Ulmer, B. M., Lemoine, M. D., Zech, A. T.L., Flenner, F., Ravens, U., Reichenspurner, H., Rol-Garcia, M., Smith, G., Hansen, A., Christ, T., Eschenhagen, T. (2018) Atrial-like engineered heart tissue: an in vitro model of the human atrium. Stem Cell Reports, 11, pp. 1378-1390. (doi: 10.1016/j.stemcr.2018.10.008)

Ford, T. J., Stanley, B., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., Sidik, N., McCartney, P., Corcoran, D., Collison, D., Rush, C., McConnachie, A., Touyz, R., Oldroyd, K., Berry, C. (2018) Stratified medical therapy using invasive coronary function testing in angina: CorMicA trial. Journal of the American College of Cardiology, 72, pp. 2841-2855. (doi: 10.1016/j.jacc.2018.09.006)

Ford, T. J., Rocchiccioli, P., Good, R., McEntegart, M., Eteiba, H., Watkins, S., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., Yii, E., Sidik, N., Harvey, A., Montezano, A. C., Beattie, E., Haddow, L., Oldroyd, K. G., Touyz, R. M., Berry, C. (2018) Systemic microvascular dysfunction in microvascular and vasospastic angina. European Heart Journal, 39, pp. 4086-4097. (doi: 10.1093/eurheartj/ehy529)

Rossitto, G., Touyz, R. M., Petrie, M. C., Delles, C. (2018) Much Ado about N...atrium: modelling tissuesodium as a highly sensitive marker of subclinicaland localized oedema. Clinical Science, 132, pp. 2609-2613. (doi: 10.1042/CS20180575)

Tromp, J., Ouwerkerk, W., Demissei, B.G., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H.L., Lang, C.C., Metra, M., Ng, L.L., Ponikowski, P., Samani, N.J., van Veldhuisen, D.J., Zannad, F., Zwinderman, A.H., Voors, A.A., van der Meer, P. (2018) Novel endotypes in heart failure: effects on guideline-directed medical therapy. European Heart Journal, 39, pp. 4269-4276. (doi: 10.1093/eurheartj/ehy712)

Shiraishi, Y., Nagai, T., Kohsaka, S., Goda, A., Nagatomo, Y., Mizuno, A., Kohno, T., Rigby, A., Fukuda, K., Yoshikawa, T., Clark, A. L., Cleland, J. G.F. (2018) Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide. Clinical Research in Cardiology, 107, pp. 1103-1110. (doi: 10.1007/s00392-018-1283-6)

Abuosa, A. M., Elshiekh, A. H., Qureshi, K., Abrar, M. B., Kholeif, M. A., Kinsara, A. J., Andejani, A., Ahmed, A. H., Cleland, J. G.F. (2018) Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin. Indian Heart Journal, 70, pp. S96-S100. (doi: 10.1016/j.ihj.2018.06.011)

Campbell, R. T., Petrie, M. C., McMurray, J. J.V. (2018) Redefining heart failure phenotypes based on ejection fraction. European Journal of Heart Failure, 20, pp. 1634-1635. (doi: 10.1002/ejhf.1325)

Henry, A. D., MacQuaide, N., Burton, F.L., Rankin, A.C., Rowan, E.G., Drummond, R.M. (2018) Spontaneous Ca2+ transients in rat pulmonary vein cardiomyocytes are increased in frequency and become more synchronous following electrical stimulation. Cell calcium, 76, pp. 36-47. (doi: 10.1016/j.ceca.2018.09.001)

Campbell, R. T., Petrie, M. C., McMurray, J. J.V. (2018) Talking to patients with heart failure about end of life. European Journal of Heart Failure, 20, pp. 1763-1765. (doi: 10.1002/ejhf.1321)

Dobbin, S. J.H., Cameron, A. C., Petrie, M. C., Jones, R. J., Touyz, R. M., Lang, N. N. (2018) Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart, 104, pp. 1995-2002. (doi: 10.1136/heartjnl-2018-313726)

Connolly, A., Kelly, A., Campos, F. O., Myles, R., Smith, G., Bishop, M. J. (2018) Ventricular endocardial tissue geometry affects stimulus threshold and effective refractory period. Biophysical Journal, 115, pp. 2486-2498. (doi: 10.1016/j.bpj.2018.11.003)

Streng, K. W., Nauta, J. F., Hillege, H. L., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Voors, A. A. (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology, 271, pp. 132-139. (doi: 10.1016/j.ijcard.2018.04.001)

Santema, B. T., Kloosterman, M., Van Gelder, I. C., Mordi, I., Lang, C. C., Lam, C. S.P., Anker, S., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Ter Maaten, J. M., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Rienstra, M., Voors, A. A. (2018) Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. European Heart Journal, 39, pp. 3867-3875. (doi: 10.1093/eurheartj/ehy421)

Cao, T. H., Jones, D. J. L., Quinn, P. A., Chan, D. C. S., Hafid, N., Parry, H. M., Mohan, M., Sandhu, J. K., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Voors, A. A., Lang, C. C., Ng, L. L. (2018) Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clinical Proteomics, 15, (doi: 10.1186/s12014-018-9213-1)

Docherty, K. F., Jhund, P. S. (2018) Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early? Heart, 104, pp. 1812-1813. (doi: 10.1136/heartjnl-2018-313371)

MacDonald, E., Quinn, T. A. (2018) Mechanical Determinants of the Chronotropic Response to Sinoatrial Stretch. (doi: 10.1016/j.yjmcc.2018.07.030)

Kristensen, S. L., Rørth, R., Jhund, P. S., Shen, L., Lee, M. M.Y., Petrie, M. C., Køber, L., McMurray, J. J.V. (2018) Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial. European Journal of Heart Failure, 20, pp. 1549-1556. (doi: 10.1002/ejhf.1201)

Narang, R., Saxena, A., Desai, A., Ramakrishnan, S., Thangjam, R. S., Kulkarni, S., Narvencar, K., Jacques' e Costa, A. K., Dias, A., Sukharamwala, R., Cleland, J. (2018) Prevalence and determinants of hypertension in apparently healthy schoolchildren in India: a multi-center study. European Journal of Preventive Cardiology, 25, pp. 1775-1784. (doi: 10.1177/2047487318790056)

Graham, L. A., Aman, A., Campbell, D. D., Augley, J., Graham, D., McBride, M. W., Fraser, N. J., Ferreri, N. R., Dominiczak, A. F., Padmanabhan, S. (2018) Salt stress in the renal tubules is linked to TAL specific expression of uromodulin and an upregulation of heat shock genes. Physiological Genomics, 50, pp. 964-972. (doi: 10.1152/physiolgenomics.00057.2018)

Ghouri, I. A., Kelly, A., Salerno, S., Garten, K., Stølen, T., Kemi, O.-J., Smith, G. L. (2018) Characterization of electrical activity in post-myocardial infarction scar tissue in rat hearts using multiphoton microscopy. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.01454)

Zhang, J., Pellicori, P., Pan, D., Dierckx, R., Clark, A.L., Cleland, J.G.F. (2018) Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology, 269, pp. 196-200. (doi: 10.1016/j.ijcard.2018.06.070)

Maack, C. et al. (2018) Treatments targeting inotropy. European Heart Journal, (doi: 10.1093/eurheartj/ehy600)

Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G.F., Fu, M., Gheorghiade, M., Lam, C. S.P., Mehra, M. R., Neaton, J. D., Nessel, C. C., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B. (2018) Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. New England Journal of Medicine, 379, pp. 1332-1342. (doi: 10.1056/NEJMoa1808848)

Rush, C. J., Campbell, R. T., Jhund, P. S., Petrie, M. C., McMurray, J. J.V. (2018) Association is not causation: treatment effects cannot be estimated from observational data in heart failure. European Heart Journal, 39, pp. 3417-3438. (doi: 10.1093/eurheartj/ehy407)

Shah, P., Pellicori, P., Rimmer, S., Rigby, A. S., Clark, A. L. (2018) Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction. International Journal of Cardiology, 268, pp. 166-169. (doi: 10.1016/j.ijcard.2018.05.029)

Guzik, T. J., Antoniades, C., Baker, A. H., Harrison, D. G., Loughrey, C. M., Maffia, P., Murphy, E., Nicklin, S. A., Peter, K., Pearson, J., Casadei, B. (2018) What matters in Cardiovascular Research? Scientific discovery driving clinical delivery. Cardiovascular Research, 114, pp. 1565-1568. (doi: 10.1093/cvr/cvy214)

Cuthbert, J. J., Pellicori, P., Rigby, A., Pan, D., Kazmi, S., Shah, P., Clark, A. L. (2018) Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. European Journal of Heart Failure, 20, pp. 1426-1435. (doi: 10.1002/ejhf.1247)

Shah, S. J. et al. (2018) One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial. JAMA Cardiology, 3, pp. 968-977. (doi: 10.1001/jamacardio.2018.2936)

van Meer, B. J., Sala, L., Tertoolen, L. G.J., Smith, G. L., Burton, F. L., Mummery, C. L. (2018) Quantification of muscle contraction in vitro and in vivo using MUSCLEMOTION software: from stem cell-derived cardiomyocytes to zebrafish and human hearts. Current Protocols in Human Genetics, 99, (doi: 10.1002/cphg.67)

Keene, D., Arnold, A., Shun-Shin, M. J., Howard, J. P., Sohaib, S. A., Moore, P., Tanner, M., Quereshi, N., Muthumala, A., Chandresekeran, B., Foley, P., Leyva, F., Adhya, S., Falaschetti, E., Tsang, H., Vijayaraman, P., Cleland, J. G.F., Stegemann, B., Francis, D. P., Whinnett, Z. I. (2018) Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. ESC Heart Failure, 5, pp. 965-976. (doi: 10.1002/ehf2.12315)

Halliday, B. P., Gulati, A., Ali, A., Newsome, S., Lota, A., Tayal, U., Vassiliou, V. S., Arzanauskaite, M., Izgi, C., Krishnathasan, K., Singhal, A., Chiew, K., Gregson, J., Frenneaux, M. P., Cook, S. A., Pennell, D. J., Collins, P., Cleland, J. G.F., Prasad, S. K. (2018) Sex and age-based differences in the natural history and outcome of dilated cardiomyopathy. European Journal of Heart Failure, 20, pp. 1392-1400. (doi: 10.1002/ejhf.1216)

Berry, C., Mangion, K., Pathan, F. (2018) Spotlight on strain following myocardial infarction. JACC: Cardiovascular Imaging, 11, pp. 1445-1447. (doi: 10.1016/j.jcmg.2018.01.004)

Blinova, K., Dang, Q., Millard, D., Smith, G., Pierson, J., Guo, L., Brock, M., Lu, H. R., Kraushaar, U., Zeng, H., Shi, H., Zhang, X., Sawada, K., Osada, T., Kanda, Y., Sekino, Y., Pang, L., Feaster, T. K., Kettenhofen, R., Stockbridge, N., Strauss, D. G., Gintant, G. (2018) International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Reports, 24, pp. 3582-3592. (doi: 10.1016/j.celrep.2018.08.079)

Cleland, J. G.F., Clark, R. A. (2018) Telehealth: delivering high-quality care for heart failure. Lancet, 392, pp. 990-991. (doi: 10.1016/S0140-6736(18)31995-0)

Puntmann, V. O., Valbuena, S., Hinojar, R., Petersen, S. E., Greenwood, J. P., Kramer, C. M., Kwong, R. Y., McCann, G. P., Berry, C., Nagel, E. (2018) Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. Journal of Cardiovascular Magnetic Resonance, 20, (doi: 10.1186/s12968-018-0484-5)

Shah, A. S.V. et al. (2018) High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet, 392, pp. 919-928. (doi: 10.1016/S0140-6736(18)31923-8)

Nagai, T., Sundaram, V., Rothnie, K., Quint, J. K., Shoaib, A., Shiraishi, Y., Kohsaka, S., Piper, S., McDonagh, T. A., Hardman, S. M. C., Goda, A., Mizuno, A., Kohno, T., Rigsby, A. S., Yoshikawa, T., Clark, A. L., Anzai, T., Cleland, J. G.F. (2018) Mortality after admission for heart failure in the United Kingdom compared to Japan. Open Heart, 5, (doi: 10.1136/openhrt-2018-000811)

Colman, M. A., Saxena, P., Kettlewell, S., Workman, A. J. (2018) Description of the human atrial action potential derived from a single, congruent data source: novel computational models for integrated experimental-numerical study of atrial arrhythmia mechanisms. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.01211)

The SCOT-HEART Investigators, et al. (2018) Coronary CT angiography and 5-year risk of myocardial infarction. New England Journal of Medicine, 379, pp. 924-933. (doi: 10.1056/NEJMoa1805971)

Tromp, J., Westenbrink, B. D., Oowerkerk, W., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Lang, C. C., Ng, L. L., Zannad, F., Zwinderman, A. H., Hillege, H. L., van der Meer, P., Voors, A. A. (2018) Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. Journal of the American College of Cardiology, 72, pp. 1081-1090. (doi: 10.1016/j.jacc.2018.06.050)

Williams, B. et al. (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39, pp. 3021-3104. (doi: 10.1093/eurheartj/ehy339)

Corcoran, D., Young, R., Adlam, D., McConnachie, A., Mangion, K., Ripley, D., Cairns, D., Brown, J., Bucciarelli-Ducci, C., Baumbach, A., Kharbanda, R., Oldroyd, K. G., McCann, G. P., Greenwood, J. P., Berry, C. (2018) Coronary microvascular dysfunction in patients with stable coronary artery disease: the CE-MARC 2 coronary physiology sub-study. International Journal of Cardiology, 266, pp. 7-14. (doi: 10.1016/j.ijcard.2018.04.061)

Panahi, M., Papanikolaou, A., Torabi, A., Zhang, J.-G., Khan, H., Vazir, A., Hasham, M. G., Cleland, J. G.F., Rosenthal, N. A., Harding, S. E., Sattler, S. (2018) Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition. Cardiovascular Research, 114, pp. 1445-1461. (doi: 10.1093/cvr/cvy145)

Gulati, A., Japp, A. G., Raza, S., Halliday, B. P., Jones, D. A., Newsome, S., Ismail, N. A., Morarji, K., Khwaja, J., Spath, N., Shakespeare, C., Kalra, P. R., Lloyd, G., Mathur, A., Cleland, J. G.F., Cowie, M. R., Assomull, R. G., Pennell, D. J., Ismail, T. F., Prasad, S. K. (2018) Absence of myocardial fibrosis predicts favorable long-term survival in new-onset heart failure: a cardiovascular magnetic resonance study. Circulation: Cardiovascular Imaging, 11, (doi: 10.1161/CIRCIMAGING.118.007722)

McDowell, K., Petrie, M. C., Raihan, N. A., Logue, J. (2018) Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obesity Reviews, 19, pp. 1189-1204. (doi: 10.1111/obr.12707)

Carrick, D., Haig, C., Maznyczka, A. M., Carberry, J., Mangion, K., Ahmed, N., May, V. T. Y., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ford, I., Radjenovic, A., Welsh, P., Sattar, N., Wetherall, K., Oldroyd, K. G., Berry, C. (2018) Hypertension, microvascular pathology and prognosis after an acute myocardial infarction. Hypertension, 72, pp. 720-730. (doi: 10.1161/HYPERTENSIONAHA.117.10786)

McEntegart, M. B., Corcoran, D., Carrick, D., Clerfond, G., Sidik, N., Collison, D., Robertson, K. R., Shaukat, A., Watkins, S., Rocchicholi, P. R., Eteiba, H., Petrie, M. P., Lindsay, M. M., Oldroyd, K. G., Berry, C. (2018) Incidence of procedural myocardial infarction and cardiac magnetic resonance imaging-detected myocardial injury following percutaneous coronary intervention with rotational atherectomy. EuroIntervention, 14, pp. 819-823. (doi: 10.4244/EIJ-D-17-01077)

Kim, S. S., Yamamoto, M. H., Maehara, A., Sidik, N., Koyama, K., Berry, C., Oldroyd, K. G., Mintz, G. S., McEntegart, M. (2018) Intravascular ultrasound assessment of the effects of rotational atherectomy in calcified coronary artery lesions. International Journal of Cardiovascular Imaging, 34, pp. 1365-1371. (doi: 10.1007/s10554-018-1352-y)

Carberry, J., Carrick, D., Haig, C., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2018) Persistent iron within the infarct core after ST-segment elevation myocardial infarction: implications for left ventricular remodeling and health outcomes. JACC: Cardiovascular Imaging, 11, pp. 1248-1256. (doi: 10.1016/j.jcmg.2017.08.027)

Kobayashi, Y., Lønborg, J., Jong, A., Nishi, T., De Bruyne, B., Høfsten, D. E., Kelbæk, H., Layland, J., Nam, C.-W., Pijls, N. H.J., Tonino, P. A.L., Warnøe, J., Oldroyd, K. G., Berry, C., Engstrøm, T., Fearon, W. F. (2018) Prognostic value of the residual SYNTAX score after functionally complete revascularization in ACS. Journal of the American College of Cardiology, 72, pp. 1321-1329. (doi: 10.1016/j.jacc.2018.06.069)

Divorty, N., Milligan, G., Graham, D., Nicklin, S. A. (2018) The orphan receptor GPR35 contributes to angiotensin II–induced hypertension and cardiac dysfunction in mice. American Journal of Hypertension, 31, pp. 1049-1058. (doi: 10.1093/ajh/hpy073)

Svanerud, J., Ahn, J.-M., Jeremias, A., van 't Veer, M., Gore, A., Maehara, A., Crowley, A., Pijls, N. H.J., De Bruyne, B., Johnson, N. P., Hennigan, B., Watkins, S., Berry, C., Oldroyd, K. G., Park, S.-J., Ali, Z. A. (2018) Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention, 14, pp. 806-814. (doi: 10.4244/EIJ-D-18-00342)

Streng, K. W., Voors, A. A., Hillege, H. L., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhusen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Lang, C. C. (2018) Waist-to-hip ratio and mortality in heart failure. European Journal of Heart Failure, 20, pp. 1269-1277. (doi: 10.1002/ejhf.1244)

Campbell, R. T., Petrie, M. C., Jackson, C. E., Jhund, P. S., Wright, A., Gardner, R. S., Sonecki, P., Pozzi, A., McSkimming, P., McConnachie, A., Finlay, F., Davidson, P., Denvir, M. A., Johnson, M. J., Hogg, K. J., McMurray, J. J.V. (2018) Which patients with heart failure should receive specialist palliative care? European Journal of Heart Failure, 20, pp. 1338-1347. (doi: 10.1002/ejhf.1240)

Docherty, K. F., Jhund, P. S., McMurray, J. J.V. (2018) Catheter ablation for atrial fibrillation with heart failure. New England Journal of Medicine, 379, pp. 491-492. (doi: 10.1056/NEJMc1806519)

Sze, S., Pellicori, P., Kamzi, S., Anton, A., Clark, A. L. (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. International Journal of Cardiology, 264, pp. 104-112. (doi: 10.1016/j.ijcard.2018.03.089)

Ford, T. J., McEntegart, M., Berry, C., Oldroyd, K. G. (2018) Arterial access for invasive coronary angiography: the 'left backhander' Heart, Lung and Circulation, 27, pp. e98-e99. (doi: 10.1016/j.hlc.2018.02.021)

Yew, S. N., Carrick, D., Corcoran, D., Ahmed, N., Carberry, J., May, V. T. Y., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ford, I., Oldroyd, K. G., Berry, C. (2018) Coronary thermodilution waveforms after acute reperfused ST‐segment–elevation myocardial infarction: relation to microvascular obstruction and prognosis. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.008957)

Lund, L. H., Claggett, B., Liu, J., Lam, C. S., Jhund, P. S., Rosano, G. M., Swedberg, K., Yusuf, S., Granger, C. B., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2018) Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. European Journal of Heart Failure, 20, pp. 1230-1239. (doi: 10.1002/ejhf.1149)

Wessler, J., Kaye, D., Gustafsson, F., Petrie, M. C., Hasenfuβ, G., Lam, C. S.P., Borlaug, B. A., Komtebedde, J., Feldman, T., Shah, S. J., Burkhoff, D. (2018) Impact of baseline hemodynamics on the effects of a transcatheter interatrial shunt device in heart failure with preserved ejection fraction. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004540)

Shah, S. V., Zimmermann, F. M., Johnson, N. P., Nishi, T., Kobayashi, Y., Witt, N., Berry, C., Jeremias, A., Koo, B.-K., Esposito, G., Rioufol, G., Park, S.-J., Oldroyd, K. G., Barbato, E., Pijls, N. H.J., De Bruyne, B., Fearon, W. F. (2018) Sex differences in adenosine-free coronary pressure indexes: a CONTRAST substudy. JACC: Cardiovascular Interventions, 11, pp. 1454-1463. (doi: 10.1016/j.jcin.2018.03.030)

Nagai, T., Sundaram, V., Shoaib, A., Shiraishi, Y., Kohsaka, S., Rothnie, K. J., Piper, S., McDonagh, T. A., Hardman, S. M.C., Goda, A., Mizuno, A., Sawano, M., Rigby, A. S., Quint, J. K., Yoshikawa, T., Clark, A. L., Anzai, T., Cleland, J. G.F. (2018) Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan. European Journal of Heart Failure, 20, pp. 1179-1190. (doi: 10.1002/ejhf.1210)

Ford, T. J., Corcoran, D., Sidik, N., McEntegart, M., Berry, C. (2018) Coronary microvascular dysfunction: Assessment of both structure and function. Journal of the American College of Cardiology, 72, pp. 584-586. (doi: 10.1016/j.jacc.2018.03.545)

Rajani, R. M., Quick, S., Ruigrok, S. R., Graham, D., Harris, S. E., Verhaaren, B. F.J., Fornage, M., Seshadri, S., Atanur, S. S., Dominiczak, A. F., Smith, C., Wardlaw, J. M., Williams, A. (2018) Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats. Science Translational Medicine, 10, (doi: 10.1126/scitranslmed.aam9507)

Solomon, S. D. et al. (2018) Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.118.004962)

Palazzuoli, A., Ruocco, G., Beltrami, M., Nuti, R., Cleland, J. G. (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clinical Research in Cardiology, 107, pp. 586-596. (doi: 10.1007/s00392-018-1221-7)

Abdul-Rahim, A. H., Shen, L., Rush, C. J., Jhund, P. S., Lees, K. R., McMurray, J. J.V. (2018) Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. European Journal of Heart Failure, 20, pp. 1139-1145. (doi: 10.1002/ejhf.1160)

Nichols, S., Gleadall-Siddall, D.O., Antony, R., Clark, A.L., Cleland, J.G.F., Carroll, S., Ingle, L. (2018) Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation? Clinical Physiology and Functional Imaging, 38, pp. 681-688. (doi: 10.1111/cpf.12468)

Findlay, I., Morris, T., Zhang, R., Mccowan, C., Shield, S., Forbes, B., McConnachie, A., Mangion, K., Berry, C. (2018) Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in NHS Scotland. European Heart Journal: Quality of Care and Clinical Outcomes, 4, pp. 155-167. (doi: 10.1093/ehjqcco/qcy007)

Pellicori, P., Cleland, J. G.F., Clark, A. L. (2018) Losing track by tracking speckles. JACC: Cardiovascular Imaging, 11, pp. 1038-1039. (doi: 10.1016/j.jcmg.2018.04.027)

Sartor, F., Papini, G., Cox, L. G. E., Cleland, J. (2018) Methodological shortcomings of wrist-worn heart rate monitors validations. Journal of Medical Internet Research, 20, (doi: 10.2196/10108)

Morgan, H. L., Butler, E., Ritchie, S., Herse, F., Dechend, R., Beattie, E., McBride, M. W., Graham, D. (2018) Modeling superimposed preeclampsia using Ang II (Angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats. Hypertension, 72, pp. 208-218. (doi: 10.1161/HYPERTENSIONAHA.118.10935)

Ford, T. J., Corcoran, D., Oldroyd, K. G., McEntegart, M., Rocchiccioli, P., Watkins, S., Brooksbank, K., Padmanabhan, S., Sattar, N., Briggs, A., McConnachie, A., Touyz, R., Berry, C. (2018) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. American Heart Journal, 201, pp. 86-94. (doi: 10.1016/j.ahj.2018.03.010)

De Lucca Camargo, L., Harvey, A. P., Rios, F. J., Tsiropoulou, S., Silva, R. D. N. d. O., Cao, Z., Graham, D., McMaster, C., Burchmore, R. J., Hartley, R. C., Bulleid, N., Montezano, A. C., Touyz, R. M. (2018) Vascular Nox (NADPH oxidase) compartmentalization, protein hyperoxidation, and endoplasmic reticulum stress response in hypertension. Hypertension, 72, pp. 235-246. (doi: 10.1161/HYPERTENSIONAHA.118.10824)

Bailey, E., McBride, M. W., McClure, J. D., Beattie, W., Graham, D., Dominiczak, A., Smith, C., Wardlaw, J. (2018) Effects of dietary salt on gene and protein expression in brain tissue of a model of sporadic small vessel disease. Clinical Science, 132, pp. 1315-1328. (doi: 10.1042/CS20171572)

Montezano, A. C., De Lucca Camargo, L., Persson, P., Rios, F. J., Harvey, A. P., Agnostopoulou, A., Palacios, R., Gandara, A. C. P., Alves-Lopes, R., Neves, K. B., Dulak-Lis, M., Holterman, C. E., Lagerblad de Oliveira, P., Graham, D., Kennedy, C., Touyz, R. M. (2018) NADPH oxidase 5 is a pro‐contractile Nox isoform and a point of cross‐talk for calcium and redox signaling‐implications in vascular function. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.009388)

Rørth, R., Jhund, P. S., Mogensen, U. M., Kristensen, S. L., Petrie, M. C., Køber, L., McMurray, J. J.V. (2018) Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction. Diabetes Care, 41, pp. 1285-1291. (doi: 10.2337/dc17-2583)

Ford, T. J., McCartney, P., Corcoran, D., Collison, D., Hennigan, B., McEntegart, M., Hildick-Smith, D., Oldroyd, K. G., Berry, C. (2018) Single versus two-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.008730)

Welsh, C., Welsh, P., Mark, P. B., Celis-Morales, C. A., Lewsey, J., Gray, S. R., Lyall, D. M., Iliodromiti, S., Gill, J. M.R., Pell, J., Jhund, P. S., Sattar, N. (2018) Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, pp. 1415-1423. (doi: 10.1161/ATVBAHA.118.310945)

Dickstein, K. et al. (2018) CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? European Journal of Heart Failure, 20, pp. 1039-1051. (doi: 10.1002/ejhf.1142)

Høydal, M. A., Kirkeby-Garstad, I., Karevold, A., Wiseth, R., Haaverstad, R., Wahba, A., Stølen, T. L., Contu, R., Ellingsen, Ø., Smith, G. L. S., Kemi, O. J., Wisløff, U. (2018) Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial-infarction heart failure. ESC Heart Failure, 5, pp. 332-342. (doi: 10.1002/ehf2.12271)

Zymliński, R., Biegus, J., Sokolski, M., Siwołowski, P., Nawrocka-Millward, S., Todd, J., Jankowska, E. A., Banasiak, W., Cotter, G., Cleland, J. G., Ponikowski, P. (2018) Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion. European Journal of Heart Failure, 20, pp. 1011-1018. (doi: 10.1002/ejhf.1156)

Sliwa, K., Petrie, M. C., Hilfiker-Kleiner, D., Mebazaa, A., Jackson, A., Johnson, M. R., van der Meer, P., Mbakwem, A., Bauersachs, J. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 20, pp. 951-962. (doi: 10.1002/ejhf.1178)

Bruegmann, T., Smith, G. L. (2018) Macrophages: new players in cardiac ageing? Cardiovascular Research, 114, pp. e47-e49. (doi: 10.1093/cvr/cvy047)

Montezano, A. C., De Lucca Camargo, L., Persson, P., Rios, F., Harvey, A., Anagnostopoulou, A., Palacios, R., Gandara, A. C. P., Alves‐Lopes, R., Neves, K., Dulak‐Lis, M., Holterman, C. E., de Oliveira, P. L., Graham, D., Kennedy, C., Touyz, R. (2018) NADPH Oxidase 5 is a pro‐contractile Nox isoform and a point of cross‐talk for calcium and redox signaling‐implications in vascular function. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.009388)

Perera, D., Clayton, T., Petrie, M. C., Greenwood, J. P., O'Kane, P. D., Evans, R., Sculpher, M., Mcdonagh, T., Gershlick, A., de Belder, M., Redwood, S., Carr-White, G., Marber, M. (2018) Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy. JACC: Heart Failure, 6, pp. 517-526. (doi: 10.1016/j.jchf.2018.01.024)

Sze, S., Pellicori, P., Kazmi, S., Rigby, A., Cleland, J. G.F., Wong, K., Clark, A. L. (2018) Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index. JACC: Heart Failure, 6, pp. 476-486. (doi: 10.1016/j.jchf.2018.02.018)

Corcoran, D., Ford, T. J., Hsu, L.-Y., Chiribiri, A., Orchard, V., Mangion, K., McEntegart, M., Rocchiccioli, P., Watkins, S., Good, R., Brooksbank, K., Padmanabhan, S., Sattar, N., McConnachie, A., Oldroyd, K. G., Touyz, R. M., Arai, A., Berry, C. (2018) Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study. Open Heart, 5, (doi: 10.1136/openhrt-2018-000924)

Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., Zile, M. R., Packer, M., Desai, A. S., Solomon, S. D., McMurray, J. J.V. (2018) Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC: Heart Failure, 6, pp. 489-498. (doi: 10.1016/j.jchf.2018.02.004)

Ambrosy, A. P., Mentz, R. J., Fiuzat, M., Cleland, J. G.F., Greene, S. J., O'Connor, C. M., Teerlink, J. R., Zannad, F., Solomon, S. D. (2018) The role of angiotensin receptor–neprilysin inhibitors in cardiovascular disease—existing evidence, knowledge gaps, and future directions. European Journal of Heart Failure, 20, pp. 963-972. (doi: 10.1002/ejhf.1159)

Bulluck, H., Dharmakumar, R., Arai, A. E., Berry, C., Hausenloy, D. J. (2018) Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation, 137, pp. 1949-1964. (doi: 10.1161/CIRCULATIONAHA.117.030693)

Rubio-Gracia, J., Demissei, B. G., ter Maaten, J. M., Cleland, J. G., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., Dittrich, H., Damman, K., Pérez-Calvo, J. I., Voors, A. A. (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. International Journal of Cardiology, 258, pp. 185-191. (doi: 10.1016/j.ijcard.2018.01.067)

Ferrari, R., Bueno, H., Chioncel, O., Cleland, J. G., Stough, W. G., Lettino, M., Metra, M., Parissis, J. T., Pinto, F., Ponikowski, P., Ruschitzka, F., Tavazzi, L. (2018) Acute heart failure: lessons learned, roads ahead. European Journal of Heart Failure, 20, pp. 842-850. (doi: 10.1002/ejhf.1169)

Salvi, D., Ottaviano, M., Muuraiskangas, S., Martınez-Romero, A., Vera-Munoz, C., Triantafyllidis, A., Cabrera Umpierrez, M. F., Arredondo Waldmeyer, M. T., Skobel, E., Knackstedt, C., Liedes, H., Honka, A., Luprano, J., Cleland, J. G.F., Stut, W., Deighan, C. (2018) An m-health system for education and motivation in cardiac rehabilitation: the experience of heartcycle guided exercise. Journal of Telemedicine and Telecare, 24, pp. 303-316. (doi: 10.1177/1357633X17697501)

Jackson, A. M., Dalzell, J. R., Walker, N. L., Coats, C. J., Jhund, P. S., Petrie, M. C. (2018) Peripartum cardiomyopathy: diagnosis and management. Heart, 104, pp. 779-786. (doi: 10.1136/heartjnl-2016-310599)

Beusekamp, J. C., Tromp, J., van der Wal, H. H., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Rossignol, P., Zannad, F., Voors, A. A., van der Meer, P. (2018) Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction. European Journal of Heart Failure, 20, pp. 923-930. (doi: 10.1002/ejhf.1079)

Metra, M., Cotter, G., Senger, S., Edwards, C., Cleland, J. G., Ponikowski, P., Cursack, G. C., Milo, O., Teerlink, J. R., Givertz, M. M., O’Connor, C. M., Dittrich, H. C., Bloomfield, D. M., Voors, A. A., Davison, B. A. (2018) Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004644)

Cosmi, F. et al. (2018) Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. European Journal of Heart Failure, 20, pp. 888-895. (doi: 10.1002/ejhf.1146)

Seferović, P. M. et al. (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 20, pp. 853-872. (doi: 10.1002/ejhf.1170)

Jhund, P. S. (2018) Analysing registries in heart failure: the case of angiotensin receptor blockers in Asians with heart failure with reduced ejection fraction. International Journal of Cardiology, 257, pp. 224-225. (doi: 10.1016/j.ijcard.2018.01.061)

Kelly, A., Salerno, S., Connolly, A., Bishop, M., Charpentier, F., Stølen, T., Smith, G. L. (2018) Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome. Cardiovascular Research, 114, pp. 724-736. (doi: 10.1093/cvr/cvx244)

Mangion, K., Gao, H., Husmeier, D., Luo, X., Berry, C. (2018) Advances in computational modelling for personalised medicine after myocardial infarction. Heart, 104, pp. 550-557. (doi: 10.1136/heartjnl-2017-311449)

Boyden, P. A., Smith, G. L. (2018) Ca2+ leak, what is it? Why should we care? Can it be managed? Heart Rhythm, 15, pp. 607-614. (doi: 10.1016/j.hrthm.2017.11.018)

Fröhlich, H., Henning, F., Täger, T., Schellberg, D., Grundtvig, M., Goode, K., Corletto, A., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Frankenstein, L., Clark, A. L. (2018) Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study. European Heart Journal: Cardiovascular Pharmacotherapy, 4, pp. 82-92. (doi: 10.1093/ehjcvp/pvx013)

Petrie, M. C., Rocchiccioli, P. (2018) Coronary angiography in heart failure: when and why? Uncertainty reigns. Heart, 104, pp. 548-549. (doi: 10.1136/heartjnl-2017-312200)

Ferreira, J. P., Rossignol, P., Demissei, B., Sharma, A., Girerd, N., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Voors, A., Zannad, F. (2018) Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart, 104, pp. 606-613. (doi: 10.1136/heartjnl-2017-311750)

Mogensen, U. M., Gong, J., Jhund, P. S., Shen, L., Køber, L., Desai, A. S., Lefkowitz, M. P., Packer, M., Rouleau, J. L., Solomon, S. D., Claggett, B. L., Swedberg, K., Zile, M. R., Mueller-Velten, G., McMurray, J. J.V. (2018) Effect of sacubitril/valsartan on recurrent events in the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF) European Journal of Heart Failure, 20, pp. 760-768. (doi: 10.1002/ejhf.1139)

Sokoreli, I., Pauws, S. C., Steyerberg, E. W., de Vries, G.-J., Riistama, J. M., Tesanovic, A., Kazmi, S., Pellicori, P., Cleland, J. G., Clark, A. L. (2018) Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study. European Journal of Heart Failure, 20, pp. 689-696. (doi: 10.1002/ejhf.1112)

Horsburgh, K. et al. (2018) Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology. Clinical Science, 132, pp. 851-868. (doi: 10.1042/CS20171620)

Linde, C., Cleland, J. G.F., Gold, M. R., Daubert, J. C., Tang, A. S.L., Young, J. B., Sherfesee, L., Abraham, W. T. (2018) The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis. European Journal of Heart Failure, 20, pp. 780-791. (doi: 10.1002/ejhf.1133)

Lee, M. M.Y. et al. (2018) Non-Invasive Versus Invasive Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: Comparisons Between the Randomized Controlled Pilot Trial and Registry. (doi: 10.1016/S0735-1097(18)30586-2)

Malmo, V., Kelly, A., Garten, K. S., Stolen, T., Rolim, N. P. L., Wisloff, U., Smith, G., Loennechen, J. P. (2018) Aerobic interval training prevents age-dependent vulnerability to atrial fibrillation in rodents. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.00206)

Gho, J. M.I.H., Schmidt, A. F., Pasea, L., Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Shah, A. D., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G., Hemingway, H., Asselbergs, F. W. (2018) An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors. BMJ Open, 8, (doi: 10.1136/bmjopen-2017-018331)

Mogensen, U. M., Køber, L., Jhund, P. S., Desai, A. S., Senni, M., Kristensen, S. L., Dukát, A., Chen, C.-H., Ramires, F., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Solomon, S. D., Swedberg, K., Packer, M., McMurray, J. J.V. (2018) Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF. European Journal of Heart Failure, 20, pp. 514-522. (doi: 10.1002/ejhf.1056)

Stewart, R. A.H., Szalewska, D., Stebbins, A., Al-Khalidi, H. R., Cleland, J. G.H., Rynkiewicz, A., Drazner, M. H., White, H. D., Mark, D. B., Roy, A., Kosevic, D., Rajda, M., Jasinski, M., Leng, C. Y., Tungsubutra, W., Desvigne-Nickens, P., Velazquez, E. J., Petrie, M. C. (2018) Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy. Open Heart, 5, (doi: 10.1136/openhrt-2017-000752)

Petrie, M. C., Connelly, D. T., Gardner, R. S. (2018) Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISH. European Journal of Heart Failure, 20, pp. 413-416. (doi: 10.1002/ejhf.1135)

Velazquez, E. J., Petrie, M. C. (2018) CABG or PCI for diabetic patients with left ventricular dysfunction: closing in on the truth? Journal of the American College of Cardiology, 71, pp. 828-831. (doi: 10.1016/j.jacc.2018.01.014)

ter Maaten, J. M., Voors, A. A., Damman, K., van der Meer, P., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., Metra, M., Navis, G., Ng, L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., de Borst, M. H. (2018) Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. International Journal of Cardiology, 253, pp. 84-90. (doi: 10.1016/j.ijcard.2017.10.010)

Conrad, N., Judge, A., Tran, J., Mohseni, H., Hedgecott, D., Crespillo, A. P., Allison, M., Hemingway, H., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet, 391, pp. 10-16. (doi: 10.1016/S0140-6736(17)32520-5)

Sala, L. et al. (2018) MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circulation Research, 122, pp. e5-e16. (doi: 10.1161/CIRCRESAHA.117.312067)

Corcoran, D., Young, R., Cialdella, P., McCartney, P., Bajrangee, A., Hennigan, B., Collison, D., Carrick, D., Shaukat, A., Good, R., Watkins, S., McEntegart, M., Watt, J., Welsh, P., Sattar, N., McConnachie, A., Oldroyd, K.G., Berry, C. (2018) The effects of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease. International Journal of Cardiology, 252, pp. 24-30. (doi: 10.1016/j.ijcard.2017.10.082)

Norman, R., Fuller, W., Calaghan, S. (2018) Caveolae and the cardiac myocyte. Current Opinion in Physiology, 1, pp. 59-67. (doi: 10.1016/j.cophys.2017.08.005)

Adamson, P. D., Hunter, A., Williams, M. C., Shah, A. S.V., McAllister, D. A., Pawade, T. A., Dweck, M. R., Mills, N. L., Berry, C., Boon, N. A., Clark, E., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D. E. (2018) Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial. Heart, 104, pp. 207-214. (doi: 10.1136/heartjnl-2017-311508)

Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Numé, A.-k., Gislason, G. H.,, Jhund, P. S., Petrie, M. C., McMurray, J. J.V., Torp-Pedersen, C., Køber, L., Kristensen, S. L. (2018) Employment status at time of first hospitalization for heart failure is associated with death and rehospitalization for heart failure. European Journal of Heart Failure, 20, pp. 240-247. (doi: 10.1002/ejhf.1046)

Adamson, P. D., Hunter, A., Madsen, D. M., Shah, A. S.V., McAllister, D. A., Pawade, T. A., Williams, M. C., Berry, C., Boon, N. A., Flather, M., Forbes, J., McLean, S., Roditi, G., Timmis, A. D., van Beek, E. J.R., Dweck, M. R., Mickley, H., Mills, N. L., Newby, D. E. (2018) High-sensitivity cardiac troponin I and the diagnosis of coronary artery disease in patients with suspected angina pectoris. Circulation: Cardiovascular Quality and Outcomes, 11, (doi: 10.1161/CIRCOUTCOMES.117.004227)

Cleland, J. G.F. (2018) Physicians Addicted to Prescribing Aspirin-a Disorder Of Cardiologists (PAPA-DOC) Syndrome: the headache of nonevidence-based medicine for ischemic heart disease? JACC: Heart Failure, 6, pp. 168-171. (doi: 10.1016/j.jchf.2017.11.014)

Platz, E., Jhund, P. S., Claggett, B. L., Pfeffer, M. A., Swedberg, K., Granger, C. B., Yusuf, S., Solomon, S. D., McMurray, J. J. (2018) Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. European Journal of Heart Failure, 20, pp. 295-303. (doi: 10.1002/ejhf.901)

Nikolaidou, T., Pellicori, P., Zhang, J., Kazmi, S., Goode, K. M., Cleland, J. G., Clark, A. L. (2018) Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure. Clinical Research in Cardiology, 107, pp. 108-119. (doi: 10.1007/s00392-017-1162-6)

Emmens, J. E., Jones, D. J.L., Cao, T. H., Chan, D. C.S., Romaine, S. P.R., Quinn, P. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., de Boer, R. A., Voors, A. A., Ng, L. L. (2018) Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. European Journal of Heart Failure, 20, pp. 260-267. (doi: 10.1002/ejhf.1101)

Ford, T. J., Corcoran, D., Berry, C. (2018) Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart, 104, pp. 284-292. (doi: 10.1136/heartjnl-2017-311446)

Cotter, G., Metra, M., Davison, B. A., Jondeau, G., Cleland, J. G.F., Bourge, R. C., Milo, O., O'Connor, C. M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Kobrin, I., Rainisio, M., Senger, S., Edwards, C., McMurray, J. J.V., Teerlink, J. R. (2018) Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? European Journal of Heart Failure, 20, pp. 317-322. (doi: 10.1002/ejhf.889)

Ouwerkerk, W., Zwinderman, A. H., Ng, L. L., Demissei, B., Hillege, H. L., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., ter Maaten, J. M., Lang, C. C., van der Harst, P., Filippatos, G., Dickstein, K., Cleland, J. G., Anker, S. D., Voors, A. A. (2018) Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF. Journal of the American College of Cardiology, 71, pp. 386-398. (doi: 10.1016/j.jacc.2017.11.041)

Feldman, T., Mauri, L., Kahwash, R., Litwin, S., Ricciardi, M. J., van der Harst, P., Penicka, M., Fail, P. S., Kaye, D. M., Petrie, M. C., Basuray, A., Hummel, S. L., Forde-McLean, R., Nielsen, C. D., Lilly, S., Massaro, J. M., Burkhoff, D., Shah, S. J. (2018) Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A phase 2, randomized, sham-controlled trial. Circulation, 137, pp. 364-375. (doi: 10.1161/CIRCULATIONAHA.117.032094)

Cleland, J. G.F., Flather, M. D., Altman, D. G., Kotecha, D. (2018) Reply: an incomplete story. Journal of the American College of Cardiology, 71, pp. 105. (doi: 10.1016/j.jacc.2017.10.078)

McCarroll, C. S. et al. (2018) Runx1 deficiency protects against adverse cardiac remodeling after myocardial infarction. Circulation, 137, pp. 57-70. (doi: 10.1161/CIRCULATIONAHA.117.028911)

Cleland, J. G.F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J.S., Manzano, L., McMurray, J. J.V., Ruschitzka, F., van Veldhuisen, D. J., von Lueder, T. G., Böhm, M., Andersson, B., Kjekshus, J., Packer, M., Rigby, A. S., Rosano, G., Wedel, H., Hjalmarson, Å., Wikstrand, J., Kotecha, D. (2018) Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. European Heart Journal, 39, pp. 26-35. (doi: 10.1093/eurheartj/ehx564)

Kristensen, S. L., Mogensen, U. M., Tarnesby, G., Gimpelewicz, C. R., Ali, M. A., Shao, Q., Chiang, Y., Jhund, P. S., Abraham, W. T., Dickstein, K., McMurray, J. J.V., Køber, L. (2018) Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. European Journal of Heart Failure, 20, pp. 136-147. (doi: 10.1002/ejhf.896)

Pellicori, P., Urbinati, A., Zhang, J., Joseph, A. C., Costanzo, P., Lukaschuk, E., Capucci, A., Cleland, J. G.F., Clark, A. L. (2018) Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study. Clinical Cardiology, 41, pp. 20-27. (doi: 10.1002/clc.22840)

Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Jhund, P. S., Petrie, M. C., Schou, M., Gislason, G. H., McMurray, J. J.V., Torp-Pedersen, C., Køber, L., Kristensen, S. L. (2018) Evidence based therapy and its association with workforce detachment following first hospitalization for heart failure. JACC: Heart Failure, 6, pp. 41-48. (doi: 10.1016/j.jchf.2017.09.019)

Beggs, S. A.S., Jhund, P. S., Jackson, C. E., McMurray, J. J.V., Gardner, R. S. (2018) Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis. Heart, 104, pp. 144-150. (doi: 10.1136/heartjnl-2016-310850)

Maznyczka, A. M., McCartney, P., Berry, C. (2018) Reference invasive tests of microvascular injury in myocardial infarction. BMJ Open, 104, pp. 90-92. (doi: 10.1136/heartjnl-2017-311695)

Lee, M. M.Y. et al. (2018) Routine Non-invasive vs Invasive Management in Patients With Prior CABG With a NSTE-ACS: a Randomised Controlled Trial. (doi: 10.1136/heartjnl-2018-BCIS.9)

Souteyrand, G., Valladier, M., Amabile, N., Derimay, F., Harbaoui, B., Leddet, P., Barnay, P., Malcles, G., Mulliez, A., Berry, C., Eschalier, R., Combaret, N., Motreff, P. (2018) Diagnosis and management of spontaneously recanalized coronary thrombus guided by optical coherence tomography ― lessons from the French “Lotus Root” registry ― Circulation Journal, 82, pp. 783-790. (doi: 10.1253/circj.cj-17-0810)

Howie, J., Wypijewski, K. J., Plain, F., Tulloch, L. B., Fraser, N. J., Fuller, W. (2018) Greasing the wheels or a spanner in the works? Regulation of the cardiac sodium pump by palmitoylation. Critical Reviews in Biochemistry and Molecular Biology, 53, pp. 175-191. (doi: 10.1080/10409238.2018.1432560)

Lachaud, Q., MacQuaide, N., Burton, F., Smith, G. (2018) High-throughput study of rabbit ventricle action potential populations in MI model. Biophysical Journal, 114, pp. 625A. (doi: 10.1016/j.bpj.2017.11.3377)

Berry, C., Carberry, J., Mangion, K. (2018) How to mend a broken heart? JACC: Cardiovascular Imaging, 11, pp. 420-422. (doi: 10.1016/j.jcmg.2017.02.017)

McAllister, D. A., Read, S., Kerssens, J., Livingstone, S., McGurnaghan, S., Jhund, P., Petrie, J., Sattar, N., Fischbacher, C., Kristensen, S. L., McMurray, J., Colhoun, H. M., Wild, S. (2018) Incidence of hospitalisation for heart failure and case-fatality among 3.25 million people with and without diabetes. Circulation, 138, pp. 2774-2785. (doi: 10.1161/CIRCULATIONAHA.118.034986)

Rørth, R., Fosbøl, E. L., Kragholm, K., Mogensen, U. M., Jhund, P. S., Petrie, M. C., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2018) Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure: a nationwide cohort study. Clinical Epidemiology, 10, pp. 917-930. (doi: 10.2147/CLEP.S164795)

Layland, J., Tong, D., Lee, M., Berry, C. (2018) ST and T-Wave Abnormality as Footprint of Myocardial Oedema in Non–ST-Elevation Myocardial Infarction. (doi: 10.1016/j.hlc.2018.06.515)

Bouabdallaoui, N. et al. (2018) Society of Thoracic Surgeons risk score and EuroSCORE-2 appropriately assess 30-day postoperative mortality in the STICH trial and a contemporary cohort of patients with left ventricular dysfunction undergoing surgical revascularization. Circulation: Heart Failure, 11, (doi: 10.1161/circheartfailure.118.005531)

Delles, C., Carrick, E., Graham, D., Nicklin, S. A. (2018) Utilising proteomics to understand and define hypertension: where are we and where do we go? Expert Review of Proteomics, 15, pp. 581-592. (doi: 10.1080/14789450.2018.1493927)

Avtaar Singh, S. S., Das De, S., Spadaccio, C., Berry, C., Al-Attar, N. (2017) An overview of different methods of myocardial protection currently employed peri-transplantation. Vessel Plus, 1, pp. 213-229. (doi: 10.20517/2574-1209.2017.26)

Van't Veer, M., Pijls, N. H.J., Hennigan, B., Watkins, S., Ali, Z. A., De Bruyne, B., Zimmermann, F. M., van Nunen, L. X., Barbato, E., Berry, C., Oldroyd, K. G. (2017) Comparison of different diastolic resting indexes to iFR: are they all equal? Journal of the American College of Cardiology, 70, pp. 3088-3096. (doi: 10.1016/j.jacc.2017.10.066)

Ford, T. J., Berry, C., De Bruyne, B., Yong, A. C.S., Barlis, P., Fearon, W. F., Ng, M. K.C. (2017) Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient. JACC: Cardiovascular Interventions, 10, pp. 2539-2547. (doi: 10.1016/j.jcin.2017.08.059)

Logie, L., Van Aalten, L., Knebel, A., Force, T., Hastie, C. J., MacLauchlan, H., Campbell, D. G., Gourlay, R., Prescott, A., Davidson, J., Fuller, W., Sutherland, C. (2017) Rab-GTPase binding effector protein 2 (RABEP2) is a primed substrate for Glycogen Synthase kinase-3 (GSK3) Scientific Reports, 7, (doi: 10.1038/s41598-017-17087-6)

Berry, C., McClure, J. D., Oldroyd, K. G. (2017) Meta-analysis of death and myocardial infarction in the DEFINE-FLAIR and iFR-SWEDEHEART trials: a hypothesis generating note of caution. Circulation, 136, pp. 2389-2391. (doi: 10.1161/CIRCULATIONAHA.117.030430)

Lei, C. L., Wang, K., Clerx, M., Johnstone, R. H., Hortigon-Vinagre, M. P., Zamora, V., Allan, A., Smith, G. L., Gavaghan, D. J., Mirams, G. R., Polonchuk, L. (2017) Tailoring mathematical models to stem-cell derived cardiomyocyte lines can improve predictions of drug-induced changes to their electrophysiology. Frontiers in Physiology, 8, (doi: 10.3389/fphys.2017.00986)

Duncan, G., Firth, K., George, V., Hoang, M. D., Staniforth, A., Smith, G., Denning, C. (2017) Drug-mediated shortening of action potentials in LQTS2 human induced pluripotent stem cell-derived cardiomyocytes. Stem Cells and Development, 26, pp. 1695-1705. (doi: 10.1089/scd.2017.0172)

Kaye, D. M., Silvestry, F. E., Gustafsson, F., Cleland, J. G., van Veldhuisen, D. J., Ponikowski, P., Komtebedde, J., Nanayakkara, S., Burkhoff, D., Shah, S. J. (2017) Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction. European Journal of Heart Failure, 19, pp. 1690-1697. (doi: 10.1002/ejhf.930)

Hilfiker-Kleiner, D., Haghikia, A., Masuko, D., Nonhoff, J., Held, D., Libhaber, E., Petrie, M. C., Walker, N. L., Podewski, E., Berliner, D., Bauersachs, J., Sliwa, K. (2017) Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. European Journal of Heart Failure, 19, pp. 1723-1728. (doi: 10.1002/ejhf.808)

Carberry, J., Carrick, D., Haig, C., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2017) Persistence of infarct zone T2 hyperintensity at 6 months after acute ST-elevation myocardial infarction: incidence, pathophysiology and prognostic implications. Circulation: Cardiovascular Imaging, 10, (doi: 10.1161/CIRCIMAGING.117.006586)

Kristensen, S. L., Jhund, P. S., Lee, M. M.Y., Køber, L., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., McMurray, J. J.V. (2017) Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes. Cardiovascular Drugs and Therapy, 31, pp. 545-549. (doi: 10.1007/s10557-017-6754-x)

Shah, P., Pellicori, P., Macnamara, A., Urbinati, A., Clark, A. L. (2017) Is swimming safe in heart failure? A systematic review. Cardiology in Review, 25, pp. 321-325. (doi: 10.1097/CRD.0000000000000154)

Shen, L., Ramires, F., Martinez, F., Bodanese, L. C., Echeverría, L. E., Gómez, E. a., Abraham, W. t., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Jhund, P. S., Gimpelewicz, C. R., McMurray, J. J.V. (2017) Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004361)

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., McMurray, J. J., Rydén, L., Schröder, S., Sun, Y., Theodorakis, M. J., Tendera, M., Tucker, L., Tuomilehto, J., Wei, Y., Yang, W., Wang, D., Hu, D., Pan, C., ACE Study Group, (2017) Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes and Endocrinology, 5, pp. 877-886. (doi: 10.1016/S2213-8587(17)30309-1)

Wong, C. M., Hawkins, N. M., Ezekowitz, J. A., Jhund, P. S., Savu, A., MacDonald, M. R., Kristensen, S. L., Petrie, M. C., McMurray, J. J.V., McAlister, F. A., Kaul, P. (2017) Heart failure in young adults is associated with high mortality: a contemporary population-level analysis. Canadian Journal of Cardiology, 33, pp. 1472-1477. (doi: 10.1016/j.cjca.2017.05.009)

MacDonald, E. A., Stoyek, M. R., Rose, R. A., Quinn, T. A. (2017) Intrinsic regulation of sinoatrial node function and the zebrafish as a model of stretch effects on pacemaking. Progress in Biophysics and Molecular Biology, 130, pp. 198-211. (doi: 10.1016/j.pbiomolbio.2017.07.012)

Mogensen, U. M., Jhund, P. S., Abraham, W. T., Desai, A. S., Dickstein, K., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Køber, L., McMurray, J. J.V. (2017) Type of atrial fibrillation and clinical outcomes in patients with heart failure and reduced ejection fraction. Journal of the American College of Cardiology, 70, pp. 2490-2500. (doi: 10.1016/j.jacc.2017.09.027)

Rutherford, E., Mangion, K., Mccomb, C., Bell, E., Cockburn, S., Talle, M., Roditi, G., Welsh, P., Woodward, R., Radjenovic, A., Struthers, A. D., Jardine, A., Berry, C., Patel, R. K., Mark, P. B. (2017) Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study. Scientific Reports, 7, (doi: 10.1038/s41598-017-14481-y)

Kobayashi, Y., Johnson, N. P., Zimmermann, F. M., Witt, N., Berry, C., Jeremias, A., Koo, B.-K., Esposito, G., Rioufol, G., Park, S.-J., Nishi, T., Choi, D.-H., Oldroyd, K. G., Barbato, E., Pijls, N. H. J., De Bruyne, B., Fearon, W. F. (2017) Agreement of the resting distal to aortic coronary pressure with the instantaneous wave-free ratio. Journal of the American College of Cardiology, 70, pp. 2105-2113. (doi: 10.1016/j.jacc.2017.08.049)

Bayes-Genis, A., Núñez, J., Zannad, F., Ferreira, J. P., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Metra, M., Lupón, J., Voors, A. A. (2017) The PCSK9-LDL receptor axis and outcomes in heart failure: BIOSTAT-CHF subanalysis. Journal of the American College of Cardiology, 70, pp. 2128-2136. (doi: 10.1016/j.jacc.2017.08.057)

Gao, H., Mangion, K., Carrick, D., Husmeier, D., Luo, X., Berry, C. (2017) Estimating prognosis in patients with acute myocardial infarction using personalized computational heart models. Scientific Reports, 7, (doi: 10.1038/s41598-017-13635-2)

Sharma, A., Demissei, B. G., Tromp, J., Hillege, H. L., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Davison, B. A., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van Veldhuisen, D. J., Cotter, G., Ezekowitz, J. A., Khan, M. A.F., Voors, A. A. (2017) A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. European Journal of Heart Failure, 19, pp. 1310-1320. (doi: 10.1002/ejhf.912)

Petrushanko, I. Y., Mitkevich, V. A., Lakunina, V. A., Anashkina, A. A., Spirin, P. V., Rubtsov, P. M., Prassolov, V. S., Bogdanov, N. B., Hänggi, P., Fuller, W., Makarov, A. A., Bogdanova, A. (2017) Cysteine residues 244 and 458–459 within the catalytic subunit of Na,K-ATPase control the enzyme's hydrolytic and signaling function under hypoxic conditions. Redox Biology, 13, pp. 310-319. (doi: 10.1016/j.redox.2017.05.021)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B., Kettlewell, S., Smith, G. L., Clancy, M. J., Delles, C., Jardine, A. G. (2017) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, 32, pp. 1617-1627. (doi: 10.1093/ndt/gfw252)

Nishi, T., Johnson, N. P., De Bruyne, B., Berry, C., Gould, K. L., Jeremias, A., Oldroyd, K. G., Kobayashi, Y., Choi, D.-H., Pijls, N. H.J., Fearon, W. F. (2017) Influence of contrast media dose and osmolality on the diagnostic performance of contrast fractional flow reserve. Circulation: Cardiovascular Interventions, 10, (doi: 10.1161/CIRCINTERVENTIONS.117.004985)

Ferreira, J. P., Rossignol, P., Machu, J.-L., Sharma, A., Girerd, N., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ter Maaten, J., Metra, M., Ng, L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Voors, A., Zannad, F. (2017) Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. European Journal of Heart Failure, 19, pp. 1284-1293. (doi: 10.1002/ejhf.900)

Gao, H., Qi, N., Feng, L., Ma, X., Danton, M., Berry, C., Luo, X. (2017) Modelling mitral valvular dynamics–current trend and future directions. International Journal for Numerical Methods in Biomedical Engineering, 33, (doi: 10.1002/cnm.2858)

Nassif, M. E., Tang, Y., Cleland, J. G.F., Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Daubert, J. C., Sherfesee, L., Schaber, D., Tang, A. S.L., Jones, P. G., Arnold, S. V., Spertus, J. A. (2017) Precision medicine for cardiac resynchronization: predicting quality of life benefits for individual patients-an analysis from 5 clinical trials. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004111)

Kristensen, S. L., Jhund, P. S., Mogensen, U. M., Rørth, R., Abraham, W. T., Desai, A., Dickstein, K., Rouleau, J. L., Zile, M. R., Swedberg, K., Packer, M., Solomon, S. D., Køber, L., McMurray, J. J.V. (2017) Prognostic value of N-terminal pro-B-type natriuretic peptide levels in heart failure patients with and without atrial fibrillation. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004409)

Cleland, J. G.F., Halliday, B. P., Prasad, S. K. (2017) Selecting patients with nonischemic dilated cardiomyopathy for ICDs. Journal of the American College of Cardiology, 70, pp. 1228-1231. (doi: 10.1016/j.jacc.2017.07.748)

Gao, H., Feng, L., Qi, N., Berry, C., Griffith, B. E., Luo, X. (2017) A coupled mitral valve - left ventricle model with fluid-structure interaction. Medical Engineering and Physics, 47, pp. 128-136. (doi: 10.1016/j.medengphy.2017.06.042)

Lu, H.R., Hortigon-Vinagre, M.P., Zamora, V., Kopljar, I., De Bondt, A., Gallacher, D.J., Smith, G. (2017) Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias. Journal of Pharmacological and Toxicological Methods, 87, pp. 53-67. (doi: 10.1016/j.vascn.2017.05.001)

Fröhlich, H., Torres, L., Täger, T., Schellberg, D., Corletto, A., Kazmi, S., Goode, K., Grundtvig, M., Hole, T., Katus, H. A., Cleland, J. G.F., Atar, D., Clark, A. L., Agewall, S., Frankenstein, L. (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clinical Research in Cardiology, 106, pp. 711-721. (doi: 10.1007/s00392-017-1115-0)

Sliwa, K., Mebazaa, A., Hilfiker-Kleiner, D., Petrie, M. C., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., van der Meer, P., Roos-Hesselink, J. W., Seferovic, P., van Spandonck-Zwarts, K., Mbakwem, A., Böhm, M., Mouquet, F., Pieske, B., Hall, R., Ponikowski, P., Bauersachs, J. (2017) Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) European Journal of Heart Failure, 19, pp. 1131-1141. (doi: 10.1002/ejhf.780)

Saxena, P., Hortigon-Vinagre, M.P., Beyl, S., Baburin, I., Andranovits, S., Iqbal, S.M., Costa, A., IJzerman, A.P., Kügler, P., Timin, E., Smith, G.L., Hering, S. (2017) Correlation between human ether-a-go-go-related gene channel inhibition and action potential prolongation. British Journal of Pharmacology, 174, pp. 3081-3093. (doi: 10.1111/bph.13942)

Cleland, J. G.F. (2017) Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! European Journal of Heart Failure, 19, pp. 1086-1088. (doi: 10.1002/ejhf.697)

Platz, E., Merz, A. A., Jhund, P. S., Vazir, A., Campbell, R., McMurray, J. J. (2017) Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review. European Journal of Heart Failure, 19, pp. 1154-1163. (doi: 10.1002/ejhf.839)

Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Gho, J. M.I.H., Shah, A. D., Yu, N., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G.F., Asselbergs, F. W., Hemingway, H. (2017) Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. European Journal of Heart Failure, 19, pp. 1119-1127. (doi: 10.1002/ejhf.709)

Berry, C. (2017) Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease. Circulation, 136, pp. 437-439. (doi: 10.1161/CIRCULATIONAHA.117.028991)

Shen, L., Jhund, P. S., Mogensen, U. M., Køber, L., Claggett, B., Rogers, J. K., McMurray, J. J.V. (2017) A re-examination of the BEST Trial using composite outcomes, including emergency department visits. JACC: Heart Failure, 5, pp. 591-599. (doi: 10.1016/j.jchf.2017.04.005)

Newby, D. et al. (2017) Aortic wall inflammation predicts abdominal aortic aneurysm expansion, rupture, and need for surgical repair. Circulation, 136, pp. 787-797. (doi: 10.1161/CIRCULATIONAHA.117.028433)

Gimpelewicz, C., Metra, M., Cleland, J. G.F., Szecsödy, P., Chang Wun, C.-C., Boer-Martins, L., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Pang, P., Ponikowski, P., Severin, T., Voors, A. A., Teerlink, J. R. (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. American Heart Journal, 190, pp. 113-122. (doi: 10.1016/j.ahj.2017.05.012)

Mangion, K., McComb, C., Auger, D. A., Epstein, F. H., Berry, C. (2017) Magnetic resonance imaging of myocardial strain after acute ST-segment-elevation myocardial infarction: a systematic review. Circulation: Cardiovascular Imaging, 10, (doi: 10.1161/CIRCIMAGING.117.006498)

Linde, C., Abraham, W. T., Gold, M. R., Daubert, C., Tang, A. S.L., Young, J. B., Sherfesee, L., Hudnall, H., Fagan, D. H., Cleland, J. G. (2017) Predictors of short-term clinical response to cardiac resynchronization therapy. European Journal of Heart Failure, 19, pp. 1056-1063. (doi: 10.1002/ejhf.795)

Cleland, J. G.F. (2017) What do cardiology and homeopathy have in common? : A belief in aspirin? JACC: Heart Failure, 5, pp. 611-614. (doi: 10.1016/j.jchf.2017.06.009)

Halliday, B. P., Cleland, J. G.F., Goldberger, J. J., Prasad, S. K. (2017) Personalizing sudden death risk stratification in dilated cardiomyopathy: past, present and future. Circulation, 136, pp. 215-231. (doi: 10.1161/CIRCULATIONAHA.116.027134)

Damman, K., Valente, M. A.E., van Veldhuisen, D. J., Cleland, J. G.F., O’Connor, C. M., Metra, M., Ponikowski, P., Cotter, G., Davison, B., Givertz, M. M., Bloomfield, D. M., Hillege, H. L., Voors, A. A. (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. International Journal of Molecular Sciences, 18, (doi: 10.3390/ijms18071470)

Shen, L., Jhund, P. S., Petrie, M. C., Claggett, B. L., Barlera, S., Cleland, J. G.F., Dargie, H. J., Granger, C. B., Kjekshus, J., Køber, L., Latini, R., Maggioni, A. P., Packer, M., Pitt, B., Solomon, S. D., Swedberg, K., Tavazzi, L., Wikstrand, J., Zannad, F., Zile, M. R., McMurray, J. J.V. (2017) Declining risk of sudden death in heart failure. New England Journal of Medicine, 377, pp. 41-51. (doi: 10.1056/NEJMoa1609758)

Ford, T. J., Corcoran, D., Berry, C. (2017) Coronary artery disease: physiology and prognosis. European Heart Journal, 38, pp. 1990-1992. (doi: 10.1093/eurheartj/ehx226)

Lamore, S. D., Ahlberg, E., Boyer, S., Lamb, M. L., Hortigon-Vinagre, M. P., Rodriguez, V., Smith, G. L., Sagemark, J., Carlsson, L., Bates, S. M., Choy, A. L., Stålring, J., Scott, C. W., Peters, M. F. (2017) Deconvoluting kinase inhibitor induced cardiotoxicity. Toxicological Sciences, 158, pp. 213-226. (doi: 10.1093/toxsci/kfx082)

Fröhlich, H., Raman, N., Täger, T., Schellberg, D., Goode, K. M., Kazmi, S., Grundtvig, M., Hole, T., Cleland, J. G.F., Katus, H. A., Agewall, S., Clark, A. L., Atar, D., Frankenstein, L. (2017) Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. International Journal of Cardiology, 238, pp. 97-104. (doi: 10.1016/j.ijcard.2017.03.028)

Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2017) Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC: Heart Failure, 5, pp. 507-517. (doi: 10.1016/j.jchf.2017.04.007)

Gao, H., Aderhold, A., Mangion, K., Luo, X., Husmeier, D., Berry, C. (2017) Changes and classification in myocardial contractile function in the left ventricle following acute myocardial infarction. Journal of the Royal Society: Interface, 14, (doi: 10.1098/rsif.2017.0203)

Corcoran, D., Hennigan, B., Berry, C. (2017) Fractional flow reserve: a clinical perspective. International Journal of Cardiovascular Imaging, 33, pp. 961-974. (doi: 10.1007/s10554-017-1159-2)

Pellicori, P., Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D., Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19, pp. 883-892. (doi: 10.1002/ejhf.825)

Sze, S., Zhang, J., Pellicori, P., Morgan, D., Hoye, A., Clark, A.L. (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clinical Research in Cardiology, 106, pp. 533-541. (doi: 10.1007/s00392-017-1082-5)

Williams, M. C., Hunter, A., Shah, A., Assi, V., Lewis, S., Mangion, K., Berry, C., Boon, N. A., Clark, E., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D. E. (2017) Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial. Heart, 103, pp. 995-1001. (doi: 10.1136/heartjnl-2016-310129)

Wang, D., Mohammad, M., Wang, Y., Tan, R., Murray, L. S., Ricardo, S., Dagher, H., van Agtmael, T., Savige, J. (2017) The chemical chaperone, PBA, reduces ER stress and autophagy and increases collagen IV α5 expression in cultured fibroblasts from men with X-linked Alport syndrome and missense mutations. Kidney International Reports, 2, pp. 739-748. (doi: 10.1016/j.ekir.2017.03.004)

Cleland, J. G.F., Pellicori, P., Clark, A. L., Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5, pp. 538-540. (doi: 10.1016/j.jchf.2017.04.003)

Hennigan, B., Johnson, N., McClure, J., Corcoran, D., Watkins, S., Berry, C., Oldroyd, K. G. (2017) Validation of the "smart" minimum FFR Algorithm in an unselected all comer population of patients with intermediate coronary stenoses. International Journal of Cardiovascular Imaging, 33, pp. 991-997. (doi: 10.1007/s10554-017-1126-y)

Plain, F., Congreve, S. D., Yee, R. S. Z., Kennedy, J., Howie, J., Kuo, C.-W., Fraser, N. J., Fuller, W. (2017) An amphipathic α-helix directs palmitoylation of the large intracellular loop of the sodium/calcium exchanger. Journal of Biological Chemistry, 292, pp. 10745-10752. (doi: 10.1074/jbc.M116.773945)

Ouwerkerk, W., Voors, A.A., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H.L., Lang, C.C., ter Maaten, J.M., Ng, L.L., Ponikowski, P., Samani, N.J., van Veldhuisen, D.J., Zannad, F., Metra, M., Zwinderman, A.H. (2017) Determinants and clinical outcome of uptitration of ACE-inhibitor and beta-blocker in patients with heart failure: a prospective European study. European Heart Journal, 38, pp. 1883-1890. (doi: 10.1093/eurheartj/ehx026)

Jhund, P. S. (2017) Obesity and heart failure: when 'epidemics' collide. European Heart Journal, 38, pp. 1934-1936. (doi: 10.1093/eurheartj/ehw357)

Kotecha, D., Flather, M. D., Altman, D. G., Holmes, J., Rosano, G., Wikstrand, J., Packer, M., Coats, A. J.S., Manzano, L., Böhm, M., van Veldhuisen, D. J., Andersson, B., Wedel, H., von Lueder, T. G., Rigby, A. S., Hjalmarson, Å., Kjekshus, J., Cleland, J. G.F. (2017) Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis. Journal of the American College of Cardiology, 69, pp. 2885-2896. (doi: 10.1016/j.jacc.2017.04.001)

Harvey, A. P., Montezano, A. C., Hood, K. Y., Lopes, R. A., Rios, F., Ceravolo, G., Graham, D., Touyz, R. M. (2017) Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: the aldosterone-mineralocorticoid receptor-Nox1 Axis. Life Sciences, 179, pp. 110-119. (doi: 10.1016/j.lfs.2017.05.002)

Aetesam-ur-Rahman, M., Berry, C. (2017) Cardiovascular Diagnosis and Therapy (CDT) editorial: the Minimalist Immediate Mechanical Intervention study. Cardiovascular Diagnosis and Therapy, 7, pp. S73-S76. (doi: 10.21037/cdt.2017.01.13)

Lopez-Gordo, E., Doszpoly, A., Duffy, M. R., Coughlan, L., Bradshaw, A. C., White, K. M., Denby, L., Nicklin, S. A., Baker, A. H. (2017) Defining a novel role for the coxsackie and adenovirus receptor in human adenovirus serotype 5 transduction in vitro in the presence of mouse serum. Journal of Virology, 91, (doi: 10.1128/JVI.02487-16)

Ritchie, J., Green, D., Chrysochou, T., Hegarty, J., Handley, K., Ives, N., Wheatley, K., Houston, G., Wright, J., Neyses, L., Chalmers, N., Mark, P., Patel, R., Moss, J., Roditi, G., Eadington, D., Lukaschuk, E., Cleland, J., Kalra, P. A. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32, pp. 1006-1013. (doi: 10.1093/ndt/gfw107)

Liu, L. C.Y., Valente, M. A.E., Postmus, D., O’Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., van der Meer, P., Voors, A. A. (2017) Identifying subpopulations with distinct response to treatment using plasma biomarkers in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, 31, pp. 281-293. (doi: 10.1007/s10557-017-6726-1)

Cleland, J. G.F., Teerlink, J. R., Davison, B. A., Shoaib, A., Metra, M., Senger, S., Milo, O., Cotter, G., Bourge, R. C., Parker, J. D., Jondeau, G., Krum, H., O'Connor, C. M., Torre-Amione, G., van Veldhuisen, D. J., McMurray, J. J.V. (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS) European Journal of Heart Failure, 19, pp. 739-747. (doi: 10.1002/ejhf.786)

McCoy, J., Bates, M., Eggett, C., Siervo, M., Cassidy, S., Newman, J., Moore, S. A., Gorman, G., Trenell, M. I., Velicki, L., Seferovic, P. M., Cleland, J. G.F., MacGowan, G. A., Turnbull, D. M., Jakovljevic, D. G. (2017) Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients. Open Heart, 4, (doi: 10.1136/openhrt-2017-000632)

Shah, P., Pellicori, P., Cuthbert, J., Clark, A. L. (2017) Pharmacological and non-pharmacological treatment for decompensated heart failure: what is new? Current Heart Failure Reports, 14, pp. 147-157. (doi: 10.1007/s11897-017-0328-x)

Demissei, B. G., Postmus, D., Cleland, J. G.F., O’Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Dittrich, H., Hillege, H. L., Voors, A. A. (2017) Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission. European Journal of Heart Failure, 19, pp. 728-738. (doi: 10.1002/ejhf.766)

Mogensen, U. M., Køber, L., Kristensen, S. L., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2017) The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF. American Heart Journal, 188, pp. 35-41. (doi: 10.1016/j.ahj.2017.02.034)

Pellicori, P., Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F., Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, 19, pp. 768-778. (doi: 10.1002/ejhf.788)

Halliday, B. P. et al. (2017) Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, 135, pp. 2106-2115. (doi: 10.1161/CIRCULATIONAHA.116.026910)

Sattar, N., Petrie, M. C., Zinman, B., Januzzi Jr., J. L. (2017) Novel diabetes drugs and the cardiovascular specialist. Journal of the American College of Cardiology, 69, pp. 2646-2656. (doi: 10.1016/j.jacc.2017.04.014)

Packer, M., O'Connor, C., McMurray, J. J.V., Wittes, J., Abraham, W. T., Anker, S. D., Dickstein, K., Filippatos, G., Holcomb, R., Krum, H., Maggioni, A. P., Mebazaa, A., Peacock, W. F., Petrie, M. C., Ponikowski, P., Ruschitzka, F., van Veldhuisen, D. J., Kowarski, L. S., Schactman, M., Holzmeister, J. (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. New England Journal of Medicine, 376, pp. 1956-1964. (doi: 10.1056/NEJMoa1601895)

Voors, A. A., Ouwerkerk, W., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Ng, L. L., Metra, M., ter Maaten, J. M., Lang, C. C., Hillege, H. L., van der Harst, P., Filippatos, G., Dickstein, K., Cleland, J. G.F., Anker, S. D., Zwinderman, A. H. (2017) Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. European Journal of Heart Failure, 19, pp. 627-634. (doi: 10.1002/ejhf.785)

Packer, M. et al. (2017) Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure : primary results of the ENABLE Trials. JACC: Heart Failure, 5, pp. 317-326. (doi: 10.1016/j.jchf.2017.02.021)

Jacobs, L., Efremov, L., Ferreira, J. P., Thijis, L., Yang, W.-Y., Zhang, Z.-Y., Latini, R., Masson, S., Agabiti, N., Sever, P., Delles, C., Sattar, N., Butler, J., Cleland, J., Kuznetsova, T., Staessen, J. A., Zannad, F. (2017) Risk for incident heart failure: a subject-level meta-analysis from the Heart “OMics” in AGEing (HOMAGE) study. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.005231)

Zakeri, R., Van Wagoner, D. R., Calkins, H., Wong, T., Ross, H. M., Heist, E. K., Meyer, T. E., Kowey, P. R., Mentz, R. J., Cleland, J. G.F., Pitt, B., Zannad, F., Linde, C. (2017) The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm, 14, pp. 763-782. (doi: 10.1016/j.hrthm.2017.01.032)

Singh, A., Greenwood, J. P., Berry, C., Dawson, D. K., Hogrefe, K., Kelly, D. J., Dhakshinamurthy, V., Lang, C. C.,, Khoo, J. P., Sprigings, D., Steeds, R. P., Jerosch-Herold, M., Neubauer, S., Prendergast, B., Williams, B., Zhang, R., Hudson, I., Squire, I. B., Ford, I., Samani, N. J., McCann, G. P. (2017) Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) study. European Heart Journal, 38, pp. 1222-1229. (doi: 10.1093/eurheartj/ehx001)

Zhang, J., Wong, K. Y.-K., Clark, A. L., Cleland, J. G.F. (2017) Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling. International Journal of Cardiology, 233, pp. 67-72. (doi: 10.1016/j.ijcard.2017.01.127)

McDiarmid, A. K., Pellicori, P., Cleland, J. G.F., Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38, pp. 942-954. (doi: 10.1093/eurheartj/ehw140)

Layland, J., Rauhalammi, S., Lee, M. M.Y., Ahmed, N., Carberry, J., Teng Yue May, V., Watkins, S., McComb, C., Mangion, K., McClure, J. D., Carrick, D., O'Donnell, A., Sood, A., McEntegart, M., Oldroyd, K. G., Radjenovic, A., Berry, C. (2017) Diagnostic accuracy of 3.0-T magnetic resonance T1 and T2 mapping and T2-weighted dark-blood imaging for the infarct-related coronary artery in Non-ST-segment elevation myocardial infarction. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.004759)

Wilson, S. J., Newby, D. E., Dawson, D., Irving, J., Berry, C. (2017) Duration of dual antiplatelet therapy in acute coronary syndrome. Heart, 103, pp. 573-580. (doi: 10.1136/heartjnl-2016-309871)

Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G.F., Colucci, W. S.,, Butler, J., Voors, A. A., Anker, S. D., Pitt, B., Pieske, B., Filippatos, G., Greene, S. J., Gheorghiade, M. (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 14, pp. 238-250. (doi: 10.1038/nrcardio.2016.203)

Filippatos, G. S. et al. (2017) Independent academic data monitoring committees for clinical trials in cardiovascular and cardiometabolic diseases. European Journal of Heart Failure, 19, pp. 449-456. (doi: 10.1002/ejhf.761)

Skobel, E., Knackstedt, C., Martinez-Romero, A., Salvi, D., Vera-Munoz, C., Napp, A., Luprano, J., Bover, R., Glöggler, S., Bjarnason-Wehrens, B., Marx, N., Rigby, A., Cleland, J. G.F. (2017) Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels, 32, pp. 408-418. (doi: 10.1007/s00380-016-0897-8)

Nymo, S. H., Aukrust, P., Kjekshus, J., McMurray, J. J.V., Cleland, J. G.F., Wikstrand, J., Muntendam, P., Wienhues-Thelen, U., Latini, R., Tandberg Askevold, E., Gravning, J., Dahl, C. P., Broch, K., Yndestad, A., Gullestad, L., Ueland, T. (2017) Limited added value of circulating inflammatory biomarkers in chronic heart failure. JACC: Heart Failure, 5, pp. 256-264. (doi: 10.1016/j.jchf.2017.01.008)

Böhm, M., Young, R., Jhund, P., Solomon, S. D., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2017) Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. European Heart Journal, 38, pp. 1132-1143. (doi: 10.1093/eurheartj/ehw570)

Urbinati, A., Pellicori, P., Guerra, F., Capucci, A., Clark, A. L. (2017) Takotsubo syndrome in the paediatric population. Journal of Cardiovascular Medicine, 18, pp. 262-267. (doi: 10.2459/JCM.0000000000000446)

Cleland, J. G.F., Mueller, C. (2017) What can we learn from SOCRATES: more questions than answers? European Heart Journal, 38, pp. 1128-1131. (doi: 10.1093/eurheartj/ehw561)

Layland, J. J., Carberry, J., May, V. T.Y., Lee, M., Eteiba, H., Lindsay, M., Petrie, M., McEntegart, M., Watkins, S., Shaukat, A., Oldroyd, K., Curzen, N., Sood, A., Balachandran, K., Das, R., Junejo, S., Hannah, A., Stewart, A., Henderson, R., McConnachie, A., Berry, C. (2017) Decision Making Using Fractional Flow Reserve is Associated With Lower Rates of Incomplete Revascularization Compared With Angiographic Guided Decision Making Amongst Patients With NSTEMI. (doi: 10.1016/s0735-1097(17)34446-7)

Rao, M. P., Al-Khatib, S. M., Pokorney, S., She, L., Romanov, A., Nicolau, J. C., Lee, K. L., Carson, P. E., Selzman, C. H., Stepinska, J., Cleland, J. G.F., Tungsubutra, W., Desvigne-Nickens, P. M., Sueta, C., Siepe, M., Lang, I. M., Feldman, A. M., Yii, M., Rouleau, J. L., Velazquez, E. J. (2017) Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure) Circulation, 135, pp. 1136-1144. (doi: 10.1161/CIRCULATIONAHA.116.026075)

Dovancescu, S., Pellicori, P., Mabote, T., Torabi, A., Clark, A. L., Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.748)

Abdul-Rahim, A. H., Perez, A.-C., MacIsaac, R. L., Jhund, P. S., Claggett, B. L., Carson, P. E., Komajda, M., McKelvie, R. S., Zile, M. R., Swedberg, K., Yusuf, S., Pfeffer, M. A., Solomon, S. D., Lip, G. Y.H., Lees, K. R., McMurray, J. J.V. (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. European Heart Journal, 38, pp. 742-750. (doi: 10.1093/eurheartj/ehw509)

Matsue, Y., van der Meer, P., Damman, K., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Gansevoort, R. T., Bakker, S. J.L., van der Harst, P., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A. (2017) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart, 103, pp. 407-413. (doi: 10.1136/heartjnl-2016-310112)

Matsue, Y., ter Maaten, J. M., Struck, J., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., van Veldhuisen, D. J., van der Meer, P., Damman, K., Voors, A. A. (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. Journal of Cardiac Failure, 23, pp. 231-239. (doi: 10.1016/j.cardfail.2016.09.007)

Small, H. Y., Akehurst, C., Sharafetdinova, L., McBride, M. W., McClure, J. D., Robinson, S. W., Carty, D. M., Freeman, D. J., Delles, C. (2017) HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia. Physiological Genomics, 49, pp. 193-200. (doi: 10.1152/physiolgenomics.00106.2016)

Cuthbert, J. J., Pellicori, P., Shah, P., Clark, A. L. (2017) New pharmacological approaches in heart failure therapy: developments and possibilities. Future Cardiology, 13, pp. 173-188. (doi: 10.2217/fca-2016-0068)

Masters, J., Morton, G., Anton, I., Szymanski, J., Greenwood, E., Grogono, J., Flett, A. S., Cleland, J. G.F., Cowburn, P. J. (2017) Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team. Open Heart, 4, (doi: 10.1136/openhrt-2016-000547)

Dierckx, R., Inglis, S. C., Clark, R. A., Prieto-Merino, D., Cleland, J. G.F. (2017) Telemedicine in heart failure: new insights from the Cochrane meta-analyses. European Journal of Heart Failure, 19, pp. 304-306. (doi: 10.1002/ejhf.759)

Graham-Brown, M. P.M., Rutherford, E., Levelt, E., March, D. S., Churchward, D. R., Stensel, D. J., McComb, C., Mangion, K., Cockburn, S., Berry, C., Moon, J. C., Mark, P. B., Burton, J. O., McCann, G. P. (2017) Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients. Journal of Cardiovascular Magnetic Resonance, 19, (doi: 10.1186/s12968-017-0337-7)

Docherty, K. F., Campbell, R. T., Jhund, P., Petrie, M. C., McMurray, J. J.V. (2017) How robust are clinical trials in heart failure? European Heart Journal, 38, pp. 338-345. (doi: 10.1093/eurheartj/ehw427)

Emdin, C. A., Hsiao, A. J., Kiran, A., Conrad, N., Salimi-Khorshidi, G., Woodward, M., Anderson, S. G., Mohseni, H., McMurray, J. J.V., Cleland, J. G.F., Dargie, H., Hardman, S., McDonagh, T., Rahimi, K. (2017) Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales) American Journal of Cardiology, 119, pp. 440-444. (doi: 10.1016/j.amjcard.2016.10.021)

Koh-Tan, H.H. C., Dashti, M., Wang, T., Beattie, W., Mcclure, J., Young, B., Dominiczak, A. F., McBride, M. W., Graham, D. (2017) Dissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3. Journal of Hypertension, 35, pp. 319-329. (doi: 10.1097/HJH.0000000000001155)

Hurst, C. H., Turnbull, D., Plain, F., Fuller, W., Hemsley, P. A. (2017) Maleimide scavenging enhances determination of protein S-palmitoylation state in acyl-exchange methods. BioTechniques, 62, pp. 69-75. (doi: 10.2144/000114516)

Gastelurrutia, P., Lupón, J., Domingo, M., Stut, W., Dovancescu, S., Cleland, J., Frankenstein, L., Bayes-Genis, A. (2017) Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Failure, 4, pp. 66-70. (doi: 10.1002/ehf2.12104)

Zhang, J., Dierckx, R., Mohee, K., Clark, A. L., Cleland, J. G.F. (2017) Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4, pp. 40-45. (doi: 10.1002/ehf2.12112)

Tsiropoulou, S., McBride, M., Padmanabhan, S. (2017) Urine metabolomics in hypertension research. Springer

Mancini, S. J., White, A. D., Bijland, S., Rutherford, C., Graham, D., Richter, E. A., Viollet, B., Touyz, R. M., Palmer, T. M., Salt, I. P. (2017) Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptorassociated kinase-4 phosphorylation. Molecular and Cellular Endocrinology, 440, pp. 44-56. (doi: 10.1016/j.mce.2016.11.010)

Gebhard, C., Rhéaume, E., Berry, C., Brand, G., Kernaleguen, A.-E., Théberge-Julien, G., Alam, M. A., Lee, C. Y.W., Boileau, L., Chabot-Blanchet, M., Guertin, M.-C., Lavoie, M.-A., Grégoire, J., Ibrahim, R., L'Allier, P., Tardif, J.-C. (2017) Beneficial effects of reconstituted high-density lipoprotein (rHDL) on circulating CD34+ cells in patients after an acute coronary syndrome. PLoS ONE, 12, (doi: 10.1371/journal.pone.0168448)

Cannon, J. A., Shen, L., Jhund, P. S., Kristensen, S. L., Køber, L., Chen, F., Gong, J., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2017) Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. European Journal of Heart Failure, 19, pp. 129-137. (doi: 10.1002/ejhf.687)

Streng, K. W., ter Maaten, J. M., Cleland, J. G.F., O’Connor, C. M., Davison, B. A., Metra, M., Givertz, M. M., Teerlink, J. R., Ponikowski, P., Bloomfield, D. M., Dittrich, H. C., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2017) Associations of body mass index with laboratory and biomarkers in patients with acute heart failure. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003350)

Kristensen, S. L., Mogensen, U. M., Jhund, P. S., Petrie, M. C., Preiss, D., Win, S., Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Gottdiener, J. S., Carson, P. E., McMurray, J. J.V. (2017) Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-Preserve) Circulation, 135, pp. 724-735. (doi: 10.1161/CIRCULATIONAHA.116.024593)

Blinova, K., Stohlman, J., Vicente, J., Chan, D., Johannesen, L., Hortigon-Vinagre, M. P., Zamora Rodriguez, V., Smith, G., Crumb, W. J., Pang, L., Lyn-Cook, B., Ross, J., Brock, M., Chvatal, S., Millard, D., Galeotti, L., Stockbridge, N., Strauss, D. G. (2017) Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias. Toxicological Sciences, 155, pp. 234-247. (doi: 10.1093/toxsci/kfw200)

Tromp, J., ter Maaten, J., Damman, K., O’Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van der Wal, M. H.L., Jaarsma, T., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2017) Serum potassium levels and outcome in acute heart failure (data from the PROTECT and COACH trials) American Journal of Cardiology, 119, pp. 290-296. (doi: 10.1016/j.amjcard.2016.09.038)

Ridker, P. M. et al. (2017) Cardiovascular efficacy and safety of Bococizumab in high-risk patients. New England Journal of Medicine, 376, pp. 1527-1539. (doi: 10.1056/NEJMoa1701488)

Cuthbert, J. J., Pellicori, P., Clark, A. L. (2017) Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Medical Devices: Evidence and Research, 10, pp. 123-132. (doi: 10.2147/mder.s113105)

Arain, F., Gullestad, L., Nymo, S., Kjekshus, J., Cleland, J. G.F., Michelsen, A., McMurray, J. J.V., Wikstrand, J., Aukrust, P., Ueland, T. (2017) Low YKL-40 in Chronic Heart Failure may predict beneficial effects of statins: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) Biomarkers, 22, pp. 261-267. (doi: 10.1080/1354750X.2016.1204003)

Pellicori, P., Carubelli, V. (2017) Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives. Giornale Italiano di Cardiologia, 18, pp. 129-138. (doi: 10.1714/2663.27298)

Pellicori, P., Salekin, D., Pan, D., Clark, A. L. (2017) This patient is not breathing properly: is this COPD, heart failure, or neither? Expert Review of Cardiovascular Therapy, 15, pp. 389-396. (doi: 10.1080/14779072.2017.1317592)

Plain, F., Turnbull, D., Fraser, N. J., Fuller, W. (2017) Understanding the rules governing NCX1 palmitoylation. Channels, 11, pp. 377-379. (doi: 10.1080/19336950.2017.1342501)

Torabi, A., Cleland, J. G.F., Sherwi, N., Atkin, P., Panahi, H., Kilpatrick, E., Thackray, S., Hoye, A., Alamgir, F., Goode, K., Rigby, A., Clark, A. L. (2016) Influence of case definition on incidence and outcome of acute coronary syndromes. Open Heart, 3, (doi: 10.1136/openhrt-2016-000487)

Fattah, C., Nather, K., McCarroll, C. S., Hortigon-Vinagre, M. P., Zamora Rodriguez, V., Flores-Munoz, M., McArthur, L., Zentilin, L., Giacca, M., Touyz, R. M., Smith, G. L., Loughrey, C. M., Nicklin, S. A. (2016) Gene therapy with Angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction. Journal of the American College of Cardiology, 68, pp. 2652-2666. (doi: 10.1016/j.jacc.2016.09.946)

Mangion, K., Gao, H., Mccomb, C., Carrick, D., Clerfond, G., Zhong, X., Luo, X., Haig, C., Berry, C. (2016) A novel method for estimating myocardial strain: assessment of deformation tracking against reference magnetic resonance methods in healthy volunteers. Scientific Reports, 6, (doi: 10.1038/srep38774)

Huethorst, E., Hortigon, M., Zamora-Rodriguez, V., Reynolds, P.M., Burton, F., Smith, G., Gadegaard, N. (2016) Enhanced human-induced pluripotent stem cell derived cardiomyocyte maturation using a dual microgradient substrate. ACS Biomaterials Science and Engineering, 2, pp. 2231-2239. (doi: 10.1021/acsbiomaterials.6b00426)

Kobayashi, Y., Johnson, N. P., Berry, C., De Bruyne, B., Gould, K. L., Jeremias, A., Oldroyd, K. G., Pijls, N. H.J., Fearon, W. F. (2016) The influence of lesion location on the diagnostic accuracy of adenosine-free coronary pressure wire measurements. JACC: Cardiovascular Interventions, 9, pp. 2390-2399. (doi: 10.1016/j.jcin.2016.08.041)

Teerlink, J. R., Felker, G. M., McMurray, J. J.V., Solomon, S. D., Adams, Jr., K. F., Cleland, J. G.F., Ezekowitz, J. A., Goudev, A., Macdonald, P., Metra, M., Mitrovic, V., Ponikowski, P., Serpytis, P., Spinar, J., Tomcsányi, J., Vandekerckhove, H. J., Voors, A. A., Monsalvo, M. L., Johnston, J., Malik, F. I., Honarpour, N. (2016) Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet, 388, pp. 2895-2903. (doi: 10.1016/S0140-6736(16)32049-9)

Carrick, D., Haig, C., Ahmed, N., Carberry, J., Teng Yue May, V., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davies, A., Abouzaid, A. M., Mordi, I., Ford, I., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation, 134, pp. 1833-1847. (doi: 10.1161/CIRCULATIONAHA.116.022603)

Vegter, E. L., Schmitter, D., Hagemeijer, Y., Ovchinnikova, E. S., van der Harst, P., Teerlink, J. R., O'Connor, C. M., Metra, M., Davison, B. A., Bloomfield, D., Cotter, G., Cleland, J. G.F., Givertz, M. M., Ponikowski, P., van Veldhuisen, D. J., van der Meer, P., Berezikov, E., Voors, A. A., Khan, M. A.F. (2016) Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. International Journal of Cardiology, 224, pp. 231-239. (doi: 10.1016/j.ijcard.2016.09.010)

Nicklin, S. A. (2016) A novel mechanism of action for angiotensin-(1-7) via the angiotensin type 1 receptor. Hypertension, 68, pp. 1342-1343. (doi: 10.1161/HYPERTENSIONAHA.116.08215)

Pellicori, P., Cleland, J. G.F., Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30, pp. 599-609. (doi: 10.1007/s10557-016-6697-7)

Nagaraja, V., Ooi, S.-Y., Nolan, J., Large, A., De Belder, M., Ludman, P., Bagur, R., Curzen, N., Matsukage, T., Yoshimachi, F., Kwok, C. S., Berry, C., Mamas, M. A. (2016) Impact of incomplete percutaneous revascularization in patients With multivessel coronary artery disease: a systematic review and meta-analysis. Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.116.004598)

Kaye, D. M., Hasenfuß, G., Neuzil, P., Post, M. C., Doughty, R., Trochu, J.-N., Kolodziej, A., Westenfeld, R., Penicka, M., Rosenberg, M., Walton, A., Muller, D., Walters, D., Hausleiter, J., Raake, P., Petrie, M. C., Bergmann, M., Jondeau, G., Feldman, T., van Veldhuisen, D. J., Ponikowski, P., Silvestry, F. E., Burkhoff, D., Hayward, C. (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003662)

Hortigon-Vinagre, M.P., Zamora, V., Burton, F.L., Green, J., Gintant, G.A., Smith, G.L. (2016) The use of ratiometric fluorescence measurements of the voltage sensitive dye Di-4-ANEPPS to examine action potential characteristics and drug effects on human induced pluripotent stem cell-derived cardiomyocytes. Toxicological Sciences, 154, pp. 320-331. (doi: 10.1093/toxsci/kfw171)

Napp, A. E. et al. (2016) Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial. European Radiology, 27, pp. 2957-2968. (doi: 10.1007/s00330-016-4620-z)

Verdura, E., Hervé, D., Bergametti, F., Jacquet, C., Morvan, T., Prieto-Morin, C., Mackowiak, A., Manchon, E., Hosseini, H., Cordonnier, C., Girard-Buttaz, I., Rosenstingl, S., Hagel, C., Kuhlenbaümer, G., Leca-Radu, E., Goux, D., Fleming, L., Van Agtmael, T., Chabriat, H., Chapon, F., Tournier-Lasserve, E. (2016) Disruption of a miR-29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathy. Annals of Neurology, 80, pp. 741-753. (doi: 10.1002/ana.24782)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., Cleland, J. G.F. (2016) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Heart, 103, pp. 255-257. (doi: 10.1136/heartjnl-2015-309191)

Demissei, B. G., Postmus, D., Liu, L. C.Y., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Edwards, C., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Voors, A. A., Hillege, H. L. (2016) Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial. International Journal of Cardiology, 223, pp. 967-975. (doi: 10.1016/j.ijcard.2016.08.271)

Ferreira, J. P., Girerd, N., Pellicori, P., Duarte, K., Girerd, S., Pfeffer, M. A., McMurray, J. J.V., Pitt, B., Dickstein, K., Jacobs, L., Staessen, J. A., Butler, J., Latini, R., Masson, S., Mebazaa, A., Rocca, H. P. B.-L., Delles, C., Heymans, S., Sattar, N., Jukema, J. W., Cleland, J. G.F., Zannad, F., Rossignol, P. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, (doi: 10.1186/s12916-016-0731-2)

Jhund, P. S. (2016) Geographic variation in heart failure - a matter of celebration or condemnation? European Journal of Heart Failure, 18, pp. 1329-1330. (doi: 10.1002/ejhf.652)

Weinberger, F., Breckwoldt, K., Pecha, S., Kelly, A., Geertz, B., Starbatty, J., Yorgan, T., Cheng, K.-H., Lessmann, K., Stolen, T., Scherrer-Crosbie, M., Smith, G., Reichenspurner, H., Hansen, A., Eschenhagen, T. (2016) Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Science Translational Medicine, 8, pp. 363ra148-363ra148. (doi: 10.1126/scitranslmed.aaf8781)

Bekfani, T., Pellicori, P., Morris, D. A., Ebner, N., Valentova, M., Steinbeck, L., Wachter, R., Elsner, S., Sliziuk, V., Schefold, J. C., Sandek, A., Doehner, W., Cleland, J. G.F., Lainscak, M., Anker, S. D., von Haehling, S. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi: 10.1016/j.ijcard.2016.07.135)

Petrie, M. C., Jhund, P. S., She, L., Adlbrecht, C., Doenst, T., Panza, J. A., Hill, J. A., Lee, K. L., Rouleau, J. L., Prior, D. L., Ali, I. S., Maddury, J., Golba, K. S., White, H. D., Carson, P., Chrzanowski, L., Romanov, A., Miller, A. B., Velazquez, E. J. (2016) Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure) Circulation, 134, pp. 1314-1324. (doi: 10.1161/CIRCULATIONAHA.116.024800)

Desai, A. S., Jhund, P. S. (2016) After TOPCAT: what to do now in heart failure with preserved ejection fraction. European Heart Journal, 37, pp. 3135-3140. (doi: 10.1093/eurheartj/ehw114)

Hennigan, B., Oldroyd, K. G., Berry, C., Johnson, N., McClure, J., McCartney, P., McEntegart, M. B., Eteiba, H., Petrie, M. C., Rocchiccioli, P., Good, R., Lindsay, M. M., Hood, S., Watkins, S. (2016) Discordance between resting and hyperemic indices of coronary stenosis severity: the VERIFY 2 study (a comparative study of resting coronary pressure gradient, instantaneous wave-free ratio and fractional flow reserve in an unselected population referred for invasive angiography) Circulation: Cardiovascular Interventions, 9, (doi: 10.1161/CIRCINTERVENTIONS.116.004016)

Sirker, A., Kwok, C. S., Kotronias, R., Bagur, R., Bertrand, O., Butler, R., Berry, C., Nolan, J., Oldroyd, K., Mamas, M. (2016) Influence of access site choice for cardiac catheterization on risk of adverse neurological events: A systematic review and meta-analysis. American Heart Journal, 181, pp. 107-119. (doi: 10.1016/j.ahj.2016.06.027)

Mangion, K., Clerfond, G., Mccomb, C., Carrick, D., Rauhalammi, S. M., McClure, J., Corcoran, D. S., Woodward, R., Orchard, V., Radjenovic, A., Zhong, X., Berry, C. (2016) Myocardial strain in healthy adults across a broad age range as revealed by cardiac magnetic resonance imaging at 1.5 and 3.0T: associations of myocardial strain with myocardial region, age, and sex. Journal of Magnetic Resonance Imaging, 44, pp. 1197-1205. (doi: 10.1002/jmri.25280)

Ahmed, N., Carberry, J., Teng, V., Carrick, D., Berry, C. (2016) Risk assessment in patients with an acute ST-elevation myocardial infarction. Journal of Comparative Effectiveness Research, 5, pp. 581-593. (doi: 10.2217/cer-2016-0017)

Small, H. Y., Nosalski, R., Morgan, H., Beattie, E., Guzik, T., Graham, D., Delles, C. (2016) The role of tumor necrosis factor-α and natural killer cells in uterine artery function and pregnancy outcome in the stroke prone spontaneously hypertensive rat. Hypertension, 68, pp. 1298-1307. (doi: 10.1161/HYPERTENSIONAHA.116.07933)

Pandit, S. V., Workman, A. (2016) Atrial electrophysiological remodeling and fibrillation in heart failure. Clinical Medicine Insights: Cardiology, 10, pp. 41-46. (doi: 10.4137/CMC.S39713)

Crocini, C., Ferrantini, C., Coppini, R., Scardigli, M., Yan, P., Loew, L. M., Smith, G., Cerbai, E., Poggesi, C., Pavone, F. S., Sacconi, L. (2016) Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. Scientific Reports, 6, (doi: 10.1038/srep35628)

Tromp, J., Meyer, S., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2016) Acute heart failure in the young: clinical characteristics and biomarker profiles. International Journal of Cardiology, 221, pp. 1067-1072. (doi: 10.1016/j.ijcard.2016.06.339)

Ross, P. D., Guy, J., Selfridge, J., Kamal, B., Bahey, N., Tanner, E., Gillingwater, T. H., Jones, R. A., Loughrey, C. M., McCarroll, C. S., Bailey, M. E.S., Bird, A., Cobb, S. (2016) Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes. Human Molecular Genetics, 25, pp. 4389-4404. (doi: 10.1093/hmg/ddw269)

Rørth, R., Wong, C., Kragholm, K., Fosbøl, E. L., Mogensen, U. M., Lamberts, M., Petrie, M. C., Jhund, P. S., Gerds, T. A., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2016) Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study. Circulation, 134, pp. 999-1009. (doi: 10.1161/CIRCULATIONAHA.116.021859)

Sokoreli, I., de Vries, J.J.G., Riistama, J.M., Pauws, S.C., Steyerberg, E.W., Tesanovic, A., Geleijnse, G., Goode, K.M., Crundall-Goode, A., Kazmi, S., Cleland, J.G.F., Clark, A.L. (2016) Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. International Journal of Cardiology, 220, pp. 202-207. (doi: 10.1016/j.ijcard.2016.06.068)

Corcoran, D., Mangion, K., Berry, C. (2016) Clinical trials for the diagnosis and management of stable ischaemic heart disease: context, status and future implications. European Medical Journal Cardiology, 4, pp. 112-121.

Rutherford, E., Talle, M. A., Mangion, K., Bell, E., Rauhalammi, S. M., Roditi, G., McComb, C., Radjenovic, A., Welsh, P., Woodward, R., Struthers, A. D., Jardine, A. G., Patel, R. K., Berry, C., Mark, P. B. (2016) Definition of myocardial tissue abnormalities in end stage renal failure with cardiac magnetic resonance imaging using T1 mapping. Kidney International, 90, pp. 845-852. (doi: 10.1016/j.kint.2016.06.014)

Cleland, J. G.F., Pellicori, P. (2016) PARADIGM-HF: does dose matter? European Journal of Heart Failure, 18, pp. 1235-1237. (doi: 10.1002/ejhf.634)

Cotter, G., Davison, B. A., Milo, O., Bourge, R. C., Cleland, J. G.F., Jondeau, G., Krum, H., O'Connor, C. M., Metra, M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Kobrin, I., Rainisio, M., Senger, S., Edwards, C., McMurray, J. J.V., Teerlink, J. R. (2016) Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of Cardiac Failure, 22, pp. 815-822. (doi: 10.1016/j.cardfail.2015.12.017)

Joseph, A. C., Prapa, M., Pellicori, P., Mabote, T., Nasir, M., Clark, A. L. (2016) Tachycardia-induced cardiomyopathy in pregnancy. Journal of Cardiovascular Medicine, 17, pp. 762-766. (doi: 10.2459/jcm.0000000000000209)

Greenwood, J. P., Ripley, D. P., Berry, C., McCann, G. P., Plein, S., Bucciarelli-Ducci, C., Dall’Armellina, E., Prasad, A., Bijsterveld, P., Foley, J. R., Mangion, K., Sculpher, M., Walker, S., Everett, C. C., Cairns, D. A., Sharples, L. D., Brown, J. M. (2016) Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA: Journal of the American Medical Association, 316, pp. 1051-1060. (doi: 10.1001/jama.2016.12680)

Bauersachs, J., Arrigo, M., Hilfiker-Kleiner, D., Veltmann, C., Coats, A. J.S., Crespo-Leiro, M. G., De Boer, R. A., van der Meer, P., Maack, C., Mouquet, F., Petrie, M. C., Piepoli, M. F., Regitz-Zagrosek, V., Schaufelberger, M., Seferovic, P., Tavazzi, L., Ruschitzka, F., Mebazaa, A., Sliwa, K. (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 18, pp. 1096-1105. (doi: 10.1002/ejhf.586)

Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2016) Effects of sacubitril/valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) according to background therapy. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003212)

Rauhalammi, S. M.O., Mangion, K., Barrientos, P. H., Carrick, D. J.A., Clerfond, G., McClure, J., McComb, C., Radjenovic, A., Berry, C. (2016) Native myocardial longitudinal (T1) relaxation time: Regional, age, and sex associations in the healthy adult heart. Journal of Magnetic Resonance Imaging, 44, pp. 541-548. (doi: 10.1002/jmri.25217)

Hawkins, N. M., Jhund, P. S., Pozzi, A., O'Meara, E., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., Petrie, M. C., Virani, S., McMurray, J. J.V. (2016) Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. European Journal of Heart Failure, 18, pp. 1162-1171. (doi: 10.1002/ejhf.614)

Jhund, P. S., McMurray, J. J.V. (2016) The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan. Heart, 102, pp. 1342-1347. (doi: 10.1136/heartjnl-2014-306775)

Morgan, H., Small, H.Y., Beattie, E., McBride, M.W., Graham, D. (2016) [OP.5D.02] Transcriptomic changes in early pregnancy-associated uterine artery remodelling in stroke prone spontaneously hypertensive rat. Journal of Hypertension, 34, pp. e63-e63. (doi: 10.1097/01.hjh.0000491501.79443.05)

ter Maaten, J. M., Damman, K., Hanberg, J. S., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Cotter, G., Davison, B., Cleland, J. G.F., Bloomfield, D. M., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., Testani, J. M. (2016) Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003109)

Carberry, J., Carrick, D., Haig, C., Rauhalammi, S. M., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, 68, pp. 385-391. (doi: 10.1161/HYPERTENSIONAHA.116.07222)

Robertson, S., Parker, A. L., Clarke, C., Duffy, M. R., Alba, R., Nicklin, S. A., Baker, A. H. (2016) Retargeting FX binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop. Journal of General Virology, 97, pp. 1911-1916. (doi: 10.1099/jgv.0.000505)

Bhattacharyya, S., Mittal, T., Abayalingam, M., Kabir, T., Dalby, M., Cleland, J. G.F., Baltabaeva, A., Rahman Haley, S. (2016) Classification of aortic stenosis by flow and gradient patterns provides insights into the pathophysiology of disease. Angiology, 67, pp. 664-669. (doi: 10.1177/0003319715611804)

Cannon, J. A., Shen, L., Jhund, P., Anand, I. S., Komajda, M., McKelvie, R. S., Zile, M. R., Carson, P. E., McMurray, J. J. V. (2016) Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-Preserve) trial. European Journal of Heart Failure, 18, pp. 1021-1031. (doi: 10.1002/ejhf.547)

Fröhlich, H., Nelges, C., Täger, T., Schwenger, V., Cebola, R., Schnorbach, J., Goode, K. M., Kazmi, S., Katus, H. A., Cleland, J. G.F., Clark, A. L., Frankenstein, L. (2016) Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. American Heart Journal, 178, pp. 28-36. (doi: 10.1016/j.ahj.2016.03.024)

Davison, B. A., Metra, M., Senger, S., Edwards, C., Milo, O., Bloomfield, D. M., Cleland, J. G., Dittrich, H. C., Givertz, M. M., O'Connor, C. M., Massie, B. M., Ponikowski, P., Teerlink, J. R., Voors, A. A., Cotter, G. (2016) Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. European Journal of Heart Failure, 18, pp. 1041-1050. (doi: 10.1002/ejhf.540)

Cleland, J. G.F., Zhang, J., Pellicori, P., Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K., Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1, pp. 539-547. (doi: 10.1001/jamacardio.2016.1161)

Wilson, M. R., Docherty, K. F., Gardner, R. S. (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber, 27, pp. 15-22. (doi: 10.1002/psb.1487)

Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., Zinman, B., EMPA-REG OUTCOME Investigators, (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine, 375, pp. 323-334. (doi: 10.1056/NEJMoa1515920)

Biegus, J., Hillege, H. L., Postmus, D., Valente, M. A.E., Bloomfield, D. M., Cleland, J. G.F., Cotter, G., Davison, B. A., Dittrich, H. C., Fiuzat, M., Givertz, M. M., Massie, B. M., Metra, M., Teerlink, J. R., Voors, A. A., O'Connor, C. M., Ponikowski, P. (2016) Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European Journal of Heart Failure, 18, pp. 830-839. (doi: 10.1002/ejhf.532)

Mangion, K., Berry, C. (2016) Advances in magnetic resonance imaging of the myocardial area at risk and salvage. Circulation: Cardiovascular Imaging, 9, (doi: 10.1161/circimaging.116.005127)

Høydal, M. A., Stølen, T. O., Kettlewell, S., Maier, L. S., Brown, J. H., Sowa, T., Catalucc, D., Condorelli, G., Kemi, O. J., Smith, G. L., Wisløff, U. (2016) Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+-homeostasis. Journal of Applied Physiology, 121, pp. 212-220. (doi: 10.1152/japplphysiol.00188.2016)

Duffy, M.R., Doszpoly, A., Turner, G., Nicklin, S.A., Baker, A.H. (2016) The relevance of coagulation factor X protection of adenoviruses in human sera. Gene Therapy, 23, pp. 592-596. (doi: 10.1038/gt.2016.32)

Feldman, T., Komtebedde, J., Burkhoff, D., Massaro, J., Maurer, M. S., Leon, M. B., Kaye, D., Silvestry, F. E., Cleland, J. G.F., Kitzman, D., Kubo, S. H., Van Veldhuisen, D. J., Kleber, F., Trochu, J.-N., Auricchio, A., Gustafsson, F., Hasenfuβ, G., Ponikowski, P., Filippatos, G., Mauri, L., Shah, S. J. (2016) Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE elevated left atrial pressure in heart failure (REDUCE LAP-HF I) Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003025)

Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J. V. (2016) Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF) Circulation, 133, pp. 2254-2262. (doi: 10.1161/CIRCULATIONAHA.115.020729)

Berry, C., Poppe, K.K., Gamble, G.D., Earle, N.J., Ezekowitz, J.A., Squire, I.B., McMurray, J.J.V., McAlister, F.A., Komajda, M., Swedberg, K., Maggioni, A.P., Ahmed, A., Whalley, G.A., Doughty, R.N., Tarantini, L. (2016) Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. QJM: An International Journal of Medicine, 109, pp. 377-382. (doi: 10.1093/qjmed/hcv087)

Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., Ng, L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M. (2016) A systems BIOlogy Study to TAilored treatment in chronic heart failure: rationale, design, and baseline characteristics of BIOSTAT-CHF. European Journal of Heart Failure, 18, pp. 716-726. (doi: 10.1002/ejhf.531)

ter Maaten, J. M., Valente, M. A.E., Damman, K., Cleland, J. G., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Bloomfield, D. M., Cotter, G., Davison, B., Subacius, H., van Veldhuisen, D. J., van der Meer, P., Hillege, H. L., Gheorghiade, M., Voors, A. A. (2016) Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002845)

Myint, P. K., Kwok, C. S., Roffe, C., Kontopantelis, E., Zaman, A., Berry, C., Ludman, P. F., de Belder, M. A., Mamas, M. A. (2016) Determinants and outcomes of stroke following percutaneous coronary intervention by indication. Stroke, 47, pp. 1500-1507. (doi: 10.1161/STROKEAHA.116.012700)

Emmens, J. E., ter Maaten, J. M., Matsue, Y., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Todd, J., van Veldhuisen, D. J., Hillege, H. L., Damman, K., van der Meer, P., Voors, A. A. (2016) Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. European Journal of Heart Failure, 18, pp. 641-649. (doi: 10.1002/ejhf.426)

Baumert, M., Porta, A., Vos, M. A., Malik, M., Couderc, J.-P., Laguna, P., Piccirillo, G., Smith, G. L., Tereshchenko, L. G., Volders, P. G.A. (2016) QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology. Europace, 18, pp. 925-944. (doi: 10.1093/europace/euv405)

Ballantyne, M. D., Pinel, K., Dakin, R., Vesey, A. T., Diver, L., MacKenzie, R., Garcia, R., Welsh, P., Sattar, N., Hamilton, G., Joshi, N., Dweck, M. R., Miano, J. M., McBride, M. W., Newby, D. E., McDonald, R. A., Baker, A. H. (2016) Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation, 133, pp. 2050-2065. (doi: 10.1161/circulationaha.115.021019)

Carrick, D., Haig, C., Carberry, J., Teng Tue May, V., Mccartney, P., Welsh, P., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Mahrous, A., Rauhalammi, S. M.O., Mordi, I., Ford, I., Radjenovic, A., Sattar, N., Oldroyd, K. G., Berry, C. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1, (doi: 10.1172/jci.insight.85768)

Pellicori, P., Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L., Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi: 10.1016/j.ijcard.2016.02.081)

Gheorghiade, M., Larson, C. J., Shah, S. J., Greene, S. J., Cleland, J. G.F., Colucci, W. S., Dunnmon, P., Epstein, S. E., Kim, R. J., Parsey, R. V., Stockbridge, N., Carr, J., Dinh, W., Krahn, T., Kramer, F., Wahlander, K., Deckelbaum, L. I., Crandall, D., Okada, S., Senni, M., Sikora, S., Sabbah, H. N., Butler, J. (2016) Developing new treatments for heart failure: focus on the heart. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002727)

Jhund, P., Tavazzi, L. (2016) Has the 'epidemic’ of heart failure been replaced by a tsunami of co-morbidities? European Journal of Heart Failure, 18, pp. 500-502. (doi: 10.1002/ejhf.529)

Shoaib, A., Farag, M., Nasir, M., John, J., Gupta, S., Pellicori, P., Antony, R., Perveen, R., Rigby, A., Goode, K. M., Yassin, A., Clark, A. L., Cleland, J. G.F. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18, pp. 556-563. (doi: 10.1002/ejhf.505)

Pellicori, P., Cleland, J.G.F. (2016) New ways to visualize and combat congestion in heart failure = Nuevos modos de visualizar y combatir la congestión en la insuficiencia cardiaca. Revista Clínica Española, 216, pp. 202-204. (doi: 10.1016/j.rce.2016.03.007)

Nisbet, A. M., Camelliti, P., Walker, N. L., Burton, F. L., Cobbe, S. M., Kohl, P., Smith, G. L. (2016) Prolongation of atrio-ventricular node conduction in a rabbit model of ischaemic cardiomyopathy: role of fibrosis and connexin remodelling. Journal of Molecular and Cellular Cardiology, 94, pp. 54-64. (doi: 10.1016/j.yjmcc.2016.03.011)

Campbell, R. T., Willox, G. P., Jhund, P. S., Hawkins, N. M., Huang, F., Petrie, M. C., McMurray, J. J. V. (2016) Reporting of lost to follow-up and treatment discontinuation in device and pharmacotherapy trials in chronic heart failure: a systematic review. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002842)

Velazquez, E. J., Lee, K. L., Jones, R. H., Al-Khalidi, H. R., Hill, J. A., Panza, J. A., Michler, R. E., Bonow, R. O., Doenst, T., Petrie, M. C., Oh, J. K., She, L., Moore, V. L., Desvigne-Nickens, P., Sopko, G., Rouleau, J. L. (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. New England Journal of Medicine, 374, pp. 1511-1520. (doi: 10.1056/NEJMoa1602001)

Johnson, N. P. et al. (2016) Continuum of vasodilator stress from rest to contrast medium to adenosine hyperemia for fractional flow reserve assessment. JACC: Cardiovascular Interventions, 9, pp. 757-767. (doi: 10.1016/j.jcin.2015.12.273)

Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D. G., Collins, P. D., Packer, M., Wikstrand, J., Coats, A. J.S., Cleland, J. G.F., Kirchhof, P., von Lueder, T. G., Rigby, A. S., Andersson, B., Lip, G. Y.H., van Veldhuisen, D. J., Shibata, M. C., Wedel, H., Böhm, M., Flather, M. D. (2016) Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. British Medical Journal, 353, (doi: 10.1136/bmj.i1855)

Lee, M. M.Y., Petrie, M. C., Rocchiccioli, P., Simpson, J., Jackson, C., Brown, A., Corcoran, D., Mangion, K., McEntegart, M., Shaukat, A., Rae, A., Hood, S., Peat, E., Findlay, I., Murphy, C., Cormack, A., Bukov, N., Balachandran, K., Papworth, R., Ford, I., Briggs, A., Berry, C. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS) Open Heart, 3, (doi: 10.1136/openhrt-2015-000371)

Williams, M. C., Hunter, A., Shah, A. S.V., Assi, V., Lewis, S., Smith, J., Berry, C., Boon, N. A., Clark, E., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D. E. (2016) Use of coronary computed tomographic angiography to guide management of patients with coronary disease. Journal of the American College of Cardiology, 67, pp. 1759-1768. (doi: 10.1016/j.jacc.2016.02.026)

Berry, C., Carrick, D., Haig, C., Oldroyd, K. G. (2016) “Waves of Edema” seem implausible. Journal of the American College of Cardiology, 67, pp. 1868-1869. (doi: 10.1016/j.jacc.2015.11.073)

Abdul-Rahim, A. H., MacIsaac, R. L., Jhund, P. S., Petrie, M. C., Lees, K. R., McMurray, J. J.V. (2016) Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial. International Journal of Cardiology, 209, pp. 310-316. (doi: 10.1016/j.ijcard.2016.02.074)

Wan Sulaiman, W.N., Caslake, M.J., Delles, C., Karlsson, H., Mulder, M.T., Graham, D., Freeman, D.J. (2016) Does high-density lipoprotein protect vascular function in healthy pregnancy? Clinical Science, 130, pp. 491-497. (doi: 10.1042/cs20150475)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Lindsay, M., Mahrous, A., Ford, I., Tzemos, N., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37, pp. 1044-1059. (doi: 10.1093/eurheartj/ehv372)

Ovchinnikova, E. S. et al. (2016) Signature of circulating microRNAs in patients with acute heart failure. European Journal of Heart Failure, 18, pp. 414-423. (doi: 10.1002/ejhf.332)

Koshy, A., Pellicori, P., Clark, A. L. (2016) The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure. Heart, 102, pp. 597-601. (doi: 10.1136/heartjnl-2015-308932)

Neisius, U., Koeck, T., Mischak, H., Rossi, S. H., Olson, E., Carty, D. M., Dymott, J. A., Dominiczak, A. F., Berry, C., Oldroyd, K. G., Delles, C. (2016) Urine proteomics in the diagnosis of stable angina. BMC Cardiovascular Disorders, 16, (doi: 10.1186/s12872-016-0246-y)

Teerlink, J. R., Felker, G. M., McMurray, J. J.V., Ponikowski, P., Metra, M., Filippatos, G. S., Ezekowitz, J. A., Dickstein, K., Cleland, J. G.F., Kim, J. B., Lei, L., Knusel, B., Wolff, A. A., Malik, F. I., Wasserman, S. M. (2016) Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure. Journal of the American College of Cardiology, 67, pp. 1444-1455. (doi: 10.1016/j.jacc.2016.01.031)

Hasenfuß, G., Hayward, C., Burkhoff, D., Silvestry, F. E., McKenzie, S., Gustafsson, F., Malek, F., Van der Heyden, J., Lang, I., Petrie, M. C., Cleland, J. G.F., Leon, M., Kaye, D. M. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387, pp. 1298-1304. (doi: 10.1016/S0140-6736(16)00704-2)

Durussel, J., Haile, D., Mooses, K., Daskalaki, E., Beattie, W., Mooses, M., Mekonen, W., Ongaro, N., Anjila, E., Patel, R., Padmanabhan, N., McBride, M., McClure, J., Pitsiladis, Y. (2016) Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies. Physiological Genomics, 48, pp. 202-209. (doi: 10.1152/physiolgenomics.00108.2015)

Damman, K., Kjekshus, J., Wikstrand, J., Cleland, J. G.F., Komajda, M., Wedel, H., Waagstein, F., McMurray, J. J.V. (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18, pp. 328-336. (doi: 10.1002/ejhf.462)

Demissei, B. G., Valente, M. A.E., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van der Meer, P., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A. (2016) Optimizing clinical use of biomarkers in high-risk acute heart failure patients. European Journal of Heart Failure, 18, pp. 269-280. (doi: 10.1002/ejhf.443)

Hafver, T. L., Hodne, K., Wanichawan, P., Aronsen, J. M., Dalhus, B., Lunde, P. K., Lunde, M., Martinsen, M., Enger, U. H., Fuller, W., Sjaastad, I., Louch, W. E., Sejersted, O. M., Carlson, C. R. (2016) Protein phosphatase 1c associated with the cardiac sodium calcium exchanger 1 regulates its activity by dephosphorylating serine 68-phosphorylated phospholemman. Journal of Biological Chemistry, 291, pp. 4561-4579. (doi: 10.1074/jbc.M115.677898)

Wilson, R., Aung, H., Ju, X., Paterson, C., Sayer, R., McIntyre, A., Going, J., Irvine, R., Berry, C. (2016) Optical coherence tomography: an experimental validation for vascular imaging of saphenous vein bypass grafts. Biomedical Physics and Engineering Express, 2, (doi: 10.1088/2057-1976/2/2/025002)

Cuba Gyllensten, I., Bonomi, A. G., Goode, K. M., Reiter, H., Habetha, J., Amft, O., Cleland, J. G.F. (2016) Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance. JMIR Medical Informatics, 4, (doi: 10.2196/medinform.4842)

Demissei, B. G., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Davison, B., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., Cotter, G. (2016) Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. International Journal of Cardiology, 204, pp. 164-171. (doi: 10.1016/j.ijcard.2015.11.141)

ter Maaten, J. M., Valente, M. A.E., Metra, M., Bruno, N., O’Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., van Veldhuisen, D. J., Hillege, H. L., Damman, K., Voors, A. A. (2016) A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clinical Research in Cardiology, 105, pp. 145-153. (doi: 10.1007/s00392-015-0896-2)

Jones, F. E., Bailey, M. A., Murray, L. S., Lu, Y., McNeilly, S., Schlötzer-Schrehardt, U., Lennon, R., Sado, Y., Brownstein, D. G., Mullins, J. J., Kadler, K. E., Van Agtmael, T. (2016) ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice. Disease Models and Mechanisms, 9, pp. 165-76. (doi: 10.1242/dmm.021741)

Huethorst, E., Krebber, M. M., Fledderus, J. O., Gremmels, H., Xu, Y. J., Pei, J., Verhaar, M. C., Cheng, C. (2016) Lymphatic Vascular Regeneration: The Next Step in Tissue Engineering. Tissue Engineering Part B: Reviews, 22, pp. 1-14. (doi: 10.1089/ten.teb.2015.0231)

Bhandari, S., Ives, N., Brettell, E. A., Valente, M., Cockwell, P., Topham, P. S., Cleland, J. G.F., Khwaja, A., El Nahas, M. (2016) Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology Dialysis Transplantation, 31, pp. 255-261. (doi: 10.1093/ndt/gfv346)

Carrick, D., Haig, C., Rauhalammi, S., Clerfond, G., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M. M., Mahrous, A., Welsh, P., Sattar, N., Ford, I., Oldroyd, K., Radjenovic, A., Berry, C. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.115.002834)

Watt, J., Kennedy, S., Ahmed, N., Hayhurst, J., McClure, J. D., Berry, C., Wadsworth, R. M., Oldroyd, K. G. (2016) The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD. Open Heart, 3, (doi: 10.1136/openhrt-2015-000342)

Mangion, K., Gao, H., Radjenovic, A., Luo, X., Haig, C., Berry, C. (2016) Pixel-tracking derived strain using the GlasgowHeart Method. Journal of Cardiovascular Magnetic Resonance, 18, (doi: 10.1186/1532-429X-18-S1-P9)

Bruno, N., ter Maaten, J. M., Ovchinnikova, E. S., Vegter, E. L., Valente, M. A.E., van der Meer, P., de Boer, R. A., van der Harst, P., Schmitter, D., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Pinto, Y. M., van Veldhuisen, D. J., Hillege, H. L., Berezikov, E., Voors, A. A. (2016) MicroRNAs relate to early worsening of renal function in patients with acute heart failure. International Journal of Cardiology, 203, pp. 564-569. (doi: 10.1016/j.ijcard.2015.10.217)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P., Clark, A. L., Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi: 10.1016/j.ijcard.2015.09.076)

Ahmed, N., Layland, J., Carrick, D., Petrie, M. C., McEntegart, M., Eteiba, H., Hood, S., Lindsay, M., Watkins, S., Davie, A., Mahrous, A., Carberry, J., Teng, V., McConnachie, A., Curzen, N., Oldroyd, K. G., Berry, C. (2016) Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. International Journal of Cardiology, 202, pp. 305-310. (doi: 10.1016/j.ijcard.2015.09.014)

Small, H. Y., Morgan, H., Beattie, E., Griffin, S., Indahl, M., Delles, C., Graham, D. (2016) Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. Placenta, 37, pp. 34-44. (doi: 10.1016/j.placenta.2015.10.022)

Zile, M. R., Jhund, P., Baicu, C. F., Claggett, B. L., Pieske, B., Voors, A. A., Prescott, M. F., Shi, V., Lefkowitz, M., McMurray, J., Solomon, S. D. (2016) Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction. Circulation: Heart Failure, 9, (doi: 10.1161/circheartfailure.115.002551)

Kristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V., Packer, M. (2016) Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002560)

Jenkins, P., Sng, S., Brooksbank, K., Brooksbank, A.J. (2016) Socioeconomic deprivation and age are barriers to the online collection of patient reported outcome measures in orthopaedic patients. Annals of the Royal College of Surgeons of England, 98, pp. 40-44. (doi: 10.1308/rcsann.2016.0007)

Cowie, M. R., Bax, J., Bruining, N., Cleland, J. G.F., Koehler, F., Malik, M., Pinto, F., van der Velde, E., Vardas, P. (2016) e-Health: a position statement of the European Society of Cardiology. European Heart Journal, 37, pp. 63-66. (doi: 10.1093/eurheartj/ehv416)

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G.F., Coats, A. J.S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M.C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., McMurray, J. J.V., Petrie, M. C. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37, pp. 2129-2200. (doi: 10.1093/eurheartj/ehw128)

Colman, M. A., Sarathy, P. P., MacQuiaide, N., Workman, A. J. (2016) A new model of the human atrial myocyte with variable T-tubule organization for the study of atrial fibrillation. Computing in Cardiology, 43, pp. 221-224. (doi: 10.23919/CIC.2016.7868719)

Boulberdaa, M., Scott, E., Ballantyne, M., Garcia, R., Descamps, B., Angelini, G. D., Brittan, M., Hunter, A., McBride, M., McClure, J., Miano, J. M., Emanueli, C., Mills, N. L., Mountford, J. C., Baker, A. H. (2016) A role for the long non-coding RNA SENCR in commitment and function of endothelial cells. Molecular Therapy, 24, pp. 978-990. (doi: 10.1038/mt.2016.41)

Platz, E., Lewis, E. F., Uno, H., Peck, J., Pivetta, E., Merz, A. A., Hempel, D., Wilson, C., Frasure, S. E., Jhund, P. S., Cheng, S., Solomon, S. D. (2016) Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. European Heart Journal, 37, pp. 1244-1251. (doi: 10.1093/eurheartj/ehv745)

Stirrat, C. t., Alam, S. R., MacGillivray, T. J., Gray, C. D., Forsythe, R., Dweck, M. R., Payne, J. R., Prasad, S. K., Petrie, M. C., Gardner, R. S., Mirsadraee, S., Henriksen, P. A., Newby, D. E., Semple, S. I.K. (2016) Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. Journal of Cardiovascular Magnetic Resonance, 18, (doi: 10.1186/s12968-016-0261-2)

McCallum, J. E., Mackenzie, A. E., Divorty, N., Clarke, C., Delles, C., Milligan, G., Nicklin, S. A. (2016) G protein-coupled receptor 35 mediates human saphenous vein vascular smooth muscle cell migration and endothelial cell proliferation. Journal of Vascular Research, 52, pp. 383-395. (doi: 10.1159/000444754)

Kristensen, S. L. et al. (2016) Geographic variations in the PARADIGM-HF heart failure trial. European Heart Journal, 37, pp. 3167-3174. (doi: 10.1093/eurheartj/ehw226)

Corcoran, D., Berry, C. (2016) How to measure myocardial infarct size by cardiac magnetic resonance imaging. Heart and Metabolism, 70, pp. 14-18.

Mangion, K., Carrick, D., Hennigan, B. W., Payne, A. R., McClure, J., Mason, M., Das, R., Wilson, R., Edwards, R. J., Petrie, M. C., McEntegart, M., Eteiba, H., Oldroyd, K. G., Berry, C. (2016) Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention. Heart, 102, pp. 1980-1987. (doi: 10.1136/heartjnl-2015-308660)

Carrick, D., Haig, C., Watkins, S., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M. M., Davie, A., Mahrous, A., Mordi, I., Rauhalammi, S., Sattar, N., Welsh, P., Radjenovic, A., Ford, I., Oldroyd, K., Berry, C. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9, (doi: 10.1161/CIRCIMAGING.115.004148)

Mangion, K., Corcoran, D., Carrick, D., Berry, C. (2016) New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction. Expert Review of Cardiovascular Therapy, 14, pp. 843-854. (doi: 10.1586/14779072.2016.1173544)

Fuller, W., Reilly, L., Hilgemann, D. W. (2016) S-palmitoylation and the regulation of NCX1. Channels, 10, pp. 75-77. (doi: 10.1080/19336950.2015.1099329)

Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., Anker, S. D., Sattar, N., Petrie, M. C., Gardner, R. S., McMurray, J. J. V. (2016) The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. European Journal of Heart Failure, 18, pp. 1491-1498. (doi: 10.1002/ejhf.543)

Emdin, C. A., Conrad, N., Kiran, A., Salimi-Khorshidi, G., Woodward, M., Anderson, S. G., Mohseni, H., Dargie, H. J., Hardman, S. M.C., McDonagh, T., McMurray, J. J.V., Cleland, J. G.F., Rahimi, K. (2016) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart, 103, pp. 55-62. (doi: 10.1136/heartjnl-2016-309706)

Cleland, J. G.F., Mareev, Y. (2015) CRT for heart failure and ESRD: more trials or more thought needed? Journal of the American College of Cardiology, 66, pp. 2630-2632. (doi: 10.1016/j.jacc.2015.10.022)

Berry, C., Corcoran, D., Hennigan, B., Watkins, S., Layland, J., Oldroyd, K. G. (2015) Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments. European Heart Journal, 36, pp. 3155-3164. (doi: 10.1093/eurheartj/ehv206)

Nam, J., Briggs, A., Layland, J., Oldroyd, K. G., Curzen, N., Sood, A., Balachandran, K., Das, R., Junejo, S., Eteiba, H., Petrie, M. C., Lindsay, M., Watkins, S., Corbett, S., O'Rourke, B., O'Donnell, A., Stewart, A., Hannah, A., McConnachie, A., Henderson, R., Berry, C. (2015) Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods. Cost Effectiveness and Resource Allocation, 2015, (doi: 10.1186/s12962-015-0045-9)

Gao, H., Li, W.G., Cai, L., Berry, C., Luo, X.Y. (2015) Parameter estimation in a Holzapfel–Ogden law for healthy myocardium. Journal of Engineering Mathematics, 95, pp. 231-248. (doi: 10.1007/s10665-014-9740-3)

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., Broedl, U. C., Inzucchi, S. E., EMPA-REG OUTCOME Investigators, (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373, pp. 2117-2128. (doi: 10.1056/NEJMoa1504720)

Layland, J., Nerlekar, N., Palmer, S., Berry, C., Oldroyd, K. (2015) Invasive assessment of the coronary microcirculation in the catheter laboratory. International Journal of Cardiology, 199, pp. 141-149. (doi: 10.1016/j.ijcard.2015.05.190)

Simpson, J., Jhund, P. S., Silva Cardoso, J., Martinez, F., Mosterd, A., Ramires, F., Rizkala, A. R., Senni, M., Squire, I., Gong, J., Lefkowitz, M. P., Shi, V. C., Desai, A. S., Rouleau, J. L., Swedberg, K., Zile, M. R., McMurray, J. J.V., Packer, M., Solomon, S. D. (2015) Comparing LCZ696 with Enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores. Journal of the American College of Cardiology, 66, pp. 2059-2071. (doi: 10.1016/j.jacc.2015.08.878)

Jolicœur, E. M., Dunning, A., Castelvecchio, S., Dabrowski, R., Waclawiw, M. A., Petrie, M. C., Stewart, R., Jhund, P. S., Desvigne-Nickens, P., Panza, J. A., Bonow, R. O., Sun, B., San, T. R., Al-Khalidi, H. R., Rouleau, J. L., Velazquez, E. J., Cleland, J. G.F. (2015) Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 66, pp. 2092-2100. (doi: 10.1016/j.jacc.2015.08.882)

Aitken, E., Kerr, D., Geddes, C., Berry, C., Kingsmore, D. (2015) Cardiovascular changes occurring with occlusion of a mature arteriovenous fistula. Journal of Vascular Access, 16, pp. 459-466. (doi: 10.5301/jva.5000336)

Simpson, J., Castagno, D., Doughty, R. N., Poppe, K. K., Earle, N., Squire, I., Richards, M., Andersson, B., Ezekowitz, J. A., Komajda, M., Petrie, M. C., McAlister, F. A., Gamble, G. D., Whalley, G. A., McMurray, J. J.V. (2015) Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis. European Journal of Heart Failure, 17, pp. 1182-1191. (doi: 10.1002/ejhf.346)

Reilly, L., Howie, J., Wypijewski, K., Ashford, M. L. J., Hilgemann, D. W., Fuller, W. (2015) Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling. FASEB Journal, 29, pp. 4532-4543. (doi: 10.1096/fj.15-276493)

Pellicori, P., Joseph, A. C., Zhang, J., Lukaschuk, E., Sherwi, N., Bourantas, C. V., Loh, H., Clark, A. L., Cleland, J. G.F. (2015) The relationship of QRS morphology with cardiac structure and function in patients with heart failure. Clinical Research in Cardiology, 104, pp. 935-945. (doi: 10.1007/s00392-015-0861-0)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., Cleland, J. G.F. (2015) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews, 2015, (doi: 10.1002/14651858.CD007228.pub3)

Deng, L., Blanco Lopez, F. J., Stevens, H., Lu, R., Caudrillier, A., McBride, M., McClure, J. D., Grant, J., Thomas, M., Frid, M., Stenmark, K., White, K., Seto, A. G., Morrell, N. W., Bradshaw, A. C., MacLean, M. R., Baker, A. H. (2015) MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circulation Research, 117, pp. 870-883. (doi: 10.1161/CIRCRESAHA.115.306806)

Jhund, P., Fu, M., Bayram, E., Chen, C.-H., Negrusz-Kawecka, M., Rosenthal, A., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V., Packer, M. (2015) Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. European Heart Journal, 36, pp. 2576-2584. (doi: 10.1093/eurheartj/ehv330)

Farag, M., Mabote, T., Shoaib, A., Zhang, J., Nabhan, A. F., Clark, A. L., Cleland, J. G. (2015) Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systematic review. International Journal of Cardiology, 196, pp. 61-69. (doi: 10.1016/j.ijcard.2015.05.160)

Mareev, Y., Cleland, J. G.F. (2015) Should β-blockers be used in patients with heart failure and atrial fibrillation? Clinical Therapeutics, 37, pp. 2215-2224. (doi: 10.1016/j.clinthera.2015.08.017)

Shadman, R., Poole, J. E., Dardas, T. F., Mozaffarian, D., Cleland, J. G.F., Swedberg, K., Maggioni, A. P., Anand, I. S., Carson, P. E., Miller, A. B., Levy, W. C. (2015) A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm, 12, pp. 2069-2077. (doi: 10.1016/j.hrthm.2015.06.039)

Butcher, C., Mareev, Y., Markides, V., Mason, M., Wong, T., Cleland, J.G.F. (2015) Cardiac resynchronization therapy update: evolving indications, expanding benefit? Current Cardiology Reports, 17, (doi: 10.1007/s11886-015-0641-5)

Akehurst, C., Small, H., Sharafetdinova, L., Forrest, R., Beattie, W., Brown, C. E., Robinson, S. W., McClure, J. D., Work, L. M., Carty, D. M., McBride, M. W., Freeman, D. J., Delles, C. (2015) Differential expression of microRNA-206 and its target genes in pre-eclampsia. Journal of Hypertension, 33, pp. 2068-2074. (doi: 10.1097/HJH.0000000000000656)

Frankenstein, L., Fröhlich, H., Cleland, J. G.F. (2015) Multidisciplinary approach for patients hospitalized with heart failure. Revista Española de Cardiología (English Edition), 68, pp. 885-891. (doi: 10.1016/j.rec.2015.05.008)

Zoccarato, A. et al. (2015) Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2. Circulation Research, 117, pp. 707-719. (doi: 10.1161/CIRCRESAHA.114.305892)

Jhund, P., McMurray, J. J.V., Chaturvedi, N., Brunel, P., Desai, A. S., Finn, P. V., Haffner, S. M., Solomon, S. D., Weinrauch, L. A., Claggett, B. L., Pfeffer, M. A. (2015) Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. European Heart Journal, 36, pp. 2463-2469. (doi: 10.1093/eurheartj/ehv295)

Cleland, J. G.F., Freemantle, N. (2015) QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion? Heart, 101, pp. 1441-1443. (doi: 10.1136/heartjnl-2015-307553)

Corcoran, D., Grant, P., Berry, C. (2015) Risk stratification in non-ST elevation acute coronary syndromes: risk scores, biomarkers and clinical judgment. International Journal of Cardiology: Heart and Vasculature, 8, pp. 131-137. (doi: 10.1016/j.ijcha.2015.06.009)

Platz, E., Jhund, P. S., Campbell, R. T., McMurray, J. (2015) Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review. European Journal of Heart Failure, 17, pp. 906-916. (doi: 10.1002/ejhf.321)

Fisher, M., Petrie, M., Ambery, P., Donaldson, J., McMurray, J. J.V., Ye, J. (2015) Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis. Lancet Diabetes and Endocrinology, 3, pp. 697-703. (doi: 10.1016/s2213-8587(15)00233-8)

Pellicori, P., Clark, A. L. (2015) Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure. European Journal of Heart Failure, 17, pp. 979-983. (doi: 10.1002/ejhf.340)

Damy, T., Hobkirk, J., Walters, M., Ciobanu, A., Rigby, A. S., Kallvikbacka-Bennett, A., Guellich, A., Dubois-Randé, J.-L., Hittinger, L., Clark, A. L., Cleland, J. G.F. (2015) Development of a human model for the study of effects of hypoxia, exercise, and sildenafil on cardiac and vascular function in chronic heart failure. Journal of Cardiovascular Pharmacology, 66, pp. 229-238. (doi: 10.1097/FJC.0000000000000262)

Campbell, R. T., Petrie, C. J., Payne, A. R., McEntegart, M. (2015) Elderly woman presenting after a collapse. Annals of Emergency Medicine, 66, pp. 338-345. (doi: 10.1016/j.annemergmed.2014.10.017)

Dierckx, R., Cleland, J. G.F., Pellicori, P., Zhang, J., Goode, K., Putzu, P., Boyalla, V., Clark, A. L. (2015) If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare, 21, pp. 331-339. (doi: 10.1177/1357633X15574947)

Eykyn, T. R., Aksentijević, D., Aughton, K. L., Southworth, R., Fuller, W., Shattock, M. J. (2015) Multiple quantum filtered 23Na NMR in the Langendorff perfused mouse heart: Ratio of triple/double quantum filtered signals correlates with [Na]i. Journal of Molecular and Cellular Cardiology, 86, pp. 95-101. (doi: 10.1016/j.yjmcc.2015.07.009)

Mordi, I., Radjenovic, A., Stanton, T., Gardner, R., McPhaden, A., Carrick, D., Berry, C., Tzemos, N. (2015) Prevalence and prognostic significance of lipomatous metaplasia in poatients with prior myocardial infarction. JACC: Cardiovascular Imaging, 8, pp. 1111-1112. (doi: 10.1016/j.jcmg.2014.07.024)

Stut, W., Deighan, C., Cleland, J. G., Jaarsma, T. (2015) Adherence to self-care in patients with heart failure in the HeartCycle study. Patient Preference and Adherence, 9, pp. 1195-1206. (doi: 10.2147/PPA.S88482)

McComb, C., Carrick, D., McClure, J. D., Woodward, R., Radjenovic, A., Foster, J. E., Berry, C. (2015) Assessment of the relationships between myocardial contractility and infarct tissue revealed by serial magnetic resonance imaging in patients with acute myocardial infarction. International Journal of Cardiovascular Imaging, 31, pp. 1201-1209. (doi: 10.1007/s10554-015-0678-y)

Jhund, P. S., Anand, I. S., Komajda, M., Claggett, B. L., McKelvie, R. S., Zile, M. R., Carson, P. E., McMurray, J. J.V. (2015) Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study. European Journal of Heart Failure, 17, pp. 809-817. (doi: 10.1002/ejhf.274)

Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., McInnes, I. B., Sattar, N., Petrie, M. C., Gardner, R. S., McMurray, J. J.V. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, 3, pp. 618-625. (doi: 10.1016/j.jchf.2015.03.014)

Blyth, M., Anthony, I., Francq, B., Brooksbank, K., Downie, P., Powell, A., Jones, B., MacLean, A., McConnachie, A., Norrie, J. (2015) Diagnostic accuracy of the Thessaly test, standardised clinical history and other clinical examination tests (Apley's, McMurray's and joint line tenderness) for meniscal tears in comparison with magnetic resonance imaging diagnosis. Health Technology Assessment, 19, pp. 1-62. (doi: 10.3310/hta19620)

Rush, C. J., Campbell, R. T., Jhund, P. S., Connolly, E. C., Preiss, D., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) Falling cardiovascular mortality in heart failure with reduced ejection fraction and implications for clinical trials. JACC: Heart Failure, 3, pp. 603-614. (doi: 10.1016/j.jchf.2015.03.013)

Menni, C. et al. (2015) Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension, 66, pp. 422-429. (doi: 10.1161/HYPERTENSIONAHA.115.05544)

Cleland, J. G.F., Mareev, Y., Linde, C. (2015) Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT? European Heart Journal, 36, pp. 1948-1951. (doi: 10.1093/eurheartj/ehv264)

Askevold, E. T., Gullestad, L., Nymo, S., Kjekshus, J., Yndestad, A., Latini, R., Cleland, J. G.F., McMurray, J. J.V., Aukrust, P., Ueland, T. (2015) Secreted frizzled related protein 3 in chronic heart failure: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA) PLoS ONE, 10, (doi: 10.1371/journal.pone.0133970)

Garg, S., Anderson, S.G., Oldroyd, K., Berry, C., Emdin, C.A., Peters, S.A.E., West, N.E.J., Kelly, D., Balachandran, K., McDonald, J., Singh, R., Devadathan, S., Redwood, S., Ludman, P.F., Rahimi, K., Woodward, M. (2015) Outcomes of percutaneous coronary intervention performed at offsite versus onsite surgical centers in the United Kingdom. Journal of the American College of Cardiology, 66, pp. 363-372. (doi: 10.1016/j.jacc.2015.05.052)

Raphael, C. E., Finegold, J. A., Barron, A. J., Whinnett, Z. I., Mayet, J., Linde, C., Cleland, J. G.F., Levy, W. C., Francis, D. P. (2015) The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most? European Heart Journal, 36, pp. 1676-1688. (doi: 10.1093/eurheartj/ehv102)

Mckinney, C.A., Kennedy, S., Baillie, G.S., Milligan, G., Nicklin, S.A. (2015) Angiotensin-(1-7) and angiotensin-(1-9) inhibit vascular smooth muscle cell growth and migration in vitro and vascular remodelling in vivo. Atherosclerosis, 241, pp. e44. (doi: 10.1016/j.atherosclerosis.2015.04.158)

MacDonald, M. R., She, L., Doenst, T., Binkley, P. F., Rouleau, J. L., Tan, R.-S., Lee, K. L., Miller, A. B., Sopko, G., Szalewska, D., Waclawiw, M. A., Dabrowski, R., Castelvecchio, S., Adlbrecht, C., Michler, R. E., Oh, J. K., Velazquez, E. J., Petrie, M. C. (2015) Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. European Journal of Heart Failure, 17, pp. 725-734. (doi: 10.1002/ejhf.288)

Mentz, R. J., Metra, M., Cotter, G., Milo, O., McKendry, C., Chiswell, K., Davison, B. A., Cleland, J. G.F., Bloomfield, D. M., Dittrich, H. C., Fiuzat, M., Ponikowski, P., Givertz, M. M., Voors, A. A., Teerlink, J. R., O'Connor, C. M. (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. European Journal of Heart Failure, 17, pp. 697-706. (doi: 10.1002/ejhf.308)

Rog-Zielinska, E.A., Craig, M.-A., Manning, J.R., Richardson, R.V., Gowans, G.J., Dunbar, D.R., Gharbi, K., Kenyon, C.J., Holmes, M.C., Hardie, D.G., Smith, G.L., Chapman, K.E. (2015) Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1α. Cell Death and Differentiation, 22, pp. 1106-1116. (doi: 10.1038/cdd.2014.181)

Ferrari, R., Böhm, M., Cleland, J. G.F., Paulus, W. J.S., Pieske, B., Rapezzi, C., Tavazzi, L. (2015) Heart failure with preserved ejection fraction: uncertainties and dilemmas. European Journal of Heart Failure, 17, pp. 665-671. (doi: 10.1002/ejhf.304)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Lindsay, M., Watkins, S., Hood, S., Davie, A., Marous, A., Sattar, N., Welsh, P., Tzemos, N., Radjenovic, A., Ford, I., Oldroyd, K., Berry, C. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8, pp. 779-789. (doi: 10.1016/j.jcmg.2015.03.007)

Pellicori, P., Kallvikbacka-Bennett, A., Dierckx, R., Zhang, J., Putzu, P., Cuthbert, J., Boyalla, V., Shoaib, A., Clark, A. L., Cleland, J. G.F. (2015) Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure. Heart, 101, pp. 1149-1158. (doi: 10.1136/heartjnl-2015-307558)

Zannad, F., Greenberg, B., Cleland, J. G.F., Gheorghiade, M., van Veldhuisen, D. J., Mehra, M. R., Anker, S. D., Byra, W. M., Fu, M., Mills, R. M. (2015) Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. European Journal of Heart Failure, 17, pp. 735-742. (doi: 10.1002/ejhf.266)

Johnson, N.P., Johnson, D.T., Kirkeeide, R.L., Berry, C., De Bruyne, B., Fearon, W.F., Oldroyd, K.G., Pijls, N.H.J., Gould, K.L. (2015) Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. JACC: Cardiovascular Interventions, 8, pp. 1018-1027. (doi: 10.1016/j.jcin.2015.01.039)

Petrie, M.C., Boyle, J.G., McKay, G.A. (2015) Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base. Diabetic Medicine, 32, pp. 981-982. (doi: 10.1111/dme.12709)

Hu, D. et al. (2015) Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors. Immunity, 42, pp. 1100-1115. (doi: 10.1016/j.immuni.2015.05.015)

McDonald, R. A., Halliday, C. A., Miller, A. M., Diver, L. A., Dakin, R. S., Montgomery, J., McBride, M. W., Kennedy, S., McClure, J. D., Robertson, K. E., Douglas, G., Channon, K. M., Oldroyd, K., Baker, A. H. (2015) Reducing in-stent restenosis therapeutic manipulation of miRNA in vascular remodeling and inflammation. Journal of the American College of Cardiology, 65, pp. 2314-2327. (doi: 10.1016/j.jacc.2015.03.549)

McArthur, L., Chilton, L., Smith, G. L., Nicklin, S. A. (2015) Electrical consequences of cardiac myocyte: fibroblast coupling. Biochemical Society Transactions, 43, pp. 513-518. (doi: 10.1042/BST20150035)

Al Halabi, S., Qintar, M., Hussein, A., Alraies, M. C., Jones, D. G., Wong, T., MacDonald, M. R., Petrie, M. C., Cantillon, D., Tarakji, K. G., Kanj, M., Bhargava, M., Varma, N., Baranowski, B., Wilkoff, B. L., Wazni, O., Callahan, T., Saliba, W., Chung, M. K. (2015) Catheter ablation for atrial fibrillation in heart failure patients. JACC: Clinical Electrophysiology, 1, pp. 200-209. (doi: 10.1016/j.jacep.2015.02.018)

Inglis, S. C., Conway, A., Cleland, J. G.F., Clark, R. A. (2015) Is age a factor in the success or failure of remote monitoring in heart failure? Telemonitoring and structured telephone support in elderly heart failure patients. European Journal of Cardiovascular Nursing, 14, pp. 248-255. (doi: 10.1177/1474515114530611)

Goncalves, A., Jhund, P.S., Claggett, B., Shah, A.M., Konety, S., Butler, K., Kitzman, D.W., Rosamond, W., Fuchs, F.D., Solomon, S.D. (2015) Relationship between alcohol consumption and cardiac structure and function in the elderly: the atherosclerosis tisk in communities study. Circulation: Cardiovascular Imaging, 8, (doi: 10.1161/circimaging.114.002846)

Kristensen, S. L., Jhund, P. S., Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Cleland, J. G.F., Carson, P. E., McMurray, J. J.V. (2015) Relative importance of history of heart failure hospitalization and N-terminal pro–B-type natriuretic peptide level as predictors of outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 3, pp. 478-486. (doi: 10.1016/j.jchf.2015.01.014)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, 36, pp. 1536-1546. (doi: 10.1093/eurheartj/ehv072)

Dalzell, J. R., Rocchiccioli, J. P., Weir, R. A.P., Jackson, C. E., Padmanabhan, N., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) The emerging potential of the apelin-APJ system in heart failure. Journal of Cardiac Failure, 21, pp. 489-498. (doi: 10.1016/j.cardfail.2015.03.007)

Dakin, R. S., Parker, A. L., Delles, C., Nicklin, S. A., Baker, A. H. (2015) Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector. Human Gene Therapy, 26, pp. 312-319. (doi: 10.1089/hum.2015.019)

Costanzo, P., Cleland, J. G.F., Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J., Atkin, S. L. (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of Internal Medicine, 162, pp. 610-618. (doi: 10.7326/M14-1551)

McCarroll, C. S., Rossor, C. L., Morrison, L. R., Morrison, L. J., Loughrey, C. M. (2015) A pre-clinical animal model of Trypanosoma brucei infection demonstrating cardiac dysfunction. PLoS Neglected Tropical Diseases, 9, (doi: 10.1371/journal.pntd.0003811)

Kukulski, T., She, L., Racine, N., Gradinac, S., Panza, J. A., Velazquez, E. J., Chan, K., Petrie, M. C., Lee, K. L., Pellikka, P. A., Romanov, A., Biernat, J., Rouleau, J. L., Batlle, C., Rogowski, J., Ferrazzi, P., Zembala, M., Oh, J. K. (2015) Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. Journal of Thoracic and Cardiovascular Surgery, 149, pp. 1312-1321. (doi: 10.1016/j.jtcvs.2014.09.117)

Filippatos, G., Khan, S. S., Ambrosy, A. P., Cleland, J. G.F., Collins, S. P., Lam, C. S.P., Angermann, C. E., Ertl, G., Dahlström, U., Hu, D., Dickstein, K., Perrone, S. V., Ghadanfar, M., Bermann, G., Noe, A., Schweizer, A., Maier, T., Gheorghiade, M. (2015) International REgistry to assess medical practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. European Journal of Heart Failure, 17, pp. 527-533. (doi: 10.1002/ejhf.262)

Nicklin, S. A., Griesenbach, U., Baker, A. H. (2015) Special focus issue on the annual meeting of the british society for gene and cell therapy. Human Gene Therapy, 26, pp. 247-248. (doi: 10.1089/hum.2015.2500)

Davison, B. A., Metra, M., Cotter, G., Massie, B. M., Cleland, J. G.F., Dittrich, H. C., Edwards, C., Filippatos, G., Givertz, M. M., Greenberg, B., Ponikowski, P., Voors, A. A., O’Connor, C. M., Teerlink, J. R. (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC: Heart Failure, 3, pp. 395-403. (doi: 10.1016/j.jchf.2015.01.007)

Smith, G. L., MacQuaide, N. (2015) The direct actions of flecainide on the human cardiac ryanodine receptor: keeping open the debate on the mechanism of action of local anesthetics in CPVT. Circulation Research, 116, pp. 1284-1286. (doi: 10.1161/CIRCRESAHA.115.306298)

Goncalves, A., Claggett, B., Jhund, P. S., Rosamond, W., Deswal, A., Aguilar, D., Shah, A. M., Cheng, S., Solomon, S. D. (2015) Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. European Heart Journal, 36, pp. 939-945. (doi: 10.1093/eurheartj/ehu514)

Feinstein, M. J., Jhund, P., Kang, J., Ning, H., Maggioni, A., Wikstrand, J., Kjekshus, J., Tavazzi, L., McMurray, J., Lloyd-Jones, D. M. (2015) Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF. European Journal of Heart Failure, 17, pp. 434-441. (doi: 10.1002/ejhf.247)

Abdul-Rahim, A. H., Perez, A.-C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., Wikstrand, J., Kjekshus, J., Lip, G. Y.H., Maggioni, A. P., Tavazzi, L., Lees, K. R., McMurray, J. (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the controlled rosuvastatin in multinational trial heart failure (corona) and the gruppo italiano per lo studio della sopravvivenza nell'insufficienza cardiaca-heart failure (gissi-hf) trials. Circulation, 131, pp. 1486-1494. (doi: 10.1161/CIRCULATIONAHA.114.013760)

Cleland, J. G.F., Butcher, C. (2015) When is it appropriate to withdraw cardiac resynchronization therapy? Guesses and evidence. JACC: Heart Failure, 3, pp. 337-339. (doi: 10.1016/j.jchf.2015.01.003)

Pellicori, P., Zhang, J., Lukaschuk, E., Joseph, A. C., Bourantas, C. V., Loh, H., Bragadeesh, T., Clark, A. L., Cleland, J. G.F. (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. European Heart Journal, 36, pp. 733-742. (doi: 10.1093/eurheartj/ehu405)

Vazir, A., Claggett, B., Jhund, P., Castagno, D., Skali, H., Yusuf, S., Swedberg, K., Granger, C.B., McMurray, J.J.V., Pfeffer, M. A., Solomon, S.D. (2015) Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. European Heart Journal, 36, pp. 669-675. (doi: 10.1093/eurheartj/ehu401)

Rannikmäe, K. et al. (2015) Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology, 84, pp. 918-926. (doi: 10.1212/WNL.0000000000001309)

Jankowska, E. A., Wojtas, K., Kasztura, M., Mazur, G., Butrym, A., Kalicinska, E., Rybinska, I., Skiba, J., von Haehling, S., Doehner, W., Anker, S. D., Banasiak, W., Cleland, J. G.F., Ponikowski, P. (2015) Bone marrow iron depletion is common in patients with coronary artery disease. International Journal of Cardiology, 182, pp. 517-522. (doi: 10.1016/j.ijcard.2014.10.006)

Metra, M., Cotter, G., El-Khorazaty, J., Davison, B. A., Milo, O., Carubelli, V., Bourge, R. C., Cleland, J. G., Jondeau, G., Krum, H., O'Connor, C. M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Rainisio, M., Kobrin, I., McMurray, J. J., Teerlink, J. R. (2015) Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. Journal of Cardiac Failure, 21, pp. 179-88. (doi: 10.1016/j.cardfail.2014.12.012)

Skogstrand, T., Leh, S., McClure, J., Dashti, M., Iversen, B. M., Graham, D., McBride, M., Hultström, M. (2015) Identification of a common molecular pathway in hypertensive renal damage. Journal of Hypertension, 33, pp. 584-596. (doi: 10.1097/HJH.0000000000000395)

Wypijewski, K. J., Tinti, M., Chen, W., Lamont, D., Ashford, M. L. J., Calaghan, S. C., Fuller, W. (2015) Identification of caveolar resident proteins in ventricular myocytes using a quantitative proteomic approach: dynamic changes in caveolar composition following adrenoceptor activation. Molecular and Cellular Proteomics, 14, pp. 596-608. (doi: 10.1074/mcp.M114.038570)

Pellicori, P., Cleland, J. G.F. (2015) Is the epidemic of heart disease really over or just evolving? American Journal of Medicine, 128, pp. e17. (doi: 10.1016/j.amjmed.2014.09.018)

Campbell, R. T., Jackson, C., Wright, A., Gardner, R. S., Ford, I., Davidson, P. M., Denvir, M. A., Hogg, K. J., Johnson, M. J., Petrie, M. C., McMurray, J. J. V. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2, pp. 25-36. (doi: 10.1002/ehf2.12027)

Dierckx, R., Cleland, J. G.F., Parsons, S., Putzu, P., Pellicori, P., Dicken, B., Boyalla, V., Clark, A. L. (2015) Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. JACC: Heart Failure, 3, pp. 224-230. (doi: 10.1016/j.jchf.2014.11.003)

Khand, A. U., Chew, P. G., Douglas, H., Jones, J., Jan, A., Cleland, J.G.F. (2015) The effect of carvedilol on b-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation. Cardiology, 130, pp. 153-158. (doi: 10.1159/000368746)

Pellicori, P., Cleland, J. G.F. (2015) Update on management of heart failure with preserved ejection fraction. Current Opinion in Cardiology, 30, pp. 173-178. (doi: 10.1097/HCO.0000000000000152)

Badar, A. A., Perez-Moreno, A. C., Hawkins, N. M., Brunton, A. P.T., Jhund, P. S., Wong, C. M., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) programme. European Journal of Heart Failure, 17, pp. 196-204. (doi: 10.1002/ejhf.221)

Kristensen, S. L., Jhund, P. S., Køber, L., Preiss, D., Kjekshus, J., McKelvie, R. S., Zile, M. R., Anand, I. S., Wikstrand, J. G.F., Wedel, H., Komajda, M., Carson, P. E., Cleland, J., McMurray, J. J.V. (2015) Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure, 17, pp. 169-176. (doi: 10.1002/ejhf.211)

Duffy, M., Ma, J., Deng, L., Dakin, R. S., Uil, T., Custers, J., Kelly, S. M., McVey, J. H., Nicklin, S. A., Baker, A. H. (2015) Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. PLoS Pathogens, 11, (doi: 10.1371/journal.ppat.1004673)

Boyalla, V., Putzu, P., Dierckx, R., Clark, A. L., Pellicori, P. (2015) Patent Ductus Arteriosus in older adults: incidental finding or relevant pathology? Journal of the American Geriatrics Society, 63, pp. 409-411. (doi: 10.1111/jgs.13256)

Alday, E. A. P., Colman, M. A., Langley, P., Butters, T. D., Higham, J., Workman, A. J., Hancox, J. C., Zhang, H. (2015) A new algorithm to diagnose atrial ectopic origin from multi lead ECG systems: insights from 3D virtual human atria and torso. PLoS Computational Biology, 11, pp. e1004026. (doi: 10.1371/journal.pcbi.1004026)

Layland, J. et al. (2015) Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. European Heart Journal, 36, pp. 100-111. (doi: 10.1093/eurheartj/ehu338)

Ghouri, I. A., Kelly, A., Burton, F. L., Smith, G. L., Kemi, O. J. (2015) 2-photon excitation fluorescence microscopy enables deeper high-resolution imaging of voltage and Ca2+in intact mice, rat, and rabbit hearts. Journal of Biophotonics, 8, pp. 112-123. (doi: 10.1002/jbio.201300109)

Metra, M., Mentz, R. J., Chiswell, K., Bloomfield, D. M., Cleland, J. G.F., Cotter, G., Davison, B. A., Dittrich, H. C., Fiuzat, M., Givertz, M. M., Lazzarini, V., Mansoor, G. A., Massie, B. M., Ponikowski, P., Teerlink, J. R., Voors, A. A., O'Connor, C. M. (2015) Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. European Journal of Heart Failure, 17, pp. 109-118. (doi: 10.1002/ejhf.207)

Dickstein, K., Normand, C., Anker, S.D., Auricchio, A., Lundqvist Blomstrom, C., Bogale, N., Cleland, J., Filippatos, G., Gasparini, M., Gitt, A., Hindricks, G., Kuck, K.-H., Ponikowski, P., Stellbrink, C., Ruschitzka, F., Linde, C. (2015) European cardiac resynchronization therapy survey II: rationale and design. Europace, 17, pp. 137-141. (doi: 10.1093/europace/euu312)

Kristensen, S. L. L., Køber, L., Jhund, P. S., Solomon, S. D., Kjekshus, J., McKelvie, R. S., Zile, M. R., Granger, C. B., Wikstrand, J., Komajda, M., Carson, P. E., Pfeffer, M. A., Swedberg, K., Wedel, H., Yusuf, S., McMurray, J. J. V. (2015) International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation, 131, pp. 43-53. (doi: 10.1161/CIRCULATIONAHA.114.012284)

Ripley, D. P., Brown, J., Everett, C. C., Bijsterveld, P., Walker, S., Sculpher, M., McCann, G. P., Berry, C., Plein, S., Greenwood, J. P. (2015) Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): a prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease. American Heart Journal, 169, pp. 17-24.e1. (doi: 10.1016/j.ahj.2014.10.008)

Dierckx, R., Pellicori, P., Cleland, J.G.F., Clark, A.L. (2015) Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews, 20, pp. 107-116. (doi: 10.1007/s10741-014-9449-4)

Layland, J., Rauhalammi, S., Watkins, S., Ahmed, N., McClure, J., Lee, M. M.Y., Carrick, D., O’Donnell, A., Sood, A., Petrie, M. C., Teng Yue May, V., Eteiba, H., Lindsay, M., McEntegart, M., Oldroyd, K. G., Radjenovic, A., Berry, C. (2015) Assessment of fractional flow reserve in patients with recent Non–ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 8, (doi: 10.1161/circinterventions.114.002207)

Pellicori, P., Costanzo, P. (2015) Betabloccanti in pazienti con scompenso cardiaco e fibrillazione atriale = [Betablockers in patients with heart failure and atrial fibrillation] Giornale italiano di cardiologia, 16, pp. 613-616. (doi: 10.1714/2066.22428)

Newby, D. et al. (2015) CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet, 385, pp. 2383-2391. (doi: 10.1016/S0140-6736(15)60291-4)

Badar, A. A., Perez-Moreno, A. C., Hawkins, N. M., Jhund, P. S., Brunton, A. P.T., Anand, I. S., McKelvie, R. S., Komajda, M., Zile, M. R., Carson, P. E., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) Clinical characteristics and outcomes of patients with coronary artery disease and angina. Circulation: Heart Failure, 8, pp. 717-724. (doi: 10.1161/CIRCHEARTFAILURE.114.002024)

Corcoran, D., Berry, C., Oldroyd, K. (2015) Current frontiers in the clinical research of coronary physiology. Interventional Cardiology, 7, pp. 97-106.

Campbell, R. T., Jhund, P. S., Dalzell, J. R., Cannon, J., Mordi, I., Sonecki, P., Tzemos, N. (2015) Diagnosis and resolution of loeffler endocarditis secondary to eosinphilic granulomatosis with polyangiitis demonstrated by cardiac magnetic resonance-t2 mapping. Circulation, 131, pp. 114-117. (doi: 10.1161/CIRCULATIONAHA.114.011291)

Pellicori, P., Kaur, K., Clark, A. L. (2015) Fluid management in patients with chronic heart failure. Cardiac Failure Review, 1, pp. 90-95. (doi: 10.15420/cfr.2015.1.2.90)

Gao, H., Qi, N., Ma, X., Griffith, B. E., Berry, C., Luo, X. (2015) Fluid-structure interaction model of human mitral valve within left ventricle. Springer International Publishing

Divorty, N., Mackenzie, A., Nicklin, S., Milligan, G. (2015) G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease. Frontiers in Pharmacology, 6, (doi: 10.3389/fphar.2015.00041)

Lopez, L. M., Hill, W. D., Harris, S. E., Valdes Hernandez, M., Munoz Maniega, S., Bastin, M. E., Bailey, E., Smith, C., McBride, M., McClure, J., Graham, D., Dominiczak, A., Yang, Q., Fornage, M., Ikram, M. A., Debette, S., Launer, L., Bis, J. C., Schmidt, R., Seshadri, S., Porteous, D. J., Starr, J., Deary, I. J., Wardlaw, J. M. (2015) Genes from a translational analysis support a multifactorial nature of white matter hyperintensities. Stroke, 46, pp. 341-347. (doi: 10.1161/STROKEAHA.114.007649)

Jhund, P. S. (2015) Heart failure management: continuing to fail or signs of success? Cardiovascular Drugs and Therapy, 29, pp. 5-6. (doi: 10.1007/s10557-015-6574-9)

Gao, H., Berry, C., Luo, X. (2015) Image-derived human left ventricular modelling with fluid-structure interaction. Springer International Publishing

Aitken, E., Geddes, C., Thomson, P., Kasthuri, R., Chandramohan, M., Berry, C., Kingsmore, D. (2015) Immediate access arteriovenous grafts versus tunnelled central venous catheters: study protocol for a randomised controlled trial. Trials, 16, (doi: 10.1186/s13063-015-0556-x)

Dalzell, J. R., Cannon, J. A., Simpson, J., Gardner, R. S., Petrie, M. C. (2015) Improving outcomes in peripartum cardiomyopathy. Expert Review of Cardiovascular Therapy, 13, pp. 665-671. (doi: 10.1586/14779072.2015.1040767)

Mangion, K., Carrick, D., Payne, A., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K., Berry, C. (2015) Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-O9)

Souteyrand, G., Amabile, N., Combaret, N., Hammas, S., Prati, F., Berry, C., Pereira, B., Lusson, J.-R., Caussin, C., Motreff, P. (2015) Invasive management without stents in selected acute coronary syndrome patients with a large thrombus burden: a prospective study of optical coherence tomography guided treatment decisions. EuroIntervention, 11, pp. 895-904. (doi: 10.4244/eijy14m07_18)

Hennigan, B., Robertson, K., Berry, C., Oldroyd, K. G. (2015) Is hyperaemia essential for accurate functional assessment of coronary stenosis severity? Interventional Cardiology Review, 10, pp. 72-78. (doi: 10.15420/icr.2015.10.2.72)

Mangion, K., Carrick, D., Payne, A. R., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K. G., Berry, C. (2015) Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-P104)

MacCannell, K.A., Chilton, L., Smith, G.L., Giles, W.R. (2015) Mathematical simulations of sphingosine-1-phosphate actions on mammalian ventricular myofibroblasts and myocytes. Springer

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K., Berry, C. (2015) Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-Q52)

Robertson, K. E., Hennigan, B., Berry, C., Oldroyd, K. G. (2015) Physiological assessment of coronary lesion severity. Coronary Artery Disease, 26, pp. e8-e14. (doi: 10.1097/MCA.0000000000000212)

Carrick, D., Haig, C., Rauhalammi, S. M., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K. G., Berry, C. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-O26)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K., Berry, C. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-O54)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K., Berry, C. (2015) Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 17, pp. O53. (doi: 10.1186/1532-429X-17-S1-O53)

Abdul-Rahim, A. H., Perez, A.-C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., Wikstrand, J., Kjekshus, J., Lip, G. Y.H., Maggioni, A. P., Tavazzi, L., Lees, K. R., McMurray, J. J.V. (2015) Response to Letter Regarding Article, “Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.” Circulation, 132, (doi: 10.1161/CIRCULATIONAHA.115.018395)

Kwok, C. S., Kontopantelis, E., Myint, P. K., Zaman, A., Berry, C., Keavney, B., Nolan, J., Ludman, P. F., de Belder, M. A., Buchan, I., Mamas, M. A. (2015) Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007–12. European Heart Journal, 36, pp. 1618-1628. (doi: 10.1093/eurheartj/ehv113)

Lewsey, J., Ebueku, O., Jhund, P. S., Gillies, M., Chalmers, J. W.T., Redpath, A., Briggs, A., Walters, M., Langhorne, P., Capewell, S., McMurray, J. J.V., MacIntyre, K. (2015) Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005. BMC Neurology, 15, (doi: 10.1186/s12883-014-0257-1)

Badar, A. A., Brunton, A. P.T., Mahmood, A. H., Dobbin, S., Pozzi, A., McMinn, J. F., Sinclair, A. J.E., Gardner, R. S., Petrie, M. C., Curry, P. A., Al-Attar, N. H.K., Pettit, S. J. (2015) The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review. Expert Review of Cardiovascular Therapy, 13, pp. 915-922. (doi: 10.1586/14779072.2015.1067139)